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Abstract 
Bovine genital campylobacteriosis is difficult to identify due to problems with the isolation of its 
causative agent Campylobacter fetus subspecies venerealis. To optimise isolation methods, three 
selective culture and three transport and enrichment media (TEMs) were evaluated using a pure 
C. fetus subsp. venerealis culture, with and without simulated field contamination by Pseudomonas 
aeruginosa. For optimal C. fetus subsp. venerealis isolation and growth, TEMs should be returned 
from the field within 48h of collection and plated within 4h onto Campylobacter selective agar 
plates incubated for 48-72h at 37°C under microaerophilic conditions. Longer transport or TEM 
incubation resulted in overgrowth of P. aeruginosa limiting C. fetus subsp. venerealis recovery.  
In order to establish an isolate collection, the parA real-time PCR assay was used to screen bull 
preputial secretions prior to culturing positive samples. A more sensitive real-time PCR assay was 
designed from the ISCfe1 insertion element and used to assess additional preputial samples, 
compared to the parA real-time assay. A proportion of real-time negative samples was also cultured. 
Two conventional PCR assays, biochemical testing and sequencing of late real-time PCR products 
were applied to cultures. The parA real-time PCR detected 174 positives out of 717 samples with 44 
Campylobacter-like organisms isolated (25.3%). Culture of 94 parA-negative and 40 untested 
samples yielded 9 Campylobacter-like isolates. ParA and ISCfe1 real-time PCR analysis of a further 
266 samples facilitated the isolation of 17 Campylobacter-like cultures from 70 positives (24.3%). 
Fourteen cultures were obtained from either ISCfe1 (8/43; 18.6%) or parA (6/51; 11.8%) negative 
samples. ISCfe1 and parA sequences were obtained from isolates not confirmed by conventional 
methods suggesting that both parA and ISCfe1 may be found in organisms other than C. fetus 
subsp. venerealis. Molecular testing of cultures (n=84) confirmed the presence of these sequences 
in isolates identified as other Campylobacter spp. or Arcobacter-like organisms, while they were 
not always detected in all biochemically confirmed C. fetus subsp. venerealis isolates. The lack of 
specificity of all methods highlights the need for more reliable C. fetus subsp. venerealis-specific 
gene targets. 
The draft genomes of two C. fetus subsp. venerealis biovars aligned to C. fetus subsp. fetus genome 
provided 26 unique C. fetus subsp. venerealis regions. In order to identify new diagnostic targets, 
13 putative conventional and one real-time PCR assays designed from contigs common to both 
C. fetus subsp. venerealis biovars were developed to screen the Campylobacter-like culture 
collection (n=84). Isolates biochemically identified as organisms other than C. fetus subsp. 
venerealis were positive on the new real-time and six conventional PCR assays, indicating that they 
were not suitable subspecies-specific markers. Seven assays detected isolates phenotyped as C. fetus 
subsp. venerealis except for two aerotolerant isolates recognized as C. fetus subsp. venerealis by 
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other published methods. These seven gene targets could be further investigated for real-time PCR 
assay development as in silico BLAST analysis confirmed their conservation in the genomes of five 
of our C. fetus subsp. venerealis isolates. However, further bioinformatics analysis revealed that 
they were found in several C. fetus subsp. fetus strains, underlining that a pan-genomics study 
including multiple C. fetus genomes is needed to identify new C. fetus subsp. venerealis-specific 
core genes. 
Variation in putative virulence, type IV secretion system (T4S) and pathogenicity island (PAI) 
genes observed from the C. fetus subsp. venerealis biovars supported the hypothesis that differences 
in virulence may exist between strains. Nine T4S and PAI conventional PCR assays were used to 
characterize the Campylobacter-like isolate collection (n=84) and other field cultures (n=21). New 
putative virulence (n=11) and PAI (n=4) conventional PCR assays were designed from unique 
C. fetus subsp. venerealis regions, and also assisted in predicting the virulence status of each isolate. 
In silico analysis of seven T4S gene sequences from C. fetus field and reference strains was 
performed to investigate if previously reported amino acid consensus sequences were conserved. A 
range of isolates were positive on different assays, including C. fetus subsp. fetus, other 
Campylobacter spp. and Arcobacter-like organisms, underlining a shared virulence and PAI gene 
content between closely related bacteria. Results contributed to the selection of C. fetus subsp. 
venerealis candidates for testing in a parallel pregnant guinea pig model, but differences in 
virulence between strains in vivo did not correlate with differences in virulence and PAI gene 
profiles. Even though T4S consensus sequences were conserved for six of the seven genes 
examined, observed sequence differences may also influence the amino acid sequence of encoded 
proteins and thus C. fetus virulence in vivo. Whilst the genes assessed here may be involved in 
C. fetus subsp. venerealis virulence, other factors and potential interactions as well as differences in 
expression during animal infection are yet to be examined. 
A pan-genomic study including C. fetus and Campylobacter-like strains isolated here, in correlation 
with further animal and virulence experiments, will contribute to improving diagnostic methods for 
bovine genital campylobacteriosis.  
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CHAPTER 1: GENERAL INTRODUCTION 
 
Bovine genital campylobacteriosis (BGC) is a widespread cattle bacterial disease that is generally 
not confirmed until its causative agent, Campylobacter fetus subspecies venerealis, is established in 
a herd, resulting in lower reproductive performance, infertility or abortion (BonDurant, 2005; Clark, 
1971). BGC can cause important economic impact to beef exporting countries while international 
guidelines require a “certification of disease free status” to export both bulls and semen 
(BonDurant, 2005; Campero, 2000; McCool et al., 1988b; OIE, 2012b; Swai et al., 2005).  
Accurate and reliable detection of the organism is thus crucial to the cattle industry, highlighting the 
need for specific, rapid and sensitive molecular-based diagnostic tests for C. fetus subsp. venerealis 
as culture has long been recognised as difficult and time-consuming (Clark, 1971; Eaglesome and 
Garcia, 1992; Hum et al., 1994a; Lander, 1990a; Monke et al., 2002). This is due to the limited 
survival of C. fetus subsp. venerealis under normal atmospheric conditions and the potential for 
rapid overgrowth of contaminants in clinical samples (Clark, 1971; Clark and Dufty, 1978; Hum et 
al., 1994a; Lander, 1990a). Adoption of microaerophillic conditions, selective culture and transport 
media has enhanced the isolation of this bacterium (Clark and Dufty, 1978; Hum et al., 1994a; 
Lander, 1990b; Lander and Gill, 1985; Monke et al., 2002; OIE, 2012a) while its detection has been 
improved by a probe-based real-time assay (McMillen et al., 2006). 
This latter test was more sensitive than isolation by culture but the high field prevalence reported 
did not always correlate with clinical signs for BGC in animals (McMillen et al., 2006); 
complicating the interpretation of results and questioning the specificity of this assay, as 
veterinarians could not provide advice to producers on the significance of the findings to herd 
fertility. The absence of evidence of disease in bovine herds screened as real-time positive may be 
explained by differences of virulence between C. fetus subsp. venerealis strains (Lew et al., 2007), 
supported by the detection of putative virulence genes from some of C. fetus subsp. venerealis field 
isolates tested (Guo, 2007; Moolhuijzen et al., 2009).  
It is currently unknown whether these virulence factors are plasmid-borne or located on the 
chromosome but recent sequencing of two complete C. fetus subsp. venerealis genomes compared 
to a previously available C. fetus subsp. fetus genome indicated unique regions suitable for further 
assay development (Barrero et al., 2013). The present study thus aims to develop and assess 
molecular protocols for C. fetus subsp. venerealis using comparative genomics and virulence 
studies in order to improve BGC diagnosis.  
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CHAPTER 2: LITERATURE REVIEW 
 
1. Introduction 
1.1. Campylobacter fetus subspecies venerealis 
1.1.1. Taxonomy of the Campylobacter genus 
In 1919, Smith and Taylor described a bacterium isolated from cattle aborted foetuses that 
they subsequently named Vibrio fetus due to its similarity with Vibrio cholerae (Smith, 1918; Smith 
and Taylor, 1919). At the time, the epithet “Vibrio” was used to describe any comma-shaped 
bacterium while “Spirillum” was used to signify spiral-shaped organism (Smith and Taylor, 1919). 
V. fetus appeared to match both these morphologies but because its predominant form during 
multiplication was comma-shaped, “Vibrio” was chosen as the most appropriate genus designation 
(Smith and Taylor, 1919). 
Later research divided V. fetus into two groups: the first included catalase-positive and hydrogen 
disulfide (H2S)-negative isolates, believed to be true V. fetus pathogens and the second group 
contained catalase-negative and H2S-positive organisms, which were supposedly a non-pathogenic, 
unnamed species (Lecce, 1958). However, isolates from both groups exhibited common oxidative 
properties and thus, catalase and H2S production did not provide a clearly delineated separation to 
divide vibrios into broad groups (Lecce, 1958).  
In subsequent years, vibrio-shaped bacteria were classified according to DNA base ratios and Vibrio 
spp. were confined to organisms having a guanidine and cytosine (G+C) content of approximately 
47% (Sebald and Véron, 1963). Vibrio-shaped organisms of veterinary significance, including 
V. fetus, which had a G+C content between 29 and 36%, were grouped into the new genus 
Campylobacter, meaning curved rod in Greek (Sebald and Véron, 1963). Previously described 
V. fetus was named Campylobacter fetus and considered the type species (Sebald and Véron, 1963). 
In 1973, Campylobacter spp. were further characterised according to their biochemical properties, 
dividing the genus into three classes: catalase positive and H2S negative strains, catalase and H2S 
positive strains and catalase negative strains (Véron and Châtelain, 1973). Catalase-positive and 
H2S-negative strains consisted of C. fetus strains, divided into two subspecies: C. fetus subsp. fetus 
and C. fetus subsp. venerealis; catalase and H2S-positive strains included C. coli and C. jejuni, 
while catalase-negative strains comprised of C. sputorum subsp. sputorum and C. sputorum subsp. 
bubulus (Véron and Châtelain, 1973). 
Since its early description, the genus Campylobacter has been under extensive revision assisted by 
improved taxonomic methods and the study of numerous isolates to better classify each species 
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(Bryner and Frank, 1955; Garrity et al., 2005a; Lecce, 1958; On, 1996; Reich et al., 1956; Sebald 
and Véron, 1963; Smith and Taylor, 1919; Véron and Châtelain, 1973). To date, over 16 
Campylobacter spp. have been recognised, grouped into the family Campylobacteraceae, which 
now also includes the genus Arcobacter (Garrity et al., 2005a; On, 1996).  
 
1.1.2. Characteristics of Campylobacter fetus organisms 
C. fetus organisms are slender microaerophillic Gram-negative curved bacteria which 
measure 0.2 to 0.3 µm in width and 0.5 to 5 µm in length (Smith and Taylor 1919; Sebald and 
Véron 1963). They usually possess a single polar hair-like flagellum even if bipolar flagella can be 
observed before cellular division (Smith and Taylor 1919; Sebald and Véron 1963). This flagellum 
allows bacterial cells to be highly motile, exhibited by active corkscrew-like movements (Smith and 
Taylor 1919). 
C. fetus organisms are fastidious slow-growing bacteria and usually, 48 to 72h of incubation are 
needed to observe small, smooth, greyish-white colonies on agar or to obtain slightly cloudy 
bacterial growth below the surface of inoculated broth (Smith and Taylor 1919). C. fetus isolates 
tend to grow well at 25°C and 37°C, but generally cannot tolerate 42°C although some thermo-
tolerant isolates have been reported (Jones et al., 1985; On and Holmes, 1991b; Véron and 
Châtelain, 1973). These bacteria have a restricted respiratory metabolism and are sensitive to 
aerobic and anaerobic conditions, typically requiring an atmosphere of 3 to 5% O2 and 10% CO2 to 
grow (Fletcher and Plastridge, 1964; Kiggins and Plastridge, 1956; Reich et al., 1956; Sebald and 
Véron, 1963; Smith and Taylor, 1919). 
Campylobacter spp. do not ferment or oxidise carbohydrates as no acid or gas production has been 
detected from growing cultural media (Garrity et al., 2005a; Lecce, 1958; Smith and Taylor, 1919). 
They are therefore defined as asaccharolytic (On 1996). C. fetus organisms have poor oxidative 
capability as only formate, lactate, pyruvate, succinate and α-ketoglutarate were reduced by C. fetus 
isolates from a pool of over 30 different substrates usually reduced by most bacteria (Lecce 1958). 
They are thus also described as biochemically non-reactive (On 1996). 
 
1.1.3. Biochemical properties of Campylobacter fetus organisms 
As described earlier (section 1.1.1), C. fetus organisms produce catalase when exposed to 
3% hydrogen peroxide (H2O2) and no H2S production is detected on lead acetate paper when tested 
with Albimi broth (Véron and Châtelain, 1973). However, when broth is enriched with 0.02% 
cysteine-HCl medium, C. fetus subsp. fetus organisms produce H2S while C. fetus subsp. venerealis 
do not (Lecce 1958). This property could have been used as a distinctive feature, but a strain 
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subsequently named C. fetus subsp. venerealis biovar intermedius also produces H2S while its other 
biochemical characteristics resemble C. fetus subsp. venerealis rather than C. fetus subsp. fetus 
(Véron and Châtelain, 1973). Therefore, C. fetus subsp. fetus and C. fetus subsp. venerealis cannot 
be well differentiated based on H2S production only, due to the existence of the C. fetus subsp. 
venerealis bv. intermedius (On, 1996).  
The differentiation of C. fetus subspecies is achieved by comparing their ability to grow in medium 
containing 1% glycine: C. fetus subsp. fetus organisms can tolerate glycine and grow well while 
C. fetus subsp. venerealis bv. venerealis and bv. intermedius bacterial cells do not (Véron and 
Châtelain, 1973). Growth in the presence of 1% glycine is the only recommended biochemical test 
(considered the gold standard) differentiating C. fetus subspecies however, it has been demonstrated 
that glycine tolerance can be acquired by phage transduction and mutation in C. fetus subsp. 
venerealis isolates, suggesting that the glycine tolerance test is not a reliable method to characterise 
C. fetus subspecies (Chang and Ogg, 1971; OIE, 2012a).  
 
1.1.4. Comparison of Campylobacter fetus subspecies 
Due to biochemical, clinical and epidemiological differences, C. fetus is divided into two 
highly related subspecies (Garrity et al., 2005a; Hum et al., 1997; Véron and Châtelain, 1973). 
Accurate subspecies identification is of particular importance in veterinary laboratories as they are 
associated with different diseases (Hum et al., 1997; On and Harrington, 2001). C. fetus subsp. fetus 
has been isolated from the intestinal and genital tracts of cattle and sheep and can cause sporadic 
abortion and occasional embryonic death (Clark, 1971; Garrity et al., 2005a; On, 1996; Skirrow, 
1994). C. fetus subsp. fetus can also be responsible for abortion, bacteraemia, enteritis, endocarditis, 
meningitis and prostate infection in humans (Farrugia et al., 1994; On, 1996; Skirrow, 1994). 
C. fetus subsp. venerealis is found in bovine genital organs and causes BGC, associated with 
abortion and infertility in female cattle (Clark, 1971; Garrity et al., 2005a; Skirrow, 1994; Véron 
and Châtelain, 1973). C. fetus subsp. venerealis has been considered as a C. fetus subsp. fetus-
defective mutant as it is restricted to the bovine genital tract and cannot colonise the cattle intestine 
(Hum et al., 1997; Véron and Châtelain, 1973).  
Currently, discrimination between the two subspecies relies on the ability of C. fetus subsp. fetus to 
tolerate 1% glycine (section 1.1.3); however, with the identification of glycine-tolerant C. fetus 
subsp. venerealis isolates and glycine-sensitive C. fetus subsp. fetus isolates, accurate C. fetus 
subspecies identification is problematic (On and Harrington, 2001; Salama et al., 1992; Vargas et 
al., 2003; Véron and Châtelain, 1973; Wagenaar et al., 2001). 
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1.2. Bovine genital campylobacteriosis (BGC) 
1.2.1. Disease description and consequences 
Bovine sexually transmitted infections are observed in countries with extensive cattle 
rangelands including Africa, Australia, North and South America (BonDurant, 2005; Campero, 
2000; Clark, 1971; Rogers et al., 1972; Swai et al., 2005). BGC, bovine venereal 
campylobacteriosis or vibriosis, caused by C. fetus subsp. venerealis is a notifiable disease listed by 
the World Organisation for Animal Health and as a consequence, is affecting the international trade 
of animals and derived products, including bull semen (BonDurant, 2005; Clark, 1971; Eaglesome 
and Garcia, 1992; OIE, 2012a, 2012b; Schurig et al., 1974). 
BGC is insidious because it usually does not cause noticeable symptoms but inhibits pregnancy 
during early gestation and economic loss is generally perceived before overt disease occurrence 
(BonDurant, 2005). Lowered reproductive performance in rangeland cattle is not always attributed 
to infection as it is often due to poor nutrition or heat stress, C. fetus subsp. venerealis infection is 
thus not often indicated as the first cause of reduced reproductive performance (BonDurant, 2005). 
BGC is suspected when poor reproductive performance is associated with extended periods between 
breeding and calf output, highly variable gestation periods within a herd, lower number of births, 
lower milk production and the introduction of confirmed carrier bulls (BonDurant, 2005). 
Both Australian beef and dairy farms are significantly affected by BGC, which can reduce branding 
rates of infected herds by up to 35%, resulting in notable economic losses, especially in newly 
exposed herds where C. fetus subsp. venerealis infections can decrease gross margins by up to 65% 
(Hum, 2007; Jakovlje and Beattie, 1969; McCool et al., 1988; Rogers et al., 1972). In Africa, South 
and North America, BGC is also linked to low reproduction rates in extensively managed beef cattle 
herds, causing significant economic impacts (BonDurant, 2005; Campero, 2000; Swai et al., 2005). 
 
1.2.2. Infection and immunity 
C. fetus subsp. venerealis organisms are mainly transmitted by bulls, which carry bacteria in 
the fornix and epithelial surfaces of the penis (Vasquez et al., 1983). Infection occurs during natural 
service between infected and uninfected animals but can also happen if females are inseminated 
with contaminated semen; or between bulls, due to contamination of bedding or equipment used for 
semen collection (BonDurant, 2005; Clark, 1971).  
Bulls carry C. fetus subsp. venerealis organisms for extended periods without apparent symptoms 
while females can host the bacteria for two to six months and experience uterine infection, early 
embryonic death and infertility (BonDurant, 2005; Clark, 1971). In heifers, the main infection site 
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of C. fetus subsp. venerealis organisms is localised in the cervix and anterior vagina (Clark et al., 
1969). After infection, the microorganism is progressively eradicated from the uterus but bacteria 
can survive longer in the vagina, even though fertility is re-established (BonDurant, 2005; Schurig 
et al., 1974). This indicates that resistance to disease differs from resistance to vaginal infection and 
implies that clearing of uterine and vaginal infections involves different mechanisms, with vaginal 
infection inhibiting the propagation of organisms in the uterus (Schurig et al., 1974). 
When C. fetus subsp. venerealis cells are inoculated via the cervico-vaginal tract, BGC can be 
induced but when C. fetus subsp. venerealis cells are administered via the intrauterine route, the 
uterus remains free of infection but both vagina and cervix are re-infected within three days 
(Schurig et al., 1974). Natural infection enhances the production of immunoglobulin A (IgA) in 
vaginal mucus which does not kill C. fetus subsp. venerealis organisms but immobilises them, while 
systemic infection initiates the production of immunoglobulin G (IgG) which establishes protective 
immunity (BonDurant, 2005). This protective immunity allows conception and can last up to two 
years (BonDurant, 2005; Clark et al., 1969). 
 
1.2.3. Treatment and control 
When C. fetus subsp. venerealis infections are detected, recommended measures include 
antibiotic treatment and vaccination of individual infected animals, or if C. fetus subsp. venerealis is 
highly prevalent, it is advised to treat and vaccinate the whole herd (BonDurant, 2005; Clark, 1971). 
The use of antibiotics can clear bulls of C. fetus subsp. venerealis but reinfection can occur if 
breeding with C. fetus subsp. venerealis-infected cows (Vasquez et al., 1983). Vaccination is thus 
considered the best control method in terms of prevention and management, leading to the 
development of several vaccines containing dead C. fetus subsp. venerealis organisms such as 
Bioabortogen-H and Repropolivac (San Jorge Bago, Argentina), C. (Vibrio) fetus vaccine 
(Onderstepoort Biological Products Ltd., South Africa), Trichguard (V5L, Fort Dodge, USA), 
Vibrin (Pfizer Animal Health, New York), Vibrio-Lepto-5 (Boehringer Ingelheim Vetmedica, Inc.) 
or Vibrovax (Pfizer Animal Health, Australia; BonDurant, 2005; Clark, 1971). 
If herds are at low risk of exposure to infected animals (no common grazing areas, no shared fence 
with infected animals, no recent introduction of mature bulls), it is appropriate to vaccinate bulls 
only, with the second injection administered before contact with females and annual subsequent 
boosters, in order to avoid C. fetus subsp. venerealis carrier-bull status (BonDurant, 2005). Culling 
of infected bulls, introduction of virgin bulls, isolation of pregnant females and artificial 
insemination are also advised when C. fetus subsp. venerealis is highly prevalent (BonDurant, 
2005). 
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1.2.4. Vaccination and experimental infection 
In an early experiment, bulls infected with C. fetus subsp. venerealis were vaccinated twice 
five weeks apart with a killed C. fetus subsp. venerealis vaccine and within two weeks after the 
second injection, the bulls were negative for C. fetus subsp. venerealis carriage (Clark et al., 1968). 
In another study, 288 bulls free of C. fetus subsp. venerealis infection were tested for preventive 
Vibrin vaccination and during the year following immunisation, none were positive for C. fetus 
subsp. venerealis, while 12.5% of non-vaccinated bulls (n=41) became infected (Bouters et al., 
1973). Some bulls injected only once were reported to be C. fetus subsp. venerealis-positive for a 
short period of time following contact with C. fetus subsp. venerealis-infected females (Bouters et 
al., 1973). 
The recommended method for bull vaccination involves two injections a month apart of a C. fetus 
subsp. venerealis strain or of a C. fetus subsp. fetus strain that has common antigens with C. fetus 
subsp. venerealis, often using an oil adjuvant. Subsequently, vaccination is performed annually, 
immediately preceding the breeding period (OIE, 2012a). Finding that vaccination of bulls with 
adequate adjuvant could clear the prepuce of C. fetus subsp. venerealis infection and enhance the 
clearing of C. fetus subsp. venerealis-infection in females led to a reduction of antibiotic use to clear 
or prevent infection (BonDurant, 2005; Bouters et al., 1973; Bryner et al., 1988; Clark et al., 1968; 
Clark et al., 1977; Corbeil et al., 1974; Flower et al., 1983; Schurig et al., 1975; Vasquez et al., 
1983). In bulls, immunisation is still practised to clear infections but not often as a preventive 
measure despite the fact that the World Organisation for Animal Health recommends bi-annual 
vaccination of bulls in uninfected herds (BonDurant, 2005; OIE, 2012a). 
In females, vaccination also requires two injections, the second being administered just before bull 
exposure to maximise antibody production during the mating period (BonDurant, 2005; OIE, 
2012a). Annual vaccination is subsequently administered, approximately one to three weeks prior to 
bull exposure (BonDurant, 2005; OIE, 2012a). Immunisation induces an IgG response and 
facilitates IgA production after natural exposure (BonDurant, 2005). IgG1 and IgG2 antibodies 
protect females against uterine infection but vaginal infection is still observed following contact 
with C. fetus subsp. venerealis-infected bulls (BonDurant, 2005).  
Some immunisation failure has been reported, probably associated with weak virulence or low 
immunogenicity of the strains used in the vaccine, or possibly related to sub-optimal dosages 
(Bryner et al., 1988; Clark et al., 1977; Cobo et al., 2003; Schurig et al., 1975; Vasquez et al., 
1983). The World Organisation for Animal Health recommends a minimum dose of 40 mg of at 
least four proven immunogenic glycoproteins to ensure adequate immunisation (OIE, 2012a). 
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The most recent vaccination models have been performed in heifers (Cobo et al., 2003; Cobo et al., 
2004). One study found that vaccination with two commercial products (Bioabortogen-H and 
Repropolivac) containing C. fetus subsp. venerealis antigens failed to induce sufficient IgG 
production to induce immunisation and did not protect tested animals (Cobo et al., 2003). A 
subsequent study by the same research team examined the efficiency of another commercial product 
(Trichguard V5L) against an experimental vaccine containing both C. fetus subsp. venerealis and 
Tritrichomonas foetus antigens (Cobo et al., 2004). Vaccination using both preparations enhanced 
the clearing of infection from the genital tract, IgG production against C. fetus subsp. venerealis 
(and T. foetus) and a higher pregnancy rate in tested females, even though the experimental vaccine 
provided better protection, inducing significantly much higher antibody titers (Cobo et al., 2004).  
Guinea pig abortifacient models have effectively been used to study pathogenicity and virulence of 
Campylobacter spp. as well as vaccine efficacy, providing a more cost effective model compared to 
the cattle natural host (Bryner et al., 1988; Bryner et al., 1979; Coid et al., 1987; Corbeil, 1980; 
Taylor and Bryner, 1984). The guinea pig model was found to be adequate when evaluating 
different vaccine doses, strains and adjuvants and indicated that an oil-based adjuvant strongly 
improved immunisation efficacy (BonDurant, 2005; Bryner et al., 1988). It was noted that vaccine 
efficacy in guinea pigs and cattle was well correlated, allowing complete evaluation in ninety days 
instead of a year trial in cattle (Bryner et al., 1988).  
 
2. Diagnostic techniques for C. fetus subsp. venerealis 
2.1. Phenotyping  
2.1.1. Culture and isolation 
C. fetus subsp. venerealis diagnosis is achieved after successful isolation of organisms from 
vaginal and preputial mucus samples, aborted foetuses or placental samples (Hum et al., 1994a; 
OIE, 2012a). To permit international importation of semen or bulls, samples and animals have to be 
proven to be negative for C. fetus subsp. venerealis infection (Monke et al., 2002; OIE, 2012b). To 
enhance semen quality, antibiotics such as gentamicin, lincomycin, spectinomycin and tylosin are 
often included to eliminate C. fetus subsp. venerealis organisms while preputial fluid is commonly 
tested by bacteriological culture (Jones et al., 1985; Monke et al., 2002). To declare a bull C. fetus 
subsp. venerealis-free, four to six negative samples are recommended while a single C. fetus subsp. 
venerealis-positive sample is considered as an indicator of herd infection rather than a single, 
isolated case (Dufty, 1967; Jones et al., 1985).  
In order to manage cattle trade efficiently, C. fetus subsp. venerealis diagnosis needs to be specific, 
sensitive and reliable (Monke et al., 2002). After successful isolation of C. fetus-like organisms, 
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diagnosis is generally confirmed on the basis of biochemical and antimicrobial susceptibility testing 
(OIE, 2012a). The primary goal is to distinguish C. fetus subsp. venerealis bv. venerealis and bv. 
intermedius from C. fetus subsp. fetus strains on the basis of their ability to grow in the presence of 
1% glycine, taking into account the variable antibiotic resistance and biochemical properties of 
C. fetus isolates (Jones et al., 1985; On and Harrington, 2001; Salama et al., 1992). 
The isolation of C. fetus has long been recognised to be difficult due to their sensitive growth 
requirements limiting survival in clinical samples under normal atmospheric conditions, and the 
potential for rapid overgrowth of more robust contaminants (Clark, 1971; Clark and Dufty, 1978; 
Dufty, 1967; Eaglesome and Garcia, 1992; Hum et al., 1994a; Lander, 1990a; Monke et al., 2002; 
OIE, 2012a). Therefore, when preputial bull samples are collected, limited exposure to the 
surrounding atmosphere, due to the microaerophillic nature of C. fetus subsp. venerealis organisms, 
is recommended (Monke et al., 2002). 
The concentration of C. fetus subsp. venerealis organisms in preputial samples can vary from less 
than 10
2
/ml to more than 2.0 x 10
5
/ml of smegma while other contaminants such as Proteus and 
Pseudomonas spp. are always abundant and difficult to eliminate as they display more rapid growth, 
reducing the opportunity for C. fetus subsp. venerealis isolation (Clark, 1971; Clark et al., 1974; 
Dufty, 1967; Lander, 1990a, 1990b; Monke et al., 2002). Contamination by other microbial agents 
is in fact very common and was reported to cover 75 to 100% of the plate in the majority of 
collected samples, despite improved media conditions, competing with C. fetus subsp. venerealis 
for space and nutrients on the plate (Monke et al., 2002). 
These problems highlighted the need for an appropriate transport medium to limit overgrowth of 
contaminants and maximise survival of C. fetus organisms upon arrival to the laboratory, even if 
less abundant in the initial sample (Lander, 1990a; Monke et al., 2002). It also led to the 
development of growth media favouring selective isolation of C. fetus organisms (Clark and Dufty, 
1978; Lander, 1990a; Skirrow, 1977). To improve C. fetus subsp. venerealis viability, samples are 
directly inoculated into a transport and enrichment medium (TEM) promptly brought to the 
laboratory and, after inoculation of the TEM onto selective growth medium, incubated under 
microaerophillic conditions (Clark and Dufty, 1978; Hum et al., 1994a; Lander, 1990a; Monke et 
al., 2002; OIE, 2012a). Routine adoption of microaerophillic growth conditions and selective 
culture media has improved the rate of C. fetus subsp. venerealis isolation (Lander, 1990a; Lander 
and Gill, 1985; Monke et al., 2002; Vargas et al., 2003). 
 25 
 
Despite the existence of standardised methods, a large number of selective culture and transport 
media are in use to isolate C. fetus subsp. venerealis organisms, and may often be laboratory-
specific (Jones et al., 1985; OIE, 2012a; van Bergen, 2005a). De Lisle et al. (1982) compared the 
efficiency of different TEMs; among them, Clark’s TEM was found to be less adapted than 
Weybridge’s TEM for C. fetus isolation (Clark et al., 1974; Hum et al., 1994a). A limitation of this 
study was the assessment of these media in terms of survival of C. fetus subsp. venerealis bacterial 
cells from cultures maintained in the laboratory rather than from clinical field samples (Jones et al., 
1985). In 1985, Jones et al. evaluated C. fetus recovery from clinical samples using Clark’s and 
Weybridge’s TEMs. Clark’s TEM allowed better isolation of C. fetus subsp. venerealis organisms 
from bull preputial secretions than Weybridge’s TEM, possibly because Weybridge’s TEM was 
incubated under aerobic conditions rather than the microaerophillic atmosphere applied to Clark’s 
TEM (Clark et al., 1974; Jones et al., 1985). 
Even though Clark’s TEM was shown to be effective, others reported it to be of limited efficiency 
and developed a TEM able to support as few as 10
2
 C. fetus subsp. venerealis organisms/ml whilst 
inhibiting proliferation of Proteus and Pseudomonas spp., by modifying Weybridge’s TEM (Clark 
et al., 1974; Clark and Dufty, 1978; Lander, 1990a). Charcoal was added because it previously 
facilitated transport, storage and multiplication of fastidious bacteria (Lander, 1990a). The 
combination of sulphate and sodium salts was added to improve the tolerance of C. fetus organisms 
to the surrounding atmosphere (Lander, 1990a). Vancomycin, trimethoprim and polymyxin B were 
also included as they were previously found useful in Skirrow’s selective growth medium (Lander, 
1990a; Skirrow, 1977). This TEM maintained viable C. fetus organisms for three days, enhanced 
bacterial multiplication and inhibited the growth of Proteus and Pseudomonas spp. (Lander, 1990a). 
Larger inocula initiated C. fetus subsp. venerealis multiplication which emphasised that successful 
C. fetus isolation relies on the initial number of C. fetus subsp. venerealis organisms, which should 
be at least as abundant as other organisms in tested samples (Lander, 1990a). 
To support survival and multiplication of C. fetus bacterial cells, TEM inocula needed to contain at 
least 10
3 
organisms/ml while smaller inocula also carried less microbial contaminants (Lander, 
1990b). To assess the effect of inoculum size, samples before and after filtration were inoculated 
directly into the newly modified Weybridge’s TEM, or directly inoculated onto culture media 
(Lander, 1990a, 1990b). Although 80.3% of C. fetus subsp. venerealis-positive samples (n=61) 
were recovered when directly inoculated onto culture media, 90.2% of the samples inoculated into 
TEM prior to inoculation of culture media were isolated (Lander, 1990b). Isolation rates from 
samples of unknown status were limited by overgrowth of contaminants in unfiltered samples or the 
lack of any bacterial growth in filtered samples and by the fact that incubation of TEM reduced 
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isolation of C. fetus subsp. venerealis organisms (Lander, 1990b). If possible, direct culture should 
be performed if samples are received within 3h, otherwise, TEM should be used prior to the 
inoculation of culture media (Lander, 1990b). 
These early studies led to the adoption of improved isolation procedures: when clinical samples are 
transported to the laboratory within 6h, selective growth media are used to isolate C. fetus subsp. 
venerealis but when transport requires more than 6h, samples are inoculated into TEMs to enhance 
C. fetus subsp. venerealis survival (Hum et al., 1994a). As mentioned earlier, some researchers 
preferred the Australian TEM, described by Clark and Dufty (1978) from Clark’s TEM although 
others favoured the modified Weybridge’s TEM; while the “Campylobacter selective agar (CSA)” 
and the “modified Skirrow’s agar (MSA)”, originally created by Skirrow are both commonly used 
(Clark et al., 1974; de Lisle et al., 1982; Dufty, 1967; Hum et al., 1994a; Lander, 1990a, 1990b; 
Skirrow, 1977).  
Hum et al. (1994a) assessed the efficiency of these two TEMs and these two selective growth 
media. Direct cultural methods isolated 94% of C. fetus subsp. venerealis-positive samples (n=19) 
using CSA while only 68% were isolated using MSA which allowed quicker and more abundant 
C. fetus subsp. venerealis recovery but also enhanced overgrowth by contaminants (Hum et al., 
1994a). The modified Weybridge’s TEM allowed isolation of 74% of C. fetus subsp. venerealis-
positive samples without heavy contamination while the Australian TEM assisted isolation of only 
25% of them (Hum et al., 1994a). That study recommended the use of modified Weybridge’s TEM 
for 6h followed by CSA to maximise C. fetus subsp. venerealis isolation, while the filtering of 
preputial washes was found to lower the number of recovered C. fetus subsp. venerealis bacterial 
cells as observed earlier (Dufty, 1967; Hum et al., 1994a; Lander, 1990b). 
Likewise, a recent study (Monke et al., 2002) evaluated three TEMs (Cary-Blair, Weybridge and 
0.85% saline solution) and three growth media (Greenbriar Plus eugon agar, sheep blood agar and 
Skirrow’s Campylobacter agar). As previously reported, the modified Weybridge’s TEM improved 
C. fetus subsp. venerealis recovery with less contamination (Hum et al., 1994a; Lander, 1990b 
Monke et al., 2002). It was also found that samples in TEM should be transported to the laboratory 
between 4 and 24h as 50% less organisms were isolated when samples were transported within 24h 
compared to within 4h (Monke et al., 2002). Incubation of TEMs prior to inoculation onto selective 
growth media resulted in overgrowth of microbial contaminants and did not enhance C. fetus subsp. 
venerealis growth (Monke et al., 2002). The three culture media examined grew a comparable 
number of C. fetus subsp. venerealis colonies but Skirrow Campylobacter agar inhibited more 
contaminants and was thus favoured in this study (Monke et al., 2002).  
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Another problem associated with the identification of C. fetus isolates remains susceptibility to 
antibiotics: previous studies stated that C. fetus subsp. venerealis is susceptible to streptomycin but 
spontaneous mutations have been reported resulting in resistance to antibiotics (Jones et al., 1985). 
In both C. fetus subspecies, streptomycin resistance is induced by phage transduction while in 
C. jejuni, resistance to tetracycline is also carried by plasmids, proven to be transmissible to C. fetus 
subsp. fetus (Chang and Ogg, 1971; Jones et al., 1985). Seven strains (n=30) exhibited resistance to 
multiple drugs including streptomycin, tetracycline, kanamycin and neomycin, highlighting that 
antimicrobial resistance was widespread among C. fetus subsp. venerealis strains (Jones et al., 
1985). Additionally, 27 strains of 30 tested strains were found to be susceptible to polymyxin B 
although this antibiotic is included in all selective media (Clark’s TEM: 100 IU/ml; modified 
Weybridge’s TEM: 10 IU/ml; CSA: 1 IU/ml and MSA: 5 IU/ml), suggesting that only polymyxin 
B-resistant strains are isolated (Hum et al., 1994a; Jones et al., 1985). As modified Weybridge’s 
TEM and CSA provided better C. fetus recovery, it may be linked to their weaker concentration of 
polymyxin B, which may have allowed polymyxin B-sensitive strains to survive (Hum et al., 
1994a). It was also pointed out that C. fetus subsp. venerealis reference strains must have been 
isolated using media containing polymyxin B, indicating the need to modify culture methods to also 
isolate polymyxin B-susceptible C. fetus subsp. venerealis strains (Hum et al., 1994a; Jones et al., 
1985). 
 
2.1.2. Biochemical testing 
In order to obtain adequate epidemiological and clinical data, precise identification of 
Campylobacter spp. is essential (On, 1996). Recently, culture methods (section 2.1.1) have been 
improved but Campylobacter organisms exhibit some fundamental biological and biochemical 
characteristics that complicate identification and C. fetus subspecies differentiation (Garrity et al., 
2005a; OIE, 2012a; On, 1996). As described earlier (section 1.1.2), they are slow-growing bacteria 
requiring fastidious growth conditions, asaccharolytic and mostly biochemically unreactive (On, 
1996; On and Holmes, 1991b, 1992). Biochemical tests commonly used to characterise other 
bacteria are of no use to identify Campylobacter organisms as they do not allow discrimination 
between species (On, 1996). Because of their constantly evolving taxonomy, accurate identification 
procedures that recognise all Campylobacter spp. have been compromised (On, 1996). 
Despite the above challenges, biochemical testing is routinely used to characterise Campylobacter 
organisms and identification procedures for catalase-positive and catalase-negative Campylobacter 
spp., mostly involving comparative tables (Table 1) are available (Garrity et al., 2005a; OIE, 2012a; 
On, 1996; van Bergen, 2005a; Véron and Châtelain, 1973).  
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According to Véron and Châtelain (1973), three biochemical tests allow biochemical phenotyping 
of Campylobacter organisms: production of catalase with 3% H2O2, growth in Albimi broth 
containing 1% glycine and production of H2S in Albimi broth containing 0.02% cysteine-HCl using 
lead acetate paper (section 1.1.3). Table 1 shows the biochemical results obtained from tests used to 
characterise different catalase-positive Campylobacter strains (Véron and Châtelain, 1973) 
Table 1. Characterisation of catalase-positive Campylobacter strains (Véron and Châtelain, 1973). 
 
From that study, catalase-positive strains tolerating glycine and producing H2S were identified as 
C. fetus subsp. fetus, those which could not grow in presence of glycine and did not produce H2S 
were characterised as C. fetus subsp. venerealis bv. venerealis while strains which could not grow 
in glycine but produced H2S were named C. fetus subsp. venerealis bv. intermedius (Véron and 
Châtelain, 1973).  
Growth at 25°C and 42°C, production of oxidase, nitrate reductase, tolerance to 3.5% sodium 
chlorine (NaCl), susceptibility to nalidixic acid and tolerance to 2,3,5-triphenyltetrazolium chloride 
(TTC) were proposed as complementary tests to characterise further Campylobacter isolates (Véron 
and Châtelain, 1973). Such tests have often been reported to be time-consuming and laborious 
although catalase, hippurate hydrolysis, oxidase, urease and H2S production tests were found to be 
useful and highly reproducible (On and Holmes, 1991b, 1992).  
Despite the publication of guidelines, the accuracy and validity of these taxonomic tables are now 
under question due to the limited number of studied strains and species while the lack of 
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standardisation of the biochemical tests performed can affect the interpretation of results (OIE, 
2012a; On, 1996; On and Holmes, 1991a; van Bergen, 2005a; Véron and Châtelain, 1973). 
Divergences between studies running identical tests on the same strain but producing highly 
variable results have been published (On, 1996; On and Holmes, 1991a; van Bergen, 2005a). For 
example, 95% of C. fetus subsp. fetus isolates are reported to tolerate 1.5% NaCl while others found 
100% of tested isolates were sensitive to the same compound (On and Holmes, 1991a). Accurate 
phenotyping requires an inoculum of at least 10
6
 CFU/ml for common biochemical tests while 
larger inocula may produce false-negative and false-positive results, affecting final species 
identification (On and Holmes, 1991a). However, such recommendations are not included in 
standard procedures, and as data are often compiled from various sources, the use of comparative 
tables as an accurate identification tool is questionable (OIE, 2012a; On 1996).  
Some isolates can exhibit rare phenotypes (Jones et al., 1985), for example, some C. fetus subsp. 
fetus strains exhibited atypical characteristics such as no H2S production using lead acetate paper, 
lack of motility, growth at 42°C and resistance to cephalothin (Jones et al., 1985). Problems can 
arise when studying newly characterised isolates as there is a lack of clear differential properties 
between C. fetus subspecies (On, 1996; Véron and Châtelain, 1973). C. fetus atypical strains have 
been reported (section 1.1.4) including C. fetus subsp. venerealis glycine-tolerant isolates and 
C. fetus subsp. fetus glycine-sensitive isolates, constituting additional causes of misidentification 
(On and Harrington, 2001; Salama et al., 1992; Vargas et al., 2003; Wagenaar et al., 2001). 
Consequently, methods assessing test results numerically were developed such as the 12 tests 
generating a code used to type six catalase-positive Campylobacter spp. (Bolton et al., 1984). 
Interpretation is simple but the restricted number of taxa recognised by these tests compared to all 
newly described species limits its usefulness (On, 1996). In fact, C. fetus subspecies are 
indistinguishable by biotyping, thus this method was not adopted by veterinary laboratories because 
accurate subspecies identification is crucial for adequate treatment (Bolton et al., 1984; On, 1996; 
Véron and Châtelain, 1973). Similarly, using 21 tests, the API Campy (Biomérieux) can identify 18 
Campylobacter spp. including both C. fetus subspecies, but it previously misidentified some field 
isolates, limiting its impact as a diagnostic kit (Huysmans et al., 1995; On, 1996; Reina et al., 
1995). 
Currently, discrimination between C. fetus subspecies relies on a single tolerance test considered as 
the gold standard for identification: growth in 1% glycine (OIE, 2012a). Existence of atypical and 
mutant strains highlights that biochemical testing is not a reliable method for the differentiation of 
C. fetus subspecies and emphasises the need to perform more than one biochemical test to limit 
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misidentification (Chang and Ogg, 1971; Hum et al., 1997; On, 1996; On and Harrington, 2001; On 
and Holmes, 1991a; Salama et al., 1992; Schulze et al., 2006; Vargas et al., 2003; Wagenaar et al., 
2001). This has led research to develop other diagnostic tools based on immunological (section 2.2) 
and molecular (section 2.3) techniques. 
 
2.2. Immunological techniques 
2.2.1. Agglutination tests 
Latex agglutination assays using immunoglobulins against different Campylobacter spp. 
have been commercialised such as Campyslide (BBL Microbiology Systems), Microscreen (Mercia 
Diagnostics) or Meritec-Campy (Meridian Diagnostics). These tests can produce false-positive 
results with non-Campylobacter spp. and false-negative reactions with C. lari due to lack of 
agglutination while results can also be influenced by inoculum size (Hazeleger et al., 1992; Hodinka 
and Gilligan, 1988; Nachamkin and Barbagallo, 1990). Of the three techniques, Microscreen 
appeared to be superior because of its ability to recognise a larger number of species, the absence of 
cross-reactions with non-Campylobacter spp. and its simplicity of use (Fang et al., 1995). A recent 
study evaluated other available latex agglutination assays and found the Microgen Campylobacter 
M46 test (Microgen Bioproducts) superior to other tested methods (Miller et al., 2008). Although 
Microscreen and Microgen Campylobacter M46 can detect C. fetus organisms, latex agglutination 
assays cannot differentiate Campylobacter spp. specifically (Fang et al., 1995; Miller et al., 2008).  
Previously, an agglutination test for C. fetus was used to measure IgA in cervico-vaginal mucus and 
considered a good indicator of herd exposure given the IgA response is still detectable several 
months after infection is cleared (Kendrick, 1967). In addition, latex agglutination assays can also 
react with non-viable Campylobacter cells so that no distinction could be made between cells 
inactivated from antibiotic treatment and those which did not survive culture (Hazeleger et al., 
1992). Therefore, agglutination tests are not recommended for the assessment of C. fetus subsp. 
venerealis in clinical samples (OIE, 2012a). 
 
2.2.2. Immunofluorescence 
In 1990, a fluorescence antibody test (FAT) was developed that could determine the 
presence of C. fetus in foetal contents, preputial secretions and vaginal mucus, but the results were 
not specific for C. fetus subsp. venerealis infections as it did not allow differentiation between 
subspecies (Lander, 1990a). Similar to other immunological methods, this test lacked sensitivity as 
only 2.7% of samples of unknown status (n=188) gave positive results by FAT (Lander, 1990b). 
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This test is neither sensitive nor specific enough to be a reliable diagnostic tool while it cannot 
evaluate current infection status (BonDurant, 2005; Hum et al., 1994b). 
Cobo et al. (2003) used an immunofluorescence antibody test (IFAT) and culture to evaluate the 
efficiency of two commercial vaccines against C. fetus subspecies and found that both methods 
correlated well in the identification of organisms in vaccinated and unvaccinated animals, even if 
some samples were negative by culture and positive by IFAT. The authors also pointed out that 
IFAT was more sensitive than FAT and less expensive, faster and easier than culture (Cobo et al., 
2003). However, as IFAT cannot differentiate between C. fetus subspecies or indicate current 
infection status, this method is not routinely used to detect C. fetus subsp. venerealis infections in 
diagnostic laboratories (OIE, 2012a). 
 
2.2.3. ELISA 
Antibody responses detected in female cattle after experimental infection and immunisation 
with C. fetus subsp. venerealis led to the development of an indirect enzyme-linked immunosorbent 
assay (ELISA) to detect IgA antibodies against C. fetus subsp. venerealis in vaginal mucus (Corbeil 
et al., 1974; Corbeil et al., 1975; Hum et al., 1991). This indirect IgA ELISA was used to screen 
BGC in New South Wales (NSW, Australia) and revealed a prevalence of 34.8% (n=84) with a 
specificity of 98.5% while sensitivity was not evaluated (Hum et al., 1994b). False-negative and 
false-positive reactions were reported, affecting its usefulness to diagnose individuals but this test 
was still found to be helpful as an indicator of herd infection (Hum et al., 1994b). 
Recently, the same ELISA was used to screen C. fetus subsp. venerealis infections in New Zealand 
and 24% of samples (n=1 230) from beef cow herds were found to be positive, with infection 
prevalent in 37 to 70% of herds (n=125) tested (McFadden et al., 2004). However, the prevalence 
revealed by ELISA was not higher in farms known to have reproductive problems while 28% of 
cows from highly fertile herds were found to be positive (McFadden et al., 2004). The titres 
observed might have resulted from previous exposure, inducing IgA persisting up to ten months in 
mucus, thus producing false-positive results while it was also suggested that animals used as 
negative controls may have been exposed to sheep herds and C. fetus subsp. fetus, potentially 
causing cross-reactions between C. fetus subspecies (McFadden et al., 2004). None of the bull 
samples (n=54) from herds with a high prevalence by IgA ELISA yielded C. fetus subsp. venerealis 
isolates while C. fetus subsp. fetus, C. jejuni and other Campylobacter spp. were recovered, 
supporting the possibility of cross-reactions between Campylobacter-like organisms and C. fetus 
subsp. venerealis in this test, as observed between C. fetus subspecies (Hum et al., 1991; McFadden 
et al., 2004). The lack of specificity of the IgA ELISA, as a result of multiple sources of false-
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positive reactions, makes it an unreliable diagnostic tool to detect C. fetus subsp. venerealis 
infections (McFadden et al., 2004). 
Consequently, immunological techniques are not considered adequate for Campylobacter diagnosis 
because of their low specificity (Cobo et al., 2003; Hodinka and Gilligan, 1988; Hum et al., 1991; 
Hum et al., 1994b; Lander, 1990a; McFadden et al., 2004; Nachamkin and Barbagallo, 1990). 
Neither serological, agglutination nor immunofluorescence tests (section 2.2) allow evaluation of 
current infectious status and are of limited use (Cobo et al., 2003; Hazeleger et al., 1992; Hum et al., 
1994b). Nevertheless, as vaccination initiates different antibody production than natural infection, 
the World Organisation for Animal Health recommends the use of an IgG ELISA for the evaluation 
of vaccinated animals (OIE, 2012a). 
 
2.3. Molecular techniques 
Due to the problems of diagnosis associated with biochemical testing and immunological 
methods, molecular techniques including pulsed-field gel electrophoresis (PFGE; section 2.3.1), 
ribotyping and genome mapping (section 2.3.2), amplified fragment length polymorphism (AFLP; 
section 2.3.3) and polymerase chain reaction (PCR; section 0) assays have been developed to 
characterise Campylobacter spp. (Wassenaar and Newell, 2000). 
 
2.3.1. Pulsed-field gel electrophoresis (PFGE) 
Restriction enzymes, digesting bacterial chromosomal DNA, allow separation of large DNA 
fragments by electrophoresis (Finney, 2001; Schwartz and Cantor, 1984; Wassenaar and Newell, 
2000). To avoid random breaks in chromosomal DNA, the bacterial mix is suspended in agarose 
before cell lysis and digestion steps and then, blocks loaded with the digested DNA are transferred 
into agarose gels, allowing detection of both chromosomal DNA and plasmids after electrophoresis 
(Finney, 2001; Schwartz and Cantor, 1984; Wassenaar and Newell, 2000). 
For Campylobacteraceae, PFGE was first developed for C. jejuni and C. coli and subsequently 
applied to other species including Helicobacter pylori or C. fetus (Hum et al., 1997; On and 
Harrington, 2001; Salama et al., 1992; Salama et al., 1995; Taylor et al., 1992a, 1992b). Similarly to 
fla typing (section 3.1.1), various electrophoresis conditions have been reported for this technique, 
resulting in different PFGE profiles for the same isolate (Vargas et al., 2003; Wassenaar and 
Newell, 2000). Many restriction enzymes have been used with ApaI, BssHII, KpnI, SalI and SmaI 
providing the best results while the combination of several enzymes increased the discriminatory 
ability of the method (Salama et al., 1995; Wassenaar and Newell, 2000). The majority of studies 
using PFGE on C. fetus strains have used SalI and SmaI and these same restriction enzymes gave 
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variable numbers of fragments for different laboratories for the same control isolates (Hum et al., 
1997; On and Harrington, 2001; Salama et al., 1992; van Bergen, 2005a; Vargas et al., 2003). 
PFGE contributed to the estimation of the genome sizes of C. fetus subsp. fetus (1.1 Mega base 
pairs), C. fetus subsp. venerealis bv. venerealis (1.3 Mb) and C. fetus subsp. venerealis bv. 
intermedius (1.5 Mb) and assisted the mapping of the genome of the reference C. fetus subsp. fetus 
strain (Salama et al., 1995). It was initially proposed that C. fetus subspecies identification could 
potentially rely on PFGE profiles but several C. fetus subsp. venerealis isolates could not be 
differentiated from C. fetus subsp. fetus based on genomic size, despite the fact that the similar 
C. fetus PFGE profiles generated correlated well with PCR testing (On and Harrington, 2001; 
Salama et al., 1992). Numerically-analysed PFGE profiles compared with previously described 
procedures did not allow accurate identification of subspecies and was not recommended as a 
diagnostic tool (Hum et al., 1997; On and Harrington, 2001). 
Likewise, numerical analysis of 12 PFGE profiles divided C. fetus isolates into two groups but 
subspecies could not be identified as previously concluded (Hum et al., 1997; Salama et al., 1992; 
Vargas, et al. 2003). Therefore, numerical analysis of PFGE profiles is considered useful for 
epidemiological studies only and not recommended for C. fetus subspecies differentiation in 
diagnostic laboratories as this procedure is time-consuming, expensive and first requires the 
isolation of pure cultures (On and Harrington, 2001; van Bergen, 2005a; Vargas et al., 2003). 
 
2.3.2. Ribotyping and genome mapping 
Ribotyping is a method which hybridises rRNA-specific probes with Southern blots 
prepared from digested bacterial DNA electrophoretically (Grimont and Grimont, 1986). Several 
copies of the rRNA genes coding for 23S, 16S and 5S rRNAs have been identified on the 
chromosome of Campylobacter spp. (Kim et al., 1993; Salama et al., 1995), exhibiting highly 
conserved regions adjacent to variable sites thus considered ideal gene targets for subtyping (Denes 
et al., 1997; Wassenaar and Newell, 2000).  
The 16S rRNA genes of 31 C. fetus field and reference strains, representing both subspecies and 
including two type strains, were successfully sequenced and aligned (On and Harrington, 2001). 
C. fetus subspecies did not exhibit polymorphisms in terms of 16S rRNA sequences, confirming the 
high degree of conservation of C. fetus 16S rRNA genes and limiting subspecies differentiation (On 
and Harrington, 2001). On the contrary, accurate subspecies differentiation of C. hyointestinalis 
strains was achieved by the same research team, facilitated by greater polymorphism of 16S rRNA 
sequences (Harrington and On, 1999). Ribotyping and 16S rRNA gene sequencing are not 
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appropriate to differentiate C. fetus subspecies, even though these techniques can successfully 
identify other Campylobacter subspecies (Denes et al., 1997; Harrington and On, 1999; On, 1996; 
On and Harrington, 2001; Wassenaar and Newell, 2000). 
Ribotyping was used to obtain C. coli and C. jejuni genomic maps and create the genomic map of 
ATCC27374 C. fetus subsp. fetus (Figure 1) using SalI, SmaI and NotI restriction enzymes (Salama 
et al., 1995; Taylor et al., 1992a). This strain had three copies of the 23S, 16S and 5S rRNA genes, 
each copy was closely located to the other rRNA genes on the chromosomal DNA as observed for 
ATCC43431 C. jejuni (Kim et al., 1993; Salama et al., 1995). Genes rpoA, rpoB and rpoD encoding 
subunits of RNA polymerase were all located close to sapA in C. fetus subsp. fetus ATCC27374; 
these genes are found in both Gram-negative and Gram-positive bacteria and are identical making 
them unsuitable C. fetus-specific diagnostic target (Salama et al., 1995). 
Figure 1. Genome map of C. fetus subsp. fetus ATCC27374 (Salama et al. 1995). 
  
2.3.3. Amplified Fragment Length Polymorphism (AFLP) 
AFLP is a DNA fingerprinting method which involves the digestion of chromosomal DNA 
using two enzymes which target four and six base pair (bp) sites respectively (Vos et al., 1995; 
Wassenaar and Newell, 2000). Fluorescently or radioactively labelled primers are used to amplify 
only the digested fragments adjacent to both sites by PCR assays (Wassenaar and Newell, 2000). 
Labelled PCR products are then denatured on polyacrylamide gels, resulting into 50 to 500 
nucleotide fragments producing 80 to 100 bands that constitute the AFLP profile (Wassenaar and 
Newell, 2000). AFLP was reported to successfully genotype C. coli strains and subtype C. jejuni 
isolates (Duim et al., 1999, 2000). AFLP has been applied to 69 C. fetus strains and AFLP profiles 
(Figure 2) with an average of 55 to 60 bands per strain were obtained (Wagenaar et al., 2001). 
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 Figure 2. AFLP profiles of 69 C. fetus strains divided by cluster analysis based on the genetic 
similarities between region 841 and 879 (arrow) of the obtained profiles (Wagenaar et al., 2001). 
AFLP profiles allowed the differentiation of C. fetus subspecies according to percent genetic 
similarity enhanced by using a cluster analysis focusing on a smaller region of the profile 
(Wagenaar et al., 2001). The patterns identified for each C. fetus subspecies were highly 
homologous, limiting the potential of this method to type individual strains despite AFLP cluster 
analysis should still be considered useful for epidemiological studies (Wagenaar et al., 2001). 
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Subsequently, the same procedure was used to evaluate further C. fetus isolates and more recent 
sequencing system and data analysis software were found to improve throughput and resolution of 
obtained profiles (van Bergen et al., 2005c). AFLP profiles also exhibited clusters for each C. fetus 
subspecies and additionally, a cluster for C. fetus subsp. venerealis bv. intermedius strains, 
including previously described glycine-tolerant H2S-positive isolates was identified (Salama et al., 
1992; van Bergen et al., 2005c). These findings confirmed genetic differences between C. fetus 
subsp. venerealis biovars, even if they share a high degree of homology (van Bergen et al., 2005c). 
This study also underlined the limited usefulness of AFLP in terms of subspecies discrimination as 
previously reported (van Bergen et al., 2005c; Wagenaar et al., 2001).  
AFLP is as complex and time-consuming as PFGE, and requires expensive equipment (OIE, 2012a; 
Wassenaar and Newell, 2000). The main advantage of both AFLP and PFGE is that a whole portion 
of the bacterial genome is sampled but pure C. fetus cultures are first required (Wagenaar et al., 
2001; Wassenaar and Newell, 2000). Nonetheless, AFLP was used to detect genetic markers 
specific to C. fetus subspecies which were subsequently exploited as PCR assays (section 0) to 
identify C. fetus subsp. venerealis isolates (van Bergen et al., 2005b). 
2.3.4. Polymerase Chain Reaction (PCR) assays 
As described earlier (section 1.1.3), C. fetus subsp. fetus isolates are currently differentiated 
from C. fetus subsp. venerealis biovars by their ability to tolerate glycine while C. fetus subsp. 
venerealis bv. intermedius isolates produce H2S, similar to C. fetus subsp. fetus. For this reason, it 
was previously determined that C. fetus subsp. venerealis diagnosis cannot rely upon biochemical 
testing only (section 2.1.2) which led to the development of molecular tools such as PFGE (section 
2.3.1) or AFLP (section 2.3.3). Such techniques were reported of limited use to routine veterinary 
laboratories (Hum et al., 1997; Salama et al., 1992; Vargas et al., 2003; Wassenaar and Newell, 
2000) which led researchers to investigate the potential of Polymerase Chain Reaction (PCR) as a 
diagnostic tool. 
A multiplex PCR (Figure 3), using C. fetus-specific primers (MG3F and MG4R, Table 2) 
amplifying a 960 bp fragment and C. fetus subsp. venerealis-specific primers (VenSF and VenSR, 
Table 2) amplifying a 142 bp fragment, was designed to differentiate C. fetus subspecies (Hum et 
al., 1997).  
Figure 3. Multiplex PCR result (Hum et al. 1997). 1: DNA ladder; 2: C. fetus subsp. venerealis-
specific product (960 and 142 bp fragments); 3: C. fetus-specific product (960 bp fragment only). 
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PFGE and this multiplex PCR were used to evaluate a large number of Australian C. fetus field 
isolates biochemically phenotyped as C. fetus subsp. venerealis (n=58) and C. fetus subsp. fetus 
(n=39) by different diagnostic laboratories (Hum et al., 1997).1Phenotyping, PFGE and PCR results 
agreed for 80.8% of isolates tested, although contradictory results obtained were mostly due to 
isolates being originally phenotyped as either the wrong C. fetus subspecies or as C. fetus instead of 
other Campylobacter spp. (Hum et al., 1997). Although no information indicating whether regions 
targeted by this assay were of high prevalence, this multiplex PCR was considered adequate and 
reliable as an additional test to confirm C. fetus diagnosis and subspecies identification as only 2% 
of isolates exhibited controversial results (Hum et al., 1997).  
The same PCR and PFGE methods and a similar biochemical phenotyping scheme were used to 
compare 31 C. fetus field and reference strains from different countries: for 28 strains, the results 
from the three methods agreed and were comparable to previous findings (Hum et al., 1997; On and 
Harrington, 2001; Salama et al., 1992). 
In contrast, 69 C. fetus strains isolated from diverse geographic locations, compared using 
biochemical phenotyping, PCR and AFLP, were identified as either subspecies by these different 
methods used (Hum et al. 1997; Wagenaar et al., 2001). Glycine tolerance identified 47 isolates as 
C. fetus subsp. fetus and 22 as C. fetus subsp. venerealis while all tested isolates produced the 
C. fetus amplicon but only 15 strains generated the C. fetus subsp. venerealis-specific fragment 
(Wagenaar et al., 2001). Seven glycine-intolerant South African isolates were recognised as C. fetus 
subsp. fetus by PCR and AFLP profiles, highlighting the good correlation between PCR and AFLP 
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while a C. fetus subsp. venerealis-PCR positive strain from the United-Kingdom (UK) could grow 
on glycine (Wagenaar et al., 2001).  
Similarly, three isolates (n=33) identified as C. fetus subsp. fetus by biochemical phenotyping were 
characterised as glycine-tolerant C. fetus subsp. venerealis isolates PCR-positives as the multiplex 
PCR evaluated consistently all tested Brazilian strains (Vargas et al., 2003). The multiplex PCR was 
found reliable, sensitive, easy to perform and able to differentiate C. fetus subspecies and adapted to 
diagnostic laboratories (Vargas et al., 2003). Correlation between PCR and PFGE results was not 
assessed as subspecies characterisation could not be achieved on the basis of DNA fragment sizes 
only, even using numerical analysis (Vargas et al., 2003). 
Table 2. Primers used in PCR assays to detect C. fetus strains across different studies. 
Primers Sequences (5’ to 3’) Amplicon  References Specificity 
MG3F 
MG4R 
GGTAGCCGCAGCTGCTAAGAT 
TAGCTACAATAACGACAACT 
960 bp 
Hum et al. 
(1997) 
C. fetus 
subspecies 
VenSF 
VenSR 
CTTAGCAGTTTGCGATATTGCCATT 
GCTTTTGAGATAACAATAAGAGCTT 
142 bp 
Hum et al. 
(1997) 
C. fetus subsp. 
venerealis 
Cf C05F 
Cf C05R 
ATGATAAGATATATTTTGTATCAG 
GATGAAGAATATTACAAGATAAT 
54 bp 
van Bergen 
et al. (2005) 
C. fetus subsp. 
venerealis 
23SF 
23SR 
TATACCGGTAAGGAGTGCTGGAG 
ATCAATTAACCTTCGAGCACCG 
650 bp 
Wang et al. 
(2002) 
Campylobacter 
CFF 
CFR 
GCAAATATAAATGTAAGCGGAGAG 
TGCAGCGGCCCCACCTAT 
435 bp 
Wang et al. 
(2002) 
C. fetus subsp. 
fetus 
CFVF 
CFVR 
CFVP1 
CCCAGTTATCCCAAGCGATCT 
CGGTTGGATTATAAATTTTAGCTTGGT 
6-FAM-CATGTTATTTAATACCGCAA 
86 bp 
McMillen 
et al. (2006) 
C. fetus subsp. 
venerealis 
CVEN-L 
CVEN-R2 
ATTAGTATTTGCAATATGTGAA 
AATTGATATTAAATTTGATTGA 
233 bp 
Abril et al. 
(2007) 
C. fetus subsp. 
venerealis 
Another set of primers (Cf C05, Table 2) specific to C. fetus subsp. venerealis was developed from 
a fragment previously identified by AFLP (van Bergen et al., 2005b). This assay was used to 
compare results obtained with AFLP and Hum’s PCR using 62 C. fetus field isolates from different 
geographic origins (Hum et al., 1997; van Bergen et al., 2005b). AFLP and Cf C05 primer set 
identified only 12 strains as C. fetus subsp. venerealis while seven additional strains were positive 
on Hum’s PCR but recognised as C. fetus subsp. fetus by AFLP (van Bergen et al., 2005b). The 
Cf C05 PCR was found to identify adequately C. fetus subsp. venerealis isolates and could be 
adapted into a multiplex PCR by adding species-specific primers (van Bergen et al., 2005b). 
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However, C. fetus subsp. venerealis bv. intermedius strains are negative on this method (OIE, 
2012a). 
Previously developed PCR assays characterised isolates as C. fetus subsp. fetus only if a C. fetus 
subsp. venerealis-specific amplicon was absent (Hum et al., 1997; On and Harrington, 2001; van 
Bergen et al., 2005b; Vargas et al., 2003; Wagenaar et al., 2001). Thus, a multiplex PCR, based on 
the surface layer sapB2 gene, was able to differentiate the five major Campylobacter spp., including 
C. fetus subsp. fetus by using a 23S rRNA Campylobacteraceae-specific primer set and species or 
subspecies-specific primers (Wang et al., 2002). The assay was found to be highly specific and 
sensitive as it recognised successfully the 124 reference Campylobacter strains tested and did not 
cross-react with other bacterial spp. (Wang et al., 2002). 
Subsequently, a novel multiplex PCR was designed using family-specific (23SF and 23SR), 
species-specific (MG3F and MG4R), C. fetus subsp. fetus-specific (CFF and CFR) as well as 
C. fetus subsp. venerealis-specific (VenSF and VenSR) primers respectively producing 650, 750 
and 435 and 142 bp amplicons (Table 2; Willoughby et al., 2005). Despite the fact that control 
strains were positive, only 24% of C. fetus subsp. fetus field isolates tested (n=42) produced the 435 
bp subspecies-specific amplicon even though none amplified the C. fetus subsp. venerealis-specific 
fragment (Willoughby et al., 2005). Only 16% of the C. fetus subsp. venerealis isolates (n=19) 
generated the 142 bp subspecies-specific amplicon, two out of which produced the C. fetus subsp. 
fetus-specific amplicon, suggesting biochemical phenotypic misidentification while other strain 
phenotypes were confirmed (Willoughby et al., 2005). Geographic variation may explain the low 
recognition of UK field isolates by both C. fetus subspecies-specific primers while these results 
highlighted the need to identify additional genetic differences between C. fetus subspecies 
(Willoughby et al., 2005). 
Despite divergent results, the use of PCR is recommended to identify C. fetus subspecies (Hum et 
al., 1997; OIE, 2012a; On and Harrington, 2001; Vargas et al., 2003; Wagenaar et al., 2001; 
Willoughby et al., 2005). A recent study obtained 100% correlation between PCR and biochemical 
phenotyping of 103 C. fetus isolates by using optimal inoculum size and two subsequent PCR 
assays instead of a multiplex PCR (Schulze et al., 2006). Some studies reported that C. fetus-
specific primers (MG3F and MG4R, Table 2) produced a fragment of 750 bp although others 
obtained a 960 bp amplicon (Hum et al., 1997; On and Harrington, 2001; Schulze, et al. 2006; 
Vargas et al., 2003; Wagenaar, et al. 2001, Willoughby, et al. 2005). Sequencing determined the 
accurate C. fetus product size as 764 bp, targeting a carbon starvation protein (Hum et al., 2010). 
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PCR has not been routinely used for BGC diagnosis and field isolates are still identified by a 
combination of selective culture, IFA and ELISA (OIE, 2012a). Minor groove binder probes, 
reported to be more specific and sensitive than others in real-time PCR assays, seemed to be more 
adaptable for routine diagnostic work, as observed for detection of bovine retroviruses (Kutyavin et 
al., 2000; Lew et al., 2004a; Lew et al., 2004b). The parA gene target, identified as C. fetus subsp. 
venerealis-specific by Hum et al. (1997), was adapted into a real-time assay using specific primers 
(CFVF and CFVR) and a fluorescent probe (CFVP1; Table 2; McMillen et al., 2006). This assay 
was found to be more sensitive and specific than Hum’s PCR, and was the first probe-based real-
time assay able to detect and quantify C. fetus subsp. venerealis organisms (McMillen et al., 2006). 
It was also more sensitive than culture which requires 1 000 cells/ml while this test detected one 
single cell/ml (McMillen et al., 2006). This assay detected a higher number of positives (16%) 
compared to culture (5%), consequently improving diagnosis of field samples exposed to prolonged 
transport (McMillen et al., 2006). Blood, faeces, semen or urine contamination did not affect the 
detection of C. fetus subsp. venerealis and the assay could be applied to crude samples following 
heat lysis, without the need for DNA extraction from pure cultures (McMillen et al., 2006). The 
parA real-time assay could be useful for routine diagnostic laboratories as it did not cross-react with 
other bacteria commonly found in the bovine flora and exhibited better detection performance than 
other available techniques (McMillen et al., 2006).  
However, as this method was highly sensitive, culture results did not often correlate with real-time 
PCR positivity (McMillen et al., 2006). The high prevalence of C. fetus subsp. venerealis identified 
by real-time PCR may be attributed to the presence of avirulent strains, which led research towards 
the identification of C. fetus subsp. venerealis virulence genes (Lew et al., 2007; Moolhuijzen et al., 
2009). The C. fetus subsp. venerealis-specific fragment was later described as a plasmid partitioning 
protein ParA, thought to be associated with plasmid segregation mechanisms (Baar et al., 2003; 
Ebersbach and Gerdes, 2005; Hum et al., 1997). Considering the discrepancies found using this 
target in PCR assays and a recent report of cross-reaction with other Campylobacter spp. suggesting 
that the parA gene may be transferrable, new robust diagnostic targets specific for C. fetus subsp. 
venerealis, which are not plasmid borne need to be identified (Spence et al., 2011; Wagenaar et al., 
2001; Willoughby et al., 2005).  
The novel ISCfe1 insertion element, composed of tranposase tnpA and tnpB genes and inverted 
repeats, was recently discovered from C. fetus subsp. venerealis. and demonstrated to be conserved 
in all C. fetus subsp. venerealis strains tested (n=25) but absent from C. fetus subsp. fetus (n=27) 
and Campylobacter spp. (n=23) (Abril et al., 2007). This element was inserted in a 
sodium/hydrogen exchanger nahE gene and in a methyltransferase metT gene in all C. fetus subsp. 
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venerealis strains analysed but not in C. fetus subsp. fetus nahE or metT genes (Figure 4; Abril et 
al., 2007). 
Figure 4. Detection of the insertion element ISCfe1 inserted in C. fetus subsp. venerealis nahE and 
metT genes (Abril et al., 2007). In all C. fetus subsp. venerealis strains, ISCfe1 was inserted in the 
sodium/hydrogen exchanger nahE gene (arrow 1) and in the putative methyltransferase metT gene 
(arrow 2), absent from C. fetus subsp. fetus strains (Abril et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
Overall, glycine tolerance, ISCfe1’s PCR and Hum’s PCR results correlated well although a C. fetus 
subsp. fetus isolate from Switzerland could grow in the presence of glycine and did not possess 
ISCfe1 but was identified as a C. fetus subsp. venerealis using Hum’s PCR (Abril et al., 2007; Hum 
et al., 1997). Another strain exhibited very discordant results as it was originally characterised as 
C. fetus subsp. venerealis while tolerating growth at 42°C and in the presence of glycine whereas 
ISCfe1 was not detected, indicating an initial error in diagnosis (Abril et al., 2007). These findings 
underlined the potential of the ISCfe1 element as a diagnostic tool but further testing on a range of 
field and reference isolates from different geographic origins was warranted (Abril et al., 2007). 
As the C. fetus subsp. venerealis isolates had several copies and variable numbers of ISCfe1, 
authors suggested that ISCfe1 might be able to replicate in the genome by transposition while the 
fact that ISCfe1 was found in all examined C. fetus subsp. venerealis strains from different 
countries, suggested a common ancestor (Abril et al., 2007). However, ISCfe1 was not associated 
with the glycine intolerance of C. fetus subsp. venerealis suggesting that expression of this element 
is not linked to this phenotypic characteristic (Abril et al., 2007). It was previously proposed that 
C. fetus subsp. venerealis was a C. fetus subsp. fetus mutant with a restricted host range, supported 
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by the fact that both species are genetically related (van Bergen et al., 2005c; Véron and Châtelain, 
1973). Interestingly, insertion elements described in bacteria are usually associated with genetic 
rearrangements, improving fitness and linked to adaptation in the host (Abril et al., 2007). It was 
speculated that ISCfe1 was acquired as a result of evolution in the cattle genital tract prior to global 
spread of C. fetus subsp. venerealis strains (Abril et al., 2007). 
 
2.3.5. Multi Locus Sequence Typing (MLST) 
 Multi locus sequence typing is a method based on the nucleotide sequencing of seven 
housekeeping genes that pinpoint single nucleotide polymorphism (SNP) at specific positions (van 
Bergen et al., 2005c). For a given locus, different alleles were identified and each SNP was given a 
numerical value (van Bergen et al., 2005c). The combination of these numerical values provides a 
seven-digit numerical code that corresponds to distinct sequence types (STs) which were readily 
associated with strain characteristics including epidemiological data (van Bergen et al., 2005c). This 
method was used to type 140 diverse C. fetus isolates and resulted in the generation of 14 STs with 
ST-4, ST-7 and ST-12 specific for C. fetus subsp. venerealis while the remaining STs were specific 
for C. fetus subsp. fetus (van Bergen et al., 2005c). Accurate C. fetus differentiation was achieved 
using MLST and the results correlated well with AFLP profiling, suggesting that this technique 
should be helpful in confirming the identity of isolates exhibiting contradictory results on other 
methods (van Bergen et al., 2005c).  
 
3. Virulence and plasmid genes in Campylobacter spp. 
Virulence factors are actively sought and characterised in order to identify pathogen-host 
interactions and potentially develop new treatments associated with bacterial infectious diseases 
(Wassenaar, 1997). By studying C. coli and C. jejuni, virulence factors associated with 
pathogenicity have been identified including flagellar motility, adherence of bacterial cells to 
mucosa, leading to host cell invasion and production of toxins (Bang et al., 2004; Bang et al., 2003; 
Ketley, 1997; Wassenaar, 1997). In the absence of extensive information for C. fetus pathogenesis, 
these factors can be investigated in other Campylobacter spp.. 
  
3.1. Flagellar genes  
 Motility relies on the bacterial flagellum, which enhances motility, assisted by the cell shape 
to enable movement in viscous media such as mucosal tissues (Ketley, 1997). Research has thus 
identified numerous flagellar genes from different Campylobacter spp. (Carrillo et al., 2004; Fouts 
et al., 2005; Moolhuijzen et al., 2009; Nuijten et al., 1990; Taylor et al., 1992a; Young et al., 1999). 
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3.1.1. Flagellin genes 
Bacterial flagella, composed of a basal body, hook and external filament, enhance 
chemotaxis and motility, enabling pathogenic Campylobacter spp. like C. jejuni to colonise the 
intestine (Nuijten et al., 1990; Young et al., 1999). Thirty genes have been reported to be involved 
in flagella formation in other bacterial spp. while flaA and flaB genes, encoding flagellin in C. coli 
and C. jejuni were identified (Guerry et al., 1990; Nuijten et al., 1990). Subsequently, flaA and flaB, 
were mapped in C. jejuni and C. coli as well as in C. fetus subsp. fetus, indicating that flagellin 
genes are conserved and commonly found in Campylobacter spp. (Salama et al., 1995; Taylor et al., 
1992a).  
The flagellin genes flaA and flaB, separated by 170 nucleotides, exhibit highly variable and constant 
regions, allowing restriction fragment length polymorphism (RFLP) after PCR amplification 
(Nachamkin et al., 1993; Nuijten et al., 1990). The use of the restriction enzyme DdeI on flaA PCR 
products obtained from C. jejuni isolates identified 18 distinct flaA types correlating well with 
strains, serotypes and outbreaks while flaB-typing was later found to correlate more closely with 
epidemiological data than flaA-typing (Mellmann et al., 2004; Nachamkin et al., 1993).  
Several fla-typing procedures have been developed with modifications to primers and restriction 
enzymes, divergence in assay conditions resulted into fla-profiles that were not readily comparable 
between laboratories and by reviewing fla-typing procedures and aligning primers used by different 
studies, a new set of primers has been recommended (Wassenaar and Newell, 2000). 
The recommended flaA C. jejuni-specific primers were subsequently adopted by others and all 
C. jejuni strains tested were found to be flaA-positive (Mellmann et al., 2004; Müller et al., 2006; 
Wassenaar and Newell, 2000). Likewise, flaA was amplified in all C. coli and C. jejuni porcine and 
bovine strains (n=40) tested and in a large number (n=117) of C. jejuni turkey strains using primers 
reported by Nachamkin et al. (1993), confirming the presence of this flagellin gene in many 
Campylobacter spp. field isolates (Bang et al., 2003, 2004).  
Recently, C. fetus. subsp. fetus and C. fetus. subsp. venerealis bv. intermedius strains were found 
positive on an assay targeting the flaB gene sequence of C. fetus. subsp. venerealis AZUL-94 while 
other C. fetus. subsp. venerealis bv. venerealis strains were negative (Moolhuijzen et al., 2009). 
These findings suggest that flaB gene sequence may differ between C. fetus subsp. venerealis 
biovars or that flaB may not be found in all C. fetus subsp. venerealis strains (Moolhuijzen et al., 
2009). Previously, flaB could be detected in different Campylobacter spp. (Mellmann et al., 2004; 
Müller et al., 2006; Nachamkin et al., 1993) using a primer set reported from C. jejuni, homology of 
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the flaB gene between C. fetus subspecies is thus not surprising but limits the potential of using this 
flagellin genes for accurate subspecies identification. 
Recombination between flagellin genes have been observed following induction to antibiotic 
resistance and natural transformation mechanisms, modifying the fla genotype of a studied strain 
(Wassenaar et al., 1995). Therefore, environmental pressure, also enhancing genetic instability 
suggests that using fla genes only to identify a strain is not reliable, even if additional methods 
could identify fla changes due to recombination (Wassenaar and Newell, 2000).  
 
3.1.2. Flagellar Apparatus 
The transportation of molecules across the two membranes of Gram-negative bacteria is 
enabled by secretion systems types I to IV (Young et al., 1999). Host-bacteria interactions are 
reported to be influenced by proteins secreted by type III mechanisms which are functional only 
when the microorganism is in close contact with a host, in which case it transports proteins to host 
cells or to the exterior of the host (Young et al., 1999). The synthesis of bacterial flagellum is 
achieved through mechanisms resembling the type III secretion system (Young et al., 1999).  
Analysis of the genome of C. jejuni NCTC11168 found that Campylobacter flagellar genes are 
expressed in an order that follows their involvement in the flagellar apparatus formation and 
assembly, as reported in Yersinia enterocolitica (Carrillo et al., 2004; Young et al., 1999). They 
were grouped into three classes according to their sigma promoters: classI genes (flhA, flhF, fliF, 
fliG, fliH, fliI, fliL, fliM, fliN fliQ, fliY) initiate transport of the flagellar apparatus components 
promoted by σ70, classII genes (flaB, flaD, flgB, flgC, flgD, flgE, flgE2, flgG, flgG2, flgH, flgI, flgK, 
fliA, fliE) are involved in the synthesis of the flagellar organelles promoted by σ54 and classIII genes 
(flaA, flaG, flgM, fliD, fliS) encode flagellar assembly as well as expression of flagellin and related 
virulence factors (cdtC) promoted by σ28 (Carrillo et al., 2004). 
By comparing the original NCTC11168 isolate with a passaged strain that exhibited reduced 
virulence characteristics including motility, it was found that a number of genes promoted by σ28 
and σ54 were absent from the attenuated strain, including flhA (Carrillo et al., 2004). Inactivation of 
flhA inhibited expression of the flagellar genes that were absent from the passaged strain resulting 
in the inability of the mutant strain to colonise the chicken intestine (Carrillo et al., 2004).  
Subsequently, inactivation of different genes (flaA, flaB, flgB, flgC, flgE2, flhB, fliA, fliD) involved 
in the synthesis and transport of flagellar apparatus resulted in reduced strain motility while 
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affecting production of proteins associated with the invasion of epithelial cells, confirming the 
importance of these genes in Campylobacter pathogenesis and virulence (Konkel et al., 2004).  
Genome analysis of five Campylobacter reference strains (C. jejuni NCTC11168, C. jejuni 
RM1221, C. coli RM2228, C. lari RM2100, C. upsaliensis RM3195) revealed that 18 open-reading 
frames (ORFs) involved in motility and chemotaxis were conserved in Campylobacter spp. and 
were absent from Helicobacter spp., while 27 additional ORFs implicated in flagellar function and 
biogenesis were found in both Campylobacter and Helicobacter strains (Fouts et al., 2005). A 
variable number of motility genes (respectively 63, 66, 58, 56, and 55) were identified in the five 
Campylobacter reference strains analysed, suggesting that different motility genes are found in 
Campylobacter spp. despite a large number of them are common to the genus (Fouts et al., 2005). 
The flgH, flhA, flhB, flhF and fliH flagellar genes were found to be conserved in both C. fetus 
subspecies while the flhA gene, activating the expression of other essential flagellar genes affecting 
Campylobacter motility, was not found in C. fetus subsp. venerealis available sequences (Carrillo et 
al., 2004; Moolhuijzen et al., 2009). The position of flhA corresponded to the unsequenced region of 
C. fetus subsp. venerealis AZUL-94 relative to the genome of C. fetus subsp. fetus 82-40 
(Moolhuijzen et al., 2009). C. fetus subsp. venerealis AZUL-94 possessed more flagellar genes (46) 
than C. fetus. subsp. fetus 82-40 (41); similarly C. jejuni was found to have more flagellar genes 
than C. coli, C. upsaliensis and C. lari (Fouts et al., 2005; Moolhuijzen et al., 2009). Further study 
of the diversity of C. fetus flagellar genes in field isolates could assist in the development of C. fetus 
subspecies-specific PCR assays for virulence if correlation to host colonisation can be demonstrated 
(Moolhuijzen et al., 2009).  
The flagellar genes flaA, flaB, flgB, flgE2, flhA, flhB, fliM and fliY were detected in all C. jejuni 
isolates tested (n=11) despite the fact that they exhibited different abilities to colonise and invade 
Caco-2 cells (Müller et al., 2006). These results also highlight that although flagellar genes are 
essential to Campylobacter motility, a range of other virulence genes are also essential to ensure 
successful colonisation and invasion of host cells. 
 
3.2. Adhesin 
 To colonise and to enhance production of bacterial secretions including toxins, bacterial 
adherence to host cells is crucial (Wassenaar, 1997). The investigation of specific adhesins in 
Campylobacter spp. has led to the discovery of four antigenic proteins PEB1, PEB2, PEB3 and 
PEB4 in C. jejuni 81-176 (Pei et al., 1991). PEB1 (28 kDa) was suggested to be involved in the 
transport of amino acid through the bacterial cell wall as well as enhancing adherence to intestinal 
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cells (Pei and Blaser, 1993). This idea was further supported by the reduced adherence and invasion 
of HeLa cells by a peb1A-mutant in vitro as well as reduced colonisation of epithelial cells in a 
mouse model (Pei et al., 1998).  
Another study investigated the impact of peb4 deletion similar to what was reported for the peb1A 
locus, the peb4-mutant strain had reduced adherence in vitro in INT 407 cells and decreased 
duration and level of colonisation in a mouse model compared to the C. jejuni NCTC11168 wild 
strain (Asakura et al., 2007a; Pei et al., 1998). A peb4-mutation was associated with reduced 
biofilm production and lowered expression of proteins involved in motility and transport such as 
FlaA (Asakura et al., 2007a). These results suggest that both PEB1 and PEB4 proteins play an 
important role in the adhesion of C. jejuni to intestinal cells (Asakura et al., 2007a; Pei et al., 1998).  
Initial attachment of bacterial cells to host tissues is promoted by binding to fibronectin which 
involves a 37 kDa outer-membrane protein, named CadF, identified from C. jejuni (Konkel et al., 
1997). A CadF-mutant strain was found to have limited adherence to INT 407 cells in vitro 
compared to the C. jejuni F38011 wild strain while a cadF gene knockout resulted in inhibition of 
intestinal tract colonisation in vivo, emphasising the importance of this adhesin in C. jejuni’s ability 
to bind to host tissues (Monteville et al., 2003; Ziprin et al., 1999). Other studies investigated the 
prevalence of cadF in C. coli and/or C. jejuni isolates and all examined strains (respectively n=117; 
n=40; n=46) were found positive by either PCR or immunoblot further suggesting that CadF may 
play an important role in Campylobacter virulence (Bang et al., 2003, 2004; Konkel et al., 1999). 
Indeed, binding of pathogens to host cells is considered a key virulence determinant as it limits 
removal of bacterial cells by fluid flow or peristalsis, while adherence to host cells is required for 
bacteria to enter host cells and has been reported to be crucial for disease propagation by C. coli and 
other bacteria (Bang et al., 2003).  
The lipoprotein JlpA (42.3 kDa) was identified from C. jejuni ATCC43431 and jlpA mutant strains 
exhibited reduced adherence to Hep-2 cells, suggesting that Campylobacter bacterial cells 
attachment to epithelial host cells may be mediated by several adhesins (Jin et al., 2001). In fact, 
CadF, JlpA and PEB1 were conserved across the genomes of C. jejuni NCTC11168, C. jejuni 
RM1221, C. coli RM2228, C. lari RM2100 and C. upsaliensis RM3195 while two proteins binding 
to fibronectin and a 43 kDa outer membrane protein were also found in these five Campylobacter 
spp. (Fouts et al., 2005). In addition, two filamentous hemagglutinin-like proteins were found in 
C. coli and C. lari that could enhance attachment of bacterial cells (Fouts et al., 2005). A new 
virulence locus was also found in C. upsaliensis: the lic genes (licA, licB, licC and licD), had not 
previously been reported in other bacterial spp. (Fouts et al., 2005). LicA and licC encode proteins 
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involved in phosphorylcholine synthesis, licB is associated with choline acquisition and licD 
encodes phosphorylcholine transfer, improving attachment to host cells (Fouts et al., 2005).  
By comparing adhesins found in Campylobacter spp., homologues to PEB1 and fibronectin binding 
genes were identified in C. fetus subsp. venerealis while others were absent from C. fetus subsp. 
venerealis available contigs despite the fact that a weak JlpA homologue was found (Moolhuijzen et 
al., 2009). PEB1 was the only known adhesin found in C. fetus subsp. fetus 82-40 genome and the 
absence of CadF suggested that C. fetus adherence occurs by a different mechanism compared to 
other Campylobacter spp. (Moolhuijzen et al., 2009). The fact that C. fetus subsp. venerealis 
colonises the genital tract only perhaps implies that other putative specialised adhesins yet to be 
identified may be involved in attachment (Moolhuijzen et al., 2009). 
 
3.3. Surface layer proteins (SLPs) 
 Invasion results from the penetration of bacteria following adherence (Friis et al., 2005) and 
putative factors involved in invasion have been identified in Campylobacter spp. (Ketley, 1997). 
Absence of invasion-associated putative factors correlated with low invasion levels in vitro while 
the ability of invaded cells to kill some bacteria but not others suggested that strains expressing 
certain virulence factors resisted host immune defences (Corbeil et al., 1975; Friis et al., 2005; 
Ketley, 1997; Thompson, 2002).  
 
3.3.1. Surface layer proteins (SLPs) 
Bacterial pathogens have developed different strategies to escape and resist immune 
responses induced by the infected host (Thompson, 2002). Antigenic variability of bacterial surface 
components helps to avoid the immune system and enhances pathogenicity of bacteria like C. fetus, 
which exhibit capsule-like proteins forming a surface layer (Thompson, 2002). 
Antigen a was first described from the cell surface of C. fetus strain 23D, which enabled bacterial 
cells to resist phagocytosis by macrophages while a mutant strain for this antigen was readily 
destroyed (McCoy et al., 1975). When antiserum to antigen a was added, both mutant and wild 
strains were phagocytosed showing that this antigen was associated with the ability of C. fetus to 
avoid phagocytosis in the absence of anti-antigen a antibodies (McCoy et al., 1975). It was also 
found that C. fetus strains were not killed by human serum while C. coli and C. jejuni were not 
resistant to complement or antibody contained in that serum (Blaser et al., 1985). The resistance to 
serum in C. fetus isolates was linked to proteins weighing 100 to 125 kDa while a proportion of 
strains subcultured in the laboratory became serum-sensitive and were reported to have lost these 
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proteins (Blaser et al., 1985). Indeed, these proteins and antigen a are identical and constitute the 
subunits of the SLPs (Thompson, 2002). 
Later, the same research team determined that S
+
 strains (which possess SLPs) could not 
functionally bind to the complement factor C3, while S
-
 strains (lacking SLPs) abundantly bound 
C3, enhancing the production of C5 convertase and the formation of the “membrane-attack 
complex” C5-9 (Blaser et al., 1988; Thompson, 2002). This resulted in massive cell killing while 
none was observed with S
+
 strains (Blaser et al., 1988; Thompson, 2002). Thus, SLPs inhibit 
binding of the complement system to the C. fetus cell surface, preventing cell lysis and phagocytic 
killing in C. fetus and enhancing bacterial survival in vivo (Blaser et al., 1988; Thompson, 2002). 
Virulence of SLPs was tested by inoculating mice intraperitoneally or orally using S
+
 and S
- 
C. fetus 
isolates (Pei and Blaser, 1990). Both strains induced death when inoculated intraperitoneally but 
mice inoculated orally with S
+
 developed persistent bacteraemia and had a higher mortality rate (Pei 
and Blaser, 1990). Mice immunised with antibodies raised against SLPs were protected against 
bacteraemia induced by S
+
 (Pei and Blaser, 1990).  
In another study, pregnant sheep were inoculated with S
+
 or S
-
 strains subcutaneously (Grogono-
Thomas et al., 2000). S
+
 strain cells were recovered from all sheep faeces examined while 90% of 
infected animals aborted with C. fetus subsp. fetus being re-isolated from the foetus and placenta 
(Grogono-Thomas et al., 2000). On the contrary, none of the S
-
 inoculated ewes aborted or excreted 
C. fetus cells but if S
-
 was administered intraplacentally, ewes aborted which confirmed that SLP 
enhance dissemination of C. fetus cells to systemic organs using the blood vessels but are not 
required to induce abortion (Grogono-Thomas et al., 2000; Thompson, 2002). 
 
3.3.2. Surface array protein genes 
S-layers or surface arrays consist of protein subunits regularly arranged which have been 
suggested to play an important role in the mediation of the host interaction with Gram-negative 
bacteria including C. fetus subsp. fetus (Blaser and Gotschlich, 1990). SLPs have been found in 
C. fetus field isolates and SDS-PAGE gel electrophoresis showed proteins at 149, 127 and 97-100 
kDa (Blaser and Gotschlich, 1990). Genetic and molecular similarities have been identified by 
comparing these proteins across different isolates, suggesting that SLPs are highly conserved 
(Blaser and Gotschlich, 1990). Some genetic variation of the SLPs has been reported even if these 
proteins must have a conserved genetic expression as suggested by their crystalline organisation and 
their conserved terminal amino acids (Tummuru and Blaser, 1993).  
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The 97 kDa-SLP of C. fetus 23D was found to be encoded by the surface array protein sapA gene 
which was then mapped on the genome of C. fetus subsp. fetus ATCC27374 (Blaser and 
Gotschlich, 1990; Salama et al., 1995). Three copies of the sapA gene exhibiting variable and 
conserved regions were identified on C. fetus 23D (Tummuru and Blaser, 1993). Some differences 
have been found between these genes, leading to variation in the expression of Sap protein epitopes 
(Tummuru and Blaser, 1993). The existence of sapA homologues highlighted the antigenic variation 
mechanism used by C. fetus strains: sapA1 was present in all examined C. fetus strains, even in 
strains lacking SLPs which were able to express the gene sequence when cloned into E. coli, 
indicating that sapA1 is a silent gene (Tummuru and Blaser, 1993). It was suggested that C. fetus 
exhibits antigenic variation as a technique to avoid recognition by the immune system as several 
pathogenic bacteria have been found to successfully evade their host immune system by exhibiting 
superficial structural variation (Tummuru and Blaser, 1993).  
Further investigation of sap genes revealed that SLPs are encoded by several genes: C. fetus 
serotype A 23D had eight genes encoding SLPs which alleles were subsequently named sapA1 to 
sapA7 while C. fetus serotype B 23D exhibited a similar parallel set of genes encoding SLPs 
(Thompson, 2002; Tu et al., 2004). Each gene had highly homologous sequences at the 5’ region 
while the rest of each gene was extremely different, resulting in antigenic variation of the expressed 
SLPs (Tu et al., 2004). All sap genes share a homologous 626 bp region in their 5’ region which 
results in the same terminal amino acid expression, corresponding to the liposaccharide binding 
sites of SLPs (Thompson, 2002). On the contrary, 3’ regions were highly heterologous as few 
nucleotides were shared across alleles resulting in highly variant amino acid expression of sapA 
genes, explaining the antigenic differences between sapA proteins (Thompson, 2002). 
Moreover, in C. fetus, SLP expression can vary quickly, continuously modifying the antigenicity of 
the S-layer, through the recombination with the genes sapC, sapD, sapE and sapF constituting 
6.2 kb of the invertible region (Thompson, 2002). The sapD, sapE and sapF genes encode proteins 
forming a type I transport system, reported to secrete bacterial toxins, proteases and SLPs among 
others (Thompson, 2002). The type I apparatus transports proteins from cytoplasm to outer cell and 
are composed of three proteins homologous to sapD, sapE and sapF (Thompson, 2002). A strain 
mutant for sapD could not bring its SLPs to the cell surface: no SLPs resulted in the absence of the 
S-layer (S
-
), rendering that strain sensitive to killing by serum antibodies (Thompson, 2002). SLP 
secretion therefore relies on sapD, sapE and sapF expression for their transport (Thompson, 2002). 
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3.3.3. The sap island 
 The sap island has been discovered as a chromosomal region of 54 kb where nine sap genes, 
the sapA promoter and genes encoding SLP secretion system are clustered (Tu et al., 2004). This 
finding indicated, along with previous observations, that the sap island resulted from selective 
pressure for SLP antigenic variability by amino acid modifications in order to influence host-
pathogen relationships and to increase virulence of C. fetus isolates (Thompson, 2002; Tu et al., 
2004). 
The sap island was found in all studied strains (n=18) which had the same downstream boundary 
(Tu et al., 2004). The mtfB gene encoding mannosyltransferase B, was identified upstream from the 
sap island on C. fetus 23D strain and its presence was assessed in tested isolates (Tu et al., 2004). It 
was found that all C. fetus subsp. venerealis strains were PCR-positive for mtfB, producing a 697 
bp-fragment, while all C. fetus subsp. fetus strains were PCR-negative (Tu et al., 2004). When the 
PCR product for mtfB was used as a probe, only C. fetus subsp. venerealis strains were positive 
again, confirming mtfB was specific to C. fetus subsp. venerealis (Tu et al., 2004).  
Rearrangements of genomic segments encoding for the S-layer protein have been described to occur 
at a high frequency with a high level of genetic recombination of the sap gene thus is not thought to 
be a suitable target for typing diagnostic samples (Wassenaar and Newell, 2000).  
 
3.4. Cytotoxin production 
 Pathogenesis of enteric Campylobacter spp. has been associated with toxin production 
including enterotoxins and cytotoxins (Wassenaar, 1997). Enterotoxins are proteins which bind to a 
receptor and enter the cell to increase the level of cyclic AMP (cAMP) within the cell resulting in 
variations in ion exchange, causing more fluid secretion and inducing diarrhoea (Wassenaar, 1997). 
The most described enterotoxins are Vibrio cholerae and E. coli heat-labile toxins, both associated 
with watery diarrhoea (Wassenaar, 1997). The C. jejuni toxin was reported to share immunological 
characteristics with the V. cholerae toxins, suggesting that they are similar (Daikoku et al., 1990; 
Wassenaar, 1997). As C. fetus subsp. venerealis infection is not associated with watery diarrhoea 
while all Campylobacter strains reported to produce enterotoxins are, it is unlikely that C. fetus 
subsp. venerealis produce this type of toxin. 
However, toxin sequences were identified in the C. fetus subsp. venerealis AZUL-94 partial 
genome which further concurs with the fact that cytotoxins are present in enteric and non-enteric 
Campylobacter spp. (Moolhuijzen et al., 2009; Wassenaar, 1997). Cytotoxins are proteins which 
kill targeted cells by different modes of action such as inhibiting the synthesis of cellular proteins or 
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the formation of actin filament and are generally associated with bloody diarrhoea (Wassenaar, 
1997). There are six cytotoxins described across Campylobacter spp.: the 70-kDa cytotoxin, the 
Vero/HeLa cell cytotoxin, the Shiga-like toxin, haemolytic cytotoxins, the hepatotoxin and the 
cytolethal distending toxin (CDT; Wassenaar, 1997). Except CDT, these toxins were only reported 
from cases associated with diarrhoea due to C. jejuni or C. coli infections (Wassenaar, 1997). 
Therefore, this review will focus on the CDT only. 
The CDT is heat-labile and sensitive to trypsin, it was first isolated from Shigella, and subsequently 
from E. coli and C. jejuni strains from different sources (Johnson and Lior, 1988). CDT was found 
to affect cell development as HeLa cells treated with CDT from C. fetus subsp. fetus produced 
enormous cells with several nuclei (Johnson and Lior, 1988). This phenomenon was explained by 
the fact that CDT inhibits cytokinesis while nuclear division is not inhibited: CDT initiates 
distension of the nucleus and cytoplasm, allowing them to contain more DNA and resulting in 
growth inhibition and finally cell death (Johnson and Lior, 1988). CDT acts on CHO, HeLa, HEp-2, 
Vero and Y-1 cells and its effects are similar to those of enterotoxins after 24h incubation (i.e. high 
AMP levels and elongated CHO cells) but at 96h, CDT causes extensive cell distension followed by 
death while enterotoxins do not cause cell death (Johnson and Lior, 1988; Wassenaar, 1997). CDT 
was also found to inhibit the cell cycle of different cell types, which was not observed from other 
bacterial toxins (Bang et al., 2003). 
Three genes in C. jejuni 81-176 were identified as cytotoxin coding genes: cdtA, B and C producing 
proteins at 30, 29 and 21 kDa respectively (Pickett et al., 1996). Primers designed from the CDT 
DNA sequence of E. coli isolates were used to amplify CDT-coding fragment in C. jejuni to obtain 
the complete CDT gene (2.6 kb; Pickett et al., 1996). The three cdt genes, expressing cdtA, cdtB, 
cdtC, exhibited conserved structures, despite observed amino acids differences between CDT 
subunits of Campylobacter spp. and E. coli (Pickett et al., 1996). By using bacterial sonicates rather 
than cultures, high CDT titers were detected in HeLa cell assays in 90% of C. jejuni strains tested 
(n=20) while CDT production by all C. coli strains examined (n=12) was low (Pickett et al., 1996). 
Additionally, CDT was detected in C. fetus ATCC27374, C. hyointestinalis ATCC35217, C. lari 
ATCC43675, and C. upsaliensis ATCC43954 indicating that CDT production is common in 
Campylobacter spp. (Pickett et al., 1996). 
The cdtB gene successfully hybridised with all C. jejuni isolates tested while this gene was also 
found in both C. coli and C. jejuni isolates but CDT production was detected only in C. jejuni 
isolates (Dassanayake et al., 2005; Pickett et al., 1996). Another study found that all C. coli and 
C. jejuni isolates tested (n=40) expressed cdtB: 95% were PCR-positive for cdtA and 90% were 
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PCR-positive for cdtC while the cluster of cdt genes was found in 82.5% of isolates (Bang et al., 
2003). However, several strains did not produce CDT in cell assays demonstrating that presence of 
these genes does not always correlate with toxin production while at least one cdt gene was absent 
in 17.5% of isolates tested by PCR and subsequently, no or low CDT was produced which might be 
due to mutations of cdt coding regions (Bang et al., 2003). In another study, the three cdt genes 
were detected in all C. jejuni strains tested (n=11) while toxin production was detected from non-
invasive and invasive strains (Müller et al., 2006). 
Nonetheless, using PCR, detection of putative cdt genes was effectively achieved from 
C. upsaliensis, C. lari, C. hyointestinalis and C. fetus while DNA hybridisation demonstrated weak 
genetic homology of cdtB sequences between Campylobacter spp. (Pickett et al., 1996). This 
implies that cdt genes are heterologous across Campylobacter spp., suggesting variation of CDT 
expression and activity according to species (Wassenaar, 1997). Recently, the three cdt genes were 
found in C. coli, C. jejuni, C. lari, C. upsaliensis (Fouts et al., 2005) while cdtA, cdtB and cdtC 
species-specific primers confirmed presence and conservation of the cdt cluster in C. coli (n=19), 
C. jejuni (n=27) and C. fetus (n=20) reference and clinical isolates (Asakura et al., 2007b). 
As previously reported, CDT activity was not detected in HeLa cell assays from C. coli isolates 
tested while high titers were produced from C. jejuni and C. fetus isolates with CDT production 
varying between strains of the same species while mutation in cdt genes were associated with lower 
CDT production, suggesting that CDT production could correlate with virulence (Asakura et al., 
2007b; Bang et al., 2003). CDT production enhanced C. jejuni adherence and invasion in vitro and 
caused pathogenic changes in mouse intestinal tracts while inoculation of mice with strains not 
producing CDT caused no significant pathologic changes and correlated with reduced adherence 
and invasion in vitro (Jain et al., 2008). Despite the fact that the cdt gene cluster was recently 
identified in both C. fetus subspecies, it is currently unknown if cdt genes are associated with 
C. fetus pathogenicity (Moolhuijzen et al., 2009). 
 
3.5. Type IV secretion systems (T4Ss), plasmids and antibiotic resistance genes 
 T4Ss are thought to influence the virulence of bacterial strains as they constitute channels 
allowing exchange of molecules by conjugation mechanisms, including plasmids (Christie et al., 
2005). Plasmids, once integrated into the recipient genome increase their genetic variability by 
potentially introducing new genes or alleles which might enhance their pathogenicity or virulence 
(Christie et al., 2005). Plasmids have been associated with the virulence of different Campylobacter 
strains and recently, VirB4, VirB6, VirB11 and VirD4 have been identified as C. fetus subsp. 
venerealis-specific T4S proteins (Bacon et al., 2000; Fouts et al., 2005; Moolhuijzen et al., 2009). 
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3.5.1. Type IV secretion systems (T4Ss) 
T4Ss regulate transport of macromolecules across the cell membranes of bacteria and are 
characterised according to their level of relatedness to conjugation systems (Christie et al., 2005). 
Conjugation mechanisms are a large subtype of T4Ss which, by DNA transfer, allow adaptation of 
bacteria to the evolving environment by acquiring traits to increase fitness (Christie et al., 2005). 
Conjugation has enabled genomic rearrangements, increasing the genome plasticity but also 
inducing the acquisition of antibiotic resistance genes and virulence factors (Christie et al., 2005). 
An overview of T4Ss was recently published (Christie et al., 2005). This review will describe the 
main proteins involved. 
T4S subunits, involved in channel formation, are usually grouped into a single operon and twelve of 
these have been identified (Christie et al., 2005). VirB1 is involved in surface structure of flagella 
and pili, bacteriophage uptake and DNA transfer while VirB2 is the main pilin subunit, 
indispensable to secretion mechanisms (Christie et al., 2005). VirB3 and VirB4 seem to act as inner 
membrane functional complexes while the lipoprotein VirB7 is found in few outer membrane T4Ss, 
associated with filament composition (Christie et al., 2005). VirB9 is found in the periplasm or the 
outer membrane of bacteria, involved in pilus assembly and channel formation (Christie et al., 
2005). VirB10, found in the inner membrane, interacts with VirB7, VirB8 and VirB9, and is 
thought to act as a coupling protein (Christie et al., 2005). VirB11 is part of the ATPase group 
involved in macromolecule secretion and enhancing membrane contact needed for T4S biogenesis 
(Christie et al., 2005). VirB4, VirB7, VirB8, VirB9 and VirB10 compose the core complex and are 
all, except VirB7, the most conserved subunits of T4Ss (Christie et al., 2005). The core complex 
weighs over 500 kDa and interaction has been proven between subunits: in H. pylori, VirB4, VirB7 
and VirB10 are located closely together, serving as a channel for DNA uptake (Christie et al., 
2005). 
T4Ss, conserved among all large Campylobacter plasmids and in C. coli, C. jejuni. C. lari and 
C. upsaliensis genomes, were thought to influence plasmid conjugation and transfer of virulence 
determinants (Fouts et al., 2005). T4Ss encoded by plasmids isolated from strains other than 
C. jejuni were highly similar to each other, to pVir and to T4Ss involved in DNA mobilisation and 
were thus presumed to be involved in conjugation rather than secretion (Fouts et al., 2005). Small 
plasmids encoded VirB2-like proteins, involved in pilus formation and DNA transfer, increasing 
DNA mobility while pCU110 encoded proteins may be involved in plasmid DNA transfer (Fouts et 
al., 2005). 
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T4S genes found on plasmids identified in C. coli, C. jejuni were absent from C. fetus subsp. fetus 
82-40 genome but present in C. fetus subsp. venerealis AZUL-94 while C. fetus subsp. venerealis-
specific contigs also contained bacteriophage-associated genes (Fouts et al., 2005; Moolhuijzen et 
al., 2009). It was suggested that the C. fetus subsp. venerealis-specific contigs may have included 
genes of plasmid origin and further research should assess presence of plasmids, T4S and 
bacteriophage genes (Moolhuijzen et al., 2009). This would assist to confirm potential suitability of 
these contigs as diagnostic targets if found absent from plasmids or other mobile elements. 
 
3.5.2. Plasmid and virulence genes 
Plasmids were not thought to be associated with Campylobacter virulence as only few 
plasmids have been isolated from virulent Campylobacter strains while virulent C. jejuni strains 
tested on a pregnant guinea pig model did not contain plasmids (Taylor and Bryner, 1984). These 
observations led to the conclusion that, in the absence of connection between the presence of 
plasmids and disease, Campylobacter pathogenicity does not depend on plasmids. The study of the 
C. jejuni strain 81-176, containing plasmids, allowed the re-evaluation of plasmids and their 
association with the virulence of Campylobacter spp. (Bacon et al., 2000). 
In the reference strain 81-176, two cryptic plasmids were identified: pTet, R plasmid encoding 
resistance to tetracycline, and pVir, encoding proteins similar to the one expressed by the “cag 
pathogenicity island” in H. pylori (Bacon et al., 2000). The tetracycline resistance gene tetO, carried 
by pTet, could not be transferred to other C. jejuni strains by conjugation and it was suggested that 
resistance to tetracycline may be transferred by natural transformation (Bacon et al., 2000). The 
four genes comB1, comB2, comB3, arranged similarly to H. pylori comb genes, and VirB11 were 
identified on the plasmid pVir, encoding proteins homologous to VirB8, VirB9, VirB10 and 
VirB11, secreted by T4Ss and involved in transfer of DNA (Bacon et al., 2000). The genes comB3 
and VirB11 could be associated to virulence as mutant strains for these genes resulted in reduced 
virulence (Bacon et al., 2000). Strains lacking comB3 displayed reduced natural transformation 
frequency compared to the reference strain 81-176 while strains lacking comB3 or VirB11 genes 
exhibited significantly less adherence and internalisation in vitro, even if their invasion ability 
remained higher than those of E. coli or the less virulent C. jejuni NCTC11168 (Bacon et al., 2000).  
Nevertheless, these four genes were not detected in C. jejuni NCTC11168 or other reference strains 
examined only 7.5% of C. coli and C. jejuni isolates tested (n=40) were PCR-positive for VirB11 
and in another study, VirB11 was found in 33% of C. jejuni turkey isolates (n=117; Bacon et al., 
2000; Bang et al., 2003, 2004). These results implied that plasmid genes were at least associated 
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with the virulence of some C. jejuni pathogenic strains while additional determinants must also 
influence Campylobacter virulence (Bacon et al., 2000). 
Other plasmids have been identified in other Campylobacter spp.: C. coli RM2228 and C. lari 
RM2100 strains contain a single plasmid, pCC178 (178 kb) and pCL46 (46 kb) respectively, while 
C. upsaliensis RM3195 had two plasmids: pCU3 (3.1 kb) and pCU110 (110 kb; Fouts et al., 2005). 
No plasmid was detected in C. jejuni ATCC11168 and RM1221 whereas the plasmid pVir was 
found in C. jejuni 81-176 (Fouts et al., 2005). Plasmids pCU110, pCL46 and pVir exhibited a 
similar coding strand but not pCC178, possibly due to the fact that genes coding for antibiotic 
resistance were adjacent to exchangeable genetic elements (Fouts et al., 2005). However, pCU3 was 
the only Campylobacter plasmid found with a defined replication site (Fouts et al., 2005).  
Campylobacter spp. containing large plasmids carry T4S genes (Bacon et al., 2000) and although 
plasmids encoding T4Ss are yet to be identified in C. fetus, a putative VirB6 homologue was found 
in two C. fetus subspecies venerealis isolates while subsequent PCR testing found 77% of C. fetus 
subsp. venerealis isolates tested (n=26) positive (Abril et al., 2007). Putative gene homologues for 
VirB4, VirB6, VirB11 and VirD4 were recently found in C. fetus subsp. venerealis strains but 
absent from C. fetus subsp. fetus while VirB9 was found in both C. fetus subspecies, indicating that 
some T4S genes are conserved in both subspecies while others seem to be subspecies-specific 
(Moolhuijzen et al., 2009). C. fetus subsp. venerealis bv. intermedius was negative on the PCR 
assays designed from these putative T4S gene sequences, showing differences of T4S genes 
between C. fetus subsp. venerealis biovars (Moolhuijzen et al., 2009). This idea is further supported 
by the fact that another VirB11 homologue gene was only found in C. fetus subsp. venerealis bv. 
intermedius (Moolhuijzen et al., 2009). These findings suggest that C. fetus subsp. fetus and C. fetus 
subsp. venerealis biovars might share different plasmid and/or T4S genes found in different C. fetus 
strains (Moolhuijzen et al., 2009). 
Recently, C. fetus strains were studied in order to improve genetic tools and identify potential 
suitable vectors (Kienesberger et al., 2007). All C. fetus subsp. fetus and C. fetus subsp. venerealis 
strains examined did not uptake DNA by transformation: even if competence was induced, only 
conjugation through E. coli allowed DNA uptake by C. fetus strains (Kienesberger et al., 2007). The 
first reported C. fetus plasmid, pCFV108, cryptic plasmid of 3.7 kb was isolated from a C. fetus 
subsp. venerealis strain (Kienesberger et al., 2007). Eighty percent of its genome served to encode 
sequences and the MobA sequence was highly similar to “relaxase” proteins sequences, initiating 
transfer of plasmid DNA in conjugative mechanisms (Kienesberger et al., 2007). The corresponding 
gene was subsequently named mobA whose sequences overlapped with mobC, ORF5 and ORF6 
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sequences (Figure 5), as previously reported from H. pylori cryptic plasmid pHe14 (Kienesberger et 
al., 2007). The smallest pCFV108 fragment necessary to induce replication would contain the repE 
gene and corresponding introns whereas, in absence of repE coding sequences, replication of two 
plasmids still occurred in both C. fetus subspecies (Kienesberger et al., 2007). It was concluded that 
the 90 bp repeat site of pCFV108 (Figure 5) was a good region to control recombinant plasmid 
replication in C. fetus isolates; and, as 90 bp is a small replicon, it could be exploited for vector 
transmission (Kienesberger et al., 2007). 
Figure 5. Map of the cryptic plasmid pCFV108 (Kienesberger et al., 2007).  
 
Very little research has been undertaken to identify plasmids in C. fetus subspecies and despite the 
identification of T4S and plasmid-borne genes in C. fetus subsp. venerealis AZUL-94 partial 
genome (Moolhuijzen et al., 2009), further research is needed to attempt to isolate plasmids from a 
wide collection of C. fetus isolates. 
 
3.5.3. Antibiotic resistance genes 
 All C. fetus strains are susceptible to cephalothin while all C. fetus subsp. fetus and the 
majority of the C. fetus subsp. venerealis strains are resistant to nalidixic acid (OIE, 2012a; On, 
1996). In fact, C. fetus subsp. fetus strains are intrinsically resistant to nalidixic acid and frequently 
susceptible to ciprofloxacin (Taylor and Chau, 1997). The genes gyrA encoding for DNA gyrase A, 
identified from Clostridium perfringens and E. coli, and gyrB, encoding for DNA gyrase B, discovered 
from Bacillus subtilis, were found in C. fetus subsp. fetus ATCC27374 (Salama et al., 1995). 
Susceptibility to ciprofloxacin was found to be associated with a mutation of the gene gyrA mapped 
to the “quinolone resistance determining region” in C. fetus subsp. fetus ATCC27374 (Taylor and 
Chau, 1997). Increased sensitivity of a naturally ciprofloxacin-resistant C. fetus human strain to that 
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antibiotic was obtained by integrating the wild gyrA allele type in a mutant strain via plasmid 
complementation (Kienesberger et al., 2007).  
Antimicrobial susceptibility testing of C. coli RM2228, C. jejuni ATCC11168 and RM1221, C. lari 
RM2100 and C. upsaliensis RM3195 indicated that these five reference strains were resistant to 
vancomycin, trimethoprim, sulfamethoxazole/Tm, oxacillin, nafcillin and cloxacillin, suggesting 
that such antibiotic resistances might be shared by all Campylobacter spp. (Fouts et al., 2005). Most 
C. coli and C. jejuni are indeed intrinsically resistant to bacitracin, cephalothin, novobiocin, 
rifampin, streptogramin B, trimethoprim, vancomycin (Taylor and Courvalin, 1988). C. lari 
RM2100 was also found resistant to fluoroquinolone/quinolone antibiotics due to a mutation of the 
gyrA gene (Fouts et al., 2005). In addition to point mutations in the gene gyrA, in C. coli and 
C. jejuni, resistance to fluoroquinolone antibiotics is also encoded by the CmeABC genes, regulating 
a multidrug efflux pump (Lin et al., 2002; Payot et al., 2006). Resistance to the macrolide 
antibiotics has been associated with point mutations in the 23S rRNA gene in C. coli and C. jejuni 
(Gibreel et al., 2005; Payot et al., 2006). C. coli RM2228 was found resistant to tilmicosin, 
erythromycin, clindamycin and azithromycin due to mutations in all three 23S rRNA genes (Fouts 
et al., 2005). C. upsaliensis RM3195 was the only strain susceptible to almost all β-lactam 
antibiotics probably due to the disruption of a ‘class D β-lactamase’ which was reported as intact in 
the genomes of three of the other strains evaluated (Fouts et al., 2005). C. coli RM2228 also 
acquired resistance to the antibiotics kanamycin and neomycin, through the aminoglycoside 3’-
phosphotransferase carried on the megaplasmid pCC178, which might have resulted from antibiotic 
administration during breeding of animals (Fouts et al., 2005). There were no mutations in gyrA, 
gyrB, 16S rRNA or folP genes, known to encode antibiotic resistance (Fouts et al., 2005). 
Resistance to tetracycline in C. coli is encoded by the gene tetO, carried on the plasmid pTet (see 
section 3.5.2; Bacon et al., 2000). Recently, two antibiotic resistance genes were identified in 
C. fetus subsp. fetus IMD523: tet(44), encoding resistance to tetracycline, doxycycline and 
minocycline through ribosomal protection, and ant(6)-Ib, encoding resistance to streptomycin 
(Abril et al., 2010). Both genes were associated with significant increased antibiotic resistance in 
recombinant mutants while gene disruptions correlated with increased sensitivity to these antibiotics 
(Abril et al., 2010).  
3.6. Phage and genomic island 
The genome of C. jejuni RM1221 contained four integrated elements that C. jejuni 
NCTC11168 did not have: CMLP1, CJ1E2, CJ1E3 and CJ1E4 (Fouts et al., 2005). Firstly, CMLP1, 
the Mu-like bacteriophage, was located upstream of CJE0275, the argC gene, and encoded proteins 
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homologous to Mu bacteriophage (Fouts et al., 2005). However, CMLP1 did not code for specific 
virulence factors but it was suggested the pathogenicity of CMPL1 is facilitated by ‘insertional 
inactivation” (Fouts et al., 2005). The CJ1E4 and CJ1E2 integrated elements were inserted into the 
3’ends of the methyionyl and arginyl-tRNA genes respectively (Fouts et al., 2005). Bacteriophage-
related endonucleases, methylases or repressors encoded by predicted ORFs were found in these 
two elements (Fouts et al., 2005). CJ1E3 seemed to be a genomic island or integrated plasmid rather 
than a bacteriophage as 73% of its proteins were homologous to those encoded by the C. coli 
megaplasmid pCC178 (Fouts et al., 2005).  
Bacteriophages are of special interest as they allow gene movements by lateral or horizontal 
transmission in order to improve bacterial fitness (Fouts et al., 2005; Wagner and Waldor, 2002). 
Genes carrying bacteriophages have been demonstrated to influence bacterial virulence through 
adhesion, invasion, host evasion and production of toxins (Fouts et al., 2005). While only CMLP1 
was proven to be inducible, the fact that the authors did not manage to demonstrate the same 
characteristic for the other elements does not indicate that they are not inducible and thus may still 
impact virulence or increase host fitness (Fouts et al., 2005).  
In addition to the putative T4S genes found in C. fetus subsp. venerealis that shared a degree of 
homology with C. coli, C. jejuni and C. lari, many genes of phage origin were found in unique 
sequences of C. fetus subsp. venerealis AZUL-94 partial genome but absent in the C. fetus subsp 
fetus 82-40 genome (Moolhuijzen et al., 2009). Similarly to plasmid work, further research is 
required to evaluate phage genes from a large collection of C. fetus subsp. venerealis isolates 
(Moolhuijzen et al., 2009).  
The T4S genes reported from C. fetus subsp. venerealis AZUL-94 were recently found on a 
genomic island in C. fetus subsp. venerealis ATCC19438 together with insertion sequences, phage 
integrases and genes of plasmid origin (Figure 6; Gorkiewicz et al., 2010). These characteristics are 
typical of pathogenicity islands (PAIs) that are acquired through horizontal transfer in order to 
increase bacterial fitness and enhance virulence (Gal-Mor and Finlay, 2006). The PAI of C. fetus 
subsp. venerealis ATCC19438 harbours virB2-virB11 and virD4 genes and PCR assays for a 
number of these T4S genes were used to screen a large number of C. fetus isolates (Gorkiewicz et 
al., 2010). The fact that 76% of assessed C. fetus subsp. venerealis strains possessed all assessed 
T4S genes and 14.9% were positive for at least one of the tested genes indicated that this PAI and 
T4S genes are common in C. fetus subsp. venerealis isolates (Gorkiewicz et al., 2010). In contrast, 
none of the C. fetus subsp. fetus strains tested were positive (n=45) suggesting that this PAI is 
specific to C. fetus subsp. venerealis (Gorkiewicz et al., 2010). 
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Figure 6. Pathogenicity island (PAI) identified in C. fetus subsp. venerealis ATCC19438 (top), 
compared to C. fetus subsp. venerealis 84-112 (middle) and plasmid pCC31 found in C. Coli 
(bottom, Gorkiewicz et al., 2010).  
On the other hand, it was recently reported that tet(44) and ant(6)-Ib were part of an “antibiotic 
resistance gene cluster” integrated into a PAI highly similar to the one recently identified in C. fetus 
subsp. venerealis ATCC19438, sharing common T4S genes with C. fetus subsp. fetus IMD523 
(Abril et al., 2010; Gorkiewicz et al., 2010). C. fetus PAIs may be useful to evaluate pathogenicity 
of C. fetus isolates but seem to share too much homology to be used for subspecies differentiation 
(Abril et al., 2010; Gorkiewicz et al., 2010). It is also interesting to note that the parA gene, which 
is the C. fetus subsp. venerealis PCR target exploited by Hum et al. (1997) and McMillen et al. 
(2006, section 0), is found on these PAIs (Figure 6; Abril et al., 2010; Gorkiewicz et al., 2010). 
 
4. Summary 
Currently, C. fetus isolates are differentiated by their ability to grow in the presence of 1% glycine, 
which is considered the gold standard for subspecies identification after isolation of pure cultures 
(OIE, 2012a). Reports of glycine-tolerant C. fetus subsp. venerealis isolates and glycine-sensitive 
C. fetus subsp. fetus isolates, together with the existence of C. fetus subsp. venerealis bv. 
intermedius, complicate accurate subspecies diagnosis (On and Harrington, 2001; Salama et al., 
1992; Vargas et al., 2003; Véron and Châtelain, 1973; Wagenaar et al., 2001). This biochemical 
trait was identified during a taxonomic study performed in 1973 which included only nine C. fetus 
subsp. venerealis strains and 18 C. fetus subsp. fetus strains, questioning the accuracy and validity 
of this characteristic as a reliable biochemical phenotyping test to discriminate C. fetus subspecies 
(OIE, 2012a; On, 1996; Véron and Châtelain, 1973). 
Genomic studies to date provided a great amount of genetic information for Campylobacter spp., 
highlighting structural and substantial genomic differences (Fouts et al., 2005). Such data is needed 
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in order to compare C. fetus subsp. venerealis to other Campylobacter genomes. The partial C. fetus 
subsp. venerealis AZUL-94 genome was aligned to the complete C. fetus subsp. fetus 82-40 
genome to identify putative C. fetus subsp. venerealis-specific gene targets (Moolhuijzen et al., 
2009). Several non-plasmid borne gene targets which could differentiate C. fetus subspecies 
followed by further evaluation of field isolates were identified such as the C. fetus subsp. venerealis 
insertion element ISCfe1 (Abril et al., 2007; Moolhuijzen et al., 2009).  
The real-time PCR assay targeting the parA gene initially detected in Hum’s PCR revealed higher 
C. fetus subsp. venerealis prevalence in Australian cattle which could not be associated with herd 
disease (Hum et al., 1997; McMillen et al., 2006). These findings highlighted that C. fetus subsp. 
venerealis isolates may vary in virulence and methods are needed to assess C. fetus subsp. 
venerealis pathogenicity (Moolhuijzen et al., 2009). This has been further complicated by the 
discovery of the parA gene on C. fetus PAIs (Abril et al., 2010; Gorkiewicz et al., 2010). 
Comparisons of C. fetus subspecies and Campylobacter genomes has also allowed the identification 
of virulence genes shared by both subspecies including Sap proteins, motility and chemotaxis 
genes, which together with new PAI gene targets could assist evaluating the virulence of C. fetus 
subsp. venerealis field isolates (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009). 
 
4.1. Aims 
 Recent research highlighted the need to develop new assays for C. fetus subspecies 
differentiation and to study the biology of virulence in C. fetus subsp. venerealis strains in 
vaccinated and non-vaccinated cattle (McMillen et al., 2006; Moolhuijzen et al., 2009). A wider 
number of isolates from diverse sources and genetic background is required in order to better 
illustrate the diversity of the C. fetus species and its two subspecies. This collection of isolates will 
be used to assess efficacy of newly proposed assays, followed by an assessment of plasmid and 
virulence genes and implications on isolate pathogenicity, which could be verified in animal 
experiments. New assays targeting non-plasmid borne C. fetus subsp. venerealis-specific genes and 
other assays specific for C. fetus subsp. venerealis key virulence genes and/or plasmid genes will be 
evaluated by screening field isolates. A pregnant guinea pig model using isolates shown to be 
epidemiologically associated with reduced reproductive performance and/or positive for virulence 
and/or plasmid genes will assist to determine specificity and the ability of the assays to predict 
disease risk and C. fetus subsp. veneralis virulence in vivo. Thus, the present research aims to 
develop and assess a new panel of molecular assays, using comparative genomics and 
virulence studies, suitable for the sensitive diagnosis of bovine genital campylobacteriosis. 
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On a broader scale, these sensitive molecular tools based on specific gene targets will be able to 
quantify C. fetus subsp. venerealis organisms and ideally differentiate virulent C. fetus subsp. 
venerealis strains that cause significant infertility from less virulent strains. It will result in better 
molecular screening of cattle on a national level, with appropriate advice provided to veterinarians 
and producers in terms of disease management. Cattle experimental infection models will support 
vaccination efficacy and adaptation of vaccine production if revealed to be necessary. The protocols 
developed will improve diagnosis and assist to determine the level of risk of transmission of BGC 
when detected in carrier bulls using the new panel of molecular assays. 
 
4.2. Objectives 
4.2.1. Objective 1: Establishment of a culture collection 
 Firstly, to identify microbiological methods for the isolation and identification of C. fetus 
subsp. venerealis as well as molecular techniques used to characterise C. fetus subsp. venerealis 
strains and virulence and plasmid genes found across Campylobacter spp., a review of the literature 
was undertaken (this chapter). Secondly, to select the optimum microbiological techniques for the 
isolation of C. fetus subsp. venerealis, an evaluation of the different recommended transport and 
culture media will be performed, using pure C. fetus subsp. venerealis and Pseudomonas 
aeruginosa cultures (Chapter 4). To establish a culture collection, current microbiological and 
molecular techniques will then be applied to a large number of abattoir samples in order to screen 
and isolate C. fetus subsp. venerealis cultures. The parA real-time assay as well as additional 
diagnostic tools, will assist identifying positive samples while Hum’s and Abril’s PCR assays will 
be used to confirm identity of resulting cultures in conjunction with biochemical phenotyping 
(Chapter 5; Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006).  
 
4.2.2. Objective 2: Identification of new putative C. fetus subspecies venerealis gene 
targets 
 After comparative analysis of two C. fetus subsp. venerealis biovar genomes (ARC Linkage 
project LP0883837) and the C. fetus subsp. fetus genome (GenBank), new putative subspecies-
specific gene targets will be identified and used for assay development. PCR assays based on these 
new targets will be used to screen the culture collection and results will be compared to biochemical 
phenotypes to assess the specificity of new C. fetus subsp. venerealis-specific assays in order to 
select new gene targets for further diagnostic test development (Chapter 6). 
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4.2.3. Objective 3: Characterisation of putative C. fetus subspecies venerealis 
virulence markers 
 In order to select isolates for animal testing, previously designed virulence and PAI gene 
PCR assays will be used to further characterise the culture collection (Gorkiewicz et al., 2010; 
Moolhuijzen et al., 2009). New putative virulence and plasmid gene targets will also be identified 
from comparative genomic analysis and used for the development of additional new PCR assays to 
assist to predict virulence status of each isolate within the collection (Chapter 7). A pregnant guinea 
pig model will be used to determine if strains are abortifacient while virulent and less virulent 
strains will be selected for further cattle experiments and additional genome sequencing. Samples 
collected from a parallel epidemiological study will be screened using the C. fetus subsp. 
venerealis-specific and putative virulence PCR assays in order to further assess newly developed 
tests. Correlation between animal models, disease occurrence and molecular profiles will be 
evaluated in order to assess the ability of newly designed tests to predict isolate virulence 
potentially associated with disease risk (Chapter 7). 
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CHAPTER 3: CHEMICALS, MEDIA, REAGENTS AND EQUIPMENT 
  
1. General chemicals and reagents 
AnalaR NORMAPUR, VWR International Pty Ltd, Murarrie, QLD, Australia 
EDTA (Ethylenediamine tetraacetic acid) [20301] 
Glycine [101194M] 
Glycerol [24388] 
Arachem, Rowe Scientific Pty Ltd, Sumner Park, QLD, Australia 
Bacteriological charcoal [RM266] 
Bio-Rad Laboratories Pty Ltd, Gladesville, NSW, Australia 
Agarose [161-3100EDU] 
Tris base [161-0716EDU] 
Invitrogen Australia Pty Ltd, Mulgrave, VIC, Australia 
Sterile inactivated bovine serum [16030074] 
Sigma-Aldrich Pty Ltd, Castle Hill, NSW, Australia 
5’Fluoro-uracil [F6627] 
Boric acid [B7901] 
Bromophenol blue [B0126] 
Calcium Chloride (CaCl2) [C1016] 
Cycloheximide [C7698] 
Disodium hydrogen phosphate (Na2HPO4) [S7907] 
Ferrous sulphate [F8048] 
Magnesium sulphate (MgSO4) [M7506] 
Nalidixic acid [N4832] 
Polymixin B [P1004] 
Potassium chloride (KCl) [P1597] 
Potassium dihydrogen phosphate (KH2PO4) [P5655] 
Sodium metabisulphite [31448] 
Sodium pyruvate [P3662] 
Sodium chloride (NaCl) [S7653] 
Trimethoprim [T78883] 
Vancomycin [V2002] 
Yeast extract [Y1625] 
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2. Microbiological media 
2.1. Commercial media 
Becton, Dickinson and Company (BD) Australia, Sydney, NSW, Australia 
Oxidase [261181] 
Catalase reagent dropper [261203] 
BioMérieux Australia Pty Ltd, Baulkham Hills, NSW, Australia 
RapID 20 E
® 
[20701] 
BOC Australia, North Ryde, NSW, Australia  
Microaerophillic special gas mixture (5% O2, 10% CO2, 85% N) [288641G] 
Oxoid Australia, ThermoFisher Scientific Australia Pty Ltd, Adelaide, SA, Australia 
Agar bacteriological (agar n°1) [LP0011]   
Antimicrobial susceptibility discs 
 Ampicillin 10 µg (AMP10) [CT0003B]  
 Apramycin 15 µg (APR15) [CT0545B]  
 Ceftiofur 30 µg (EFT30) [CT1751B] 
 Cephalothin 30 µg (KF30) [CT0010B] 
 Cotrimoxazole 25 µg (SXT25) [CT0052B] 
 Florfenicol 30 µg (FFC30) [CT1754B]  
 Gentamicin 10 µg (CN10) [CT0024B] 
 Lincospectin 109 µg (LS109) [CT1758B] 
 Nalidixic acid 30 µg (NA30) [CT0031B] 
 Neomycin 30 µg (N30) [CT0033B] 
 Polymyxin B 300 units (PB300) [CT0044B] 
 Tetracycline 30 µg (TE30) [CT0054B] 
 Trimethoprim 5 µg (W5) [CT0076B] 
Blood agar base n°2 [CM0271] 
Brilliant green [CM0329]  
Brain-heart infusion (BHI) [CM1135] 
CampyGen
TM
 sachets [CN0025] 
Campylobacter agar base (Karmali) [CM0935] 
Campylobacter selective agar plates [PP2005] 
Campylobacter selective supplement [SR0069] 
Horse blood [HB250] 
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MacConkey Agar n°3 plates [2130]  
Mueller-Hinton agar plates containing sheep blood [PP2192]  
Sheep blood agar (Columbia) plates (SBA) [PP2133] 
Triple iron sugar (TSI) slopes [TM0582] 
Tryptone soya broth [TM1022]  
Vegetable peptone n°1 [VG0100] 
Fluka analytical, Sigma-Aldrich Pty Ltd, Castle Hill, NSW, Australia 
Lead acetate paper [37104] 
L-Cysteine hydrochloride anhydrous [C1276] 
MP Biomedicals, Seven Hills, NSW, Australia  
Sodium succinate [520540980] 
Micromedia Pty Ltd, Moe, VIC, Australia 
Fluid Thioglycollate medium [4115] 
Pro-Lab Diagnostics, Cell BioSciences Pty Ltd, Heidelberg, VIC, Australia 
Microbank™ glass beads [PL.170] 
Remel, ThermoFisher Scientific Australia Pty Ltd, Adelaide, SA, Australia 
McFarland turbidity equivalence turbidity standard 0.5 [20410] 
  
2.2. Laboratory-made media 
1% glycine tolerance medium 
BHI       3.7g 
Yeast extract      0.2 g 
Agar bacteriological n°1   0.07 g 
Glycine     1 g 
Mq H2O      100 ml 
Heat to boiling to dissolve reagents while agitating. Dispense in 10 ml volume in 1 oz McCartney 
bottles. Autoclave at 121°C for 20min. Label Gly and store at 4°C until usage for up to 16 weeks. 
3.5% NaCl medium 
BHI      3.7g 
Yeast extract      0.2 g 
Agar bacteriological n°1   0.07 g 
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Sodium chloride (NaCl)   3 g 
Mq H2O      100 ml 
Heat to boiling to dissolve reagents while agitating. Dispense in 10 ml volume in 1 oz McCartney 
bottles. Autoclave at 121°C for 20min. Label NaCl and store at 4°C until usage for up to 16 weeks. 
Brain-heart infusion (BHI) enrichment broth 
BHI       3.7 g 
Yeast extract      0.2 g 
Agar bacteriological n°1   0.07 g 
Mq H2O      100 ml 
Heat to boiling to dissolve reagents while agitating. Dispense in 10 ml volume in 1 oz McCartney 
bottles. Autoclave at 121°C for 20min. Label BHI and store at 4°C until usage for up to 16 weeks. 
Clark’s TEM (Hum and McInnes, 1993) 
5’Fluoro-uracil     0.150 g 
Nalidixic acid (0.1% solution)   1.5 ml 
Polymyxin B (100 000 IU/ml)   0.5 ml 
Cycloheximide (0.1% solution)   5.0 ml 
Brilliant green (0.1% solution)   25 ml 
Sterile inactivated bovine serum   500 ml 
Dissolve 5’Fluoro-uracil in 100 ml of serum by heating to 56°C and agitating. Add dissolved 
reagents to remaining serum, add nalidixic acid and mix. Add other reagents and mix. Dispense in 
10 ml volume in 1 oz McCartney bottles with lids equipped with a neoprene seal and an inoculation 
hole. Place bottles in a bucket with some water and heat until medium just starts to coagulate. Cool 
and mash the medium in each bottle using a sterile pipette. Loosen lids, place bottles in the 
microaerophillic workstation for 4h. Tighten lids and store at 4°C for up to three months. 
FBP medium (Gorman and Adley, 2004) 
BHI or vegetable peptone n°1  5 g  
Agar bacteriological n°1   0.24 g 
Glycerol     30 ml 
Yeast extract     0.2 g 
Mq H2O     200 ml 
Growth supplement    4 ml 
Dissolve BHI (or vegetable peptone n°1), agar bacteriological n°1 and yeast extract in water by 
heating to 56°C and agitating. Add glycerol and autoclave at 121°C for 20min. Cool in water bath 
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to 56°C for 1h. Add growth supplement aseptically and dispense 150 µl in sterile Wheaton vials. 
Store at 4°C until use. 
H2S detection medium 
Brain-heart infusion     3.7g 
Yeast extract      0.2 g 
Agar bacteriological n°1   0.07 g 
Cysteine-HCl     0.03 g 
Mq H2O      100 ml 
Heat to boiling to dissolve reagents while agitating. Dispense in 10 ml volume in 1 oz McCartney 
bottles. Autoclave at 121°C for 20min. Label H2S and store at 4°C until usage for up to 16 weeks. 
Growth supplement 
Sodium pyruvate (0.0625 g/ml)   5g 
Sodium metabisulfite (0.0625 g/ml)  5g 
Ferrous sulphate (0.0625g/ml)   5g 
Mq H2O      80 ml 
Heat to 56°C to dissolve reagents while agitating. Filter through 0.2 µm sterile filter. Dispense into 
10 ml aliquots. Store at -4°C until usage. 
Karmali agar plates 
Campylobacter agar base (Karmali)  21.5 g 
Mq H2O      500 ml 
Lysed horse blood     35 ml 
Growth supplement    2 ml 
Cycloheximide (0.01g/ml)    5 ml 
Vancomycin (0.004g/ml)    2.5 ml 
Trimethoprim (0.002g/ml)    2.5 ml 
Polymyxin B (100 000 IU/ml)   12.5 µl 
Dissolve Campylobacter agar base (Karmali) in water by heating to 56°C and agitating. Autoclave 
at 121°C for 20min. Cool into water bath to 56°C for 1h. Add aseptically growth supplement, 
antibiotics and lysed horse blood and mix gently. Pour plates into sterile Petri dishes, label them 
KA and let them cool down before storage for up to 16 weeks. 
Modified Lander’s TEM (Hum et al., 2010) 
Mueller-Hinton broth     21 g 
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Bacteriological charcoal   5 g 
Mq H2O      1 000 ml 
Lysed horse blood     70 ml 
Growth supplement    4ml 
Cycloheximide (0.01 g/ml)    10 ml 
Vancomycin (0.004 g/ml)    5 ml 
Trimethoprim (0.002 g/ml)    5 ml 
Polymyxin B (100 000 IU/ml)   25 µl 
Dissolve Mueller-Hinton broth and bacteriological charcoal in water by heating to 56°C and using a 
stirrer bar. Leave stirrer bar in bottle and autoclave at 121°C for 20min. Cool in water bath to 56°C 
for approximately 1h. Add aseptically growth supplement, antibiotics and lysed horse blood. 
Dispense in sterile 10 ml vials whilst stirring to avoid charcoal settling. Store at 4°C for up to 18 
weeks. 
Modified Skirrow agar plates (Hum and McInnes, 1993) 
Blood agar base n°2    40 g 
Mq H2O     1 000 ml 
Lysed horse blood     70 ml 
Growth supplement    4ml 
Cycloheximide (0.01 g/ml)    10 ml 
Vancomycin (0.004 g/ml)    5 ml 
Trimethoprim (0.002 g/ml)    5 ml 
Polymyxin B (100 000 IU/ml)   25 µl 
Dissolve blood agar base in water by heating to 56°C and agitating. Autoclave at 121°C for 20min. 
Cool in water bath to 56°C for 1h. Add aseptically growth supplement, antibiotics and lysed horse 
blood and mix gently. Pour into sterile Petri dishes, label them SK and let them cool down before 
storage at 4°C for up to 16 weeks. 
Phosphate buffered saline (PBS)  
Sodium chloride (NaCl)    8 g 
Potassium chloride (KCl)     0.2 g 
Potassium dihydrogen phosphate (KH2PO4)   0.24 g 
Disodium hydrogen phosphate (Na2HPO4)   1.44 g 
Mq H2O      1 000 ml 
Dissolve all reagents in 900 ml of water. Adjust pH to 7.2-7.4 using 1 M NaOH or 1 M HCl. Adjust 
volume to 1 L. Sterilise by autoclaving at 121°C for 20min.  
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Vegetable peptone enrichment broth:  
Vegetable peptone n°1    10 g 
Sodium succinate     2 g 
Yeast extract       5 g 
Sodium chloride (NaCl)    5 g 
Magnesium sulphate (MgSO4)   0.01 g 
Calcium Chloride (CaCl2)    13.24 mg 
Agar bacteriological n°1     1.5 g 
Mq H2O      1 000 ml 
Dissolve agar in 100 ml of water by boiling for 10min. Dissolve all other reagents in 800 ml of 
water, add dissolved agar and adjust volume to 1 L. Adjust pH to 6.8-6.9 using 1 M NaOH or 1 M 
HCl. Boil for 5min to disperse agar. Dispense in 10 ml volume in 1 oz McCartney bottles. Sterilise 
by autoclaving at 121°C for 20min.  
  
3. Molecular reagents and kits 
3.1. Commercial reagents 
5 Prime, Quantum Scientific, Paddington, QLD, Australia 
10× Hotmaster™ Taq buffer [2200310] 
Hotmaster™ Taq DNA polymerase [2200310] 
RealMasterMix Probe 2.5x [2200700] 
Biotium, Jomar Diagnostics P/L, Stepney, SA, Australia 
GelRed
TM
 Nucleic Acid Gel Stain, 10 000x in water [4103-1] 
Fermentas, ThermoFisher Scientific Australia Pty Ltd, Adelaide, SA, Australia 
MassRuler
TM
 Low range DNA ladder, Ready-to-Use, 80-1 031 bp [SM0383] 
Invitrogen, Life Technologies Australia Pty Ltd, Mulgrave, VIC, Australia 
100 mM dNTP set [2200310] 
TOPO® TA Cloning® Kit (with pCR®2.1-TOPO®) with One Shot TOP10 Chemically Competent 
E. coli and PureLink™ Quick Plasmid Miniprep Kit [K450002] 
BigDye® Terminator version 3.1 Cycle Sequencing Kit, Applied Biosystems® [4337455] 
QIAGEN Pty Ltd, Chadstone, VIC, Australia 
QIAamp DNA mini kit [51306] 
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USB, in vitro, Noble Park North, VIC, Australia 
Affymetrix USB ExoSAP-IT® For PCR Product Clean-Up, 1mL [SB78201] 
 
3.2. Laboratory-made reagents 
6X loading buffer 
Glycerol     3 ml 
Bromophenol blue    25 mg 
Mq H2O     10 ml 
Mix glycerol and bromophenol blue and adjust volume to 10 ml with water. Store at 4°C. 
Tris-Borate EDTA (TBE) buffer 10X stock 
TRIS base     107.8 g 
Boric acid     55 g 
EDTA (0.5M) pH 8.0    40 ml 
Mq H2O     1 000 ml   
Dissolve above reagents in 800 ml of water and adjust pH to 8.3 using boric acid. Add water to 
adjust volume to 1 L. 
TBE buffer 1X 
TBE buffer 10X stock   200 ml 
Mq H2O     1 800 ml 
Make a working solution by diluting the X10 stock 1: 10. 
2% TBE agarose gel containing 1% GelRed
TM
 Nucleic Acid Gel Stain 
Agarose     8 g 
TBE 1X     400 ml 
GelRed
TM
 Nucleic Acid Gel Stain  40 µl 
Dissolve agarose in TBE in a 500 ml bottle with the lid on and loosen by melting in the microwave. 
Add 40 µl of GelRed
TM
 Nucleic Acid Gel Stain and swirl gently to mix. Cool into water bath to 
55°C. Seal electrophoresis tray with autoclave tape and place it onto a level area. Place combs into 
the tray (12 or 26 welled-comb) and pour cooled agarose half way up the comb teeth. Let set for 
approximately 1h. Remove autoclave tape and place tray into electrophoresis chamber filled with 
TBE 1X. Remove combs gently. Load gel by combining 1 µl of 6X loading buffer with either 1.6 µl 
of DNA ladder or 5 µl of PCR product. Place the lid and run gel at 80V for approximately 45min. 
Visualise gel using GelDoc
TM
 XR+ system and save gel picture. 
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4. Equipment and softwares 
 Applied Biosystems, Foster city, California, USA 
3130xl Genetic Analyzer  
Primer Express version 2 
Bio-Rad Laboratories Pty Ltd, Gladesville, NSW, Australia 
DNA Engine
®
 Thermal Cycler  
GelDoc
TM
 XR+ system  
Sub-Cell
®
 Model 192 Agarose Gel Electrophoresis systems 
Corbett Life Science, QIAGEN Pty Ltd, Chadstone, VIC, Australia 
Corbett Rotor-Gene RG-3000   
Don Whitley Scientific Pty Ltd, North Gosford, NSW, Australia 
Whitley DG250 Workstation 
Gene Codes Corporation, Ann Arbor, Michigan, USA 
Sequencher version 4.5 
Weber Scientific International Ltd, Teddington, United Kingdom 
Improved Neubauer haemocytometer  
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CHAPTER 4: OPTIMISATION OF CAMPYLOBACTER FETUS SUBSPECIES 
VENEREALIS MICROBIOLOGICAL ISOLATION METHODS 
 
1. Introduction 
As described in Chapter 2 (section 2.1.1), it is well recognised that isolation of C. fetus organisms is 
difficult (Clark, 1971; Eaglesome and Garcia, 1992; Hum et al., 1994a; Lander, 1990a; Monke et 
al., 2002). This is due to their sensitive growth requirements, limited survival under normal 
atmosphere and the rapid overgrowth of contaminants in clinical samples (Clark, 1971; Clark and 
Dufty, 1978; Hum et al., 1994a; Lander, 1990a; Vargas et al., 2003). To limit overgrowth of 
contaminants and maximise survival of C. fetus organisms upon arrival to the laboratory, samples 
are inoculated into TEM, prior to the inoculation of selective growth medium incubated under 
microaerophilic conditions (Clark and Dufty, 1978; Hum et al., 1994a; Lander, 1990a; Monke et al., 
2002; OIE, 2012a).  
Routine adoption of TEMs, selective culture media and microaerophilic growth conditions has 
increased the rate of C. fetus subsp. venerealis isolation (Clark et al., 1974; Lander, 1990b; Lander 
and Gill, 1985; Monke et al., 2002; OIE, 2012a; Vargas et al., 2003). Despite the development of 
international standards, a large number of laboratory-specific selective culture and transport media 
are still used to isolate C. fetus subsp. venerealis (OIE, 2012a; van Bergen, 2005a). In a local 
Australian diagnostic laboratory (personal observation from samples accessed through the 
Biosecurity Queensland bacteriological laboratory, DAFF), bovine preputial samples are frequently 
contaminated with Pseudomonas aeruginosa, which limits isolation of C. fetus subsp. venerealis, 
despite following recommended procedures (Hum and McInnes, 1993; OIE, 2012a).  
The aim of this chapter was to evaluate different TEMs and selective growth media in order to 
determine the optimum culture methods for C. fetus subsp. venerealis isolation using pure cultures 
of C. fetus subsp. venerealis and P. aeruginosa. As TEMs usually require up to three days to reach a 
diagnostic laboratory under Australian field conditions, extended transport time was here simulated 
in order to assess chances of C. fetus subsp. venerealis recovery after prolonged transport. This 
study was undertaken to assist in the selection of media and procedures to be subsequently applied 
to isolate C. fetus subsp. venerealis from bovine abattoir samples (Chapter 5). 
   
2. Methods 
2.1. Bacterial strains 
 The C. fetus subsp. venerealis DAFF reference isolate 98-109383 and a P. aeruginosa field 
isolate (PA240609) were used to evaluate the different TEMs and selective growth media. 
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Commercially purchased and laboratory-made media, biochemical tests as well as antibiotics used 
to culture and characterise these two isolates are detailed in Chapter 3. 
The C. fetus subsp. venerealis reference isolate 98-109383 (used as positive control for C. fetus 
subsp. venerealis) was sourced from the Biosecurity Queensland bacteriological laboratory (DAFF) 
and grown at 37°C for 48h under microaerophillic conditions in brain-heart infusion (BHI) 
enrichment broth (3.7% BHI, 0.2% yeast extract, 0.07% agar bacteriological n°1). In addition to 
microscopic examination confirming the presence of small Gram-negative curved rods, a range of 
phenotypic tests were utilised as currently recommended (OIE, 2012a). These included: oxidase and 
catalase tests, the ability to grow at 25°C and 42°C, growth in the presence of 1% glycine or 3.5% 
sodium chloride (NaCl), production of H2S using TSI slopes (Oxoid) and cysteine-HCl medium 
using lead acetate paper, and susceptibility to nalidixic acid (30 µg) and cephalothin (30 µg).  
A pure Pseudomonas sp. culture was isolated from a bull preputial sample obtained from a local 
abattoir and submitted to the Biosecurity Queensland bacteriological laboratory (DAFF) for BGC 
testing on the 24
th
 of June 2009. The isolate was picked from a sheep blood agar (SBA, Oxoid) 
incubated at 37°C aerobically. This field isolate, named PA240609, was identified as P. aeruginosa 
after microscopic examination of Gram-negative rods, on the basis of oxidase and catalase-positive 
results, production of a typical metallic oil-like pigment and grape-like odour as well as its ability to 
grow on MacConkey agar plates (Oxoid) and at 42°C (Garrity et al., 2005b). Its identity was further 
confirmed by the API 20E
®
 (Biomérieux). P. aeruginosa PA240609 was cultured in tryptone soya 
broth (Oxoid) under the same conditions until growth was equivalent to a McFarland turbidity 
standard 0.5, corresponding to approximately 1.5 x 10
8
 cells/ml. Mueller-Hinton plates containing 
sheep blood agar (Oxoid) were used to assess the antimicrobial sensitivity of P. aeruginosa 
PA240609 and of P. aeruginosa DAFF reference isolate Q13 against ampicillin (10 µg), apramycin 
(15 µg), ceftiofur (30 µg), cotrimoxazole (25 µg), lincospectin (109 µg), neomycin (30 µg), 
tetracycline (30 µg), florfenicol (30 µg) and gentamicin (10 µg) following Biosecurity Queensland 
(DAFF) internal procedures based on recommended standards (CLSI, 2011). Resistance to 
polymyxin B (300 units) and trimethoprim (5 µg) were also tested as these two antibiotics are 
included in TEMs and culture media evaluated in this chapter (section 2.2).  
 
2.2. TEMs, selective culture media and incubation conditions 
 Three TEMs were compared in this chapter: sterile phosphate-buffered saline (PBS), Clark’s 
TEM (Hum and McInnes, 1993) and the modified Lander’s TEM (Hum et al., 2010) as well as three 
selective culture media: Campylobacter selective agar plates (Oxoid), Karmali (Karmali et al., 
1986) agar (Oxoid) plates and modified Skirrow agar plates (Hum and McInnes, 1993). The 
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modified Skirrow and Karmali agar plates were supplemented with the same antimicrobial agents 
(100 µg/ml cycloheximide, 20 µg/ml vancomycin, 10 µg/ml trimethoprim, 2 500 IU/ml polymyxin 
B) and growth factors (0.025% ferrous sulphate w/v, 0.025% sodium metabisulphite w/v, 0.025% 
sodium pyruvate w/v) as contained in the modified Lander’s TEM (Hum et al., 2010). 
Commercially purchased and laboratory-made media are detailed in Chapter 3. Transport and 
enrichment media (TEMs) were incubated under aerobic conditions at 37°C and selective culture 
media were incubated at 37°C in 75% humidity, using either anaerobic jars and CampyGen
TM
 
microaerophilic sachets (Oxoid) or using a workstation (Don Whitley Scientific) with a 
microaerophilic gas mixture (5% O2, 10% CO2, 85% N; see Chapter 3).  
   
2.3. Evaluation of TEMs and selective culture media spiked with pure cultures 
2.3.1. C. fetus subsp. venerealis pure culture 
 Eight 10 ml-sterile tubes of each of the three TEMs (PBS, Clark’s TEM and modified 
Lander’s TEM) were inoculated with 100 µl of brain-heart infusion enrichment broth containing 
C. fetus subsp. venerealis 98-109383 at a concentration of approximately 7.5 x 10
7
 cells/ml 
(McFarland standard 0.25). To simulate transport time, two tubes of each TEM were stored at room 
temperature for 4h, 24h, 48h and 72h. Once simulated transport time was reached, aliquots of 10 µl 
of each TEM were used to inoculate the three selective culture media (modified Skirrow, Karmali 
and Campylobacter selective agar plates) using plastic disposable loops. Following storage at room 
temperature for the different time periods, TEMs were also incubated at 37°C for one or three days 
and subsequently, 10 µl of each TEM were used to inoculate the different selective culture media as 
described above. Selective culture media were incubated at 37°C in a microaerophilic workstation 
(Don Whitley Scientific) and visually inspected for the presence of C. fetus subsp. venerealis 
colonies at 48h, 72h and seven days after plate inoculation. Bacterial growth of C. fetus subsp. 
venerealis was recorded as heavy (>50
 
colonies), moderate (10-50 colonies) or light (<10
 
colonies). 
   
2.3.2. C. fetus subsp. venerealis/P. aeruginosa mixed culture 
 The same experiment (section 2.3.1) was repeated using a C. fetus subsp. venerealis 98-
109383 BHI enrichment broth (approximately 7.5 x 10
7
 cells/ml) spiked with 10 µl of 
P. aeruginosa PA240609 pure culture (approximately 1.5 x 10
8
 cells/ml, McFarland turbidity 
standard 0.5). The mixed C. fetus subsp. venerealis/P. aeruginosa broth was used to inoculate eight 
10 ml-sterile tubes of Clark’s and modified Lander’s TEMs, which were subjected to the same 
procedures outlined in section 2.3.1. Recovery of C. fetus subsp. venerealis colonies was evaluated 
as described in section 2.3.1 while overgrowth by P. aeruginosa was recorded as complete (100% 
of the plate), heavy (2/3 of the plate), moderate (1/3 of the plate) and light (few colonies). 
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3. Results 
3.1. Biochemical phenotyping and antimicrobial sensitivity of tested bacterial strains 
 The DAFF reference isolate 98-109383 was confirmed to be C. fetus subsp. venerealis bv. 
venerealis (Table 3) using OIE recommended biochemical tests (OIE, 2012a). The P. aeruginosa 
field isolate PA240609 had a similar antimicrobial resistance profile compared to P. aeruginosa 
DAFF reference isolate Q13 with the exception of having intermediate susceptibility for neomycin 
(30 µg) whereas Q13 was resistant (Table 4). 
Table 3. Biochemical phenotyping of the C. fetus subsp. venerealis reference isolate 98-109383 
based on tests recommended by the World Organisation for Animal Health (OIE, 2012a). 
 25°C 42°C Oxidase Catalase 1% 
glycine 
H2S
a
  H2S
b
 3.5% 
NaCl 
Nalidixic 
acid 
Cephalothin 
C. fetus subsp. 
venerealis 
V - + V - - V
1 
- V S 
98-109383 + - + + - - - - R S 
V= variable (positive or negative) 
R= resistant; s= Susceptible 
a 
Using triple iron sugar (TSI) slope; 
b
 in cysteine-HCl medium using lead acetate paper 
1
Biovar venerealis: negative; biovar intermedius: positive  
Table 4. Antimicrobial sensitivity of the P. aeruginosa PA240609 compared to P. aeruginosa Q13 
following Biosecurity Queensland procedures based on recommended standards (CLSI, 2011). 
 Zone size (mm) P. aeruginosa Q13 P. aeruginosa PA240609 
 R I S Zone size (mm) Result Zone size (mm) Result 
Ampicillin (10 µg)  ≥ 13 14–16 ≤ 17 6.5 R 6.5 R 
Apramycin (15 µg) ≥ 11 12-14 ≤ 15 13.6 I 13 I 
Ceftiofur (30 µg)  ≥ 17 18-20 ≤ 21 16.2 R 12.7 R 
Cotrimoxazole (25 µg) ≥ 10 11-15 ≤ 16 6.3 R 6.5 R 
Lincospectin (109 µg) ≥ 10 11-12 ≤ 13 16.5 S 16.3 S 
 Neomycin (30 µg)  ≥ 12 13-16 ≤ 17 7.5 R 12.6 I 
Tetracycline (30 µg)  ≥ 11 12-14 15 11.9 I 13.2 I 
Florfenicol (30 µg)  ≥ 14 15-18 ≤ 19 6.5 R 6.5 R 
Gentamicin (10 µg)  ≥ 12 13-14 ≤ 15 16.3 S 15.5 S 
Polymyxin B (300 units)  ≥ 8 9-11 ≤ 12 13.9 S 15 S 
Trimethoprim (5 µg) ≥ 10 11-15 ≤ 16 6.5 R 6.5 R 
R= Resistant; I= Intermediate; S= Susceptible 
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3.2. Media spiked with a pure C. fetus subsp. venerealis culture 
Table 5. Comparison of three transport and enrichment media (TEMs; PBS, modified Lander’s and 
Clark's TEMs) and three selective culture media (modified Skirrow SK, Karmali KA and 
Campylobacter C) under different conditions of simulated transport and incubation using a pure 
C. fetus subsp. venerealis culture. Growth of colonies was recorded as: - (no growth), + (light, <10 
colonies), + + (moderate, 10-50 colonies) and +++ (heavy, >50
 
colonies) while dried plates were 
discarded (x). 
   Growth of colonies after incubation of selective culture media 
   48h 72h 7 days 
Simulated 
transport 
of TEMs 
Incubation 
of TEMs 
Plate 
Modified 
Lander 
Clark PBS 
Modified 
Lander  
Clark PBS 
Modified 
Lander 
Clark PBS 
4h 
0 day 
SK + + + + +++ +++ ++ +++ ++ 
KA +++ +++ +++ +++ +++ +++ +++ +++ +++ 
C ++ ++ ++ ++ ++ +++ ++ +++ +++ 
1 day 
SK +++ ++ + +++ +++ ++ +++ +++ ++ 
KA +++ +++ ++ +++ +++ ++ +++ +++ +++ 
C ++ +++ + +++ +++ ++ +++ +++ ++ 
3 days 
SK +++ +++ + +++ +++ + ++ +++ ++ 
KA +++ +++ ++ +++ +++ ++ +++ x x 
C +++ +++ ++ +++ +++ ++ +++ +++ ++ 
24h 
0 day 
SK + +++ + ++ +++ + ++ +++ ++ 
KA + +++ + ++ +++ + +++ +++ ++ 
C + ++ + ++ ++ + ++ +++ ++ 
1 day 
SK ++ +++ ++ +++ +++ ++ +++ +++ ++ 
KA +++ +++ + +++ +++ + +++ +++ ++ 
C +++ +++ + +++ +++ + +++ +++ ++ 
3 days 
SK +++ +++ ++ +++ +++ +++ x +++ +++ 
KA +++ +++ +++ +++ +++ +++ +++ +++ +++ 
C +++ +++ +++ +++ +++ +++ +++ +++ +++ 
48h 
0 day 
SK +++ ++ - +++ ++ - +++ ++ - 
KA +++ + - +++ ++ + +++ ++ ++ 
C +++ + - +++ ++ - +++ ++ - 
1 day 
SK ++ + - +++ ++ - +++ +++ - 
KA ++ ++ - +++ +++ - x +++ - 
C ++ ++ - +++ +++ - +++ +++ - 
3 days 
SK +++ +++ - +++ +++ + +++ +++ ++ 
KA +++ +++ - +++ +++ + +++ +++ ++ 
C ++ + - +++ +++ - +++ +++ + 
72h 
0 day 
SK ++ + - +++ ++ - +++ ++ - 
KA ++ + - +++ ++ - +++ x x 
C ++ + - +++ ++ - +++ ++ - 
1 day 
SK +++ +++ - +++ +++ - x x - 
KA +++ +++ - +++ +++ - +++ +++ - 
C +++ +++ + +++ +++ + +++ +++ ++ 
3 days 
SK +++ +++ - +++ +++ + +++ +++ ++ 
KA +++ +++ - +++ +++ + +++ +++ ++ 
C +++ +++ - +++ +++ + +++ +++ ++ 
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When spiked TEMs were stored for 4h after inoculation (simulated transport time) and plated onto 
selective culture media with or without TEM incubation, the C. fetus subsp. venerealis recovery 
from Clark’s and modified Lander’s TEMs was comparable, with longer incubation of agar plates 
leading to more confluent growth (Table 5). When simulated transport time was extended to 24h 
with or without TEM incubation before plating, Clark’s TEM promoted more C. fetus subsp. 
venerealis growth compared to the modified Lander’s TEM or PBS (Table 5). When storage of 
spiked TEMs was extended to 48h and 72h (simulated transport time), more growth was obtained 
from the modified Lander’s TEM following 24h incubation after storage at room temperature, with 
longer incubation of selective culture media resulting in more abundant C. fetus subsp. venerealis 
recovery (Table 5).  
Compared to Clark’s and the modified Lander’s TEMs, a low number of C. fetus subsp. venerealis 
colonies was recovered from PBS under most of the different tested conditions (Table 5). Using 
PBS as a TEM resulted in light C. fetus subsp. venerealis growth and poor recovery following 
prolonged storage (Table 5). If PBS vials were stored at room temperature for up to 24h and the 
inoculated selective culture media were incubated for seven days; satisfactory C. fetus subsp. 
venerealis recovery was obtained (Table 5).  
Incubation of TEMs at 37°C prior to culture led to heavier C. fetus subsp. venerealis growth if 
TEMs were left at room temperature for less than 48h. When TEMs were stored at room 
temperature for 48h to 72h, incubation of TEMs prior to inoculation of selective culture media did 
not increase C. fetus subsp. venerealis recovery (Table 5).  
Comparison of modified Skirrow, Karmali or Campylobacter selective agar plates did not identify a 
single test selective culture medium that was superior to the others in supporting growth of C. fetus 
subsp. venerealis colonies. However, longer incubation times promoted better C. fetus subsp. 
venerealis recovery, with 72h incubation necessary to obtain heavy growth of C. fetus subsp. 
venerealis regardless of TEM simulated transport and incubation times (Table 5).  
 
3.3. Media spiked with a C. fetus subsp. venerealis/P. aeruginosa mixed culture 
 Use of the modified Lander’s TEM did not eliminate P. aeruginosa as a contaminant, 
resulting in inhibition of C. fetus subsp. venerealis growth except for the following test conditions: 
1) if it was immediately plated out within 4h of storage at room temperature;  
2) if it was stored for up to 24h at room temperature and incubated at 37°C for one day prior to 
inoculation of selective culture media (Table 6).  
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Table 6. Comparison of two transport media (Clark's and modified Lander’s TEMs) and three 
slective culture media (Skirrow SK, Karmali KA and Campylobacter C plates) under different 
conditions of simulated transport and incubation using a mixed C. fetus subsp. venerealis/P. 
aeruginosa culture. Recovery of C. fetus subsp. venerealis colonies was recorded as - (no growth), 
+ (light, <10 colonies), + + (moderate, 10-50 colonies) and +++ (heavy, >50
 
colonies) while dried 
plates were discarded (x). Overgrowth by P. aeruginosa was recorded as  (light, few colonies),  
(moderate, 1/3 of the plate),  (heavy, 2/3 of the plate) and  (confluent, 100% of the plate).  
   Incubation time of plates 
   48h 72h 7 days 
Simulated transport  
of TEMs 
Incubation  
of TEMs 
Plate 
Modified 
Lander 
Clark 
Modified 
Lander 
Clark 
Modified 
Lander 
Clark 
4h 
0 day 
SK ++ ++ ++ ++ +++ +++ 
KA ++ ++ ++ ++  ++ 
C ++ ++ ++ ++ +++ +++ 
1 day 
SK  +++  +++ x +++ 
KA  +++  +++ x +++ 
C  +++  +++ x +++ 
3 days 
SK  +  ++ x +++ 
KA  +  +++ x  
C  ++  +++ x +++ 
24h 
0 day 
SK  +  ++ x ++ 
KA  ++  +++ x +++ 
C  +  ++ x ++ 
1 day 
SK  +++  +++ x +++ 
KA + +++  +++ x +++ 
C + +++  +++ x +++ 
3 days 
SK x x  +++ x +++ 
KA x x  +++ x +++ 
C x x  +++ x +++ 
48h 
0 day 
SK     x  
KA     x  
C  ++  +++ x +++ 
1 day 
SK  +  +++ x +++ 
KA  +  +++ x +++ 
C  +  +++ x +++ 
3 days 
SK x x  +++ x +++ 
KA x x  ++ x  
C x x  +++ x +++ 
72h 
0 day 
SK  +  +++ x +++ 
KA  +  ++ x ++ 
C  -  + x ++ 
1 day 
SK x x  +++ x +++ 
KA x x  +++ x +++ 
C x x  +++ x +++ 
3 days 
SK  +++  +++  +++ 
KA  +++  +++  +++ 
C  +++  +++  +++ 
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Clark’s TEM permitted C. fetus subsp. venerealis recovery while limiting growth of P. aeruginosa, 
with the amount of C. fetus subsp. venerealis growth dependent on TEM simulated transport time 
and length of incubation at 37°C (Table 6). When Clark’s TEM was stored at room temperature for 
up to 24h (simulated transport), 24h incubation increased C. fetus subsp. venerealis recovery while 
prolonged TEM incubation (3 days) favoured overgrowth by P. aeruginosa (Table 6).  
When comparing recovery of C. fetus subsp. venerealis in the presence of P. aeruginosa from the 
three test selective culture media, only Campylobacter selective agar plates inhibited growth of 
P. aeruginosa while yielding a satisfactory number of C. fetus subsp. venerealis colonies under 
most tested conditions (Table 6). 
In the presence of P. aeruginosa, Clark’s TEM stored at room temperature for up to 48h (simulated 
transport) and incubated at 37°C for one day prior to inoculation of Campylobacter selective agar 
plates provided the best combination of TEM and culture media for C. fetus subsp. venerealis 
recovery (Table 6). 
  
4. Discussion 
Previous studies have assessed different TEMs and selective culture media with most researchers 
favouring Lander’s TEM even if C. fetus subsp. venerealis isolation was also achieved from Clark’s 
TEM (Clark and Dufty, 1978; Clark et al., 1974; de Lisle et al., 1982; Hum et al., 1994a; Jones et 
al., 1985; Lander, 1990a, 1990b; Monke et al., 2002). In this study, comparison of Clark’s and 
modified Lander’s TEMs indicated that both TEMs are suitable for the transport of C. fetus subsp. 
venerealis samples, but that transport time and level of sample contamination with P. aeruginosa 
greatly influences the success of isolation.  
In the absence of contamination with P. aeruginosa, if samples were cultured within 24h, use of 
both TEMs resulted in similar levels of C. fetus subsp. venerealis recovery while better C. fetus 
subsp. venerealis recovery was obtained from the modified Lander’s TEM if longer transport times 
were simulated, as previously reported by others (Hum et al., 1994a; Lander, 1990a, 1990b; Monke 
et al., 2002). However, when a pure culture of P. aeruginosa was mixed with C. fetus subsp. 
venerealis to simulate field contamination, Clark’s TEM was superior to Lander’s TEM as it 
permitted C. fetus subsp. venerealis recovery for up to 72h of simulated transport. In contrast, the 
modified Lander’s TEM was too contaminated, despite previous reports indicating that Lander’s 
TEM was more efficient in preventing P. aeruginosa overgrowth (Hum et al., 1994a; Lander, 
1990a, 1990b; Monke et al., 2002).  
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It should be noted that even though P. aeruginosa PA240609, here used to compare TEMs, may not 
represent field diversity, these results suggest that for diagnostic samples that are highly 
contaminated with P. aeruginosa and which require several days to reach a laboratory under typical 
Australian field conditions, Clark’s TEM can improve C. fetus subsp. venerealis isolation over the 
modified Lander’s TEM. Presence of other contaminants such as Proteus mirabilis may 
differentially affect the efficiency of the TEMs here tested (Clark et al., 1974; Dufty, 1967; Lander, 
1990b). The present study found that if TEMs can be cultured onto selective agar within 24h of 
TEM inoculation, both Clark’s and Lander’s TEMs allow successful C. fetus subsp. venerealis 
isolation, even in the presence of P. aeruginosa.  
Incubation of TEMs at 37°C following simulated transport conditions was found to enhance C. fetus 
subsp. venerealis recovery but not in the presence of P. aeruginosa which limited C. fetus subsp. 
venerealis isolation. Even though this study only simulated field contamination by P. aeruginosa, it 
was previously reported that incubation of TEM increased C. fetus subsp. venerealis numbers but 
also resulted in overgrowth of culture media by other competitive fast-growing bacterial spp. 
commonly found in bull smegma, affecting isolation of pure C. fetus subsp. venerealis cultures 
(Lander, 1990a; Monke et al., 2002). 
In previous studies, differences in media preferences were demonstrated based on recovery of 
C. fetus subsp. venerealis colonies and contaminants overgrowth with some researchers favouring 
Campylobacter selective agar over the modified Skirrow agar while others preferred Skirrow’s agar 
compared to other tested media (Hum et al., 1994a; Monke et al., 2002). The present study found 
that the Campylobacter selective agar was the most appropriate culture medium for the isolation of 
C. fetus subsp. venerealis, under the different tested conditions, including simulated P. aeruginosa 
sample contamination.  
High humidity and temperature conditions have been found to enhance P. aeruginosa colonisation 
in plants while its occurrence was reduced when humidity and temperature were lowered (Green et 
al., 1974). It was suggested that climates with frequent rainfall would favour P. aeruginosa invasion 
whilst warmer Australian temperatures were associated with higher prevalence of P. aeruginosa 
infection in humans, correlating with higher isolation rates from Asia-Pacific and Latin America 
patients compared to other regions (Collaco et al., 2011; Gales, 2001; Green et al., 1974). In fact, 
this bacterium is widely found in Australia and tropical areas of south-east Asia; associated with 
dermatitis, mastitis, metritis and pneumonia in cattle (Quinn et al., 2011). P. aeruginosa is a 
common bull semen contaminant although its role in bovine genital infection is not evident 
(Eaglesome and Garcia, 1992). These findings suggest that contamination with P. aeruginosa may 
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particularly be an issue in sub-tropical/tropical climates and differences in media preference 
observed in the literature for the isolation of C. fetus subsp. venerealis could reflect differences in 
climate and/or Pseudomonas spp. subtypes and prevalence (Clark et al., 1974; Hum et al., 1994a; 
Lander, 1990a; Monke et al., 2002). 
TEMs and selective culture media developed to isolate C. fetus subsp. venerealis originally 
contained certain antibiotics in order to limit overgrowth of common bull preputial contaminants 
(Clark et al., 1974; Lander, 1990a). However, characterisation of C. fetus subsp. venerealis strains 
susceptible to polymyxin B and to 5-fluoro-uracil led to a reduction in polymyxin B concentration 
while 5-fluoro-uracil was not included in the media (Jones et al., 1985; Hum et al., 2010). Such 
differences may further explain discrepancies observed between the different TEMs and selective 
culture media tested here and the literature (Clark et al., 1974; Hum et al., 1994a; Hum and 
McInnes, 1993; Lander, 1990a; Monke et al., 2002). The P. aeruginosa field isolate PA240609 
used to simulate field contamination was in fact susceptible to high polymyxin B concentrations 
(300 units), consistent with results obtained for 69 bovine P. aeruginosa isolates (Hariharan et al., 
1995). Clark’s TEM contains 100 IU of polymyxin B/ml compared to 2.5 IU/ml in the modified 
Lander’s TEM which probably contributed to the better C. fetus subsp. venerealis recovery obtained 
here from Clark’s TEM in the presence of P. aeruginosa (Clark et al., 1974; Hum et al., 2010).  
Pseudomonas aeruginosa has intrinsic resistance to a large number of commonly used antibiotics, 
assisted by the impermeability of its outer membrane and multi-drug efflux pumps (Poole, 2001; 
Quinn, 1992). P. aeruginosa is frequently resistant to the majority of first and second generation 
cephalosporins in addition to clindamycin, chloramphenicol, erythromycin, kanamycin, nalidixic 
acid, many penicillins, sulfonamide, tetracyclines, trimethoprim and vancomycin (Wiedemann and 
Atkinson, 1991). Plasmids encoding resistance to ampicillin, carbenicillin, gentamicin, kanamycin, 
neomycin, paromycin, streptomycin, sulphonamide and tetracycline have also been identified in 
P. aeruginosa (Trevors, 1991). The fact that both the P. aeruginosa field isolate PA240609 and 
reference strain Q13 were resistant or showed intermediate susceptibility to ampicillin, neomycin, 
tetracycline and trimethoprim was thus not surprising. Antibiotics which are usually more efficient 
against P. aeruginosa include third-generation cephalosporins but P. aeruginosa strains evaluated 
here against ceftiofur were found to be resistant, as previously reported for 69 bovine P. aeruginosa 
isolates (Garrity et al., 2005b; Hariharan et al., 1995). Bull semen is often supplemented with 
antimicrobials to limit bacterial overgrowth before artificial insemination which may contribute to 
increasing antibiotic resistance in bovine P. aeruginosa strains (Eaglesome and Garcia, 1995).  
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Recommended antimicrobials for P. aeruginosa include aminoglycosides such as lincospectin or 
gentamicin to which P. aeruginosa strains tested here were found to be susceptible (Garrity et al., 
2005b). Antimicrobial sensitivity testing of 116 bovine P. aeruginosa isolates showed that the 
majority of strains were susceptible to amikacin, cefepime, cefoperazone/sulbactam, ceftazidime, 
ciprofloxacin, gentamicin, imipenem, meropenem, piperacillin and tobramycin (Ohnishi et al., 
2011). Such antibiotics could potentially be added to C. fetus subsp. venerealis culture media but 
P. aeruginosa strains are increasingly becoming resistant to multiple classes of antibiotics and 
strains exhibiting a multiple resistance phenotype are emerging in humans, accentuating the fact 
that the results obtained here may be strain-specific (Gales, 2001). Indeed, 4.3% of previously 
evaluated bovine P. aeruginosa strains (n=116) exhibited resistance to gentamicin (Ohnishi et al., 
2011) while a recent German study found that all C. fetus subsp. venerealis isolates tested (n=50) 
were susceptible to gentamicin, although this antibiotic is included in both Clark’s and modified 
Lander’s TEMs (Hänel et al., 2011; Hum et al., 2010; Hum and McInnes, 1993).  
Although overgrowth by contaminants such as P. aeruginosa, P. mirabilis and fungi was also 
reported to limit recovery of C. fetus subsp. venerealis from bovine samples by early studies, only 
one P. aeruginosa and one P. mirabilis field isolates were tested by Lander et al. (1990a) when 
evaluating their new TEM while other studies evaluated a limited number of field samples or 
bovine secretions spiked with pure C. fetus subsp. venerealis cultures (Clark et al., 1974; Hum et 
al., 1994a; Lander, 1990a, 1990b; Monke et al., 2002). Antimicrobial sensitivity of additional 
P. aeruginosa and C. fetus subsp. venerealis strains as well as other fast-growing bacterial spp. such 
as P. mirabilis should be evaluated to identify antibiotics which could limit contaminant 
overgrowth without affecting isolation of C. fetus subsp. venerealis.  
 
5. Conclusions and future directions 
Currently available TEMs and selective growth media for C. fetus subsp. venerealis were assessed 
in order to evaluate the chances of isolating this bacterium from bull preputial samples under 
Australian field conditions. Prolonged transport time of TEMs to Australian diagnostic laboratories 
often results into overgrowth of selective growth media by P. aeruginosa which was here simulated 
using an isolate obtained from a bull preputial sample collected from a local abattoir.  
This chapter confirmed the challenges of culturing a fastidious pathogen that is slow-growing 
compared to a non-fastidious contaminant that is fast-growing and commonly found in bull 
preputial samples. All media tested here supported C. fetus subsp. venerealis growth but simulated 
contamination with P. aeruginosa and transport times were found to affect recovery of C. fetus 
subsp. venerealis. Bull preputial contaminants including P. aeruginosa, P. mirabilis and fungi are 
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known to affect the chances of successful C. fetus subsp. venerealis isolation (Clark et al., 1974; 
Dufty, 1967; Eaglesome and Garcia, 1992; Hum et al., 2010; Lander, 1990b; Monke et al., 2002), 
underlining that veterinarians should meticulously clean bull prepuces from any fecal material 
before aseptically collecting samples to minimise field contamination.  
For optimal C. fetus subsp. venerealis isolation and growth, this study recommends that TEMs 
should be brought back to the laboratory within 48h and plated out within 4h if possible, and 
definitely within 24h, onto Campylobacter selective agar plates incubated for 48 to 72h at 37°C 
under microaerophilic conditions. TEM incubation was found to be unnecessary for diagnostic 
samples when prolonged transport time is unavoidable, but could still be applied to samples brought 
to the laboratory within 4h in order to increase C. fetus subsp. venerealis cell numbers prior to 
inoculation of selective culture media. PBS as a TEM is not recommended but in the absence of 
TEM, could be used when transport time is kept to an absolute minimum. These findings will assist 
isolating C. fetus subsp. venerealis from bull preputial secretions from abattoir samples (Chapter 5).  
Further investigation, including antimicrobial susceptibility testing, of additional C. fetus subsp. 
venerealis and P. aeruginosa field isolates as well as other fast-growing contaminants commonly 
found in bovine secretions is needed in order to further improve culture media for BGC testing. 
Such research should consider evaluating C. fetus subsp. venerealis isolates and fast-growing 
contaminants from various geographical areas in order to have a better representation of the field 
diversity as the antimicrobial resistance profiles of organisms present in bovine samples may vary 
depending on regions and climates. 
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CHAPTER 5: ESTABLISHMENT OF AN ISOLATE COLLECTION 
 
1. Introduction 
Molecular tools used to identify C. fetus subsp. venerealis were reviewed in Chapter 2 (section 2.3) 
and recent advances include the development of a parA real-time PCR assay that improved 
detection of the bacterium over isolation by culture (McMillen et al., 2006). The high field 
prevalence reported was suggested to be possibly attributed to differences in virulence between 
C. fetus subsp. venerealis strains as real-time results did not always correlate with disease 
occurrence (Guo, 2007; McMillen et al., 2006). To investigate potential virulence variation in 
C. fetus subsp. venerealis strains, this study first needs to establish a culture collection and the parA 
real-time assay remains the most sensitive method to detect presence of the bacterium from crude 
samples in spite of a recent report of false-positive reactions (McMillen et al., 2006; Spence et al., 
2011). 
Evaluation of microbiological methods (Chapter 4) determined that both Clark’s and modified 
Lander’s TEMs (Hum et al., 2010; Hum and McInnes, 1993) were suitable for the transport of 
C. fetus subsp. venerealis while Campylobacter selective agar plates (Oxoid) were the most 
appropriate selective medium for its isolation. Despite PBS not being useful for the prolonged 
transport of samples, isolation of C. fetus subsp. venerealis could still be achieved when transport 
time was minimal. Additionally, the tricamper sampling device was reported as a practical and 
helpful sampling tool, facilitating C. fetus subsp. venerealis isolation and detection (McMillen et 
al., 2006). To identify putative C. fetus subsp. venerealis infected samples, this study used the parA 
real-time assay to screen bull preputial secretions and applied four inoculation procedures to 
maximise chances of isolation.  
As the parA target was previously not consistently detected in all C. fetus subsp. venerealis strains, 
we thought that the newly described C. fetus subsp. venerealis-specific ISCfe1 insertion element 
could be a useful target for diagnostic test development (Abril et al., 2007; Willoughby et al., 2005). 
A new real-time assay was designed from ISCfe1 reported sequences (Abril et al., 2007) which was 
used concurrently with the parA real-time assay to screen additional samples; sensitivity and 
specificity of both tests were also evaluated in comparison with culture results. The parA real-time 
assay and two C. fetus subsp. venerealis-specific conventional PCR methods were applied to the 
isolated Campylobacter-like pure cultures, assisted by sequencing of unusual positives and 
biochemical phenotyping for definitive identification of C. fetus subsp. venerealis (Abril et al., 
2007; Hum et al., 1997; OIE, 2012a). 
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2. Material and methods 
2.1. Reference cultures  
 Campylobacter spp. cultures were sourced from BGC cases (Donaldson and Clark, 1970; 
Newsam and Peterson, 1964), from Biosecurity Queensland (DAFF), from the American Type 
Culture Collection (ATCC), and from the National Collection of Type Cultures (NCTC, Table 7). 
Reference cultures were grown at 37°C under microaerophillic conditions in either BHI enrichment 
broth (3.7% brain heart-infusion, 0.2% yeast extract, 0.07% agar bacteriological n°1) or 
thioglycollate broths (Micromedia) for 72h (see Chapter 3, section 2). 
Table 7. Campylobacter spp. reference strains used in Chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
American Type Culture Collection (ATCC) 
2
Department of Agriculture, Fisheries & Forestry (DAFF) 
3
National Collection of Type Cultures (NCTC) 
 
2.2. Sampling and isolation procedures 
 Sampling and isolation procedures are summarised in Figure 7. Tricamper sampling devices 
were used to collect preputial secretions for culture and real-time testing from bull genital tracts 
collected at a local abattoir between July 2009 and December 2011. At first, the tricamper was 
applied directly to Campylobacter selective agar plates, prior to being transferred to sterile PBS. 
After real-time PCR testing of the PBS sample, bull preputial secretions that produced positive real-
time Ct scores were re-sampled using two additional tricamper sampling devices to transfer to 
Clark’s (Hum and McInnes, 1993) and to the modified Lander’s (Hum et al., 2010) TEMs 
respectively, while an additional Campylobacter selective agar plate (Oxoid) was inoculated from 
the PBS. After 24h incubation at 37°C in aerobic conditions, a loop full of both TEMs was used to 
inoculate further Campylobacter selective agar plates.  
Species Strain Source 
C. fetus subsp. venerealis 19438 ATCC
1
 
C. fetus subsp. venerealis 33561 ATCC
1
 
C. fetus subsp. venerealis 98-109383 DAFF
2
 
C. fetus subsp. venerealis  B6 Donaldson and Clark (1970)  
C. fetus subsp. venerealis 642-21 Newsam and Peterson (1964)  
C. fetus subsp. fetus 15926 ATCC
1
 
C. fetus subsp. fetus 25936 ATCC
1
 
C. hyointestinalis N3145 Field isolate, DAFF
2
 
C. jejuni subsp. jejuni 11168 NCTC
3
 
C. sputorum subsp. bubulus Y4291-1 Field isolate, DAFF
2
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Figure 7. Sampling and isolation procedures 
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Plates were incubated at 37°C in 75% humidity, using either anaerobic jars and CampyGen
TM
 
microaerophilic sachets or the microaerophilic workstation (Don Whitley Scientific). The four 
inoculated Campylobacter selective agar plates (from Tricamper, PBS, Clark’s and modified 
Lander’s TEMs) were visually inspected for Campylobacter-like colonies 48h and 72h after 
inoculation. Campylobacter selective agar plates and SBA plates were used to subculture 
Campylobacter-like colonies prior to enrichment in liquid broth medium.  
Enrichment was performed at 37°C under microaerophillic conditions for 72h using BHI (as 
described in section 2.1) or vegetable peptone (1% vegetable peptone n°1, 0.2% sodium succinate, 
0.5% yeast extract, 0.5% sodium chloride, 0.0001% magnesium sulphate, 0.0001% calcium 
chloride, 0.15% agar bacteriological n°1) enrichment broths (see Chapter 3, section 2). The latter 
was introduced from isolate 412 onwards to ensure that isolates could potentially be used for cattle 
studies. According to Australian quarantine law (www.daff.gov.au/aqis) which prohibits the use 
imported meat peptones at any stage prior to large animal experimentation, Clark’s TEM was 
discontinued and storage media were also modified.  
 
2.3. Biochemical assays 
 Growth in 1% glycine medium and H2S production using TSI slopes were performed to 
initially screen all Campylobacter-like isolates prior to storage (section 2.4). A representative subset 
of isolates (n=51) were recovered from storage and subjected to biochemical phenotyping using the 
following tests in addition to growth in 1% glycine and H2S production using TSI slope: growth at 
25°C and 42°C, catalase and oxidase tests, H2S production in cysteine-HCl medium using lead-
acetate paper, aerobic growth, susceptibility to nalidixic acid and cephalothin (30 µg) as 
recommended (OIE, 2012a). Isolates were phenotyped as C. fetus subsp. venerealis, C. fetus subsp. 
fetus, thermophilic Campylobacter spp. or aerotolerant Arcobacter-like organisms (Table 8). 
Table 8. Phenotyping of Campylobacter-like isolates based on recommended tests (OIE, 2012a). 
 25°C 42°C Oxidase Catalase 1% 
glycine 
H2S
a
 H2S
b
 Aerobic 
growth 
Nalidixic 
acid 
C. fetus subsp. venerealis V - + V - - V
1
 - V 
C. fetus subsp. fetus + V + + + - V - R 
Thermophilic 
Campylobacter species 
V + V V V V + - R 
Aerotolerant Arcobacter-
like organisms 
+ - V + - - - + V 
V= variable (positive or negative); R= resistant 
a
Using triple iron sugar (TSI) slope; 
b
 in cysteine-HCl medium using lead acetate paper 
1
Biovar venerealis: negative; biovar intermedius: positive   
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2.4. Storage of isolates 
 Campylobacter-like isolates were frozen at -80°C in Wheaton vials using three different 
storage methods: (1) Microbank™ glass beads, 500 µl of lysed horse blood (Oxoid) and colonies 
harvested with a cotton swab from two SBA plates, (2) 15% enrichment broth/85% FBP medium 
(Gorman and Adley, 2004) using BHI or vegetable peptone n°1 (Oxoid) instead of nutrient broth 
and (3) 85% enrichment broth/15% glycerol (Gorman and Adley, 2004).  
2.5. ParA real-time Polymerase Chain Reaction (real-time PCR) testing  
 The parA real-time PCR (McMillen et al., 2006) was performed in a 25 µl reaction using 
RealMasterMix Probe 2.5x (5 Prime), 900 nM of each primers and 125 nM of probe (synthesised 
by Sigma-Aldrich, Table 9). In this study, lysates with a Ct score<40 were considered positive 
while Ct score=40 was used as a cut-off value between positive and negative samples. The parA 
real-time PCR (McMillen et al., 2006) was used to screen 5 µl of crude lysate from preputial 
samples as template and to confirm identity of isolates using 50 ng of genomic DNA (gDNA) 
template extracted from pure cultures using a commercial kit as per manufacturer’s instructions 
(QIAamp DNA mini kit, QIAGEN, see Chapter 3 section 3.1). 
Table 9. Primers and probes used in Chapter 5. 
Primer  Sequence (5’ to 3’) Publication 
VenSF CTTAGCAGTTTGCGATATTGCCATT 
Hum et al. 1997 
VenSR GCTTTTGAGATAACAATAAGAGCTT 
Mg3F GGTAGCCGCAGCTGCTAAGAT 
Mg4R TAGCTACAATAACCACAACT 
CFVEN-L ATTAGTATTTGCAATATGTGAA 
Abril et al. 2007 
CFVEN-R2 AATTGATATTAAATTTGATTGA 
CFVF CCCAGTTATCCCAAGCGATCT 
McMillen et al. 2006 CFVR CGGTTGGATTATAAATTTTAGCTTGGT 
CFVP3 6FAM-CATGTTATTTAATACCGCAA-MGBNFQ 
ISCfe1F CCGAATTTACGCCTATGGACTT 
this chapter ISCfe1R CTTGCTGGTTACTATTTGATTTATTGCT 
ISCfe1P 6FAM-ACGGCTCTGCTAGATG-MGBNFQ 
 
2.6. Design of ISCfe1 real-time PCR assay 
 GenBank Accessions AM260752, AM286430, AM286431 and AM286432 were aligned 
using Sequencher version 4.5 in order to identify regions of conservation for real-time assay design. 
Using Primer Express version 2 (Applied Biosystems), primers and a fluorescent 3’ MGB-DNA 
probe were designed (synthesised by Sigma-Aldrich). Primers, probe and target sequence 
specificity was confirmed using BLASTn searches (http://www.ncbi.nlm.nih.gov/BLAST/; sourced 
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online on the 28
th
 of January 2010). Sequences of primers and probe are detailed in Table 9. The 
ISCfe1 real-time assay for C. fetus subsp. venerealis was performed in a 25 µl reaction by using 
RealMasterMix Probe 2.5x with 500 nM ISCfe1TaqF and ISCfe1TaqR primers, 62.5 nM 
ISCfe1TaqP fluorescent 3’ MGB-DNA probe, and 5 µl of heat-lysed cells or 50 ng of purified 
gDNA in a Corbett Rotor-Gene RG-3000. The ISCfe1 assay thermal profile was 50°C for 2min, 
94°C for 2min, and 45 cycles of denaturation at 94°C for 20 s, annealing at 60°C for 20s, and 
extension at 72°C for 20s. Serial dilutions of C. fetus subsp. venerealis (98-109383, Table 7) and 
C. fetus subsp. fetus (ATCC15926 and ATCC25936, Table 7) gDNA extracts were used to optimise 
assay conditions and to determine cut-off value between positive and negative samples (Ct=40), 
samples with a Ct score≤40 were considered as positive. Other Campylobacter spp. 
(C. hyointestinalis N3145, C. jejuni subsp. jejuni NCTC11168 and C. sputorum subsp. bubulus 
Y4291-1, Table 7) gDNA extracts were used to investigate assay specificity. The fluorescence 
signal detected after each extension step indicated a positive result when reaching a threshold of 
0.1. Quantitative evaluation of target cells/ml were estimated using a standard curve generated with 
gDNA and crude cell lysates prepared from serial dilutions of known cells and colonies numbers of 
C. fetus subsp. venerealis strains. 
 
2.7. Sensitivity comparison 
 Ten µl from each 72h enriched thioglycollate broth culture of C. fetus subsp. venerealis 
reference strains B6 (Donaldson and Clark, 1970) and 642-21 (Newsam and Peterson, 1964) and 
ATCC19438 (Table 7) were diluted 1:10 in formalin to decrease cell motility. Bacterial cell counts 
were performed in duplicates using an improved Neubauer haemocytometer. Serial log dilutions 
were prepared in PBS in duplicates using the same C. fetus subsp. venerealis enriched broth 
cultures and 100 µl of each dilution was spread onto SBA plates to count CFU after 72h incubation 
at 37°C under microaerophillic conditions. Heat lysates from each duplicated serial log dilution 
were used as template for both parA and ISCfe1 real-time assays in order to correlate number of 
detected cells, Ct scores and CFUs. Heat lysis and real-time assays were performed as described in 
sections 2.5 and 2.6.  
 
2.8. Conventional PCR assays 
 Primers (Table 9) were synthesised through Sigma-Aldrich and PCR assays were 
undertaken in 20 µl reactions using 1× PCR reaction buffer with 25 mM Mg
2+
 (10× Hotmaster™ 
Taq buffer, 5 Prime), 1U Hotmaster™ Taq DNA polymerase (5 Prime), 1 µM of each forward and 
reverse primers, 1 µM dNTPs (Invitrogen) and 1.25 ng of gDNA. The reactions were amplified in a 
DNA Engine
®
 Thermal Cycler using the following parameters for Abril’s PCR (Abril et al., 2007): 
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initial denaturation at 94°C for 2min, 35 cycles at 95°C for 20s, annealing at 55°C for 20s, and 
extension at 72°C for 2min, with a final extension at 72°C for 10min. Hum’s PCR (Hum et al., 
1997) was performed as previously described (McMillen et al., 2006). 
 
2.9. Cloning and sequencing 
 The parA and ISCfe1 real-time PCR products from gDNA extracts that produced late 
positive results (Ct=35-40) were ligated into a cloning vector (pCR®2.1-TOPO®; TOPO® TA 
Cloning® Kit; Invitrogen) as per manufacturer’s instructions. Plasmids with inserted products were 
sequenced using the M13 primers (Invitrogen) and the BigDye® version 3.1 technology (Applied 
Biosystems), as recommended. Sequences were analysed on the 3130xl Genetic Analyzer at the 
Griffith University DNA Sequencing Facility (School of Biomolecular and Biomedical Science, 
Griffith University, Nathan, QLD, Australia). Sequences were visualised, edited and aligned using 
Sequencher version 4.5 to remove all vector sequences prior to further analysis. To investigate if 
perhaps mis-priming with other species could occur, BLASTn searches of real-time products were 
performed (http://www.ncbi.nlm.nih.gov/BLAST/; sourced online on the 7th of November 2012) 
and aligned to similar sequences using Geneious version 5.6 (Drummond et al., 2012). 
 
2.10.  Statistical analysis 
 For index tests compared with the gold standard of isolation by culture, sensitivity was 
calculated as the number of test positive as a proportion of culture positive, and number of test 
negative as a proportion of culture negative. Proportions are presented as percentages with 95% 
confidence intervals (CI). Concordance between parA and ISCfe1 real-time assays was assessed 
using a Bland-Altman plot (Bland and Altman, 1995). Agreement between dichotomous tests was 
assessed using Cohen’s Kappa where <0.4 is regarded as poor agreement, 0.4 to 0.75 as fair 
agreement and >0.75 as good agreement. Data was analysed using SAS 9.3 (www.sas.com) and 
STATA 12 (www.stata.com). 
 
3. Results 
3.1. ParA real-time testing of 717 bull preputial secretions 
 The parA real-time assay was used to evaluate 717 heat lysates from bull preputial 
secretions and 174 of the tested samples produced an amplicon with Ct score ≤40 (24.3%), 130 with 
Ct score <35 and 44 with 35 ≤Ct score ≤40 (Figure 8). A further 41 samples had a Ct score >40 and 
no Ct score was obtained from the remaining 502 samples (Figure 8). A total of 268 samples tested 
on the parA real-time assay were cultured: all 174 samples which produced a Ct score ≤40, six 
samples with Ct score>40 and 88 of those samples with no Ct score (Figure 8). 
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Figure 8. Flowchart: screening of 717 Australian bull preputial secretions using the parA real-time assay to isolate Campylobacter-like by culture. 
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Campylobacter-like isolates were obtained from 51 of the 268 parA tested samples cultured (Figure 
10).  
Table 10. Contingency table for parA real-time PCR testing relative to isolation by culture of 
Campylobacter-like organisms at a cut-off Ct score≤40. Sensitivity was 86.3(74.3-93.7)% and 
specificity 40.1(37.3-41.8)%. 
 Campylobacter-like 
organism isolated 
No Campylobacter-like 
organism isolated 
Total 
parA Ct score ≤40 (positive) 44 130 174 
parA Ct score >40 (negative) 7 87 94 
Total 51 217 268 
A total of 44 parA-positive samples yielded Campylobacter-like isolates (Ct score<35: 35/130; 
35≤Ct score≤40: 9/44, Figure 8, Table 11) equating to a 25.3% isolation success from 174 parA-
positive samples (44/174, Table 11). Culture performed on a total of 94 parA-negative samples 
yielded a further seven Campylobacter-like isolates (Ct score>40 or no Ct score: 7/94, Figure 8, 
Table 11). Forty samples not subjected to parA real-time testing were also cultured, of which 
Campylobacter-like isolates were obtained from two samples (Figure 8, Table 11). 
Table 11. Summary of results. 
Method ParA real-time 
testing only (n=771) 
ParA and ISCfe1 real-time 
testing (n=266) 
parA real-time PCR  174/771 (24.3%) 114/266 (42.9%) 
Culture-positive/parA-positive 44/174 (25.3%) 25/114 (21.9%) 
Culture-positive/parA-negative 7/94 (7.4%) 6/122 (4.9%) 
Culture-positive/parA-unknown 2/40 (5%) NA† 
   
Culture (n=53) (n=31) 
Hum’s PCR* 19/53 (35.8%) 15/31 (48.4%) 
Abril’s PCR 46/53 (86.8%) 30/31 (9.7%) 
parA real-time PCR 51/53 (96.2%) 31/31 (100%) 
ISCfe1 real-time PCR 50/53 (94.3%) 28/31 (90.3%) 
   
Phenotyping (n=53) (n=31) 
Glycine-intolerant, H2S-negative 45/53 (84.9%) 27/31 (87.1%) 
Glycine-tolerant, H2S-negative 5/53 (9.4%) 4/31 (1.3%) 
Glycine-tolerant, H2S-positive 3/53 (5.7%) NA 
*Based on the presence of both 960 and 142 bp products; 18 other isolates produced the 142 bp 
amplicon only. 
†NA not applicable 
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3.2. Preliminary phenotyping of 53 Campylobacter-like isolates 
 The ability of the 53 obtained pure Campylobacter-like isolates to grow in 1% glycine 
medium and to produce H2S on TSI slopes was tested (Table 12). Forty-five glycine-intolerant, 
H2S-negative isolates were identified as putative C. fetus subsp. venerealis and five glycine-
tolerant, H2S-negative isolates as putative C. fetus subspecies fetus (Table 12). Three glycine-
tolerant isolates produced H2S on TSI slopes and were classified as putative Campylobacter spp. 
(Table 12).  
Table 12. Preliminary phenotyping (growth in 1% glycine medium and production of H2S on TSI 
slopes) results obtained from 53 Campylobacter-like isolates. 
 No production of H2S on 
TSI slopes 
Production of H2S on 
TSI slopes 
Total 
Glycine-intolerant 
Campylobacter-like isolates 
45 0 45 
Glycine-tolerant 
Campylobacter-like isolates 
5 3 8 
Total 
50 3 53 
After gDNA extraction from the pure Campylobacter-like cultures, 51 of the 53 isolates were 
positive on the parA real-time assay (96.2%, Table 11). Hum’s PCR only confirmed 19 of the 53 
isolates (35.8%) as C. fetus subsp. venerealis (exhibiting both 960 and 142 bp fragments) with an 
additional 15 out of 53 isolates producing only the 142 bp fragment (28.3%, Table 11). A much 
greater proportion of the isolates were positive on Abril’s PCR (46 isolates out of 53; 86.8%) 
including all isolates positive Hum’s PCR being also positive on the parA real-time assay (Table 
11). The seven Campylobacter-like isolates cultured from samples screened as parA negative 
(isolates 317, 400, 628, 672, 673, 676 and 708, Table 13) were all glycine-intolerant and did not 
produce H2S on TSI slopes. Abril’s PCR identified five of these as C. fetus subsp. venerealis, but 
only one of these isolates was positive (both fragments) using Hum’s PCR (Table 13). There was 
poor agreement between results obtained from the parA real-time assay, Hum’s and Abril’s 
conventional PCR assays for the 53 Campylobacter-like isolates (Table 14). 
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Table 13. Characterisation of 84 Campylobacter-like isolates obtained from real-time PCR testing of bull preputial secretions. 
 Real-time assays Conventional assays Biochemical assays 
Isolate 
Ct score  
lysate parA
1
 
 Ct score  
gDNA parA
1
 
Ct score 
 lysate ISCfe1
2
 
 Ct score  
gDNA ISCfe1
2
 
Hum
3
  
960 bp 
Hum
3 
142bp 
Abril
4
 
ISCfe1 
1% 
glycine
5
  
H2S 
TSI
5 
Phenotyping 
4 31.57 26.88 ND* 25.55 Yes Yes Yes - - ND 
8 31.29 31.15 ND 27.28 Yes Yes Yes - - ND 
10 32.57 17.58 ND 11.07 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
31 30.25 30.49 ND 13.17 Yes Yes Yes - - ND 
130 34.12 26.53 ND 31.25 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
153 33.90 29.33 ND 28.06 No Yes Yes - - ND 
154 27.11 35.40 ND 29.82 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
158 36.77 31.02 ND 29.98 No Yes Yes - - aerotolerant Arcobacter-like  
166 34.37 34.78 ND 30.58 No Yes Yes - - aerotolerant Arcobacter-like  
214 28.84 18.46 ND 9.44 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
217 27.52 15.31 ND 10.79 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
218 32.70 34.07 ND 29.04 Yes Yes Yes + - C. fetus subsp. fetus 
227 25.64 14.54 ND 9.63 Yes Yes Yes - - aerotolerant Arcobacter-like 
229 31.92 14.71 ND 10.10 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
258 30.82 35.23 ND 33.63 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
272 33.78 35.75 X 41.12 No No No - - ND 
273 29.92 38.86 ND 33.64 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
289 35.12 37.64 ND 32.25 No No Yes - - aerotolerant Arcobacter-like 
305 15.95 37.82 ND 33.12 No No Yes - - aerotolerant Arcobacter-like 
306 28.50 37.10 ND 31.65 Yes Yes Yes - - aerotolerant Arcobacter-like  
312 36.53 38.29 ND 31.72 Yes Yes Yes - - aerotolerant Arcobacter-like 
317 41.34 22.94 ND 33.31 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
331 30.81 40.44 ND 31.91 No Yes Yes + - ND 
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 Real-time assays Conventional assays Biochemical assays 
Isolate 
Ct score 
lysate parA
1
 
 Ct score 
gDNA parA
1
 
Ct score 
lysate ISCfe1
2
 
 Ct score  
gDNA ISCfe1
2
 
Hum
3
 
960 bp 
Hum
3
 
142bp 
Abril
4
 
ISCfe1 
1% 
glycine
5
  
H2S 
TSI
5 
Phenotyping 
334 35.03 36.88 ND 30.53 No No Yes + - ND 
337 29.34 33.99 ND 31.12 No Yes Yes + - C. fetus subsp. fetus 
340 27.00 41.16 ND 32.97 No No Yes - - ND 
344 28.55 36.59 ND 30.70 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
347 34.50 38.71 X 34.74 No Yes No - - aerotolerant Arcobacter-like 
385 31.20 36.95 X 30.94 No No No - - thermophilic Campylobacter sp. 
399 28.6 37.17 ND 34.56 No No Yes - - ND 
400 40.77 32.29 ND 27.35 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
412 29.65 34.34 ND 33.18 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
430 32.34 32.35 ND 33.43 No Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
475 28.36 17.43 ND 11.60 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
520 28.82 32.46 ND 31.52 Yes Yes Yes + + thermophilic Campylobacter sp. 
521 35.60 35.47 ND 37.78 No No Yes - - C. fetus subsp. venerealis bv. venerealis 
530 34.09 36.14 ND 27.99 No Yes Yes + + thermophilic Campylobacter sp. 
531 37.89 37.93 ND 35.20 No No Yes + + thermophilic Campylobacter sp. 
537 22.80 15.92 ND 16.93 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
540 36.71 14.48 ND 14.71 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
543 29.92 27.51 ND 33.19 No Yes Yes - - ND 
562 31.16 39.46 ND 37.04 No No Yes - - ND 
573 38.68 36.96 X 35.51 No No No + - ND 
628 No Ct score 34.76 ND no Ct score No No Yes - - C. fetus subsp. venerealis bv. venerealis 
635 28.08 16.99 ND 15.51 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
672 No Ct score 36.76 ND 35.36 No No Yes - - aerotolerant Arcobacter-like  
673 No Ct score 35.79 ND 35.56 No No Yes - - aerotolerant Arcobacter-like 
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 Real-time assays Conventional assays Biochemical assays 
Isolate 
Ct score 
lysate parA
1
 
 Ct score 
gDNA parA
1
 
Ct score 
 lysate ISCfe1
2
 
 Ct score  
gDNA ISCfe1
2
 
Hum
3
 
960 bp 
Hum
3
 
142bp 
Abril
4
 
ISCfe1 
1% 
glycine
5
  
H2S 
TSI
5
 Phenotyping 
676 No Ct score 36.95 X 34.74 No No No - - thermophilic Campylobacter sp. 
708 No Ct score 39.51 X no Ct score No No No - - ND 
729 ND 38.80 ND 35.57 No No Yes - - aerotolerant Arcobacter-like 
742 ND 37.86 ND 28.93 No No Yes - - C. fetus subsp. venerealis bv. venerealis 
744 ND 37.59 ND 28.96 No No Yes - - C. fetus subsp. venerealis bv. intermedius 
787 34.8 31.36 39.81 27.66 No No Yes - - ND 
830 30.96 35.51 25.07 31.35 No Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
849 24.30 27.99 17.20 32.91 No No Yes + - thermophilic Campylobacter sp. 
856 34.06 25.88 no Ct score 41.23 No No No - - ND 
857 26.49 34.94 no Ct score no Ct score No No Yes - - ND 
859 23.85 13.64 24.73 8.99 Yes Yes Yes - - ND 
863 34.88 33.31 37.41 28.01 No No Yes + - thermophilic Campylobacter sp. 
882 26.41 34.83 no Ct score 37.01 No Yes Yes + - C. fetus subsp. fetus 
883 31.27 33.76 38.64 30.23 Yes Yes Yes - - ND 
884 27.81 33.98 25.82 30.80 Yes Yes Yes - - ND 
889 25.51 32.30 23.37 32.75 No No Yes - - ND 
890 27.56 32.32 no Ct score 33.34 No No Yes - - C. fetus subsp. venerealis bv. intermedius 
923 27.47 18.43 32.17 12.73 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
924 30.36 15.17 33.16 12.03 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
926 23.74 15.88 23.85 11.09 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
948 42.79 34.91 37.10 29.82 Yes Yes Yes - - ND 
951 30.99 15.74 28.56 12.07 Yes Yes Yes - - C. fetus subsp. venerealis bv. intermedius 
953 42.00 34.32 29.38 25.91 Yes Yes Yes - - ND 
954 42.41 31.94 32.89 28.46 No No Yes - - ND 
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 Real-time assays Conventional assays Biochemical assays 
Isolate 
Ct score 
lysate parA
1
 
 Ct score 
gDNA parA
1
 
Ct score 
lysate ISCfe1
2
 
 Ct score  
gDNA ISCfe1
2
 
Hum
3
 
960 bp 
Hum
3
 
142bp 
Abril
4
 
ISCfe1 
1% 
glycine
5
  
H2S 
TSI
5
 Phenotyping 
955 No Ct score 25.02 37.84 24.66 Yes Yes Yes - - ND 
957 25.15 14.94 24.29 11.94 Yes Yes Yes - - C. fetus subsp. venerealis bv. venerealis 
964 34.41 33.87 no Ct score 27.33 Yes Yes Yes - - ND 
970 37.08 29.46 31.72 26.53 Yes Yes Yes - - ND 
979 32.27 34.91 25.57 31.72 Yes Yes Yes + - C. fetus subsp. fetus 
991 38.91 36.28 32.80 31.94 No No Yes - - ND 
1001 No Ct score 35.83 32.57 33.45 No No Yes - - ND 
1011 32.15 35.29 39.86 33.69 No No Yes - - ND 
1012 28.99 33.65 No Ct score 30.74 No No Yes - - ND 
1014 29.17 27.66 No Ct score 27.06 No Yes Yes - - ND 
1025 No Ct score 22 32.03 12.79 Yes Yes Yes - - ND 
1036 28.51 34.87 No Ct score No Ct score No No Yes - - C. fetus subsp. venerealis bv. venerealis 
1
McMillen at al. 2006 
2
This study 
3
Hum et al. 1997 
4
Abril et al. 2007 
5
Growth in 1% glycine medium; production of H2S on triple-sugar iron (TSI) slope (OIE, 2012a) 
*ND not determined; a random selection of 51 representative isolates were subjected to biochemical phenotyping (parallel PhD project, Ameera Koya) 
 gDNA genomic DNA 
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Table 14. Number of positive and negative results in agreement between parA real-time PCR, 
Hum’s and Abril’s conventional PCR assays for 53 Campylobacter-like isolates. The kappa statistic 
(in brackets) represents the measure of agreement between pairs of tests, 0= no agreement, 1= 
perfect agreement. 
 ParA real-time 
PCR
1
 
(n=51 positive) 
Hum’s PCR2 
960 bp 
(n=19 positive) 
Hum’s PCR2 
142 bp 
(n=34 positive) 
Abril’s PCR3 
ISCfe1 
(n=46 positive) 
ParA real-time 
PCR
1
 
 19 positive 
2 negative  
32 disagree 
(0.04) 
33 positive 
1 negative 
19 disagree 
(0.03) 
44 positive 
0 negative 
9 disagree 
(-0.06) 
Hum’s PCR2  
960 bp 
 
  19 positive 
19 negative 
15 disagree 
(0.46) 
19 positive 
7 negative 
27 disagree 
(0.16) 
Hum’s PCR2  
142 bp 
   32 positive 
5 negative 
16 disagree 
(0.24) 
Abril’s PCR3 
ISCfe1 
 
 
 
    
1
McMillen at al. 2006; 
2
Hum et al. 1997; 
3
Abril et al. 2007 
 
3.3. Cloning and sequencing of parA real-time products 
 Analysis of sequences for nine out of ten isolates indicated that gDNA extracts yielding late 
Ct scores (35-40) could be due to false-positive parA real-time results as indicated by failure to 
obtain full sequence of the parA real-time target for isolates 154 (Ct=35.40), 273 (Ct=38.86), 331 
(Ct=40.44), 340 (Ct=41.16), 530 (Ct=36.14), 676 (Ct=36.95), 708 (Ct=39.51), 729 (Ct=38.80) and 
744 (Ct=37.59). Some sequences contained only CFVF and/or CFVR primer sequences (result not 
shown) suggesting that primer dimer initiated these late Ct scores. Sequence analysis of the parA 
real-time product obtained from isolate 672 (Ct=36.76) was found to be 100% identical to the parA 
real-time target (GenBank Accession AY903214) and to other C. fetus subsp. venerealis parA 
sequences (GenBank Accessions AY750964, EU443150, HQ644125, HQ644126 and HQ644127), 
confirming it to be a true parA positive.  
BLASTn searches also indicated 89-93% identity with other recent C. fetus subsp. venerealis parA 
sequences (GenBank Accessions HQ644122, HQ644123, HQ644124, HQ644128, HQ644129 and 
HQ644130) and 81% identity with the truncated parA gene sequence (GenBank Accession 
FN594949) found in C. fetus subsp. fetus IMD523 (Abril et al., 2010; Chaban et al., 2012). 
 99 
 
3.4. New ISCfe1 real-time assay  
 As many Campylobacter-like isolates were positive on Abril’s PCR while some isolates 
were cultured from parA negative samples; by aligning the four sequences containing the ISCfe1 
insertion element, a new real-time assay was designed from a conserved region of the element, 
targeting the partial tnpB transposase gene. The ISCfe1 real-time amplicon is 71 bp long; probe and 
primer sequences are reported in Table 9 (see also Figure 10). Serial dilutions of probe, primer and 
gDNA of C. fetus subsp. venerealis were used to determine optimal assay conditions. Genomic 
DNA extracts from other Campylobacter reference strains (Table 7) were negative on the ISCfe1 
real-time assay. 
 
3.5. Analytic sensitivity comparison of parA and ISCfe1 real-time assays 
 CFU and cell counts of C. fetus subsp. venerealis correlated well (Table 15). Serial log 
dilutions of C. fetus subsp. venerealis in PBS used as template after heat lysis in both real-time PCR 
assays indicated that both methods are highly sensitive, with the ISCfe1 real-time assay able to 
detect less than a single cell (Table 15).  
Table 15. Correlation of cell and CFU counts with parA and ISCfe1 real-time Ct scores obtained 
from the C. fetus subsp. venerealis reference strains B6 (Donaldson and Clark, 1970), 642-21 
(Newsam and Peterson, 1964) and ATCC19438 diluted in PBS. 
Dilutions Cell counts CFU counts SD* Ct score on 
parA 
SD Ct score on 
ISCfe1 
SD 
undiluted 1.66 x 10
7
 confluent ND
†
 16.47 0.742 13.63 0.351 
10
-1
 1.66 x 10
6
 confluent ND 18.37 0.563 15.41 0.212 
10
-2
 1.66 x 10
5
 confluent ND 21.24 0.924 18.35 0.595 
10
-3
 1.66 x 10
4
 confluent ND 25.75 0.252 23.14 0.730 
10
-4
 1.66 x 10
3
 confluent ND 29.41 1.161 26.85 1.839 
10
-5
 1.66 x 10
2
 165.4 29.143 32.21 1.126 29.94 1.991 
10
-6
 1.66 x 10
1
 16.4 7.197 36.25 0.956 32.34 1.538 
10
-7
 1.66 x 10
0
 1.6 2.070 39.38 1.215 36.29 1.063 
10
-8
 1.66 x 10
-1
 0 0 42.37 0.550 39.22 1.019 
*SD standard deviation 
 †ND not determined 
ISCfe1 real-time assay was found to be more sensitive than the parA real-time assay, amplifying 
targeted sequence 2.92 cycles earlier as shown by the Bland-Altman plot (Figure 9). Only one 
measurement fell outside the 95% limits of agreement (2.01–3.83) for Ct scores obtained from 
C. fetus subsp. venerealis strains diluted 10
-6
 in PBS (Figure 9). 
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Figure 9. Blatman-plot analysis showing agreement between average Ct scores obtained on parA 
and ISCfe1 real-time PCR assays from serial dilutions of C. fetus subsp.venerealis reference strains 
B6 (Donaldson and Clark, 1970), 642-21 (Newsam and Peterson, 1964) and ATCC19438 in PBS. 
Mean difference was 2.920, 95% limits of agreement (2.011-3.829). Ct scores for one out of nine 
dilutions (11.11%) were outside the limits of agreement. 
 
 
The equation of the standard curve obtained from the serial log dilutions against Ct scores for the 
parA real-time PCR assay (result not shown) is: y = -3.3852x + 45.976; R² = 0.996. The efficiency 
of the parA real-time PCR assay here equals 97.4% (10
(-1/-3.3852) – 1; 97.4%). The equation of the 
standard curve obtained from the serial log dilutions against Ct scores for the ISCfe1 real-time PCR 
assay (result not shown) is: y = -3.3297x + 42.778; R² = 0.9946. The efficiency of the new ISCfe1 
real-time PCR assay is 99.7% (10
(-1/-3.3297) – 1; 99.7%). 
 
3.6. ParA and ISCfe1 real-time testing of 266 bull preputial secretions 
 Both parA and ISCfe1 real-time assays were used concurrently to evaluate a further 266 heat 
lysates from bull preputial secretions which assisted the isolation of 31 additional Campylobacter-
like isolates from 235 cultured samples (Table 16). The ISCfe1 real-time assay detected 121 out of 
266 tested lysates (45.5%), 23 ISCfe1-positive samples yielded Campylobacter-like isolates (Table 
16). The parA real-time assay detected 114 out of 266 tested samples (42.9%, Table 16). Of the 235 
cultured samples, 25 of these 114 parA-positive samples grew Campylobacter-like organisms 
(21.9%, Table 16).Only 70 out of 266 screened lysates were positive on both real-time assays 
(26.3%, Table 16); agreement between both tests was poor (Kappa=0.28). Seventeen 
Campylobacter-like isolates were grown from the 70 samples positive on both assays (24.3%) while 
no isolate was obtained from the 71 samples negative on both assays which were cultured (101 
negative samples, Table 16). Eight isolates were obtained out of 44 ISCfe1-negative/parA-positive 
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samples (18.2%) and six isolates were grown out of 51 ISCfe1-positive/parA-negative samples 
(11.8%, Table 16). 
Table 16. Comparison of of 266 screened bull preputial secretions using the ISCfe1 and parA real-
time PCR assays to isolate Campylobacter-like by culture. 
1
This study 
2
McMillen at al. 2006 
 
Table 17. Specificity and sensitivity (bolded) of the new ISCfe1 real-time assay relative to isolation 
of Campylobacter-like organisms by culture (n=235) was 74.2% and 52% respectively. Kappa 
agreement between the two methods was poor (0.12). 
 
Table 18. Specificity and sensitivity (bolded) of the parA real-time assay relative to isolation of 
Campylobacter-like organisms by culture (n=235) samples was 80.6% and 56.4% respectively. 
Kappa agreement between the two methods was poor (0.17). 
   Isolation positive Isolation negative Total 
parA-positive Samples 25 89 114 
Percentage (%) 80.64 43.63  
parA-negative Samples 6 115 121 
Percentage (%) 19.35 56.37  
Total 31 204 235 
 
 
 ISCfe1
1
-positive ISCfe1-negative 
Total 
screened 
 
parA
2
 
positive 
parA 
negative Total 
parA 
positive 
parA 
negative Total 
Real-time PCR screening 70 51 121 44 101 145 266 
Samples cultured 70 51 121 43 71 114 235 
Cultures isolated 17 6 23 8 0 8 31 
Isolation success 24.3% 11.8% 19.0% 18.6% 0.0% 7.0% 13.2% 
   Isolation-positive Isolation-negative Total 
ISCfe1-positive Samples 23 98 121 
Percentage (%) 74.19 48.04  
ISCfe1-negative Samples 8 106 114 
Percentage (%) 25.81 51.96  
Total 31 204 235 
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3.7. Preliminary phenotyping of 31 Campylobacter-like isolates 
 Twenty-seven out of 31 pure Campylobacter-like isolates were found to be glycine-
intolerant (possible C. fetus subsp. venerealis) while four isolates were glycine-tolerant (putative 
C. fetus subsp. fetus), all isolates were negative for H2S production on TSI slopes (Table 11). 
After gDNA extractions, all 31 isolates were positive on the parA real-time assay (100%) and 28 
out of 31 were also positive on the ISCfe1 real-time assay (90.3%, Table 11). Fifteen out of 31 
gDNA extracts produced both fragments on Hum’s PCR (48.4%) and three others produced solely 
the 142 bp fragment (9.7%), the remaining 13 isolates were negative (41.9%, Table 11). Thirty out 
of 31 isolates were also positive on Abril’s PCR (96.8%, Table 11); the single extract that was 
negative was also negative on both Hum’s PCR and the ISCfe1 real-time assay (isolate 856, Table 
13).  
There was poor agreement between results obtained from Hum’s and Abril’s PCR assays 
(Kappa=0.06) and from the ISCfe1 real-time assay and Hum’s PCR (Kappa=0.07) for the 31 
Campylobacter-like isolates. Agreement between ISCfe1 real-time assay and Abril’s conventional 
PCR was perfect (Kappa=1). 
 
3.8. Cloning and sequencing of ISCfe1 real-time PCR products 
 Analysis of sequences for two out of five isolates indicated that gDNA extracts yielding late 
Ct scores (35-40) could be due to false-positive ISCfe1 real-time results as isolates 521 (Ct=37.78) 
and 573 (Ct=35.51) failed to produce complete ISCfe1 target sequence. Sequence analysis of three 
out of five late ISCfe1 real-time products matched 100% the assay’s target, underlining that late 
amplification could still identify true ISCfe1 positive results as obtained for isolates 531 (Ct=35.20), 
672 (Ct=35.36) and 673 (Ct=35.56).  
Sequence analysis of the ISCfe1 real-time products obtained from two other positive isolates (676: 
Ct=34.74; 979: Ct=31.72) indicated that nucleotide substitution and insertion could occur (Figure 
10). Despite BLAST specificity of the assay primers was verified (28/01/2010), BLASTn searches 
of altered ISCfe1 real-time products (06/11/2012) revealed that transposase sequences found in 
C. coli 6067, C. jejuni subsp. jejuni IA3902 and H. pylori F16 (GenBank Accessions JQ613155, 
CP001876 and AP011940) share 86-91% identity with the ISCfe1 real-time target (Figure 10), 
suggesting that mis-priming with other closely related organisms could be occurring.  
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Figure 10. The ISCfe1 real-time PCR assay targets the partial transposase gene tnpB, conserved in ISCfe1 sequences (GenBank accession AM260752, 
AM286430, AM286431 and AM286432).  
 
 
Sequences analysis of some ISCfe1 real-time products showed that nucleotide substitution and insertion (isolates 676 and 979: T instead of C position 
33; A insertion between position 44 and 45) could occur. BLASTn searches revealed that transposase sequences found in C. coli 6067, C. jejuni subsp. 
jejuni IA3902 and H. pylori F16 (GenBank Accessions JQ613155, CP001876 and AP011940) share 86-91% identity with the ISCfe1 real-time target. 
Location of primers and probe is indicated; variable sites are highlighted.
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3.9. Biochemical versus molecular results of 51 Campylobacter-like isolates 
 A random subset of Campylobacter-like isolates (n=51) were subjected to biochemical 
phenotyping: 17 were phenotyped as C. fetus subsp. venerealis bv. venerealis, 12 as C. fetus subsp. 
venerealis bv. intermedius, four as C. fetus subsp. fetus, seven as thermophilic Campylobacter spp. 
and 11 as aerotolerant Arcobacter-like organisms (Table 13; Appendix 1, Table A).  
Isolates phenotyped as C. fetus subsp. venerealis (both biovars, n=29) were all positive on Abril’s 
PCR, 16 were also positive on Hum’s PCR, seven others produced only the 142 bp amplicon while 
the remaining six were negative on Hum’s PCR (Table 13). The four isolates phenotyped as C. fetus 
subsp. fetus were positive on both real-time assays and Abril’s PCR; two were also positive on 
Hum’s PCR while the other two exhibited only the 142 bp fragment (Table 13). The remaining 18 
organisms phenotyped as thermophilic Campylobacter spp. (n=7) or as aerotolerant Arcobacter-like 
organisms (n=11) were all positive on both real-time assays, with the majority positive on Abril’s 
(n=15) and a proportion on Hum’s (n=4) PCR assays (Table 13).  
 
4. Discussion 
In order to develop new diagnostic methods for C. fetus subsp. venerealis, this project needed to 
establish a culture collection. Bull preputial samples were collected over 18 months, methods used 
in this chapter thus evolved over time in order to improve detection of the bacterium, assisting in 
the isolation of C. fetus subsp. venerealis and Campylobacter-like pure cultures.  
To identify putative C. fetus subsp. venerealis infections, the parA real-time PCR assay was firstly 
applied to 717 bull preputial samples and on the basis of a positive result (n=174), samples were 
cultured to obtain 44 isolates. Whilst the parA real-time assay detected a much higher proportion of 
positive samples compared to isolation by culture, the specificity (86.3%) and sensitivity (40.1%) of 
this assay is questionable (McMillen et al., 2006). As this research determined, some of the parA 
positives yielding late Ct scores can result from primer dimer interaction while culturing of a 
proportion of parA negative samples to identify the possibility of false-negative results also yielded 
C. fetus subsp. venerealis isolates.  
Absence of the parA target from C. fetus subsp. venerealis isolates has previously been reported 
(Willoughby et al., 2005) while a different parA sequence type recently described from six clinical 
samples would also be missed by this test (Chaban et al., 2012). Although results presented in this 
study show that real-time pre-testing can assist in the isolation of the organism, these findings 
confirm that the parA real-time assay should not be used alone to assess bulls positive for C. fetus 
subsp. venerealis, culture must always be performed simultaneously as recommended (OIE, 2012a). 
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Due to the non-specificity of the parA gene target and to the consistent detection of the ISCfe1 
insertion element in all C. fetus subsp. venerealis strains previously tested by Abril et al. (2007), a 
new real-time PCR assay based on a conserved transposase region within this element was 
designed. Whilst this is a contentious target for a molecular assay, the initial analysis did appear to 
confirm that the sequence may be specific for C. fetus subsp. venerealis. Sensitivity studies with 
spiked cultures from three C. fetus subsp. venerealis reference strains showed that it was more 
sensitive than the parA real-time assay whilst other reference spp. tested were negative.  
Both tests were used concurrently to screen 266 additional bull preputial samples, detecting similar 
rates of positives, and a further 31 isolates were obtained. Even though no isolation was achieved 
from samples negative on both tests, ISCfe1 positive/parA negative (6/51; 11.8%) and ISCfe1 
negative/parA positive (8/44; 18.2%) samples did yield some C. fetus. subsp. venerealis isolates by 
culture. In contrast to the assay sensitivity screening using spiked cultures, the ISCfe1 real-time 
assay was found to be less specific (74.2%) and sensitive (52%) than the parA real-time assay 
(80.6% and 56.4%) compared to isolation by culture from bull preputial samples. 
Evaluation of gDNA extracts from obtained cultures (n=84) revealed that only 34 isolates were 
positive on Hum’s PCR (both C. fetus and C. fetus subsp. venerealis amplicons), 18 produced only 
the parA-specific fragment while the remaining 32 were negative. The parA gene was previously 
found in C. hyointestinalis isolates which lacked the larger C. fetus-specific fragment in Hum’s 
PCR indicating that similar parA sequences could be present in closely related Campylobacter spp. 
(Spence et al., 2011). Moreover, in the present study, some isolates that produced both amplicons 
on Hum’s PCR, or that were parA positive only, were identified as C. fetus subsp. fetus, 
thermophilic Campylobacter spp. and other aerotolerant Arcobacter-like organisms, providing 
further evidence of the existence of closely related parA positive organisms other than C. fetus 
subsp. venerealis.  
The parA gene, required for plasmid partitioning, was recently reported to be located on a C. fetus 
subsp. venerealis-specific PAI while a C. fetus subsp. fetus-specific genomic island was newly 
found to harbour a truncated parA gene (Abril et al., 2010; Baar et al., 2003; Gorkiewicz et al., 
2010). Although previous attempts to isolate plasmids were unsuccessful in identifying the possible 
source of parA in C. fetus subsp. venerealis; and as PAI are known to result from horizontal 
transfer, these new findings do support the possible transferability of the parA gene (Abril et al., 
2010; Baar et al., 2003; Gorkiewicz et al., 2010; Willoughby et al., 2005). The parA real-time target 
shares 81% identity with the partial parA gene (GenBank Accession FN594949) located on C. fetus 
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subsp. fetus IMD523 genomic island (Abril et al., 2010), confirming its presence in both C. fetus 
subspecies. 
This project found the ISCfe1 insertion element (Abril et al., 2007) in 76 of tested isolates (n=84), 
34 of them being also positive on Hum’s PCR. Previously, detection of ISCfe1 correlated well with 
the phenotypic trait of glycine tolerance and Hum’s PCR results (Abril et al., 2007). However, in 
this study, some glycine-tolerant ISCfe1 positive isolates were phenotyped as C. fetus subsp. fetus 
and others as thermophilic Campylobacters spp. while some glycine-sensitive ISCfe1 positive 
isolates were identified as aerotolerant Arcobacter-like cultures based on full biochemical 
phenotype, some being also positive on Hum’s PCR. Even though C. fetus subsp. venerealis 
glycine-tolerant as well as C. fetus subsp. fetus glycine-sensitive isolates have been reported (On 
and Harrington, 2001; Salama et al., 1992; Vargas et al., 2003; Wagenaar et al., 2001), these 
atypical results indicate that the ISCfe1 insertion element is found in closely related species. 
Several ISCfe1 real-time products exhibited sequence variation revealing high similarity with 
C. coli 6067, C. jejuni subsp. jejuni IA3902 and H. pylori F16 transposase sequences (GenBank 
Accessions JQ613155, CP001876 and AP011940). Indeed, the complete ISCfe1 insertion element 
(GenBank Accession AM260752) shares 71 to 78% identity with these sequences and C. jejuni 
CJG9 plasmid sequence (GenBank Accessions AJ490186) and up to 75% identity with 114 
H. pylori putative transposase sequences located onto IS607 insertion elements. As transposition of 
IS607 to E. coli was previously demonstrated while mobile DNA regions such as insertion elements 
are acquirable by horizontal transfer (Kersulyte et al., 2000; Mahillon and Chandler, 1998), these 
findings support the idea that transposition may move ISCfe1 onto other genetic elements that can 
spread them from C. fetus subspecies to other Campylobacter spp. and Campylobacter-like 
organisms (Abril et al., 2007). This study reports that the whole ISCfe1 insertion element will not 
provide specific C. fetus subsp. venerealis markers. 
The presence of similar organisms in the bull prepuce samples screened here confirms perhaps the 
difficulties veterinary diagnostic laboratories may encounter if relying on culture with limited 
biochemical screening. Alternatively, biochemical phenotyping of the Campylobacter-like isolates 
can be questionable as described for glycine tolerance which can be acquired by phage transduction 
and mutation (Chang and Ogg, 1971). The ability of C. fetus subsp. venerealis biovar intermedius 
and C. fetus subsp. fetus isolates to tolerate higher glycine concentrations than C. fetus subsp, 
venerealis biovar venerealis (Salama et al., 1992) may be associated with an indel mutation in the 
cation symporter gene involved in the transport of both alanine and glycine reported from C. fetus 
subsp. venerealis biovar venerealis strain B6 but absent from C. fetus subsp. venerealis biovar 
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intermedius strain 642-21 and C. fetus subsp. fetus strain 82-40 (Barrero et al., 2013). It is yet to be 
determined whether this mutation is consistently present in C. fetus subsp. venerealis biovar 
venerealis field isolates and if the correlation to glycine intolerance is consistent.  
Interestingly, several Campylobacter-like isolates appeared to be aerotolerant during the phenotypic 
screen yet positive on all assays including Hum’s PCR. The ability of some Campylobacter-like 
isolates to grow aerobically may have resulted from the exposure to the FBP components which 
have been reported to improve the aerotolerance of C. fetus strains (George et al., 1978). Addition 
of FBP to enrichment broth was reported to allow 98% of C. fetus isolates tested (n=64) to grow in 
21% oxygen (George et al., 1978). Pyruvate, a FBP component, is believed to quench to reactive 
oxygen species toxic to Campylobacter metabolism such as hydrogen peroxide, reducing their 
concentration in culture media and enabling bacterial growth in up to 91% oxygen as reported for 
C. jejuni (Verhoeff-Bakkenes et al., 2008). In this study, biochemical phenotyping of 51 
Campylobacter-like isolates was performed after recovery from the storage medium containing FBP 
as it provided better bacterial growth (results not shown). It may be possible that Campylobacter-
like isolates identified as Arcobacter-like organisms may have exhibited a transient stage of 
aerotolerance. Another atypical finding was the ability of some Campylobacter-like isolates to grow 
at 42°C although thermophilic C. fetus isolates have been previously reported (Jones et al., 1985; 
On and Harrington, 2001).  
Current methods and the interpretation of both biochemical and molecular C. fetus subsp. venerealis 
screening could pose a challenge for most routine veterinary diagnostic laboratories as previously 
reported (Hum et al, 1997; On and Harrington, 2001; Vargas et al, 2003; Wagenaar et al., 2001).  
  
5. Conclusions and future directions 
Considering that real-time testing of suspected BGC samples can be achieved within 2h while 
successful isolation of a pure C. fetus culture requires at least 72h, this study showed that molecular 
evaluation of crude samples could assist detecting infected samples upon arrival to the laboratory. 
More rigorous cultural procedures could be applied to samples tested as real-time positives to 
increase the chances of C. fetus subsp. venerealis isolation while biochemical phenotyping and 
molecular characterisation of obtained cultures is still needed to confirm identity.  
Although real-time detection assisted culture isolation, this study reports that both parA and ISCfe1 
gene targets can be present in C. fetus subsp. fetus, Campylobacter spp. and other Arcobacter-like 
organisms, raising concern about the use of real-time C. fetus subsp. venerealis-specific markers or 
diagnostic tools without concurrent culture and biochemical phenotyping results.  
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This chapter also underlines the problem of biochemical identification (gold standard) relying on a 
few phenotypic traits which were originally used to define the C. fetus subspecies after evaluation 
of a limited number of tested strains. Even if the culture collection presented in this study exhibits 
atypical biochemical and molecular characteristics, the large number of isolates here obtained may 
be more representative of the field diversity of the C. fetus and Campylobacter-like organisms 
present in the bull prepuce. 
This diverse collection of isolates, together with complete C. fetus subsp. venerealis genomes 
(Barrero et al., 2013; Stynen et al., 2011), will contribute to further strain molecular differentiation 
in order to identify more reliable diagnostic targets for C. fetus subsp. venerealis (Chapter 6) as well 
as virulent strains (Chapter 7).  
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CHAPTER 6: EVALUATION OF PUTATIVE SUBSPECIES GENE TARGETS TO 
IDENTIFY CAMPYLOBACTER FETUS SUBSPECIES VENEREALIS 
 
1. Introduction 
Due to the lack of reliable discriminatory biochemical tests to distinguish between Campylobacter 
fetus subspecies, it was previously suggested that the identification of C. fetus subsp. venerealis 
should not solely be based upon biochemical phenotyping (Chapter 2, section 1.1.3). Early research 
focused on the development of molecular methods (Chapter 2, section 2.3), but most are considered 
of limited use for diagnostic purposes due to the costs of reagents and equipment and the 
requirement for pure cultures (Hum et al., 1997; Salama et al., 1992; van Bergen et al., 2005c; van 
Bergen et al., 2005b; Wagenaar et al., 2001; Wassenaar and Newell, 2000). Nevertheless, some 
conventional PCR assays targeting C. fetus subsp. venerealis-specific DNA sequences (Chapter 2, 
section 0) were developed and recommended as co-techniques to confirm the identity of suspected 
C. fetus subsp. venerealis isolates by international standards (OIE, 2012a).   
The multiplex PCR designed by Hum et al. (1997) has been widely adopted; and appeared to 
correlate well with biochemical phenotyping of C. fetus isolates (Hum et al., 1997; On and 
Harrington, 2001; Schulze et al., 2006; Vargas et al., 2003). Subsequently, a sensitive real-time 
PCR assay designed from the subspecies-specific parA gene targeted by Hum’s PCR revealed a 
much higher prevalence of C. fetus subsp. venerealis in crude samples compared to culture 
(McMillen et al., 2006). Reports of false-reactions using the parA gene underlined the need for a 
more consistent diagnostic test (Spence et al., 2011; Willoughby et al., 2005). A recently discovered 
ISCfe1 insertion element was shown to be present in all C. fetus subsp. venerealis strains tested 
(Abril et al., 2007). This project thus designed a new real-time PCR assay based on a conserved 
region of this element and concurrently used both parA and ISCfe1 real-time assays to identify 
putative C. fetus subsp. venerealis infections from bull preputial secretions (Chapter 5).  
All positive samples and a proportion of negative samples were cultures using recommended 
microbiological techniques outlined in Chapter 4. Although real-time PCR screening assisted in the 
isolation of Campylobacter-like organisms by culture, both parA and ISCfe1 gene targets were 
detected from isolates phenotyped as C. fetus subsp. fetus, thermophilic Campylobacter spp. and 
aerotolerant Arcobacter-like organisms while they were not always found in all biochemically 
confirmed C. fetus subsp. venerealis isolates (Chapter 5). These results indicated that additional 
C. fetus subsp. venerealis-specific gene targets are needed.  
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The draft genomes of two C. fetus subsp. venerealis (bv. venerealis B6 and bv. intermedius 642-21) 
reference strains aligned to a previously available C. fetus subsp. fetus (82-40) genome resulted in 
the identification of 26 unique C. fetus subsp. venerealis regions (Barrero et al., 2013). The aim of 
this chapter was to design new putative conventional PCR assays from draft contigs common to 
both biovars to evaluate the Campylobacter-like culture collection in order to identify new reliable 
diagnostic targets for C. fetus subsp. venerealis. 
 
2. Methods 
2.1. Bacterial strains, culture conditions and DNA extraction 
 Reference cultures of C. fetus subsp. venerealis bv. venerealis B6 (Donaldson and Clark, 
1970) and bv. intermedius 642-21 (Newsam and Peterson, 1964) were sourced from BGC cases 
(Table 19). The other C. fetus and Campylobacter reference cultures were obtained from 
Biosecurity Queensland (DAFF) or from the American Type Culture Collection (Table 19).  
Table 19. Campylobacter spp. reference cultures used in Chapter 6. 
Species Strain Source 
C. coli  33559 ATCC
1 
 
C. fetus subsp. fetus 15926 ATCC
1
 
C. fetus subsp. venerealis 19438 ATCC
1
 
C. fetus subsp. venerealis 33561 ATCC
1
 
C. fetus subsp. venerealis 98-109383 DAFF
2
 
C. fetus subsp. venerealis  B6 Donaldson and Clark (1970)  
C. fetus subsp. venerealis 642-21 Newsam and Peterson (1964)  
C. hyointestinalis 35217 ATCC
1
 
C. jejuni 33560  ATCC
1
 
C. lari 35221 ATCC
1
 
C. upsaliensis  43954 ATCC
1
 
1
American Type Culture Collection (ATCC)  
2
Department of Agriculture, Fisheries & Forestry (DAFF)  
 
The Campylobacter-like culture collection isolates (n=84) were obtained from bull preputial 
secretions (Chapter 5). The identity of the isolates and previous biochemical and molecular test 
results are reported in Chapter 5, Table 13. Cultures were grown at 37°C under microaerophillic 
conditions in BHI enrichment broth (3.7% brain heart-infusion, 0.2% yeast extract, 0.07% agar 
bacteriological n°1) or thioglycollate broths for 72h (see Chapter 3, 2). Genomic DNA was 
extracted from reference and Campylobacter-like cultures using a commercial kit (QIAamp DNA 
mini kit, QIAGEN, see Chapter 3 section 3.1). 
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2.2. New putative conventional PCR assays for C. fetus subsp. venerealis 
2.2.1. Selection of unique C. fetus subsp. venerealis contigs 
 Illumina/GAII technology was used to sequence the genomes of C. fetus subsp. venerealis 
bv. venerealis B6 and bv. intermedius 642-21 (Barrero et al., 2013). The two new draft genomes 
were assembled in respectively 80 and 126 contigs using De novo assembly and aligned to the 
reference C. fetus subsp. fetus (82-40) genome using MuMmer version 3 in order to identify regions 
unique to C. fetus subsp. venerealis (Barrero et al., 2013; Kurtz et al., 2004). Gaps obtained after 
dot plot comparisons of aligned genome sequences indicated regions that were absent from the 
C. fetus subsp. fetus genome. Twenty-six regions longer than 200 bp were considered to be unique 
for C. fetus subsp. venerealis and suitable for assay development (Barrero et al., 2013). Thirteen 
regions that were not annotated to putative virulence factors or PAI genes using COG categories 
and KEGG pathways were used for PCR design in October 2010 (contigs available upon request). 
 
2.2.2. Design of new primers from unique C. fetus subsp. venerealis draft contigs 
 Using Primer3 Input version 0.4.0, new primers were designed to target the 13 C. fetus 
subsp. venerealis unique draft contigs (Rozen and Skaletsky, 2000). To ensure that the locations of 
the primers targeted regions unique to C. fetus subsp. venerealis, coverage histograms were visually 
inspected to verify that the average number of reads that aligned to the C. fetus subsp. fetus genome 
was less than 10. To minimise risk of primer dimers as a result of non-specific binding affinity, 
RNAhybrid was used to check that the free energy of designed primers was higher than -20 
kcal/mol (Rehmsmeier et al., 2004). The specificity of new primers was investigated using BLASTn 
searches (http://www.ncbi.nlm.nih.gov/BLAST/) and in silico PCR amplifications against all 14 
Campylobacter reference strains (Table 20) available online (Bikandi et al., 2004). The PCR targets 
were annotated using a combination of Genemark.hmm for prokaryotes version 2.6 (Lukashin and 
Borodovsky, 1998), BLAST (BLASTn, BLASTp, tBLASTx) searches and genes predictions from 
the draft C. fetus subsp. venerealis bv. venerealis B6 and bv. intermedius 642-21 genomes (Barrero 
et al., 2013), deposited on YABI (Hunter et al., 2012). Geneious version 5.6.3 was used to align 
new conventional PCR targets to the draft contigs they were designed from in order to illustrate 
locations of new primer sets and PCR target annotations (Drummond et al., 2012). 
  
2.2.3. New conventional PCR assays conditions 
 New primer sets were synthesised through Sigma-Aldrich and PCR assays were undertaken 
in 20 µl reactions using 1 ×PCR reaction buffer with 25 mM Mg
2+
 (10× Hotmaster™ Taq buffer), 
1U Hotmaster™ Taq DNA polymerase), 1 µM of each forward and reverse primers, 1 µM dNTPs 
and 1.25 ng of gDNA. The reactions were amplified in a DNA Engine
®
 Thermal Cycler using the 
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following parameters: initial denaturation at 94°C for 2min, 30 cycles at 94°C for 20s, annealing at 
60°C for 10s, and extension at 60°C for 30s, with a final extension at 72°C for 10min. Annealing 
temperatures of new primer sets were selected using gradient PCR runs ranging from 55°C to 65°C. 
The PCR profile here described was used with all new primer sets except when using primers 
targeting a hypothetical protein (contig ab51_contig98_4075-4315) for which the annealing 
temperature was modified to 59°C. C. fetus subsp. venerealis B6 and 642-21 (Table 19) gDNA 
extracts were used to optimise the new conventional PCR assays conditions as per manufacturer 
recommendations. Once assays conditions were optimised and annealing temperatures selected, all 
other reference C. fetus and Campylobacter spp. (Table 19) gDNA extracts were used to confirm 
assay specificity prior to test the Campylobacter-like culture collection (n=84). Products were 
separated in 2%TBE (89 mM Tris borate, 2 mM EDTA, pH 8) agarose gels containing 1% 
GelRed
TM
 Nucleic Acid Gel Stain (Biotium) using MassRuler
TM
 Low range DNA ladder 
(Fermentas) and were visualised under Trans-UV light using GelDoc
TM
 XR+ system.  
Table 20. Campylobacter spp. (n=14) used for in silico verifications (Bikandi et al., 2004). 
Species Strain 
C. concisus 13826 
C. curvus 525.92 
C. fetus subsp. fetus 82-40 
C. hominis ATCCBAA-381
1
 
C. jejuni RM1221 
C. jejuni subsp. doylei 269.97 
C. jejuni subsp. jejuni 81-176 
C. jejuni subsp. jejuni ICDCCJ07001 
C. jejuni subsp. jejuni 81116 
C. jejuni subsp. jejuni IA3902 
C. jejuni subsp. jejuni M1 
C. jejuni subsp. jejuni NCTC11168
2
 
C. jejuni subsp. jejuni S3 
C. lari RM2100 
1
American Type Culture Collection (ATCC) 
2
National Collection of Type Cultures (NCTC)  
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2.3. New D-mycarose 3-C-methyltransferase real-time PCR assay 
2.3.1. Design  
 The D-mycarose 3-C-methyltransferase gene, conserved in both C. fetus subsp. venerealis 
bv. venerealis B6 (cfvv_43_gene_46) and bv. intermedius 642-21 (cfvi_51_gene_17) genomes was 
considered for real-time PCR assay development. In C. fetus subsp. venerealis, the D-mycarose 3-
C-methyltransferase gene is 1 272 bp-long while a homologous gene (1 251 bp) is found in C. fetus 
subsp. fetus 82-40 (GenBank Accession ABK82051). BLASTn was used to align both C. fetus D-
mycarose 3-C-methyltransferase genes, highly and somewhat similar regions (identities: 
595/1566=37%, gaps: 609/1566= 38%) were avoided in order to design a C. fetus subsp. venerealis-
specific real-time assay from the unique region of the gene. Primers and a fluorescent 3’ MGB-
DNA probe (synthesised by Applied Biosystems) were designed using Primer Express version 2. 
Geneious version 5.6.3 was used to align primers, probe and real-time target to C. fetus D-mycarose 
3-C-methyltransferase genes (Drummond et al., 2012). Primers, probe and target sequence 
specificity was confirmed using BLASTn searches. The D-mycarose 3-C-methyltransferase real-
time PCR assay was performed in a 25 µl reaction by using RealMasterMix Probe 2.5x with 500 
nM D-mycarose 3-C-methyltransferase-F and D-mycarose 3-C-methyltransferase-R primers, 62.5 
nM D-mycarose 3-C-methyltransferase-P fluorescent 3’ MGB-DNA probe, and 5 µl of heat-lysed 
cells or 50 ng of purified gDNA in a Corbett Rotor-Gene RG-3000. Heat lysis was executed as 
previously described (McMillen et al., 2006). The D-mycarose-3-C-methyltransferase real-time 
PCR assay thermal profile was 50°C for 2min, 94°C for 2min, and 45 cycles of denaturation at 
94°C for 20s, annealing at 60°C for 20s, and extension at 68°C for 20s. Serial dilutions of C. fetus 
subsp. venerealis (ATCC19438 and 98-109383, Table 19) and C. fetus subsp. fetus (ATCC15926, 
Table 19) gDNA extracts were used to optimise assay conditions and to determine cut-off value 
between positive and negative samples (Ct=40), samples with a Ct score<40 were considered as 
positive. The fluorescence signal detected after each extension step indicated a positive result when 
reaching a threshold of 0.1648. Quantitative evaluation of target cells/ml were estimated using a 
standard curve generated with gDNA and crude cell lysates prepared from serial dilutions of known 
cells and colonies numbers of C. fetus subsp. venerealis strains. All other reference C. fetus subsp. 
venerealis and Campylobacter spp. (Table 19) gDNA extracts were used to investigate assay 
specificity, as well as in silico PCR amplifications against the 14 Campylobacter reference strains 
(Table 20) available online (Bikandi et al., 2004).  
 
2.3.2.  Sensitivity comparison 
 Ten µl from each 72h enriched thioglycollate broth culture of C. fetus subsp. venerealis 
reference strains B6 (Donaldson and Clark, 1970) and 642-21 (Newsam and Peterson, 1964) and 
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ATCC19438 (Table 7) were diluted 1:10 in formalin to decrease cell motility. Bacterial cell counts 
were performed in duplicates using an improved Neubauer haemocytometer. Serial log dilutions 
were prepared in PBS in duplicates using the same C. fetus subsp. venerealis enriched broth 
cultures and 100 µl of each dilution was spread onto SBA plates to count CFU after 72h incubation 
at 37°C under microaerophillic conditions. Heat lysates from each duplicated serial log dilution 
were used as template for the new D-mycarose 3-C-methyltransferase real-time assay in order to 
correlate number of detected cells with Ct scores and colony counts. Results were compared to 
those previously obtained with parA and ISCfe1 real-time assays using the same methodology 
(Chapter 5). Heat lysis and real-time runs were performed as described (section 2.3.1). 
 
2.4. Assessment of newly designed methods 
 In order to assess the usefulness of the newly designed conventional (n=13) and real-time 
PCR (n=1) assays, results presented in this chapter from the Campylobacter-like culture collection 
(n=84) were compared to previously determined phenotypes and molecular results (Chapter 5, 
Table 13) obtained using published and recommended methods (Abril et al., 2007; Hum et al., 
1997; OIE, 2012a). Biochemical profiling identified 29 isolates as C. fetus subsp. venerealis, four as 
C. fetus subsp. fetus, seven as thermophilic Campylobacter spp. and 11 as aerotolerant Arcobacter-
like organisms (Appendix 1). The remaining 33 had not been biochemically phenotyped. 
 
2.5. Multi Locus Sequence Typing (MLST) 
 To assist the selection of isolates from the Campylobacter-like culture collection for genome 
sequencing, five isolates (214, 229, 475, 540 and 635) that were previously phenotyped as C. fetus 
subsp. venerealis, positive on Hum’s and Abril’s PCR assays as well as on both parA and ISCfe1 
real-time assays (Chapter 5, Table 13) were analysed using MLST (van Bergen et al., 2005c). 
Primers were synthesised through Sigma-Aldrich (van Bergen et al., 2005c). PCR reactions were 
performed in 20 µl reactions using 1× PCR reaction buffer with 25 mM Mg
2+
 (10× Hotmaster™ 
Taq buffer), 0.5 U Hotmaster™ Taq DNA polymerase, 0.2 µM of each forward and reverse 
primers, 0.2 µM dNTPs and 1.25 ng of gDNA. The reactions were amplified in a DNA Engine
®
 
Thermal Cycler using previously described parameters (van Bergen et al., 2005c). PCR products 
were separated and visualised as detailed in section 2.2.3. PCR products were purified using 
ExoSAP-IT
®
 PCR product clean-up (USB) and sequenced using the BigDye® version 3.1 
technology and analysed on the 3130xl Genetic Analyzer at the Griffith University DNA 
Sequencing Facility. Sequencing reactions were prepared using primers reported by van Bergen et 
al. (2005c) according to the manufacturer’s instructions (Applied Biosystems). Sequences were 
visualised, edited and aligned using Sequencher version 4.5 prior to further analysis. Additionally, 
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the MLST genes of reference C. fetus subsp. venerealis strains B6 and 642-21 were confirmed from 
draft genomes sequences deposited on YABI (Hunter et al., 2012) while the PCR specific for the 
glyA gene was performed prior to sequencing the resulting product in order to verify glyA 
sequences. 
 
3. Results 
3.1. Evaluation of new putative conventional PCR assays 
3.1.1. New putative conventional PCR targets 
 Thirteen new primer sets were designed from the 13 unique draft contigs common to both 
B6 and 642-21 C. fetus subsp. venerealis genomes that were not annotated to putative known 
virulence factors or PAI genes. The new PCR assays targeted genes which were annotated as either 
putative membrane proteins (n=3), metabolic enzymes (n=5) or hypothetical /predicted proteins 
(n=5). New primer sequences and PCR target annotations are detailed in Table 21. Initial BLASTn 
analysis of the PCR target yielded no other significant hit in Genbank than C. fetus subsp. veneralis 
AZUL-94 sequences (May 2011) while recent BLAST searches (June 2012) found all new putative 
PCR targets in the newly published C. fetus subsp. venerealis ATCC19438 genome (Stynen et al., 
2011). Alignments of new PCR targets to corresponding draft contigs show locations of primers and 
putative PCR target annotations (Figures 11-17). 
 
3.1.2. Reference cultures 
 C. fetus subsp. venerealis reference strains tested (Table 19, n=5) were positive on the 13 
new putative conventional PCR assays designed from draft contigs common to both B6 and 642-21 
C. fetus subsp. venerealis genomes while all the other Campylobacter reference strains (Table 19, 
n=6) were negative. Gel pictures (Appendix 3, Figures A-H) show the PCR products obtained with 
three C. fetus subsp. venerealis reference strains (1-B6; 2-642-21; 3-98-109383) while no amplicon 
was produced from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-
ATCC35221; 7-ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-
water). The two C. fetus subsp. venerealis reference strains ATCC19438 and ATCC33561 (Table 
19) were also appositive on the 13 new conventional PCR assays while no in silico PCR product 
was obtained from any of the other Campylobacter reference strains (Table 20, n=14) tested online 
(results not shown).  
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Table 21. New primer sequences and putative PCR target annotations. 
Contig number 
Forward primer sequence 
(5’to 3’) 
Reverse primer sequence 
 (5’to 3’) 
Amplicon  
(bp) 
Putative PCR target annotation using tBLASTx 
(top hit, species, E-value, accession number) 
ab51_contig98_4075-
4315 
ACAGGAGATAACAGATGGCAAGT TCGGTTTTGCCGATTTTTAC 150 
Hypothetical protein CFV354_0553, C. fetus subsp. 
venerealis NCTC10354, 5e-07, EGU23640.1* 
cfvv_28.1-4317.505-
1097 
GAGCAAACGCTCTGACACAA CAGCCACCATCTTGTTTTGA 158 
Putative periplasmic binding protein, C. fetus subsp. 
venerealis NCTC10354, 1e-30, EGU23633.1* 
cfvv_28.1-
4317.1697-2142 
AGCATAAGGTGCTAGGGTTG CGCTGCGAAGTCAAAATGTA 197 Gp27, C. fetus, 2e-54, A0RNP0_CAMFF† 
cfvv_36.1-
147294.32158-32473 
GTTATCGTGCAAGGCAAACA GCGCACTTTACCGAGTTTTT 150 Serpentine_recp domain containing protein, 2e-05† 
cfvv_43.1-
43748.31801-32913 
GCATTTGGAAACTGGGAAAA CCGCATTTTGCCATATCTTT 176 
Putative oxidoreductase, Helicobacter canadensis 
MIT 98-5491, 6e-24, ZP_04870167.1* 
cfvv_43.1-
43748.37070-37996 
CTCCATAGCTGGGGAAATCA GCGCCAAATCTCTTCTATGC 195 
Molybdenum cofactor biosynthesis protein 1 B; Fe- 
S oxidoreductase, C. fetus subsp. venerealis 
NCTC10354, 1e-40, EGU24666.1* 
cfvv_43.1-
43748.38016-39466 
AAGCGATCAACTGCTTTTCA TATCGCCTATTGGGCTAGGA 172 
D-mycarose 3-C-methyltransferase, C. fetus subsp. 
venerealis str. Azul-94, 2e-48,UPI0001BCDDAF† 
cfvv_44.1-
6162.1810-2822 
TCAAACTATGGCAGTAGCAA CGGAAGTAGAGCCATCATCC 232 
Glycosyl transferase, group 2 family protein, C. fetus 
subsp. venerealis NCTC10354, 2e-45, EGU24673.1* 
cfvv_45.1-
4689.3424-4598 
AACTGCGGGTTAAGAGCTGA TATTCTGCGCCTCCAAAAAC 203 
Hypothetical protein CfetvA_13105, C. fetus subsp. 
venerealis str. Azul-94, 5e-39, ZP_06009991.1* 
cfvv_46.1-11977.84-
1196 
TCCGGGATTTAGCGTATCTT TTCCACCTTTGTCCGTTTTT 164 
Hypothetical protein CFV354_1756, C. fetus subsp. 
venerealis NCTC10354, 3e-30, EGU24680.1* 
cfvv_46.1-
11977.1215-2434 
GCTAGCTCTTGGTGGCTTTC CGTGAGCTAGCGTAAAGCTG 214 
Predicted protein, Helicobacter winghamensis 
ATCCBAA-430, e-120, C3XKD3_9HELI† 
cfvv_52.1-1223.50-
1223 
AGAGCACGCCTATTGTACGC TGGATAACCAGCTTTGACGA 175 Serpentine_recp domain containing protein, 2e-38† 
cfvv_79.1-1308.319-
829 
TCCATGCAATCTGACCGTAA AAGCCAAGCAGAAATTTGGA 198 
Hypothetical protein CFV354_0737, C. fetus subsp. 
venerealis NCTC 10354, 2e-24, EGU23801.1* 
*BLAST (http://blast.ncbi.nlm.nih.gov/, accessed on 27
th
 of June 2012)  
 
†YABI (http://ccg.murdoch.edu.au/yabi, accessed on 27th of June 2012)
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Figure 11. New putative hypothetical protein (A-150 bp; ab51_contig98_4075-4315) and periplasmic binding protein (B-158 bp; cfvv_28.1-4317.505-
1097) conventional PCR assays. 
 118 
 
Figure 12. New putative Gp27 (A-197 bp; cfvv_28.1-4317.1697-2142) and serpentine domain containing protein (B-150 bp; cfvv_36.1-147294.32158-
32473) conventional PCR assays. 
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Figure 13. New putative oxidoreductase (A-176 bp; cfvv_43.1-43748.31801-32913) and Molybdenum cofactor biosynthesis protein1B (B-195 bp; 
cfvv_43.1-43748.37070-37996) conventional PCR assays. 
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Figure 14. New putative D-mycarose 3-C-methyltransferase (A-172 bp; cfvv_43.1-43748.38016-39466) and glycosyl transferase (B-232 bp; 
cfvv_44.1-6162.1810-2822) conventional PCR assays. 
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Figure 15. New putative hypothetical protein (A-203 bp; cfvv_45.1-4689.3424-4598 and B-164 bp; cfvv_46.1-11977.84-1196) conventional PCR 
assays. 
 122 
 
Figure 16. New putative predicted protein (A-214 bp; cfvv_46.1-11977.1215-2434) and serpentine domain containing protein (B-175 bp; cfvv_52.1-
1223.50-1223) conventional PCR assays. 
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Figure 17. New putative hypothetical protein conventional PCR assay (198 bp; cfvv_79.1-1308.319-829). 
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3.1.3. Screening of the Campylobacter-like culture collection 
 Results obtained from the Campylobacter-like culture collection (n=84) against the 13 new 
putative conventional PCR assays are presented in Table B (Appendix 2). Isolates 4, 399, 412, 520, 
530, 543 and 562 were not evaluated on all 13 assays (Table B, Appendix 2) as they could not be 
resuscitated following storage and gDNA extracts from these cultures yielded low gDNA content.  
Less than 25% of the Campylobacter-like culture collection was positive for the new putative 
hypothetical protein (ab51_contig98_4075-4315: 18/84; 21.4%), periplasmic binding protein 
(cfvv_28.1-4317.505-1097: 15/79; 19%) and oxidoreductase (cfvv_43.1-43748.31801-32913: 
18/79; 22.8%) conventional PCR assays (Figure 18). New assays putatively annotated to Gp27 
(cfvv_28.1-4317.1697-2142: 22/79; 27.8%), two different serpentine_recp domain containing 
proteins (cfvv_36.1-147294.32158-32473: 21/79; 26.6% and cfvv_52.1-1223.50-1223: 25/78; 
32.1%), Molybdenum cofactor biosynthesis protein 1B (cfvv_43.1-43748.37070-37996: 37/78; 
47.4%), glycosyl transferase (cfvv_44.1-6162.1810-2822; 28/80=35%) and two different 
hypothetical proteins (cfvv_45.1-4689.3424-4598: 24/80; 30% and cfvv_79.1-1308.319-829: 33/78; 
42.3%) amplified 25 to 50% of the Campylobacter-like culture collection (Figure 18). More than 
50% of the Campylobacter-like culture collection was positive for the new putative D-mycarose 3-
C-methyltransferase (cfvv_43.1-43748.38016-39466: 55/78; 70.5%), hypothetical (cfvv_46.1-
11977.84-1196: 48/ 79; 60.8%) and predicted (cfvv_46.1-11977.1215-2434: 50/79; 63.3%) proteins 
conventional PCR assays (Figure 18). 
Out of the 13 new putative conventional PCR assays, six assays targeting Molybdenum cofactor 
biosynthesis protein 1B (cfvv_43.1-43748.37070-37996), D-mycarose 3-C-methyltransferase 
(cfvv_43.1-43748.38016-39466), glycosyl transferase (cfvv_44.1-6162.1810-2822), hypothetical 
(cfvv_46.1-11977.84-1196, cfvv_79.1-1308.319-829) and predicted protein (cfvv_46.1-
11977.1215-2434) detected isolates biochemically confirmed as C. fetus subsp. venerealis as well 
as isolates phenotyped as C. fetus subsp. fetus, thermophilic Campylobacter spp. and Arcobacter-
like aerotolerant organisms (Figure 18). Only isolates phenotyped as C. fetus subsp. venerealis 
(13/29: 34.5% to 15/29; 51.7%) were positive on the six other assays putatively annotated to two 
different hypothetical proteins (ab51_contig98_4075-4315, cfvv_45.1-4689.3424-4598), 
periplasmic binding protein (cfvv_28.1-4317.505-1097), Gp27 (cfvv_28.1-4317.1697-2142), 
serpentine_recp domain containing protein (cfvv_36.1-147294.32158-32473) and oxidoreductase 
(cfvv_43.1-43748.31801-32913); except for a single Arcobacter-like organism (isolate 227) that 
was positive on these six assays (Figure 18). Only biochemically confirmed C. fetus subsp. 
venerealis isolates were positive on the new putative serpentine_recp domain containing protein 
conventional PCR assay (cfvv_52.1-1223.50-1223) with the exception of two Arcobacter-like 
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organisms (isolates 227 and 312, Figure 18). These two isolates were previously positive on both 
parA and ISCfe1 real-time PCR assays as well as being identified as C fetus subsp. venerealis by 
Hum’s and Abril’s conventional PCR assays (Chapter 5, Table 13). 
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Figure 18. Comparison of the positive molecular results obtained on the 13 new putative conventional PCR assays and previously determined 
biochemical phenotypes of the Campylobacter-like culture collection.  
*Isolate 227; †isolates 227 and 312
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3.2. Evaluation of new D-mycarose 3-C-methyltransferase real-time PCR assay 
3.2.1. New D-mycarose 3-C-methyltransferase real-time PCR assay 
 Many Campylobacter-like isolates (55/78=70.5%, Figure 19), including a large proportion 
of isolates biochemically phenotyped as C. fetus subsp. venerealis (21/29; 72.4%, Figure 19), were 
positive on the new conventional PCR assay partially targeting the putative D-mycarose 3-C-
methyltransferase gene (cfvv_43.1-43748.38016-39466, Figure 14). By aligning the two complete 
D-mycarose 3-C-methyltransferase gene sequences found in C. fetus subspecies and avoiding 
regions conserved in both subspecies, a new real-time assay was designed from the unique C. fetus 
subsp. venerealis region of that gene (Figure 20). The D-mycarose 3-C-methyltransferase real-time 
amplicon is 74 bp long; probe and primer sequences are reported in Table 22.  
Table 22. New D-mycarose 3-C-methyltransferase real-time assay primers and probe sequences. 
  
Serial dilutions of probe, primer and gDNA of C. fetus subsp. venerealis (ATCC19438 and 98-
109383) and C. fetus subsp. fetus (ATCC15926) were used to determine optimal assay conditions. 
Genomic DNA extracts from the other Campylobacter reference strains (Tables 19, n=6) were 
negative on the D-mycarose 3-C-methyltransferase real-time PCR assay (no Ct score) and no In 
silico PCR product was obtained from any of the Campylobacter reference strains (Table 20, n=14) 
tested online (results not shown). All gDNA extracts from the C. fetus subsp. venerealis reference 
strains (Table 19, n=5) produced positive Ct scores on the new D-mycarose 3-C-methyltransferase 
real-time PCR assay (ATCC19438: 22.64; ATCC33561: 32.94; B6: 18.08; 642-21: 17.64; 98-
109383; 15.91). 
   
3.2.2. Sensitivity comparison 
 Colony growth and cell counts of C. fetus subsp. venerealis correlated well (Table 23). 
Serial log dilutions of C. fetus subsp. venerealis in PBS used as template after heat lysis in the new 
D-mycarose-3-C-methyltransferase real-time PCR assay indicated that this test is less sensitive than 
both parA and ISCfe1 real-time PCR assays (Table 23). An average of 16 C. fetus subsp. venerealis 
cells were required to produce a Ct score on the D-mycarose 3-C-methyltransferase real-time PCR 
assay (Table 23) while parA and ISCfe1 real-time PCR assays could detect as low as one cell (Table 
15). 
 Sequence (5’ to 3’) 
D-mycarose 3-C-methyltransferase-F AGAGCCGAAAATACTACTGCTAAAGG 
D-mycarose 3-C-methyltransferase-R AAAGCTATTTTGGCCTCATTTTTG 
D-mycarose 3-C-methyltransferase-P 6FAM-ATTGCGCGTATGGGTAT-MGBNFQ 
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Figure 19. The new D-mycarose 3-C-methyltransferase real-time PCR assay was designed from the D-mycarose 3-C-methyltransferase gene conserved 
in both C. fetus subsp. venerealis biovars. Alignment to the D-mycarose 3-C-methyltransferase gene found in C. fetus subsp. fetus 82-40 (GenBank 
Accession ABK82051) indicates nucleotide differences between C. fetus subspecies (highlighted). 
  
Table 23. Correlation of cell and CFU counts with D-mycarose 3-C-methyltransferase, parA and ISCfe1 real-time Ct scores obtained from C. fetus 
subsp. venerealis reference strains B6 (Donaldson and Clark, 1970), 642-21 (Newsam and Peterson, 1964) and ATCC19438 diluted in PBS. 
Dilutions Cell counts CFU counts *SD 
Ct score on D-mycarose  
3-C-methyltransferase1 
SD Ct score on parA2 SD Ct score on ISCfe11 SD 
undiluted 1.66 x 107 confluent †ND 18.12 1.023 16.47 0.742 13.63 0.351 
10-1 1.66 x 106 confluent ND 20.00 0.220 18.37 0.563 15.41 0.212 
10-2 1.66 x 105 confluent ND 22.98 0.560 21.24 0.924 18.35 0.595 
10-3 1.66 x 104 confluent ND 27.81 0.213 25.75 0.252 23.14 0.730 
10-4 1.66 x 103 confluent ND 32.65 0.727 29.41 1.161 26.85 1.839 
10-5 1.66 x 102 165.4 29.143 35.71 1.081 32.21 1.126 29.94 1.991 
10-6 1.66 x 101 16.4 7.197 39.07 2.731 36.25 0.956 32.34 1.538 
10-7 1.66 x 100 1.6 2.070 No Ct score ND 39.38 1.215 36.29 1.063 
10-8 1.66 x 10-1 0.0 0 No Ct score ND 42.37 0.550 39.22 1.019 
*SD standard deviation; †ND not determined; 1this study; 2McMillen et al. 2006
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The equation of the standard curve obtained from the serial log dilutions against Ct scores for D-
mycarose 3-C-methyltransferase real-time PCR assay (result not shown) is: y = -3.7121x + 42.897; 
(R² = 0.9882). The efficiency of the new D-mycarose 3-C-methyltransferase real-time PCR assay is 
86% (10
(-1/-3.7121) – 1; 99.7%). This new assay is less efficient than parA and ISCfe1 real-time PCR 
assays (see Chapter 5, section 3.5). 
 
3.2.1. Screening of the Campylobacter-like culture collection 
 Results obtained from the Campylobacter-like culture collection against the new D-
mycarose-3-C-methyltransferase real-time assay are detailed in Table C (Appendix 2). Isolates 4, 
399, 520, 530 and 562 (n=5) were not evaluated (Table C, Appendix 2). Evaluation of the 
Campylobacter-like culture collection (n=79) using the new D-mycarose 3-C-methyltransferase 
real-time PCR assay found only 32 positive isolates (32/79; 40.5%) while the remaining 47 (47/79; 
59.5%) did not produce a Ct score (Figure 20).  
Despite 56.8% of the isolates that were biochemically confirmed as C. fetus subsp. venerealis 
(17/29; 56.8%) were positive on the new D-mycarose 3-C-methyltransferase real-time assay, 41.4% 
did not produce a Ct score (12/29; 41.4%, Figure 20) although they were all positive on Abril’s 
PCR, two being also positive on Hum’s PCR (Table C, Appendix 2). Similarly, out of 19 
Campylobacter-like isolates of unknown biochemical phenotype that did not produce a Ct score 
(Figure 28), 15 were positive on Abril’s PCR, six being also positive on Hum’s PCR (Table C, 
Appendix 2). None of the Campylobacter-like isolates biochemically phenotyped as C. fetus subsp. 
fetus were positive on the new D-mycarose 3-C-methyltransferase real-time assay although three 
Arcobacter-like aerotolerant organisms (isolates 227, 289 and 672) and a thermophilic 
Campylobacter sp. (isolate 531) produced Ct scores (Figure 28). These four isolates were all 
positive on Abril’s PCR while isolate 227 was also positive on Hum’s PCR (Table C, Appendix 2).  
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Figure 20. Comparison of the results obtained with the new D-mycarose 3-C-methyltransferase 
real-time PCR assay and previously determined biochemical phenotypes of the Campylobacter-like 
culture collection. 
 
3.3. MLST  
The PCR products obtained from isolates 214, 229, 475, 540 and 635 for the seven 
housekeeping genes exhibited the nucleotides substitutions specific for C. fetus subsp. venerealis in 
loci determining STs (results not shown). The combination of these nucleotides in these variable 
loci matched exactly the C. fetus subsp. venerealis-specific ST-4 (results not shown). Reference 
strains B6 and 642-21 MLST profile also corresponded to ST-4 (result not shown; reported in 
Barrero et al., 2013). 
 
4. Discussion 
As conventional and real-time PCR assays previously used in this study produced false-reactions, 
detecting Campylobacter-like isolates biochemically phenotyped as organisms other than C. fetus 
subsp. venerealis (Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006), new gene targets are 
needed in order to identify accurately this bacterium (Chapter 5). Comparative analysis of available 
C. fetus genomes revealed 26 regions unique for C. fetus subsp. venerealis assisted the design of 13 
new conventional PCR assays (October 2010) from draft contigs not annotated to putative known 
virulence factors or PAI genes (Barrero et al., 2013). C. fetus subsp. venerealis, C. fetus subsp. fetus 
and other Campylobacter reference strains were tested to confirm the specificity of newly 
developed assays prior to evaluating the Campylobacter-like culture collection that consists of 29 
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C. fetus subsp. venerealis, four C. fetus subsp. fetus, seven thermophilic Campylobacter spp., 11 
Arcobacter-like aerotolerant organisms and 33 isolates of unknown phenotypes.  
Dissimilar proportions of the culture collection were positive on the new putative conventional PCR 
assays with the majority of Campylobacter-like isolates positive on the assay targeting the partial 
D-mycarose 3-C-methyltransferase gene (cfvv_43.1-43748.38016-39466: 55/78; 70.5%), including 
a large number of biochemically confirmed C. fetus subsp. venerealis phenotypes (21/29; 72.4%). 
The D-mycarose 3-C-methyltransferase is a metabolic enzyme involved in the “biosynthesis of type 
II polyketide products”, encoded by the mtmC gene, essential to the biosynthesis of the 2,6-
deoxyhexose sugars forming mithramycin (Gonzalez et al., 2001; Kanehisa and Goto, 2000). The 
D-mycarose 3-C-methyltransferase gene was previously found in the C. fetus subsp. fetus 82-40 
genome (Fouts et al., 2005). By aligning the complete sequences of both C. fetus D-mycarose 3-C-
methyltransferase genes, a new real-time assay was designed from a C. fetus subsp. venerealis-
specific region that shared low homology with C. fetus subsp. fetus. This new real-time assay was 
found to be as specific but less sensitive than parA or ISCfe1 real-time tests, probably due to the 
fact that the D-mycarose 3-C-methyltransferase gene only has a single copy in C. fetus subsp. 
venerealis B6 and 642-21 genomes compared to parA and ISCfe1 which are present as more than 
one copy.  
When tested agaisnt the Campylobacter-like culture collection, the D-mycarose 3-C-
methyltransferase real-time target was detected in 40.5% of evaluated isolates (32/79; 40.5%), 
including one thermophilic Campylobacter sp. (n=7) and three Arcobacter-like aerotolerant 
organisms (n=11) while only 58.6% of the biochemically confirmed C. fetus subsp. venerealis 
isolates were positive (17/29; 58.6%). Even though assay specificity was verified using BLASTn 
searches and other Campylobacter spp. gDNA extracts, these findings point out that the new D-
mycarose 3-C-methyltransferase real-time assay produced both false-negative and false-positive 
results and is not a suitable C. fetus subsp. venerealis-specific diagnostic tool. Likewise, evaluation 
of the 13 new PCR targets against the Campylobacter-like culture collection indicated that, in 
addition to C. fetus subsp. venerealis isolates, isolates identified as C. fetus subsp. fetus, 
thermophilic Campylobacter spp. and aerotolerant Arcobacter-like organisms were also positive on 
six of the new putative PCR assays. These results suggest that they are not reliable C. fetus subsp. 
venerealis-specific gene targets. Only isolates biochemically characterised as C. fetus subsp. 
venerealis were positive on the other seven putative new assays, except for two aerotolerant 
Arcobacter-like organisms (isolate 227: 7/7; isolate 312: 1/7) that were also previously positive on 
Hum and Abril’s PCR assays (Abril et al., 2007; Hum et al., 1997). Such irregularities make further 
correlation between biochemical and molecular results difficult and question the validity of the 
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actual identification of such strains based on biochemical phenotyping. As previously hypothesised, 
it may be possible that such strains exhibited transient aerotolerance after recovery from storage 
into a FBP medium which is known to increase oxygen tolerance of other Campylobacter spp. 
(Verhoeff-Bakkenes et al., 2008). 
The current study used two draft C. fetus subsp. venerealis genomes to develop molecular tests that 
were both specific and sensitive for this bacterium (Barrero et al., 2013). To date, only a single 
C. fetus subsp. fetus and three C. fetus subsp. venerealis genomes have been sequenced and it is 
likely that this is insufficient to identify subspecies-specific DNA regions suitable for diagnostic 
assay development (Barrero et al., 2013; Fouts et al., 2005; Stynen et al., 2011). Pan-genomic 
studies compare multiple genomes to find genes present in all strains, called “core genes”, from 
genes absent in one or several strains, called “dispensable genes” (Medini et al., 2005; Tettelin et 
al., 2005). Core genes encode bacterial essential functions including binding, cell envelope, 
housekeeping, regulation and transport while dispensable genes, often containing extrachromosal 
and mobile elements such as phages and transposons, enhance bacterial facultative traits such as 
adaptation, antibiotic resistance or colonisation (Medini et al., 2005; Tettelin et al., 2005). 
Evaluation of 13 C. jejuni genome sequences estimated that the core genome of C. jejuni contains 
1 295 gene families while annotation of the 1 080 C. jejuni strain M1 core genes demonstrated that 
the majority of these were associated with enzymatic activity, intracellular, metabolic and other 
cellular functions (Friis et al., 2010).  
Interestingly, the seven new putative PCR assays on which mainly isolates biochemically 
phenotyped as C. fetus subsp. venerealis targeted hypothetical proteins and genes were positive 
belong to these categories. Two out of these seven assays target hypothetical proteins 
(ab51_contig98_4075-4315, cfvv_45.1-4689.3424-4598) while the other five amplify either 
putative periplasmic binding protein (cfvv_28.1-4317.505-1097), Gp27 (cfvv_28.1-4317.1697-
2142), serpentine receptor proteins (cfvv_36.1-147294.32158-32473 and cfvv_52.1-1223.50-1223) 
or oxidoreductase (cfvv_43.1-43748.31801-32913). The putative periplasmic binding protein is a 
transmembrane protein orthologous to the “ribose transport system substrate-binding protein”, 
encoded by the rbsB gene, which is an ATP-binding cassette (ABC)-transporter involved in the 
transport of the monosaccharide ribose (Iida et al., 1984; Kanehisa and Goto, 2000). The two 
different putative serpentine receptor proteins are part of the largest family of membrane receptors 
known as “seven-transmembrane receptors”; these heptahelical chemoreceptors are involved in 
numerous cellular functions depending on their family (Pierce et al., 2002). Gp27 is a DNA 
methylation enzyme, orthologous to the DNA adenine methylase, encoded by the dam gene, 
involved in “DNA replication termination factors and mismatch repairs” (Brooks et al., 1983; 
 133 
 
Kanehisa and Goto, 2000). The putative oxidoreductase is a metabolic enzyme part of the radical S-
adenosylmethionine (SAM) family, it contains an iron-sulphur domain, which is required as a 
cofactor for the activation and catalytic activity of lysine-2,3-aminomutase (Petrovich et al., 1991).  
Unfortunately, the sensitivity of these seven assays very low, with only 34.5% (putative periplasmic 
binding protein: 10/29; 34.5%) to 51.7% (hypothetical protein: 15/29; 51.7%) of biochemically 
confirmed C. fetus subsp. venerealis isolates being positive despite analysis of all assays developed 
here confirmed conservation of the PCR targets in the newly sequenced genome of C. fetus subsp. 
venerealis reference strain ATCC19438 (Stynen et al., 2011). A pan-genomic study analysed 96 
C. coli and C. jejuni genomes and estimated that respectively 76% and 82% of their core genes 
overlapped while another recent study investigating nucleotide and amino acid variability within the 
core genes of 73 Salmonella enterica genomes found that the core genome is composed of 
conserved and highly variable core genes (Leekitcharoenphon et al., 2012; Lefébure et al., 2010). 
Comparison of 17 different Campylobacter spp. genomes found that 647 genes comprised the genus 
Campylobacter core genome while 82 and 35 core genes were found to be unique to C. coli and 
C. jejuni, respectively (Lefébure and Stanhope, 2009; Lefébure et al., 2010). Further analysis of 
fully sequenced and completely annotated C. fetus genomes is needed to confirm if the seven new 
putative PCR targets are in fact part of the C. fetus subsp. venerealis conserved core genome but 
absent from the core genomes of C. fetus subsp. fetus and other Campylobacter spp..  
Nonetheless, conserved core genes include housekeeping genes which were targeted in the MLST 
scheme that allows unequivocal differentiation of C. fetus subspecies (Friis et al., 2010; Laing et al., 
2011; Leekitcharoenphon et al., 2012; Lefébure et al., 2010; van Bergen et al., 2005c). The identity 
of five Campylobacter-like isolates, provisionally assigned to C. fetus subsp. venerealis by 
previously published biochemical and molecular methods, were verified by MLST (Abril et al., 
2007; Hum et al., 1997; McMillen et al., 2006; OIE, 2012a; van Bergen et al., 2005c). MLST 
results matched exactly ST-4, the most common sequence type for C. fetus subsp. venerealis (van 
Bergen et al., 2005c). Ideally, all Campylobacter-like isolates should be tested by this method to 
validate their identity but cost limited the number of strains examined in this study. MLST was 
recently adapted into a high resolution melting curve system which was five times less expensive 
than other typing methods and identified irrevocably tested C. jejuni strains (Lévesque et al., 2011).  
Another way to further confirm isolate identity would be to amplify and sequence a 555 bp region 
of the cpn60 gene, encoding the chaperonin protein, found in all eubacteria including Arcobacter, 
Campylobacter and Helicobacter spp. (Hill et al., 2006). This method allowed accurate 
discrimination of 15 Campylobacter spp. including both C. fetus subspecies which had highly 
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homologous cpn60 gene sequences (identities: 554/555 = 99%; GenBank Accessions DQ059443 
and DQ059454, DQ059454, DQ059455) but were found to differ by a SNP in position 369 for 
which C. fetus subsp. venerealis ATCC19438 exhibited a G while the three C. fetus subsp. fetus 
strains examined had an A instead (Hill et al., 2006). If this SNP is consistently found in additional 
C. fetus strains, this technique could be a good alternative to MLST as it could assist discriminating 
C. fetus subspecies at lower costs. It could also be particularly be useful to further investigate the 
identity of isolates phenotyped as Arcobacter-like isolates given that cpn60 gene sequences of 
C. fetus subsp. venerealis ATCC19438 and Arcobacter strains shared only 71-72% identity 
(GenBank Accessions DQ059443 and DQ059460, DQ059471, DQ059474, DQ059481), exhibiting 
multiple nucleotide differences (Hill et al., 2006). 
Recently, new real-time PCR assays for C. fetus and C. fetus subsp. venerealis were respectively 
designed from the nahE gene and the ISCfe1 insertion element sequences by two different research 
teams (McGoldrick et al., 2013; van der Graaf-van Bloois et al., 2013). Both teams found that the 
C. fetus-specific assays could amplify all C. fetus isolates tested while assays designed for C. fetus 
subsp. venerealis were not as specific or sensitive and could thus not be used as reliable diagnostic 
tools for C. fetus subsp. venerealis detection from crude samples (McGoldrick et al., 2013; van der 
Graaf-van Bloois et al., 2013). Even though other real-time PCR assays could be designed from 
unique C. fetus subsp. venerealis sequences now available from the genomes of C. fetus subsp. 
venerealis ATCC19438, B6 or 642-21, these findings provide extra evidence that sequencing of 
additional C. fetus genomes followed by a pan-genomic study including genomes of other closely 
related organisms, is required in order to identify new subspecies-specific targets and further 
improve molecular diagnostic methods for BGC (McGoldrick et al., 2013; Stynen et al,; 2011; van 
der Graaf-van Bloois et al., 2013). 
 
5. Conclusions and future directions 
In an effort to discover new putative gene targets for C. fetus subsp. venerealis, 13 new 
conventional and a new real-time PCR assays were designed from contigs absent from the C. fetus 
subsp. fetus 82-40 genome but common to two Australian C. fetus subsp. venerealis draft genomes 
(Barrero et al., 2013; Fouts et al., 2005). Despite the verification of assay specificity using C. fetus 
and other Campylobacter reference strains, screening against an Australian Campylobacter-like 
culture collection did not identify any of the new tests to be sensitive or specific enough to replace 
existing methodologies (Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006; OIE, 2012a).  
Discrepancies between biochemical and molecular results complicated the interpretation of results 
underlining that more work is needed to validate the identification of atypical strains. MLST and 
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cpn60 gene sequencing (Hill et al., 2006; van Bergen et al., 2005c) could be applied to the whole 
isolate collection in order to further investigate and confirm the identity of strains biochemically 
phenotyped as C. fetus subsp. fetus, C. fetus subsp. and venerealis, Campylobacter sp. and 
Arcobacter-like organisms and assist selecting potential candidates for further genome sequencing.  
The MLST scheme published for C. fetus strains was indeed here found to correlate well with other 
published methods (Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006; OIE, 2012a; van 
Bergen et al., 2005c). By aligning multiple C. fetus housekeeping gene sequences, it may be 
possible to convert the existing scheme (van Bergen et al., 2005c) into a high resolution melting 
curve system, distinguishing SNPs between C. fetus subspecies, in order to reliably identify of 
C. fetus subsp. venerealis from crude diagnostic samples.  
A pan-genomic study, including additional C. fetus and other Campylobacter spp. complete 
genomes, could assist identifying reliable markers for C. fetus subsp. venerealis strains by first 
determining C. fetus subsp. venerealis conserved core genes absent from closely related organisms. 
Multi-locus sequence analysis of a comprehensive set of core genes identified from 50 pan-
genomes was applied to differentiate 15 species of the subclass Actinobacteridae (Adékambi et al., 
2011). A similar approach could be investigated to identify the different species of the family 
Campylobacteraceae.  
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CHAPTER 7: CHARACTERISATION OF THE ISOLATE COLLECTION USING 
PUTATIVE VIRULENCE AND PATHOGENICITY ISLAND GENE PCR ASSAYS 
 
1. Introduction 
It has previously been suggested that the high C. fetus subsp. venerealis prevalence detected by the 
parA real-time PCR assay in herds showing no evidence of reproductive problems may be 
explained by differences in virulence between C. fetus subsp. venerealis strains (Guo, 2007; 
McMillen et al., 2006; Moolhuijzen et al., 2009). Despite the fact that this study confirmed that 
homologous parA genes are found in other Campylobacter-like organisms (Chapter 5), cultures 
biochemically confirmed as C. fetus subsp. venerealis were isolated from herds which did not 
always exhibit clinical signs for BGC (personal communication with our local abattoir’s 
management team); further suggesting that not all C. fetus subsp. venerealis strains may cause 
disease.  
In the absence of information about C. fetus pathogenesis, it was proposed that virulence factors 
studied in other pathogenic Campylobacter spp. could be investigated as virulence markers in 
C. fetus subsp. venerealis (Chapter 2, section 3). Virulence factors involved in the pathogenesis of 
C. jejuni and C. coli include motility, adhesion, invasion, chemotaxis and toxin production (Ketley, 
1997; Wassenaar, 1997). By comparing five Campylobacter spp. genomes (C. coli RM2228, C. lari 
RM2100, C. upsaliensis RM3195, C. jejuni NCTC11168, and RM1221) genes encoding these 
factors were described (Fouts et al., 2005). Subsequently, a partial C. fetus subsp. venerealis 
(AZUL-94) genome aligned to the complete C. fetus subsp. fetus (82-40) genome identified putative 
C. fetus and C. fetus subsp. venerealis-specific virulence genes (Moolhuijzen et al., 2009). 
Additionally, antibiotic resistance genes, genomic islands, phages and plasmids encoding T4S genes 
were identified in the five Campylobacter spp. genomes (Fouts et al., 2005). T4S and phage-like 
genes, also found in C. fetus subsp. venerealis AZUL-94 but absent from C. fetus subsp. fetus 82-
40, were recently detected on a genomic island in C. fetus subsp. venerealis ATCC19438, including 
genes of putative plasmid origin and integrases (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009). 
These features are characteristic of PAIs which are acquired through horizontal transfer in order to 
increase bacterial fitness and enhance virulence (Gal-Mor and Finlay, 2006; Schmidt and Hensel, 
2004). Even though this island was thought to be unique to C. fetus subsp. venerealis, a highly 
similar PAI harbouring two new antibiotic resistance and identical T4S genes was recently 
identified in C. fetus subsp. fetus IMD523 and found to be transferrable by conjugation (Abril et al., 
2010; Gorkiewicz et al., 2010). These findings indicate that even if these PAIs are too similar to 
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differentiate C. fetus isolates, they may be useful to evaluate strain pathogenicity as PAIs are 
usually found in pathogenic organisms (Gal-Mor and Finlay, 2006; Schmidt and Hensel, 2004). 
Previously published T4S and PAI gene conventional PCR assays were used to characterise the 
Campylobacter-like culture collection in order to select isolates for testing potential strain 
differences in virulence in animal trials (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009. New 
putative virulence and PAI gene targets identified from recently sequenced C. fetus subsp. 
venerealis (bv. venerealis B6 and bv. intermedius 642-21) genomes that were absent from the 
C. fetus subsp. fetus (82-40) genome were used to design new tests to further predict the potential 
virulence of each isolate (Barrero et al., 2013). Additional Australian and UK C. fetus were also 
characterised using the previously published and new putative virulence and PAI gene PCR assays. 
Several biochemically confirmed C. fetus subsp. venerealis isolates, exhibiting different virulence 
and PAI molecular profiles, were tested in a pregnant guinea pig model (parallel PhD project). 
Analysis of seven T4S gene sequences from field and reference C. fetus isolates was performed to 
investigate if previously identified consensus sequences were conserved in these strains. 
  
2. Methods 
2.1. Bacterial strains, culture conditions and DNA extraction 
 C. fetus subsp. venerealis reference cultures bv. venerealis B6 (Donaldson and Clark, 1970) 
and intermedius 642-21 (Newsam and Peterson, 1964) were sourced from BGC cases (Table 24). 
The other C. fetus and Campylobacter reference cultures were obtained from Biosecurity 
Queensland (DAFF) and from the American Type Culture Collection (ATCC, Table 24).  
Table 24. Campylobacter spp. reference cultures used in Chapter 7. 
Species Strain Source 
C. coli  33559 ATCC
1 
 
C. fetus subsp. fetus 15926 ATCC
1
 
C. fetus subsp. fetus 25936 ATCC
1
 
C. fetus subsp. venerealis bv. venerealis 19438 ATCC
1
 
C. fetus subsp. venerealis bv. venerealis 98-109383 DAFF
2
 
C. fetus subsp. venerealis bv. venerealis B6 Donaldson and Clark (1970)  
C. fetus subsp. venerealis bv. intermedius 642-21 Newsam and Peterson (1964)  
C. hyointestinalis 35217 ATCC
1
 
C. jejuni 33560  ATCC
1
 
C. lari 35221 ATCC
1
 
C. upsaliensis  43954 ATCC
1
 
1
American Type Culture Collection (ATCC) 
2
Department of Agriculture, Fisheries & Forestry (DAFF)  
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The Campylobacter-like culture collection (n=84) was established from bull preputial secretions; 
identity of isolates, previous biochemical and molecular results are reported in Chapter 5, Table 13.  
In addition, 12 C. fetus Australian field cultures were isolated from bovine abortion cases, from 
preputial samples from bulls from herds with a history of confirmed subfertility and from preputial 
or vaginal mucus samples collected from cattle of unknown fertility status (Table 25). Nine other 
C. fetus isolates were obtained from the United Kingdom (UK): one isolate was sourced from a 
bovine abortion case while the other eight were cultured from bovine and ovine samples collected 
from animals of unknown fertility status (Table 25).  
Table 25. Australian and UK C. fetus field cultures used in Chapter 7. 
Isolate Isolation Origin Phenotype Source 
D8147/2 31/10/1974 Bovine C. fetus subsp. venerealis DAFF
1
 
‡EQC0017 14/10/2009 Bovine C. fetus subsp. venerealis bv. venerealis DAFF1 
F591/1 04/10/1984 Bovine C. fetus subsp. fetus DAFF
1
 
J4494/6B 09/09/1980 Bovine C. fetus subsp. venerealis DAFF
1
 
Q492 09/11/2007 Bovine C. fetus subsp. venerealis DAFF
1
 
‡A8 2011 Bovine C. fetus subsp. venerealis bv. venerealis DAFF1 
†75838 2012 Bovine C. fetus subsp. venerealis bv. venerealis DAFF1 
†76223 2012 Bovine C. fetus subsp. venerealis bv. intermedius DAFF1 
87-29394 1987 Bovine C. fetus subsp. venerealis bv. venerealis DAFF
1
 
‡09-125181/3 05/10/2009 Bovine C. fetus subsp. venerealis bv. venerealis DAFF1 
‡Becks 21/12/2009 Bovine C. fetus subsp. venerealis bv. intermedius This study2 
‡K8 16/01/2012 Bovine C. fetus subsp. venerealis bv. intermedius This study2 
BT08/04 2004 Bovine C. fetus subsp. fetus UK
3
 
BT23/02 2002 Bovine C. fetus subsp. venerealis bv. venerealis UK
3
 
BT47/00 2000 Bovine C. fetus subsp. venerealis bv. intermedius UK
3
 
BT54/00 2000 Bovine C. fetus subsp. fetus UK
3
 
†BT102/00 2000 Bovine C. fetus subsp. venerealis bv. venerealis UK3 
BT194/02 2002 Bovine C. fetus subsp. venerealis bv. intermedius UK
3
 
BT268/06 2006 Ovine C. fetus subsp. fetus UK
3
 
BT277/06 2006 Ovine C. fetus subsp. fetus UK
3
 
BT376/03 
 
2003 Bovine C. fetus subsp. venerealis bv. venerealis UK
3
 
1
Department of Agriculture, Fisheries & Forestry (DAFF); phenotypes were determined by the 
Biosecurity Queensland bacteriological diagnostic laboratory at the time of isolation. 
2
Isolates from preputial samples collected from farm animals (Queensland, Australia); phenotypes 
were determined as recommended (OIE, 2012a). 
3
Isolates from the United Kingdom (UK), provided and phenotyped by Professor Diane Newell’s 
research team in 2010; BT102/00 was previously reported (Willoughby et al., 2005). 
†Isolates from bovine aborted foetuses. 
‡Isolates from cattle from herds with a history of subfertility. 
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Cultures were grown at 37°C under microaerophillic conditions in brain-heart infusion (Oxoid) 
enrichment broth (3.7% brain heart-infusion, 0.2% yeast extract, 0.07% agar bacteriological n°1) or 
in thioglycollate broth
 
for 72h (see Chapter 3 section 2.2). Genomic DNA was extracted from 
cultures using a commercial kit (QIAamp DNA mini kit, QIAGEN, see Chapter 3 section 3.1). 
  
2.2. Published pathogenicity island (PAI) gene conventional PCR assays 
 Primers previously described for orf21, orf26/27, VirB8/9, VirB10, VirB11 and VirD4 
(Table 26) were used to amplify distinct regions of the reported C. fetus subsp. venerealis PAI 
(Gorkiewicz et al., 2010). 
Table 26. Published virulence and pathogenicity island (PAI) gene conventional PCR assays. 
Target Primer  Sequence (5’ to 3’) Amplicon (bp)  Publication 
orf21 
3Dv3’  CGGTTGCGATGCTAATACACTA 
261  
Gorkiewicz  
et al. 2010 
3Dv5’  TTTATCGCTTGGTAGCGTATTG 
orf26/27 
Trans 4  ATCACTCAGCAGCAAGAGCG 
555 
Top/traE1  TTGCACGTGCGAGTTCAGGC 
VirB8/9 
VirB8-1  ACCTAGTTCGCTTACGACAG 
1 011 
VirB9-1  CTTTGGGATATTTATTGCGTGC 
VirB10 
VirB10-1  CAGCAAAGATGGCGTAACTC 
352  
VirB10-2  CTTCAAGTGCAGTGTTTGCC 
VirB11 
VirB11-1  ATGAGATAGCTTATAATGGTGG 
573 
VirB11-2  TTGGTTTCATTCTTAGGCAGC 
VirD4 
TaxB2  CATACAATGTTCTAGCCGAGC 
478 
TaxB3 CCATCAGGCTGATTTGCTTC 
VirB9 
nC1165g2R  TGACAAAGATGAGCGGATAG 
151 
Moolhuijzen  
et al. 2009 
nC1165g2R TACCTGTTCGCCGTTTTC 
VirB11 
C1023G2F AACATCTACCCATAATGACCG 
501 
C1023G2R TGCTTTTTGCTTCACTAGGA  
VirD4 
nC1165g6F ATGTTCTAGCAGAGCTTGG 
101 
nC1165g6R TGACATTACGCCACTCTT 
 
Primers were synthesised by Sigma-Aldrich and PCR assays were undertaken in 20 µl reactions 
using 1 ×PCR reaction buffer with 25 mM Mg
2+
 (10× Hotmaster™ Taq buffer), 1 U Hotmaster™ 
Taq DNA polymerase, 1 µM of each forward and reverse primers, 1 µM dNTPs and 1.25 ng of 
tested gDNA. The reactions were amplified in a DNA Engine
®
 Thermal Cycler using the following 
parameters with primers targeting orf21, orf26/27, VirB10 and VirD4: initial denaturation at 95°C 
for 5min, followed by 30 cycles of denaturation at 95°C for 30s, annealing at 53.5°C for 30s, and 
extension at 72°C for 2min including a final extension of 10min at the end. When using primers 
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designed for VirB8/9 and VirB11, the above profile was modified: initial denaturation at 94°C for 
2min, followed by 30 cycles of denaturation at 94°C for 20s, annealing at 57.4°C for 30s, extension 
parameters remaining the same. Products were separated in 2% TBE (89 mM Tris borate, 2 mM 
EDTA, pH 8) agarose gels containing 1% GelRed
TM
 Nucleic Acid Gel Stain using MassRuler
TM
 
Low range DNA ladder and were visualised under Trans-UV light using GelDoc
TM
 XR+ system. 
The published PAI gene PCR assays were applied to gDNA extracts from reference strains (Table 
24), from the Campylobacter-like culture collection (Chapter 5, Table 13) and from the Australian 
and UK C. fetus field cultures (Table 25). 
  
2.3. Published type IV secretion system (T4S) gene conventional PCR assays 
 Primers previously described for VirB9, VirB11 and VirD4 (Table 26) were used to amplify 
putative C. fetus T4S genes (Moolhuijzen et al., 2009). Primers were synthesised by Sigma-Aldrich 
and PCR assays were undertaken as detailed in section 2.2. The reactions were amplified in a DNA 
Engine
®
 Thermal Cycler as previously described (Moolhuijzen et al., 2009). PCR products were 
separated and visualised as detailed in section 2.2. These putative T4S gene PCR assays were used 
to screen gDNA extracts from the reference strains (Table 24), from the Campylobacter-like culture 
collection (Chapter 5, Table 13) and from the Australian and UK C. fetus field cultures (Table 25). 
  
2.4. New putative conventional PCR assays for C. fetus subsp. venerealis 
2.4.1. Selection of unique C. fetus subsp. venerealis contigs 
 Illumina/GAII technology was used to sequence the genomes of C. fetus subsp. venerealis 
bv. venerealis B6 and bv. intermedius 642-21 (Barrero et al., 2013). The two new draft genomes 
were assembled in respectively 80 and 126 contigs using De novo assembly and aligned to the 
reference C. fetus subsp. fetus (82-40) genome using MuMmer version 3 in order to identify regions 
unique to C. fetus subsp. venerealis (Barrero et al., 2013; Kurtz et al., 2004). Gaps obtained after 
dot plot comparisons of aligned genome sequences indicated regions that were absent from the 
C. fetus subsp. fetus genome. Twenty-six regions longer than 200 bp were considered to be unique 
for C. fetus subsp. venerealis and suitable for assay development (Barrero et al., 2013). Thirteen 
regions that were annotated to putative virulence factors or PAI genes using COG categories and 
KEGG pathways were used for PCR design in October 2010 (contigs available upon request). 
 
2.4.2. Design of new primers from unique C. fetus subsp. venerealis draft contigs 
 Using Primer3 Input version 0.4.0, new primers were designed to target the 13 C. fetus 
subsp. venerealis unique draft contigs (Rozen and Skaletsky, 2000). To ensure that the locations of 
the primers targeted regions unique to C. fetus subsp. venerealis, coverage histograms were visually 
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inspected to verify that the average number of reads that aligned to the C. fetus subsp. fetus genome 
was inferior to 10. To minimise risk of primer dimers as a result of non-specific binding affinity, 
RNAhybrid was used to check that the free energy of designed primers was higher than -20 
kcal/mol (Rehmsmeier et al., 2004). The specificity of the new primers was confirmed using 
BLASTn (http://www.ncbi.nlm.nih.gov/BLAST/) and in silico PCR amplifications against all 14 
Campylobacter reference strains (Table 20, see Chapter 6) available online (Bikandi et al., 2004). 
The PCR targets were annotated using a combination of Genemark.hmm for prokaryotes version 
2.6, BLAST (BLASTn, BLASTp, tBLASTx) and genes predictions from the draft C. fetus subsp. 
venerealis bv. venerealis (B6) and bv. intermedius (642-21) genomes, deposited on YABI (Barrero 
et al., 2013; Hunter et al., 2012; Lukashin and Borodovsky, 1998). Geneious version 5.6.3 was used 
to align new PCR targets to the draft contigs they were designed from in order to illustrate the 
location of primers and PCR target annotations (Drummond et al., 2012). 
  
2.4.3. New conventional PCR assay conditions 
 New primers were synthesised by Sigma-Aldrich and PCR assays were undertaken as 
detailed in section 2.2. The reactions were amplified in a DNA Engine® Thermal Cycler using the 
following parameters: initial denaturation at 94°C for 2min, 30 cycles at 94°C for 20s, annealing at 
64°C for 10s, and extension at 60°C for 30s, with a final extension at 72°C for 10min. Annealing 
temperatures were selected using gradient PCR runs ranging from 55°C to 65°C. The PCR profile 
here described was used with most new primer sets except that the annealing temperature was 
modified to 60°C when using primers targeting the putative bacteriophage DNA transposition 
protein B (ab51_contig161_2580-2904), prophage Mu (ab51_contig198_772-939), hypothetical 
proteins (ab51_contig207_4; ab51_contig_341) and P-type conjugative transfer protein TrbL 
(ab51_contig_429). The annealing temperature was further reduced to 59°C when using primers 
amplifying the putative surface array (cfvv_19.2623-3742.537-1071) and phage portal/prophage 
Mu (cfvv_26.1-3968.2595-3321) proteins. C. fetus subsp. venerealis reference strains B6 and 642-
21 (Table 24) gDNA extracts were used to optimise the new PCR conditions as per manufacturer 
recommendations. Once assay conditions were optimised, all reference C. fetus and Campylobacter 
spp. (Table 24) gDNA extracts were used to confirm assay specificity prior to screening the 
Campylobacter-like culture collection (Chapter 5, Table 13) and the Australian and UK C. fetus 
field cultures (Table 25). PCR products were separated and visualised as detailed in section 2.2. 
 
2.4.4. Specificity of newly designed assays 
 In order to further assess the specificity of the newly designed virulence and PAI gene PCR 
assays (n=15), results obtained in this chapter from the Campylobacter-like culture collection and 
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the Australian and UK C. fetus field cultures were compared to previously determined biochemical 
phenotypes (Chapter 5, Table 13 and Table 25 respectively). Biochemical profiling of the 
Campylobacter-like culture collection identified 29 isolates as C. fetus subsp. venerealis, four as 
C. fetus subsp. fetus, seven as thermophilic Campylobacter spp., 11 as aerotolerant Arcobacter-like 
organisms (Appendix 1, Table A). The remaining 33 were not fully biochemically phenotyped. 
Australian and UK field cultures were biochemically phenotypes are detailed in Table 25. 
 
2.4.5. Sequencing of putative virulence gene PCR products 
 To investigate if the putative adhesin/invasin virulence gene target sequence 
(ab51_contig207_1) was identical in random positive Campylobacter-like isolates, PCR products 
obtained from isolates 635, 676, 856 and 991 (Chapter 5, Table 13) were sequenced. Products were 
purified using ExoSAP-IT
®
 PCR product clean-up, sequenced using the BigDye® version 3.1 
technology and analysed on the Applied Biosystems 3130xl Genetic Analyzer at the Griffith 
University DNA Sequencing Facility. Sequencing reactions were prepared using the primers 
reported for the putative adhesin/invasin virulence gene (ab51_contig207_1, Table 27) according to 
the manufacturer’s instructions (Applied Biosystems). Sequences were visualised, edited and 
aligned using Sequencher version 4.5 prior to further analysis. Geneious version 5.6 (Drummond et 
al., 2012) was used to align sequenced PCR products to the putative adhesin/invasin PCR target and 
to the available C. lari RM2100 adhesin/invasin sequence (GenBank Accession YP_002576152.1). 
 
2.5. Selection of C. fetus subsp. venerealis isolates for animal testing 
 Virulence and PAI molecular profiles for the Campylobacter-like culture collection and 
Australian and UK C. fetus field cultures were compared to those obtained from the C. fetus subsp. 
venerealis reference strains in order to assist selecting isolates to be tested in a pregnant guinea pig 
model. Animal experiments were undertaken to investigate potential differences in virulence and in 
pathological outcome between C. fetus subsp. venerealis strains. Pregnant guinea pig infection trials 
were approved by the University of Queensland Animal Ethics Committee (animal ethics number: 
SVS/143/11/ARC LINKAGE) and performed by Ameera Koya in a parallel PhD project. Isolates 
for testing in the pregnant guinea pig model were grown in vegetable peptone n°1 enrichment broth 
(1% vegetable peptone, 0.2% sodium succinate, 0.5% yeast extract, 0.5% sodium chloride, 0.0001% 
magnesium sulphate, 0.0001% calcium chloride, 0.15% agar bacteriological n°1; Chapter 3, section 
2.2) and a dose of 10
7
 CFU/ml of each strain was used to inoculate guinea pigs by intra-peritoneal 
injection.  
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Two isolates (540 and EQC0017) were tested onto two groups of five guinea pigs at week five-six 
of pregnancy: four animals were challenged while a control animal was inoculated with 1 ml of 
sterile broth (personal communication, Ameera Koya). Other isolates (635, 924, 76223 and B6) 
were also tested onto four groups of four guinea pigs at week six of pregnancy (personal 
communication, Ameera Koya). Animals were euthanised at 12 days post-inoculation if not aborted 
while culture was performed from dams and foetuses post-abortion or at post-mortem in order to 
recover C. fetus subsp. venerealis colonies from all tested guinea pigs (personal communication, 
Ameera Koya). Strain virulence was evaluated as the percentage of animals that aborted and time 
required to induce abortion post-inoculation (personal communication, Ameera Koya); results were 
associated with virulence and PAI profiles of the different tested isolates in order to assess the 
ability of the PCR assays to predict in vivo virulence in the pregnant guinea pig model. 
 
2.6. In Silico analysis of type IV secretion system (T4S) genes 
 Nucleotide sequences of seven T4S genes (VirB3/B4, VirB7, VirB8, VirB9, VirB10, 
VirB11 and VirD4) from newly sequenced C. fetus subsp. venerealis bv. venerealis (B6) and bv. 
intermedius (642-21) genomes (Barrero et al., 2013) as well as from partially annotated genomes of 
an additional four field strains (635, 830, 924 and 957) from the Campylobacter-like culture 
collection (Chapter 5, Table 13) were obtained from the Centre of Comparative Genomics (CCG, 
personal communication, May 2012, Gabriel Keeble-Gagnère). The genomes of 635, 830, 924 and 
957 are currently being assembled after 454 sequencing, sequences accessed were thus preliminary 
data. Amino acid sequences were predicted and compared to previously published motifs and 
consensus sequences identified from Agrobacterium tumefaciens T4S genes (Bailey et al., 2006; 
Banta et al., 2011; Bayliss et al., 2007; Christie et al., 2005; Jakubowski et al., 2005; Kumar and 
Das, 2001, 2002; Rabel et al., 2003; Stephens et al., 1995). Consensus sequences obtained from 
T4S conserved regions from a range of Gram-negative bacteria including C. jejuni (supplemental 
material to Christie et al. 2005, accessible online at http://mmg.uth.tmc.edu/faculty/faculty-peter-
christie.html) were also consulted to evaluate if variable amino acids found in C. fetus subsp. 
venerealis sequences have been previously reported. Geneious version 5.6.3 was used to align and 
analyse the sequences (Drummond et al., 2012).  
  
3. Results 
3.1. Screening with known pathogenicity island (PAI) genes (Gorkiewicz et al., 2010) 
The three C. fetus subsp. venerealis bv. venerealis reference strains tested were positive on the 
conventional PCR assays for the six known PAI genes (Gorkiewicz et al., 2010) while the single 
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C. fetus subsp. venerealis bv. intermedius and the other Campylobacter reference strains were 
negative (n=7; Table 24).  
Evaluation of the Campylobacter-like culture collection (n=82) resulted in only a single isolate 
(635) being positive on all six known PAI gene conventional PCR assays (Gorkiewicz et al., 2010) 
while 76 isolates were negative on all assays (Table C, Appendix 3). Isolates 4 and 562 could not be 
resuscitated following storage; these isolates were not evaluated on all six published PAI gene 
conventional PCR assays (Table C, Appendix 3). Two isolates (317 and 412) were positive for 
VirB10, VirB11 and VirD4; one isolate (1025) was positive for VirB10 and two others (334 and 
399) were positive for VirD4 only (Table C, Appendix 3).  
Screening of the Australian and UK C. fetus field cultures (Table 25; n=21) identified only one 
isolate that was positive for five of the six PAI genes (D8147/2) while 15 isolates were negative on 
all six known PAI gene PCR assays described by Gorkiewicz et al. (2010, Table C, Appendix 3). 
Two isolates (76223 and BT102/00) obtained from bovine abortion cases were positive for three of 
the six PAI genes (Table C, Appendix 3). Two additional isolates (75838 and K8) were positive for 
orf26/27 and VirD4 while isolate F591/1 was only positive for VirD4 (Table C, Appendix 3). 
When the Campylobacter-like culture collection and Australian and UK C. fetus field cultures are 
combined, only one out of 103 isolates tested (1%) was positive on all six PAI gene targets, 11 
isolates were positive for at least one PAI gene target (10.7%) while the remaining 91 isolates 
(88.3%) were negative on all six assays (Table C, Appendix 3). 
  
3.2. Screening of type IV secretion system (T4S) genes (Moolhuijzen et al., 2009) 
 Either C. fetus subsp. venerealis bv. venerealis (n=3) or C. fetus subsp. venerealis bv. 
intermedius (n=1) reference strains were positive on the three published T4S gene PCR assays 
(Moolhuijzen et al., 2009) while all the other Campylobacter reference strains were negative (n=7; 
Table 24).  
As only a few isolates were positive on the published PAI gene PCR assays (Table C, Appendix 3), 
three previously described T4S PCR assays (Moolhuijzen et al., 2009) were also used to screen the 
Campylobacter-like culture collection (n=84). Eighteen isolates were positive on the T4S PCR 
targeting VirB11, four additional isolates were positive for VirB9 and VirD4 while 60 isolates were 
negative on the three T4S gene PCR assays (Table C, Appendix 3). Single isolates were only 
positive on the assays targeting VirB9 (isolate 334) and VirD4 (isolate 130; Table C, Appendix 3). 
Screening of the Australian and UK C. fetus field isolates (Table 25, n=21) found eight isolates 
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positive for VirB11, one of which (BT102/00) was also positive for VirD4 (Table C, Appendix 3). 
The PCR targeting VirB9 detected three additional isolates, one of which (D8147/2) was also 
positive for VirD4 (Table C, Appendix 3). 
When the results from screening the Campylobacter-like culture collection and Australian and UK 
C. fetus field cultures are combined, 35 out of 105 isolates tested (33.3%) were positive on at least 
one T4S gene PCR while 70 (66.7%) were negative on all assays (Table C, Appendix 3). 
Different isolates were positive on the VirB11 and VirD4 PCR assays depending on whether PAI 
gene or T4S gene primers were used (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009), even if 
four isolates (317, 412, 635 and D8147/2) were positive on both VirD4 assays (Table C, Appendix 
3; Figure 21).  
Figure 21. Comparison of the positive results obtained on the PAI and T4S VirB11 and VirD4 gene 
PCR assays (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009) with the Campylobacter-like culture 
collection and Australian and UK C. fetus field cultures. 
1
Pathogenicity island (PAI) gene PCR assays (Gorkiewicz et al. 2010).
 
2
Type IV secretion system (T4S) gene PCR assays (Moolhuijzen et al. 2009). 
*Isolate BT102/00 positive on both PAI and T4S VirB11 PCR assays. 
†Isolate D8147/2 positive on both PAI and T4S VirD4 PCR assays. 
‡Isolates 317, 412 and 635 positive on both PAI and T4S VirD4 PCR assays. 
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Both VirD4 PCR assays amplify the same region of the VirD4 gene, the PAI VirD4 PCR target 
(Gorkiewicz et al., 2010) is 377 bp longer than the T4S VirD4 PCR target (Moolhuijzen et al., 
2009) with a single base difference at position 888 (Figure 22). The PAI (Gorkiewicz et al., 2010) 
and T4S (Moolhuijzen et al., 2009) VirD4 gene sequences shared only 67% identity (Figure 22).  
Twenty-six Campylobacter-like and Australian and UK C. fetus field cultures were positive on the 
T4S VirB11 PCR (Moolhuijzen et al., 2009) while five isolates were positive on the PAI VirB11 
PCR (Gorkiewicz et al., 2010), with only one isolate (BT102/00) positive on both tests (Table C, 
Appendix 3, Figure 29). Both VirB11 PCR assays target the same region of the VirB11 gene, with 
the PAI VirB11 PCR (Gorkiewicz et al., 2010) target being 72 bp longer (Figure 23) than the T4S 
VirD4 PCR target (Moolhuijzen et al., 2009). The PAI (Gorkiewicz et al., 2010) and T4S 
(Moolhuijzen et al., 2009) VirB11 gene sequences share only 61% identity, multiple nucleotide 
differences between both VirB11 PCR targets and gene sequences were observed (Figure 23).  
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Figure 22. Difference between previously reported C. fetus subsp. venerealis VirD4 gene sequences (GenBank Accession NZ_ACL01001165 and 
EU443150.2) and conventional PCR assays (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009).  
 
 
Available VirD4 gene sequences share only 67% identity (identities: 1492/2209=67%, gaps: 698/2209=31%; partial alignment shown). The 
pathogenicity island (PAI) VirD4 PCR target (Gorkiewicz et al., 2010) is 377 bp longer than the type IV secretion system (T4S) VirD4 PCR target 
(Moolhuijzen et al., 2009). Location of primers (T4S: nC1165g6F and nC1165g6R; PAI: TaxB2 and TaxB3) is indicated and nucleotide differences are 
highlighted.  
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Figure 23. Difference between previously reported C. fetus subsp. venerealis VirB11 gene sequences (GenBank Accession NZ_ACL01001023 and 
EU443150.2) and conventional PCR assays (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009).  
Available VirB11 gene sequences share 61% identity (identities: 636/1034 = 61%, gaps: 73/1034 = 7%; partial alignment shown). The pathogenicity 
island (PAI) VirB11 PCR target (Gorkiewicz et al., 2010) is 72 bp longer than the type IV secretion system (T4S) VirB11 PCR target (Moolhuijzen et 
al., 2009). Primers (T4S: C1023G2F and C1023G2R; PAI: VirB11-1 and VirB11-2) are indicated and nucleotides differences are highlighted.  
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3.3. Evaluation of new putative virulence and PAI gene conventional PCR assays 
3.3.1. New putative virulence and PAI gene conventional PCR targets 
 Out of the 13 unique regions, two draft contigs putatively annotated as the bacteriophage 
DNA transposition protein B were identical (ab51_contig161_2580-2904 and ab51_contig163_616-
940), and similarly, two draft contigs putatively annotated as identical surface array protein 
(cfvv_19.2623-3742.537-1071 and cfvv_62.1433-2552.537-1071, Appendix 3). Another draft 
contig was unsuitable for primer design (not shown). Fifteen new primer sets were designed for ten 
out of 12 draft contigs (Appendix 3). New PCR assays target either putative PAI genes (n=4), genes 
of phage origin (n=3) and a virulence gene (n=1) common to both C. fetus subsp. venerealis B6 and 
642-21 genomes. Other PCR assays were designed from draft contigs unique to the B6 genome, 
amplifying either a putative virulence gene (n=1), genes of plasmid origin (n=2) and a T4S gene 
(n=1). Some other assays were designed from draft contigs unique to 642-21 genome amplifying 
either putative virulence genes (n=2) or a T4S gene (n=1). New primer sequences and putative PCR 
target annotations are detailed in Table 27. Alignments of new PCR targets to corresponding 
contigs show locations of primers and putative PCR target annotations (Figures 24-31). 
 
3.3.2. Reference cultures 
 All C. fetus subsp. venerealis reference strains (n=4) were positive on the eight new putative 
PCR assays (section 3.3.1) designed from draft contigs common to both C. fetus subsp. venerealis 
B6 and 642-21 genomes while all the other Campylobacter reference strains tested were negative 
(n=7; Table 24). All C. fetus subsp. venerealis bv. venerealis reference strains (n=3) were positive 
on the four new PCR assays (section 3.3.1) designed from draft contigs unique to C. fetus subsp. 
venerealis (bv. venerealis) B6 genome but C. fetus subsp. venerealis bv. intermedius (n=1) and the 
other Campylobacter (n=7; Table 24) reference strains were negative. On the contrary, all the 
C. fetus subsp. venerealis bv. venerealis (n=3) or the other Campylobacter (n=7) reference strains 
tested were negative on the three new PCR assays (section 3.3.1) designed from draft contigs 
unique to the C. fetus subsp. venerealis (bv. intermedius) 642-21 genome as solely 642-21 was 
positive (bv. intermedius: n=1, Table 24).  
Gel pictures show the PCR products obtained with both C. fetus subsp. venerealis biovars (Figures 
I-L), with either C. fetus subsp. venerealis bv. venerealis (Figures M-N) or bv. intermedius (Figures 
O-P) reference strains tested while the other reference strains were negative (Appendix 3). 
 No in silico PCR product was obtained from any of the Campylobacter reference strains (n=14; 
Table 20) screened online (results not shown). 
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Table 27. New primer sequences and putative PCR target annotations designed from C. fetus subsp. venerealis B6 and/or 642-21 unique contigs. 
Contig number 
Primer sequences 
(5’to 3’) 
Amplicon  
(bp) 
Putative PCR target annotation 
using tBLASTx (top hit) 
Species, E-value, accession number 
Designed 
 from 
ab51_contig82_1 
GTTTTGCAATTAGGGCAATC 
194 Transposase OrfB 
C. fetus subsp. venerealis NCTC10354, 
3e-38, ACA64449.1  
B6 and  
642-21 
GCTATGGCTAAAATTTGGGGTA 
ab51_contig82_2 
CTGTTGTGGTATGAGCTTTATCCTT 
244 Transposase OrfB 
C. fetus subsp. venerealis NCTC10354, 
3e-48, ACA64449.1  
B6 and 
 642-21 
CAAGGCGGACTACCTAGCTTT 
ab51_contig130_
46-8645_1  
CTTGGTGCAGCCTATGACAA 
244 
Fic protein;  
hypothetical protein 
C. fetus subsp. venerealis NCTC10354, 
0.015, EGU24819.1;  
C. fetus subsp. venerealis NCTC10354, 
6e-11, ACS15153.1 
B6 and  
642-21 
GGCTTTTCGCCTTCTTTTCT 
ab51_contig130_
46-8645_2 
TGGCAGTAGTGGCTCAAATG  
179 
Fic protein; hypothetical protein 
CFV354_1928 
C. fetus subsp. venerealis NCTC10354, 
6e-17, EGU24820.1; 
C. fetus subsp. venerealis NCTC10354, 
1e-05, EGU24821.1 
B6 and 
 642-21 
CCTCGATTGCTGTGCTATGA 
ab51_contig161_
2580-2904  
TCTGCCACTTAAGGCACTTG  
153 
Putative bacteriophage  
DNA transposition protein B; 
hypothetical protein 
CFV354_1545 
C. jejuni subsp. jejuni S3, 3e-05, 
YP_005659263.1;  
C. fetus subsp. venerealis NCTC10354, 
5e-25, EGU24499.1 
B6 and 
 642-21 
ATCCACTTTGAGCCGATACG 
ab51_contig198
_772-939  
GCCTCTTAGAGTAGTAGGCGATAA 
150 
Prophage Mu protein;  
 
hypothetical protein 
CFV354_1544 
Helicobacter bilis ATCC43879, 3e-09, 
ZP_04581197.1;  
C. fetus subsp. venerealis NCTC10354, 
7e-25, EGU24498.1 
B6 and  
642-21 
TGAAAACTTCTCCAGCTTCTCTC 
cfvv_19.2623-
3742.537-1071 
AAGTTGCTACGGCAGCTGAT 
226 Surface array protein 
C. fetus subsp. venerealis NCTC10354, 
4e-88, EGU23645.1 
B6 and  
642-21 
CCAGCAGCCGAATCAGTAAT 
cfvv_26.1-
3968.2595-3321 
TGCTCCACTGCAAACTATCG 
246 
Phage portal protein;  
 
prophage Mu protein  
C. fetus subsp. venerealis Azul-94, 4e-
25, UPI0001BCE1B1;  
Helicobacter bilis ATCC43879, 4e-22, 
C3XGQ9_9HELI 
B6 and 
 642-21 
TCCGTTGCTCTACGCCTACT 
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Contig number 
Primer sequences 
(5’to 3’) 
Amplicon  
(bp) 
Putative PCR target annotation 
using tBLASTx (top hit)  
Species, E-value, accession number 
Designed 
 from 
ab51_contig207_
1  
AAAACTCCACCTGTGCCATC 
227 
Putative adhesin/invasin;  
 
hypothetical protein 
CFV354_1912 
C. lari RM2100, 4e-14, 
YP_002576152.1;  
C. fetus subsp. venerealis 
NCTC10354,7e-42, EGU24808.1  
B6 
GTTCCAGAACCAACGCAAAT 
ab51_contig207_
2  
TACATTGCGGCTGCAGTAAG 
245 
Plasmid pVir; 
 
hypothetical protein 
CFV354_1895 
C. jejuni subsp. jejuni IA3902, 4e-07, 
CP001877.1;  
C. fetus subsp. venerealis NCTC10354, 
9e-36, EGU24792.1 
B6 
GGAGCTGGTGGTCAAAATGT 
ab51_contig207_
3  
ATCCCAGCTAAAAGGGGAGA 
198 
Putative type IV secretion 
protein VirD4 
C. fetus subsp. venerealis NCTC10354, 
3e-36, EGU24801.1 
B6 
ACTCGACCACTCGCAACTCT 
ab51_contig207_
4 
CCATCAACCCTTGCATCTTT 
151 
Hypothetical protein 
CFV354_1907;  
hypothetical protein 
CJSA_pVir0009 encoded by the 
plasmid pVir 
C. fetus subsp. venerealis NCTC10354, 
9e-25, EGU24803.1;  
C. jejuni subsp. jejuni IA3902, 7e-04, 
YP_005661546.1 
B6 
GAGCCGAAATGGCAATAAAA 
ab51_contig76  
TGCTAAAAGCTGATGGCTCA 
175 Fic family protein 
Helicobacter pullorum MIT 98-5489, 
3e-84, C5F2H4_9HELI† 
642-21 
GATGGCGGTGTTGCTATTTT 
ab51_contig341  
TTTCTCCGGTTTCAGGATTG  
160 
Hypothetical protein 
CfetvA_05787;  
outer membrane protein HorA 
C. fetus subsp. venerealis str. Azul-94, 
2e-26, ZP_06008793.1; Helicobacter 
cetorum MIT99-5656, 4e-05, 
YP_006220409.1 
642-21 
AAAGTGCCAGATGAGGATGG 
ab51_contig429 
TGGCATACAAGCACTTCGAG 
153 
P-type conjugative transfer 
protein TrbL;  
hypothetical protein 
CFV354_1960 
C. jejuni subsp. jejuni 1997-7, 3e-18, 
EIB60295.1;  
C. fetus subsp. venerealis NCTC10354, 
2e-21, EGU24851.1 
642-21 
ACATTGGTTGCGAGTTGTGA 
*BLAST (http://blast.ncbi.nlm.nih.gov/), accessed on 27
th
 of June 2012. 
†YABI (http://ccg.murdoch.edu.au/yabi), accessed on 27th of June 2012. 
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Figure 24. New putative transposase orfB pathogenicity island conventional PCR assays: A-194 bp (ab51_contig82_1) and B-244 bp 
(ab51_contig82_2) designed from a draft contig found on the pathogenicity island of both B6 and 642-21 genomes.  
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Figure 25. New putative fic protein pathogenicity island conventional PCR assays: A-179 bp (ab51_contig130_46-8645_1) and B-244 bp 
(ab51_contig130_46-8645_2) designed from a draft contig found on the pathogenicity island of both B6 and 642-21 genomes. 
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Figure 26. New putative bacteriophage DNA transposition protein B (A-153 bp; ab51_contig161_2580-2904) and prophage Mu protein (B-150 bp 
(ab51_contig198_772-939) conventional PCR assays designed from draft contigs found in both B6 and 642-21 genomes. 
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Figure 27. New putative surface array protein (A-226 bp; cfvv_19.2623-3742.537-1071) and phage portal/prophage Mu proteins (B-246 bp; cfvv_26.1-
3968.2595-3321) conventional PCR assays designed from draft contigs found in both B6 and 642-21 genomes. 
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Figure 28. New putative adhesin/invasin (A-227 bp; ab51_contig207_1) and plasmid pVir (B-245 bp; ab51_contig207_2) conventional PCR assays 
designed from a draft contig unique to B6 genome. 
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Figure 29. New putative type IV secretion protein VirD4 (A-198 bp; ab51_contig207_3) and hypothetical/plasmid pVir protein (B-151 bp; 
ab51_contig207_4) conventional PCR assays designed from draft contigs unique to B6 genome. 
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Figure 30. New putative fic family protein (A-175 bp; ab51_contig76) and P-type IV conjugative transfer protein TrbL (B-153 bp; ab51_contig429) 
PCR assays designed from draft contigs found in 642-21 genome.  
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Figure 31. New putative hypothetical/outer membrane protein HorA conventional PCR (160 bp; ab51_contig341) designed from a draft contig unique 
to 642-21 genome. 
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3.3.3. Screening of the Campylobacter-like culture collection 
 Results obtained from the Campylobacter-like culture collection (n=84) against the 15 new 
putative virulence and PAI gene conventional PCR assays are presented in Table E (Appendix 3). 
Isolates 4, 31, 520 and 562 were not evaluated on the 15 new putative virulence and PAI gene 
conventional PCR assays (Table E, Appendix 3).  
Less than 20% of the Campylobacter-like culture collection was positive on the following new 
putative assays: plasmid pVir (ab51_contig207_2: 16/83; 19.3%), type IV secretion system protein 
VirD4 (ab51_contig207_3: 8/83; 9.6%), hypothetical/plasmid pVir protein (ab51_contig207_4: 
6/83; 7.2%) and P-type conjugative transfer protein TrbL (ab51_contig429: 9/83; 10.8%) PCR 
assays (Figure 32). New assays putatively annotated to fic proteins (ab51_contig130_46-8645_1: 
23/83; 27.7%; ab51_contig130_46-8645_2: 32/83; 38.6% and ab51_contig76: 25/83; 30.1%), 
surface array protein (cfvv_19.2623-3742.537-1071: 18/81; 22.2%), phage portal/prophage Mu 
proteins (cfvv_26.1-3968.2595-3321: 17/81; 21% and ab51_contig198_772-939; 28/83; 33.7%), 
adhesin/invasin (ab51_contig207_1: 18/83; 21.7%) and hypothetical/outer membrane protein HorA 
(ab51_contig341: 19/83; 22.9%) detected 20 to 40% of the Campylobacter-like culture collection 
(Figure 32). More than 40% of the Campylobacter-like culture collection was positive on the new 
putative transposase orfB (ab51_contig82_1: 37/83; 44.6% and ab51_contig82_2: 57 out of 83; 
68.7%) and bacteriophage DNA transposition protein B (ab51_contig161_2580-2904: 41/83; 
49.4%) PCR assays (Figure 32). 
Isolates biochemically confirmed as C. fetus subsp. venerealis as well as C. fetus subsp. fetus, 
thermophilic Campylobacter spp. and Arcobacter-like aerotolerant organisms were positive on the 
15 new putative virulence and PAI gene conventional PCR assays (Table E, Appendix 3; Figure 
32). Isolates other than C. fetus subsp. venerealis were only positive on one or two new PCR assays 
except for two thermophilic Campylobacter spp. (530 and 676), three Arcobacter-like (158, 166 and 
227) and two C. fetus subsp. fetus (882 and 979) isolates which were positive on three to 11 new 
putative virulence and PAI gene PCR assays (Table E, Appendix 3; Figure 32). These isolates were 
all previously found positive on both parA and ISCfe1 real-time assays although two isolates (530 
and 676) failed to produce full parA real-time target sequence while two others (676 and 979) 
showed ISCfe1 real-time target sequence variations (Chapter 5). All these isolates (except for 676) 
were positive on Abril’s PCR with two isolates (227 and 979) identified as C. fetus subsp. 
venerealis in Hum’s PCR (Chapter 5, Table 13).  
Australian and UK field cultures (n=21) biochemically characterised as C. fetus subsp. venerealis 
and C. fetus subsp. fetus were also positive on the 15 new putative virulence and PAI gene 
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conventional PCR assays (Table F, Appendix 3). The C. fetus subsp. fetus strains were positive on 
three to nine new putative virulence and PAI gene PCR assays confirming that these gene targets 
are found in both C. fetus subspecies (Table F, Appendix 3; Figure 33). 
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Figure 32. Comparison of the positive molecular results obtained on newly designed putative virulence and pathogenicity island gene conventional 
PCR assays (n=15) and previously determined biochemical phenotypes of the Campylobacter-like culture collection. 
 
*Isolates 530, 676, 849 and 863 respectively positive on four, five, two and one out of 15 PCR assays. 
†Isolates 337, 882 and 979 respectively positive on one, six and three out of 15 PCR assays. 
‡Isolates 158, 166 and 227 respectively positive on seven, four and 11 out of 15 PCR assays; isolates 289, 306, 312 and 672 were positive only on one 
PCR assay while isolate 729 was positive on two PCR assays. 
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Figure 33. Comparison of the positive molecular results obtained on newly designed putative virulence and pathogenicity island gene conventional 
PCR assays (n=15) and previously determined biochemical phenotypes of the Australian and UK C. fetus field cultures.  
 
*All C. fetus subsp. fetus isolates tested (n=5) were positive on three to nine out 15 new PCR assays.
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3.4. Sequencing of putative virulence gene PCR products 
 PCR products for sequencing were randomly selected. Sequence analysis of the putative 
adhesin/invasin (ab51_contig207_1) PCR product obtained from isolate 635 was identical to the 
assay target, based on a contig unique to C. fetus subsp. venerealis B6 genome (Figure 34). On the 
opposite, multiple nucleotide substitutions were observed from the PCR products generated from 
isolates 676, 856 and 991 (Figure 34). Translation of altered PCR products (Figure 34) indicated 
that most of these substitutions were not affecting identity of corresponding amino acids (isolates 
676, 856 and 991: A instead of T position 51, T instead of C position 69, C instead of T position 72, 
T instead of C position 84, G instead of T position 129, G instead of A position 135, A instead of G 
position 159, A instead of T position 165, TGA instead of ACT positions 168-170, T instead of C 
position 174 and G instead of A position 207; isolate 676: C instead of A position 9, G instead of A 
position 117, C instead of T position 183; isolate 856: A instead of G position 105 and 114). 
However, three nucleotide substitutions induced missense mutations resulting in different amino 
acids (isolates 676, 856 and 991: T instead of C position 68 encoding isoleucine instead of valine, T 
instead of A position 76 encoding tyrosine instead of phenylalanine, G instead of A position 145 
encoding threonine instead of isoleucine, Figure 34). tBLASTx searches of altered PCR products 
did not produce any other significant hit other than the previously reported adhesin/invasin found in 
C. lari RM2100 (4e-14, 39/70 identities) and the hypothetical protein found in C. fetus subsp. 
venerealis ATCC19438 (1e-40, 72/75 identities) to which the conventional PCR target was 
putatively annotated (Table 27).  
 
3.5. Isolates selected for animal model testing 
3.5.1. Virulence and PAI gene molecular profiles 
 As the C. fetus subsp. venerealis reference strains B6 and 642-21 (Table 24) were sourced 
from bovine abortion cases (Donaldson and Clark, 1970; Newsam and Peterson, 1964) and the new 
putative virulence and PAI gene PCR assays were designed from draft contigs common to both or 
either genomes, results obtained from these strains in all assays described here were used as a point 
of comparison. Reference and field isolates matching either B6 (Table 28) or 642-21 (Table 29) 
virulence and PAI profiles were proposed as candidates for animal experiments (parallel PhD 
projects). Isolates biochemically confirmed as C. fetus subsp. venerealis, positive on both Hum and 
Abril PCR assays (Chapter 5, Table 13), and also positive on some previously published and new 
PAI and/or T4S gene conventional PCR assays (Tables C-E, Appendix 3) were further 
recommended (highlighted rows, Tables 28-29) in order to evaluate if these assays could be used to 
predict C. fetus subsp. venerealis virulence in animals. Molecular profiles of the C. fetus subsp. 
venerealis isolates tested on the pregnant guinea pig model are summarised in Table 30. 
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Figure 34. Alignment of putative adhesin/invasin (ab51_contig207_1) PCR target with the PCR products obtained from four Campylobacter-like 
isolates (635, 676, 856 and 991). The PCR product obtained from isolate 635 matched 100% the assay’s target while products from isolates 676, 856 
and 991 exhibited multiple nucleotide substitutions. Only three substitutions resulted into different amino acids than the ones encoded by the assay’s 
target. Variable sites are highlighted. 
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Table 28. Molecular profiles of the field and reference isolates matching results obtained on new and published virulence and pathogenicity island gene 
conventional PCR assays with the C. fetus subsp. venerealis biovar venerealis reference strain B6.  
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*8 - - - - - - - - - + - + + - - - + + - - - - - 
130 - - - - - - - + + + - + - - - - + - - - - - - 
†317 - - - + + + + + + + - - - - - - - - - - - - - 
†412 - - - + + + + + + + - - - - - - - - - - - - - 
635 + + + + + + + + + + + + + + + + + + + + - - - 
*979 - - - - - - - - + + - - - - - - + + + + - - - 
*1025 - - - + - - + + + + + + + + - - + + - - - - - 
*D8147/2 - + + + + + + + + + + + + + + + + + + + - - + 
†F591/1 - - - - - + + - + + + + + - + - + + - - - - - 
*†BT268/06 - - - - - - + - - + - - + + - - - - - - - - - 
‡BT102/00 - + - + + - + + - + + + + + - - - - + - - - - 
‡ATCC19438 + + + + + + + + + + + + + + - + + + + + - - - 
‡B6 + + + + + + + + + + + + + + + + + + + + - - - 
98-109383 + + + + + + + + + + + + + + + + + + + + - - - 
*Isolates 8 and 1025 were not biochemically phenotyped; isolates 979, F591/1 and BT268/00 were identified as C. fetus subsp. fetus; all remaining 
isolates were characterised as C. fetus subsp. venerealis biovar venerealis (Tables 24-25; Chapter 5, Table 13). 
†Isolates 317, 412, F591/1 and BT268/06 were negative on Hum’s PCR; all other isolates being positive (Chapter 5, Table 13). 
‡Isolates cultured from bovine abortion cases. 
C. fetus subsp. venerealis biovar venerealis isolates (n=2) matching exactly the virulence and PAI gene profile of the reference strain B6. 
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Table 29. Molecular profiles of reference and field isolates matching results obtained on new and published virulence and pathogenicity island gene 
conventional PCR assays with the C. fetus subsp. venerealis biovar intermedius reference strain 642-21.  
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10 - - - - - - + + + + + + + + + + + - 
214 - - - - - - + + + + + + + + + + + - 
217 - - - - - - + + + + + + + + - + + + 
227 - - - - - - + + + + + + + + + + + + 
229 - - - - - - + + + + + + + + + + + + 
475 - - - - - - + + + + + + + + + + + + 
537 - - - - - - + + + + + + + + + + + - 
540 - - - - - - + + + + + + + + + + + + 
859 - - - - - - + + + + + + + + + + - - 
923 - - - - - - + + + + + + + + + + + + 
924 - - - - - - + + + + + + + + + + + - 
926 - - - - - - + + + + + + + + + + + - 
951 - - - - - - + + + + + + + + + + + - 
955 - - - - - - + + + + + + + + - + + - 
957 - - - - - - + + + + + + + + + + + + 
970 - - - - - - + + + + + + + - + + + - 
‡EQC0017 - - - - - - + - + + + + + + + + + - 
J4494/6B - - - - - - + + + + + + + + + + + - 
‡A8 - - - - - - + + + + + + + + + + + + 
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†75838 - + - - - + + + + + + + + + + + + + 
†76223 - + - + - + + + + + + + + + + + + + 
‡09-125181/3 - - - - - - + + + + + + + + + + + - 
‡K8 - + - - - + + + + + + + + + + + + + 
†642-21 - - - - - - + + + + + + + + + + + + 
*Isolates 859, 955 and 970 were not biochemically phenotyped; isolate 227 was identified as Arcobacter-like organism and J4494/6B as C. fetus subsp. 
venerealis; isolates 475, 924, 957, EQC0017, A8, 75838 and 09-125181/3 were characterised as C. fetus subsp. venerealis biovar venerealis while all 
remaining isolates were phenotyped as C. fetus subsp. venerealis biovar intermedius (Tables 24-25; Chapter 5, Table 13). All isolates were positive on 
Hum’s and Abril’s PCR assays (Chapter 5, Table 13). 
1 
Type IV secretion system (T4S) gene PCR (Moolhuijzen et al. 2009).  
†Isolates cultured from bovine abortion cases. 
‡Isolates cultured from cattle herds with a history of subfertility.  
C. fetus subsp. venerealis biovar intermedius isolates (n=6) matching exactly the virulence and PAI gene profile of the reference strain 642-21. 
Isolates 76223 and K8 were positive the PAI PCR assays targeting orf26/27 and VirD4; 76223 was also positive on the PAI PCR targeting VirB10 
while the reference strain 642-21 was negative on all published PAI gene PCR assays. 
C. fetus subsp. venerealis biovar venerealis (n=4) and Arcobacter-like (n=1) isolates matching exactly the virulence and PAI gene profile of the 
reference strain 642-21. Isolates 75838 was positive on the PAI PCR assays targeting orf26/27 and VirD4 while the reference strain 642-21 was 
negative on all published PAI gene PCR assays. 
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Table 30. Molecular profiles of the C. fetus subsp. venerealis isolates tested on a pregnant guinea pig model compared to the C. fetus subsp. venerealis 
B6 and 642-21 reference strains.  
 Gorkiewicz et al. 2010 
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†EQC0017 - - - - - - - - + - + + + + + + + - - - - + + - 
540 - - - - - - - - + + + + + + + + + - - - - + + + 
924 - - - - - - - - + + + + + + + + + - - - - + + - 
‡76223 - + - + - + - - + + + + + + + + + - - - - + + + 
‡642-21 - - - - - - - - + + + + + + + + + - - - - + + + 
635 + + + + + + + + - + + + + + + + + + + + + - - - 
‡B6 + + + + + + + + - + + + + + + + + + + + + - - - 
†Isolates cultured from cattle herds with a history of subfertility.  
‡Isolates cultured from bovine abortion cases 
 
Highlighted cells (blue) indicate positive results obtained on new and published virulence and PAI gene conventional PCR assays. 
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3.5.2. Ability of new and published virulence and PAI gene assays to predict disease  
 C. fetus subsp. venerealis isolates used for inoculation of pregnant guinea pigs were selected 
by considering their virulence and PAI gene molecular profiles (Tables 28-29), origin of isolates, as 
well as antimicrobial resistance profiles (personal communication, Ameera Koya). Isolates 
EQC0017, 540, 635, 924, 76223 and B6 were tested using a pregnant guinea pig model, molecular 
profiles are summarised in Table 30 while results obtained by Ameera Koya are presented in Table 
31. 
Table 31. Preliminary data obtained by Ameera Koya after inoculation of pregnant guinea pigs 
using different C. fetus subsp. venerealis isolates. 
Inoculum 
Percentage of challenged animals 
which aborted (%) 
Average abortion time 
(hours) 
Isolation by 
culture* 
Sterile broth 0 N/A† No 
EQC0017 0 N/A† Yes 
540 75 92 Yes 
635 17 284 Yes 
924 33 20 Yes 
76223 100 74 Yes 
B6 17 125 Yes 
*C. fetus subsp. venerealis was isolated by culture from the dams or foetuses post animal challenge. 
†N/A non-applicable, no abortion was observed. 
More guinea pigs aborted when challenged with 540 than 924 (75% versus 33%) even if the 
average abortion time was shorter with 924 than 540 (20 versus 92h). Yet, all animals (100%) 
challenged with 76223 aborted within 72h while no abortion was induced in guinea pigs inoculated 
with EQC0017 (Table 31). Isolates EQC0017, 540, 924 and 76223 had a virulence and PAI gene 
profile resembling that of 642-21 (Table 30). Isolates 540, 76223 and 642-21 were positive on the 
same 12 virulence and PAI gene PCR assays while EQC0017 and 924 were positive on respectively 
ten and 11 of these assays (Table 30). Isolate 76223 was also positive on three out of six published 
PAI PCR assays (orf26/27, VirB10 and VirD4) on which 642-21, 540, 924 and EQC0017 were all 
negative (Table 30), suggesting that the published PAI gene targets could be indicative of enhanced 
strain virulence. However, both 635 and B6 were positive on the same 20 virulence and PAI gene 
PCR assays including all six published PAI genes screened for (Table 30) but seemed to be less 
virulent than 76223, as a much lower percentage of abortion rates was observed from challenged 
animals (17%) and the average abortion time was markedly increased (284 and 125 h, Table 31). 
Isolates 635 and B6 were negative for three putative virulence and T4S gene targets on which 540 
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and 76223 were positive while 924 and EQC0017 were positive on two out of three of these assays 
(Table 30).  
 
3.6. In Silico analysis of type IV secretion system (T4S) genes 
 The current version of the seven T4S gene sequences VirB3/4, VirB7, VirB8, VirB9, 
VirB10, VirB11 and VirD4, obtained from B6, 642-21 (Barrero et al., 2013), 635, 830, 924 and 957 
(personal communication, May 2012, Gabriel Keeble-Gagnère, CCG) were aligned to previously 
available C. fetus T4S gene sequences (Abril et al., 2010; Gorkiewicz et al., 2010; Moolhuijzen et 
al., 2009) and compared to published motifs and consensus sequences identified from 
Agrobacterium tumefaciens (Bailey et al., 2006; Banta et al., 2011; Bayliss et al., 2007; Christie et 
al., 2005; Jakubowski et al., 2005; Kumar and Das, 2001, 2002; Rabel et al., 2003; Stephens et al., 
1995).  
 
3.6.1. VirB3/4 
 The fused VirB3/B4 gene sequences from the C. fetus subsp. venerealis reference strains B6 
and 642-21 (Barrero et al., 2013) shared only 60% identity (identities: 1765/2927=60%; gaps: 
301/2927=10%, result not shown). The VirB4 nucleotide sequence from isolate 635 was identical to 
the VirB3/B4 sequence from B6 while the VirB4 nucleotide sequences from isolates 924 and 957 
matched 100% 642-21 VirB3/B4 sequence (results not shown). The VirB4 nucleotide sequence 
from ATCC19438 (GenBank Accession EU443150.2; Gorkiewicz et al. 2010) was almost identical 
(identity: 2745/2790=98%; gaps: 45/2790=1%) while C. fetus subsp. fetus IMD523 VirB4 sequence 
(GenBank Accession FN594949.1, Abril et al. 2010) was highly similar (identity: 2714/2895=93%; 
gaps: 150/2895=5%) to B6 VirB3/B4 sequence (result not shown). The VirB4 nucleotide sequence 
from isolate 830 was not similar to B6 (identities: 1456/2891=50%; gaps: 544/2891=18%) or 642-
21 (identities: 1433/3039=47%; gaps: 777/3039=25%) VirB3/B4 sequences (results not shown). 
The partial VirB4 nucleotide sequence from AZUL-94 (GenBank Accession NZ_ACL01001165; 
Moolhuijzen et al. 2009) shared only 13% identity (identities: 399/3026=13%; gaps; 
2433/3026=80%) with B6 VirB3/B4 sequence and was not further studied.  
Four motifs (Walker motifs A, B, C and D) were previously described from the VirB4 proteins of 
19 bacterial spp. (Rabel et al., 2003). The Walker motif A “GxxGxGK[T/S]” (Rabel et al., 2003) 
was conserved as GQSGGGKT in B6 (Barrero et al., 2013), ATCC19438 (GenBank Accession 
EU443150.2; Gorkiewicz et al. 2010), IMD523 (GenBank Accession FN594949.1, Abril et al. 
2010) and 635; as GKSGGGKT in 642-21 (Barrero et al., 2013), 924 and 957; and as GGTGSGKT 
in 830 (Figure 35). The Walker motif B “x4DE[A/F]W” (Rabel et al., 2003) was conserved as 
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CFIDEAW in B6 (Barrero et al., 2013), ATCC19438 (GenBank Accession EU443150.2; 
Gorkiewicz et al. 2010), IMD523 (GenBank Accession FN594949.1, Abril et al. 2010) and 635; as 
GLFIDEAW in 642-21 (Barrero et al., 2013), 924 and 957; and as FCFIDEAW in 830 (Figure 36 
A). The Walker motif C “Dx3[D/N]” (Rabel et al., 2003) was also found as DNETT in B6 (Barrero 
et al., 2013), ATCC19438 (GenBank Accession EU443150.2; Gorkiewicz et al. 2010), IMD523 
(GenBank Accession FN594949.1, Abril et al. 2010) and 635; as DNAID in 642-21 (Barrero et al., 
2013), 924 and 957; and as DNKED in 830 (Figure 36 B). The Walker motif D “R[K/M]x8[T/S]Q” 
(Rabel et al., 2003) was conserved as RKENGFLFLGTQ in B6 (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2; Gorkiewicz et al. 2010), IMD523 (GenBank Accession 
FN594949.1, Abril et al. 2010) and 635; as RKLNGFLVLGTQ in 642-21 (Barrero et al., 2013), 
924 and 957; and as RKTGGVGCFGFQ in 830 (Figure 37). Underlined amino acids previously 
identified as essential for pilus production, plasmid, phage and DNA transfer after mutational 
experiments (Rabel et al., 2003) were all observed in the C. fetus VirB4 sequences analysed here, 
with the exception of the substitution threonine (T, underlined) to phenylalanine (F, bolded and 
underlined) which has not been previously described (supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html). 
 
3.6.2. VirB7 
 The complete VirB7 gene sequences from the C. fetus subsp. venerealis reference strains B6 
and 642-21 (Barrero et al., 2013) shared only 52% identity (identities: 278/527=52%; gaps: 
115/527=21%, result not shown). VirB7 was not found in the current genome data of isolate 830. 
The VirB7 nucleotide sequence from AZUL-94 (GenBank Accession ZP_06010409.1; Moolhuijzen 
et al. 2009) was identical to B6 VirB7 sequence while VirB7 nucleotide sequences from 924 and 
957 matched 100% the 642-21 VirB7 sequence. The VirB7 nucleotide sequences from ATCC19438 
(GenBank Accession EU443150.2; Gorkiewicz et al. 2010) and isolate 635 were identical while a 
single base difference (identities: 248/249=99%; gaps: 0/249=0%) was observed in the VirB7 
nucleotide sequence from C. fetus subsp. fetus IMD523 (GenBank Accession FN594949.1, Abril et 
al. 2010). VirB7 sequences from 635, ATCC19438 and IMD523 shared little identity with B6 
(identities: 134/553= 24%; gaps: 344/553= 62%) or 642-21 (identities: 147/448=32%; gaps: 
221/448=49%) VirB7 sequences while no similarity with other nucleotide or protein sequence 
available online was found (BLAST searches, results not shown).  
tBLASTx analysis of the VirB7 642-21 nucleotide sequence revealed that its encoded amino acids 
were highly similar to those encoding Cpp44 and CagT in other Campylobacter spp. (top hits): C. 
hominis ATCCBAA-381 (YP_001405777.1, query coverage: 90%, e-value: 5e-30), C. lari RM2100 
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(YP_002576146.1 query coverage: 94%, e-value: 1e-26), C. coli (YP_063438.1, query coverage: 
92%, e-value: 6e-25), C. jejuni subsp. jejuni S3 (YP_005660358.1, query coverage: 92%, e-value: 
2e-24) and C. upsaliensis RM3195 (ZP_00371910.1, query coverage= 94%, e-value=1e-16). The 
previously described VirB7 amino acid motif “P32[I/L/V]NK35” required to form bonds with VirB9 
identified from A. tumefaciens (Bayliss et al., 2007) could not be found in the C. fetus sequences 
examined here (Figure 38). 
 
3.6.3. VirB8 
 The complete VirB8 gene sequences from the C. fetus subsp. venerealis reference strain B6 
(Barrero et al., 2013) matched 100% VirB8 nucleotide sequences from ATCC19438 (GenBank 
Accession EU443150.2; Gorkiewicz et al. 2010) and isolate 635, while it was almost identical 
(identity: 686/705=97%; gaps:0/706=0%) to C. fetus subsp. fetus IMD523 (GenBank Accession 
FN594949.1, Abril et al. 2010) VirB8 sequence (results not shown). VirB8 was not found in the 
current version of the genomes of 642-21, 924 and 957 while the VirB8 nucleotide sequence from 
isolate 830 shared only 49% identity (identities: 373/749=49%; gaps: 142/749=18%) with B6 
VirB8 sequence (results not shown).  
The VirB8 amino acid consensus “Y105VxxRE[T/S]YD/N113” previously reported for 
A. tumefaciens (Kumar and Das, 2001) was conserved as YVKAREGYY in the translated VirB8 
nucleotide sequences of B6 (Barrero et al., 2013), 635, ATCC19438 (GenBank Accession 
EU443150.2; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01000545; 
Moolhuijzen et al. 2009) and IMD523 (GenBank Accession FN594949.1, Abril et al. 2010); and as 
YVKNRELIN in isolate 830 VirB8 sequence (Figure 39). Apart from isolate 830, the VirB8 
invariant amino acids (underlined) identified from A. tumefaciens (Kumar and Das, 2001) were 
conserved in all C. fetus VirB8 sequences while YVKAREGYY matched 100% the residues 
previously reported from a C. jejuni strain (supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html). The leucine (L, bolded) and isoleucine 
(I, bolded and underlined) residues here observed from isolate 830 VirB8 sequence (Figure 39) 
have previously been reported from E. coli, C. jejuni and H. pylori strains (supplemental material to 
Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html).  
Kumar and Das (2001) also identified five indispensable amino acids to VirB8 activity in 
A. tumefaciens: G78, S87, A100, R107 and T192 which were respectively conserved as G80, N89, Y102, 
K109 and A198 in B6 (Barrero et al., 2013), 635, ATCC19438 (GenBank Accession EU443150.2; 
Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01000545; Moolhuijzen et al. 
2009) and IMD523 (GenBank Accession FN594949.1, Abril et al. 2010; Figure 39). The same 
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residues were observed from isolate 830 VirB8 sequence except for S80, S102 and K198 (Figure 39). 
The substitutions serine to asparagine (S87 to N89), alanine to tyrosine or serine (A100 to Y102 or S102), 
arginine to lysine (R107 to K109) and threonine to or lysine (T192 to K198) have been previously found 
in other bacterial spp. (Kumar and Das, 2001; supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html) and are not believed to affect VirB8 
function. The substitution glycine to serine (G78 to S80) observed in isolate 830 VirB8 sequence 
resulted in the loss of VirB8 activity in A. tumefaciens (Kumar and Das, 2001) while the 
significance of the substitution of threonine to alanine (T192 to A198) observed here in other C. fetus 
strains is currently unknown. The threonine to methionine substitution previously led to the loss of 
VirB8 function in A. tumefaciens (Kumar and Das, 2001). 
The motif “R210xxNPxGxxV219”, previously reported as potential interaction site for VirB9 in 
A. tumefaciens (Bailey et al., 2006), was conserved as R218IKNPLGFKV227 in isolates B6 (Barrero 
et al., 2013), 635, ATCC19438 (GenBank Accession EU443150.2; Gorkiewicz et al. 2010) and 
IMD523 (GenBank Accession FN594949.1, Abril et al. 2010; Figure 39); and as 
T218LKNPLGFKV227 in isolate 830 (Figure 39). The same conserved residues (underlined) were 
observed in all C. fetus sequences except for the substitution arginine to threonine (R210 to T218, 
bolded) found in isolate 830 which has not been previously reported (supplemental material to 
Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html; Bailey et al., 2006). 
  
3.6.4. VirB9 
 The complete VirB9 gene sequences from the C. fetus subsp. venerealis reference strains B6 
and 642-21 (Barrero et al., 2013) shared only 62% identity (identities: 622/993=62%; gaps: 
105/993=10%, result not shown). VirB9 nucleotide sequences from isolates 635, ATCC19438 
(GenBank Accession EU443150.2; Gorkiewicz et al. 2010) and AZUL-94 (GenBank Accession 
NZ_ACL01001165; Moolhuijzen et al. 2009) were identical to the VirB9 sequence from B6 while 
the VirB9 nucleotide sequences from isolates 924 and 957 matched 100% 642-21 VirB9 sequence 
(results not shown). The C. fetus subsp. fetus IMD523 VirB9 nucleotide sequence (GenBank 
Accession FN594949.1, Abril et al. 2010) shared 99% identity with B6 sequence (identities: 
936/942=99%; gaps: 0/942=0%). The VirB9 nucleotide sequence from isolate 830 was not similar 
to B6 (identities: 566/1229=46%; gaps: 340/1229=27%) or 642-21 (identities: 571/1246=45%; 
gaps: 377/1246=30%) VirB9 sequences (results not shown) and was thus not further studied.  
The N-terminal VirB9 amino acid consensus previously identified from A. tumefaciens and 70 
bacterial spp. “DRYGIFE63GDWNKTNVTRYLSVFYP” (Jakubowski et al. 2005; supplemental 
material to Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html;) was 
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conserved as DRYGIFEGDWNKSENTVFSIVFYP in the translated VirB9 nucleotide sequences of 
B6 (Barrero et al., 2013), 635, ATCC19438 (GenBank Accession EU443150.2; Gorkiewicz et al. 
2010), AZUL-94 (GenBank Accession NZ_ACL01001165; Moolhuijzen et al. 2009) and IMD523 
(GenBank Accession FN594949.1, Abril et al. 2010); in 642-21 (Barrero et al., 2013), 924 and 957, 
it was conserved as DRYGLFEGFWNKQNTTILIPVFYP (Figure 40). The invariant glutamic acid 
residue (E, underlined) was conserved in all analysed sequences while multiple variable residues 
(bolded) were observed (Figure 40) compared to the previously reported consensus (Jakubowski et 
al. 2005; supplemental material to Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-
peter-christie.html).  
Similarly, the C-terminal VirB9 amino acid consensus “YGPDDG206TYFFPFVVLRG” 
(supplemental material to Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-
christie.html; Jakubowski et al. 2005) was conserved as FVPDDGTYLFPFYILRG in the translated 
VirB9 nucleotide sequences B6 (Barrero et al., 2013), 635, ATCC19438 (GenBank Accession 
EU443150.2; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01001165; 
Moolhuijzen et al. 2009) and IMD523 (GenBank Accession FN594949.1; Abril et al. 2010); and as 
FIPDDGTYIFPFFILRG in 642-21 (Barrero et al., 2013), 924 and 957 (Figure 40). The invariant 
glycine residue (G, underlined) was conserved in all sequences examined here while several 
differences of amino acids (bolded) were again recognised (Figure 40) when compared to the 
consensus previously obtained from A. tumefaciens and 70 bacterial spp. (Jakubowski et al. 2005; 
supplemental material to Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-
christie.html).  
Despite several mutations in the N- and C- terminal regions of VirB9 have been found to affect 
VirB9 interactions with VirB10 and VirB7 in A. tumefaciens strains (Jakubowski et al., 2005), it is 
currently unknown if the differences of amino acids reported here affect VirB9 function and/or 
interaction with other T4S genes. The alignment indicates a VirB9 amino acid consensus common 
to all C. fetus sequences analysed in this study (Figure 40, highlighted residues). 
 
3.6.5. VirB10 
The complete VirB10 gene sequences from the C. fetus subsp. venerealis reference strain B6 
(Barrero et al., 2013) was identical to the VirB10 nucleotide sequences from ATCC19438 
(GenBank Accession EU443150.2; Gorkiewicz et al. 2010) and isolate 635 while a single base 
difference (identities: 1166/1167=99%, gaps: 0/1167=0%) was observed in the VirB10 nucleotide 
sequence from AZUL-94 (GenBank Accession NZ_ACL01001165; Moolhuijzen et al. 2009, results 
not shown). The C. fetus subsp. fetus IMD523 VirB10 nucleotide sequence (GenBank Accession 
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FN594949.1, Abril et al. 2010) matched B6 VirB10 sequence at 99% (identities=1160/1167; 99%; 
gaps: 0/1167=0%, result not shown). VirB10 was not found in the current version of the genomes of 
642-21, 924 and 957 while the VirB10 nucleotide sequence from isolate 830 shared only 50% 
identity (identities: 661/1300=50%; gaps: 218/1300=16%) with the B6 VirB10 sequence (results 
not shown).  
The VirB10 amino acid consensus “S262xGxDxLG269xxG272xxG275xVDxH280” previously reported 
from A. tumefaciens (Banta et al., 2011) was conserved as SGASDELGGSGMQGYVD-H in the 
translated VirB10 nucleotide sequences of B6, ATCC19438, AZUL-94 and 635 (Figure 41 A). This 
amino acid sequence, including variable (bolded) and conserved (underlined) residues, is similar to 
the sequence previously reported from a C. jejuni strain: “SGATDELLGASGVQGTVDNH” 
(supplemental material to Christie et al. 2005, http://mmg.uth.tmc.edu/faculty/faculty-peter-
christie.html). The three invariant glycine residues (G269xxG272xxG275, underlined), essential to 
substrate transfer and T-pilus biogenesis in A. tumefaciens (Banta et al., 2011), were also conserved 
in these C. fetus subsp. venerealis strains (Figure 41 A). A completely different VirB10 amino acid 
sequence was observed from isolate 830 while only two out of three glycine residues (underlined) 
from the G269xxG272xxG275 reported motif (Banta et al., 2011) were conserved (Figure 41 B).  
 
3.6.6. VirB11 
 The complete VirB11 gene sequences from the C. fetus subsp. venerealis reference strains 
B6 and 642-21 (Barrero et al., 2013) shared only 61% identity (identities: 638/1034=61%; gaps: 
73/1034=7%, result not shown). VirB11 was not found in the current available genome data of 
isolate 830. VirB11 nucleotide sequences from ATCC19438 (GenBank Accession EU443150.2; 
Gorkiewicz et al. 2010) and isolate 635 were identical to the B6 VirB11 sequence while the VirB11 
nucleotide sequences from isolates 924 and 957 matched 100% the 642-21 VirB11 sequence 
(results not shown). The VirB11 nucleotide sequence from AZUL-94 (GenBank Accession 
NZ_ACL01001023; Moolhuijzen et al. 2009) also shared 98% identity with 642-21 VirB11 
nucleotide sequence (identities: 989/999=98%; gaps: 0/999=0%) while C. fetus subsp. fetus 
IMD523 VirB11 nucleotide sequence (GenBank Accession FN594949.1, Abril et al. 2010) was 
almost identical (identities: 993/996= 99%; gaps: 0/996= 0%) to B6 VirB11 sequence (results not 
shown).  
The VirB11 amino acid consensus “G169PTGSGKT176” previously reported from A. tumefaciens 
corresponding to the “GxxGxxGKT/S Walker box A nucleotide-binding site” (Stephens et al., 
1995) was conserved as GETGSGKT in the translated VirB11 nucleotide sequences of all strains 
examined (Figure 42). The lysine residue (K, underlined) required for the virulence of 
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A. tumefaciens strains (Stephens et al., 1995) was conserved in all analysed sequences. It was noted 
that the amino acid glutamic acid (E, bolded) instead of proline (P) had been previously observed in 
a Escherichia coli VirB11 sequence (supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html) while it was replaced by glycine (G) in 
C. jejuni 81-176 (Bacon et al., 2000). Proline and glutamic acid are interchangeable (Strecker, 
1960), thus this single difference of amino acid compared to the reported consensus (Stephens et al., 
1995) is not believed to affect the functionality of the VirB11 gene or the virulence of the C. fetus 
subsp. venerealis examined strains. 
   
3.6.7. VirD4 
The complete VirD4 gene sequences from the C. fetus subsp. venerealis reference strains B6 and 
642-21 (Barrero et al., 2013) shared only 54% identity (identities: 1302/2372=54%; gaps: 
490/2372=20%, result not shown). VirD4 nucleotide sequences from isolates 635 and ATCC19438 
(GenBank Accession EU443150.2; Gorkiewicz et al. 2010) were identical to the VirD4 sequence 
from B6 while the VirD4 nucleotide sequences from isolates 924 and 957 matched 100% 642-21 
VirD4 sequence (results not shown). The VirD4 nucleotide sequence from C. fetus subsp. fetus 
IMD523 (GenBank Accession FN594949.1, Abril et al. 2010) was highly similar (identity: 
2020/2210=91%; gaps: 4/2210=4%) to B6 VirD4 sequence (result not shown) while the VirD4 
nucleotide sequence from AZUL-94 (GenBank Accession NZ_ACL01001165; Moolhuijzen et al. 
2009) shared only 67% identity (identities: 1492/2209=67%; gaps; 698/2209=31%) with B6 VirD4 
sequence. The VirB9 nucleotide sequence from isolate 830 was not similar to B6 (identities: 
1112/2397=46%; gaps: 666/2397=27%) or 642-21 (identities: 1302/2372=51%; gaps: 
377/2372=19%) VirD4 sequences (results not shown).  
The nucleotide-binding motif “G151xG153xG155xnK174” previously identified from A. tumefaciens 
(Kumar and Das, 2002) was conserved as “GKGVGx19K” in the translated VirD4 nucleotide 
sequences of B6, 642-21 (Barrero et al., 2013), ATCC19438 (GenBank Accession EU443150.2; 
Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01001165; Moolhuijzen et al. 
2009), IMD523 (GenBank Accession FN594949.1, Abril et al. 2010), 635, 924 and 957; and as 
““GKTAGx19K in isolate 830 (Figure 43). With the exception of the amino acid substitution 
threonine (T, bolded) instead of glycine (G) observed for isolate 830 VirD4 sequence previously 
identified in Legionella pneumophila strains (supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html), all other invariant residues (underlined) 
reported from A. tumefaciens (Kumar and Das, 2002) were conserved in the C. fetus VirD4 
sequences examined here (Figure 43). The residues G151, K152 and K174 identified as essential to 
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VirD4 function in A. tumefaciens as observed in mutation negative experiments (Kumar and Das, 
2002) were also found in all C. fetus VirD4 sequences analysed here (Figure 43). 
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Figure 35. In Silico analysis of the VirB3/B4 gene sequences. 
 
Despite multiple nucleotide differences (highlighted, partial alignment) observed from isolates B6, 642-21 (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2: 6426-9215; Gorkiewicz et al. 2010), IMD523 (GenBank Accession FN594949.1: 3511-6405), 635, 830, 924 and 
957, the invariant amino acid histadine (H, boxed) and the “Walker motif A” (boxed) previously reported from 19 bacterial spp. (Rabel et al., 2003) are 
conserved in all C. fetus sequences examined here. 
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Figure 36. In Silico analysis of the VirB3/B4 gene sequences. 
 
Highlighted nucleotides indicate variable sites in VirB3/4 sequences obtained from isolates B6, 642-21 (Barrero et al., 2013), ATCC19438 (GenBank 
Accession EU443150.2: 6426-9215; Gorkiewicz et al. 2010), IMD523 (GenBank Accession FN594949.1: 3511-6405), 635, 830, 924 and 957. The 
invariant residues aspartic and glutamic acids (D and E) part of the “Walker motif B” (A- boxed, partial alignment), as well as the first aspartic acid 
(D) of the “Walker motif C” (B-boxed, partial alignment), previously reported from 19 bacterial spp. (Rabel et al., 2003), are conserved in all C. fetus 
sequences examined here.  
 
 
 181 
 
Figure 37. In Silico analysis of the VirB3/B4 gene sequences. 
 
Despite multiple nucleotide differences (highlighted, partial alignment) observed from isolates B6, 642-21 (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2: 6426-9215; Gorkiewicz et al. 2010), IMD523 (GenBank Accession FN594949.1: 3511-6405), 635, 830, 924 and 
957, the invariant amino acid glutamine (Q, boxed) and the Walker motif D previously reported from 19 bacterial spp. (Rabel et al., 2003) are 
conserved in all C. fetus sequences examined here. 
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Figure 38. In silico analysis of the VirB7 gene sequences. Different nucleotides and amino acids (highlighted) were observed from isolates B6, 642-21 
(Barrero et al., 2013), ATCC19438 (GenBank Accession EU443150.2: 11203-11451; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession 
ZP_06010409.1: 6241-6753; Moolhuijzen et al. 2009) IMD523 (GenBank Accession FN594949.1: 8393-8641; Abril et al. 2010), 635, 924 and 957 
VirB7 sequences. The VirB7 consensus reported from A. tumefaciens (Bayliss et al., 2007) was not conserved in the C. fetus strains examined here.  
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(Figure 38 continued) 
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Figure 39. In silico analysis of translated VirB8 nucleotide sequences. 
 
The region reported from A. tumefaciens (Kumar and Das, 2001) is conserved as YVKAREGYY (boxed) in B6, (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2: 11452-12156; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01000545: 1-634; Moolhuijzen et 
al. 2009), IMD523 (GenBank Accession FN594949.1: 8642-9346) and 635; and as YVKNRELIN (boxed) in 830. The five amino acids essential to 
VirB8 function in A. tumefaciens (Kumar and Das, 2001) were conserved as G/S80, N89, Y/S102, K109 and A/K198 (boxed) in all C. fetus VirB8 sequences 
analysed here. The motif “RxxNPxGxxV” previously found in A. tumefaciens (Bailey et al., 2006) was also found in four C. fetus VirB8 sequences. 
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Figure 40. In Silico analysis of translated VirB9 nucleotide sequences. 
 
The consensus reported from A. tumefaciens and 70 other bacterial strains (supplemental material to Christie et al. 2005, 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html; Jakubowski et al., 2005) is not identical to the consensus observed from B6, 642-21 
(Barrero et al., 2013), ATCC19438 (GenBank Accession EU443150.2: 12988-13929; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession 
NZ_ACL01001165: 743-1684; Moolhuijzen et al. 2009), IMD523 (GenBank Accession FN594949.1: 10180-11121) 635, 924 and 957 VirB9 
sequences. Red squares show invariant residues while blue ones indicate residues found in the majority of the 70 strains previously examined. 
Highlighted residues point out amino acids common to all C. fetus sequences analysed here. 
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Figure 41. In Silico analysis of the VirB10 gene sequences.  
 
The amino acid consensus reported from A. tumefaciens (Banta et al., 2011) is conserved in B6, (Barrero et al., 2013), ATCC19438 (GenBank 
Accession EU443150.2: 13922-15088; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01001165: 1677-2843; Moolhuijzen et al. 
2009), IMD523 (GenBank Accession FN594949.1: 11114-12280) and 635 (A- partial alignment) VirB10 sequences. This VirB10 consensus was not 
conserved in isolate 830 while this strain shared only 50% identity with the VirB10 nucleotide sequences of other C. fetus strains examined here (B- 
partial alignment, identities: 661/1300=50%; gaps: 218/1300=6%). 
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Figure 42. In Silico analysis of the VirB11 gene sequences.  
 
Despite multiple nucleotide differences (highlighted, partial alignment) observed from isolates B6, 642-21 (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2: 15085-16080; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01001023: 2072-3070; 
Moolhuijzen et al. 2009), IMD523 (GenBank Accession FN594949.1: 12277-13272), 635, 924 and 957 VirB11 sequences, the amino acid consensus 
reported from A. tumefaciens (Stephens et al., 1995) is conserved in all C. fetus strains examined here (boxed). 
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Figure 43. In Silico analysis of the VirD4 gene sequences. 
Despite multiple nucleotide differences (highlighted, partial alignment) were observed from isolates B6, 642-21 (Barrero et al., 2013), ATCC19438 
(GenBank Accession EU443150.2: 16080-18287; Gorkiewicz et al. 2010), AZUL-94 (GenBank Accession NZ_ACL01001165: 3837-5348; 
Moolhuijzen et al. 2009), IMD523 (GenBank Accession FN594949.1: 13272-15479), 635, 830, 924 and 957 VirD4 sequences, the amino acid motif 
reported from A. tumefaciens (Kumar and Das, 2002) is conserved in all C. fetus sequences examined here (boxed). 
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4. Discussion 
Previous research suggested that the high prevalence of C. fetus subsp. venerealis in healthy cattle 
herds, based on parA real time PCR screening, could be due to the presence of avirulent strains 
(McMillen et al., 2006; Moolhuijzen et al., 2009). Subsequent screening of putative virulence 
factors based on the partial genome sequence of C. fetus subsp. venerealis strain AZUL-94 
confirmed variability in the distribution of putative virulence genes in other evaluated strains (Guo, 
2007; Moolhuijzen et al., 2009). The aim of this chapter was to extend this screening using newly 
available draft genome sequence data from C. fetus subsp. venerealis reference strains B6 and 642-
21 (Barrero et al., 2013) and to compare virulence and PAI gene distribution with results obtained 
from the pregnant guinea pig model using the characterised strains. 
Factors determining bacterial pathogenesis often involve horizontal transfer of virulence genes by 
insertion elements, phages, plasmids and transposons; resulting in many virulence genes being 
collocated on PAIs within bacterial genomes (Gal-Mor and Finlay, 2006; Schmidt and Hensel, 
2004). In order to interact with infected cells, these factors often need to be exposed on the bacterial 
cell surface or secreted directly into infected host cells (Schmidt and Hensel, 2004). T4Ss can 
transfer proteins into infected host cells and are also involved in DNA transfer (Christie et al., 2005; 
Schmidt and Hensel, 2004). T4Ss usually contain 12 subunits (VirB1-11 and VirD4), among which 
VirB7, VirB9 and VirB10 compose the core T4S VirB/D4 complex, acting as a channel for DNA 
uptake; while VirB4, VirB11 and VirD4 are ATPases enhancing secretion of macromolecules and 
contact needed for T4S biogenesis (Atmakuri et al., 2004; Banta et al., 2011; Christie et al., 2005). 
Several pathogens such as Agrobacterium tumefaciens, Bartonella spp., Bordetella pertussis, 
Brucella spp., H. pylori, and Legionella pneumophila harbour T4Ss on their PAIs which has been 
reviewed by Schmidt and Hensel (2004).  
T4S genes were found to be conserved among large Campylobacter plasmids, as well as in C. coli, 
C. jejuni, C. lari, C. upsaliensis and both C. fetus subspecies genomes (Abril et al., 2010; Fouts et 
al., 2005; Gorkiewicz et al., 2010; Moolhuijzen et al., 2009). The C. fetus subsp. venerealis PAI, 
which contains a T4S, was identified in ATCC19438 and its presence in C. fetus subsp. venerealis 
isolates was assessed by screening for seven genes spread over the island (Gorkiewicz et al., 2010). 
All PAI genes were found in 76% of the C. fetus subsp. venerealis isolates tested while 14.9% of 
the strains examined were positive for at least one of the PAI gene targets, with only six isolates 
negative for all genes analysed (Gorkiewicz et al., 2010). As PAIs are hypothesised to be absent in 
non-pathogenic bacterial strains (Gal-Mor and Finlay, 2006; Schmidt and Hensel, 2004), the present 
study was undertaken to assist the selection of C. fetus subsp. venerealis isolates for testing in the 
pregnant guinea pig model. The Campylobacter-like culture collection as well as the Australian and 
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UK C. fetus field cultures were first evaluated using the six published PAI gene conventional PCR 
assays (Gorkiewicz et al., 2010). Out of a total of 103 field isolates, only one was positive for all six 
PAI gene targets here tested (1%) while 11 isolates were positive on one to five PCR assays 
(10.7%). Results obtained in this study differ considerably from those obtained by Gorkiewicz et al. 
(2010), suggesting that most of the field isolates tested do not possess this PAI, implying that they 
may not be pathogenic. The fact that the majority of these isolates were obtained from abattoir 
samples rather than from herds showing evidence of clinical signs for BGC may have affected the 
low PAI gene prevalence observed here. 
Some of the T4S genes previously identified in the partial genome sequence of C. fetus subsp. 
venerealis AZUL-94 (Moolhuijzen et al., 2009) were homologous to those found on the PAI of 
ATCC19438, and were therefore also investigated in the Campylobacter-like culture collection and 
in the Australian and UK C. fetus field cultures. Surprisingly, a much higher proportion of field 
isolates were positive on these assays (33.3%) with 35 out of 105 isolates here tested amplifying 
positive on at least one T4S gene target. Different gDNA extracts were positive on the conventional 
PCR assays targeting VirB11 and VirD4 depending on whether PAI (Gorkiewicz et al., 2010) or 
T4S (Moolhuijzen et al., 2009) gene primers were used, with only four field isolates positive on 
both VirD4 PCR assays. Alignment of VirD4 gene targets indicated that the consensus sequences 
are almost identical but that the PAI gene target is much longer; suggesting that the full VirD4 gene 
sequence reported by Gorkiewicz et al. (2010) is not found in all C. fetus subsp. venerealis strains. 
In silico analysis of complete VirD4 gene sequences confirmed that ATCC19438 and AZUL-94 
shared only 67% identity. Multiple nucleotide differences between VirB11 PCR targets also 
confirmed that the reported PAI VirB11 sequence is not identical in all C. fetus subsp. venerealis 
isolates while indicating that the VirB11 T4S gene target reported by Moolhuijzen et al. (2009) is 
more prevalent than the PAI gene target in the field isolates tested here. In silico analysis of 
complete VirB11 gene sequences also confirmed that ATCC19438 and AZUL-94 shared only 61% 
identity.  
Sequencing of C. fetus subsp. venerealis bv. venerealis B6 and bv. intermedius 642-21 genomes 
revealed that B6’s PAI is highly similar to that identified from C. fetus subsp. venerealis bv. 
venerealis ATCC19438, while 642-21’s PAI was highly divergent (Barrero et al., 2013). The PAI 
of B6 contains an insertion of 21kb encoding 19 genes including VirB4, VirB8-11 and VirD4 T4S 
genes which displayed significant nucleotide differences (Barrero et al., 2013). The PAI of 642-21 
includes a 8.6 kb region conserved in the PAI of ATCC19438 whereas in its 5’end region, weak 
homology to ATCC19438’s PAI was observed, displaying different gene arrangements and 
encoding distinct genes (Barrero et al., 2013). These findings emphasise that C. fetus subsp. 
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venerealis PAI differs between strains and highlights the need for supplementary C. fetus subsp. 
venerealis PAI and virulence gene targets to further evaluate the virulence status of the 
Campylobacter-like culture collection. 
Comparative analysis of available C. fetus genomes revealed 26 regions unique for C. fetus subsp. 
venerealis (Barrero et al., 2013) which led to the design of 15 new conventional PCR assays from 
draft contigs annotated to putative known virulence factors or PAI genes (October 2010). New PCR 
assays targeted putative PAI genes (n=4), genes of phage origin (n=3) and one putative virulence 
gene (n=1) common to both B6 and 642-21 C. fetus subsp. venerealis genomes. Other PCR assays 
were designed from draft contigs unique to the B6 genome, amplifying putative virulence gene 
(n=1), genes of plasmid origin (n=2) and a T4S gene (n=1). Three other assays were designed from 
draft contigs unique to 642-21 genome amplifying putative virulence genes (n=2) and a T4S gene 
(n=1). Despite the fact that none of the other Campylobacter reference strains were positive on 
these new putative virulence and PAI gene conventional PCR assays, positive results were obtained 
from Campylobacter-like field isolates biochemically confirmed as C. fetus subsp. venerealis, 
C. fetus subsp. fetus, thermophilic Campylobacter spp. and Arcobacter-like aerotolerant organisms. 
The five C. fetus subsp. fetus Australian and UK field isolates were positive on three to nine of 
these 15 new assays, indicating that putative PAI and virulence gene targets evaluated here are also 
shared between C. fetus subspecies field strains from other countries. 
PAIs identified from C. fetus subsp. venerealis ATCC19438 and C. fetus subsp. fetus IMD523 were 
83% identical (GenBank Accessions EU443150.2 and FN594949.1) further confirming high 
homology between some virulence, T4S and PAI genes found in both C. fetus subspecies (Abril et 
al., 2010; Barrero et al., 2013; Gorkiewicz et al., 2010; Moolhuijzen et al., 2009). Previously, core 
genes were reported to encode a bacterial species’ essential functions while dispensable genes 
enhance a bacterial species’ diversity, encoding accessory features such as antibiotic resistance or 
those facilitating colonisation and/or survival (Medini et al., 2005; Tettelin et al., 2005). 
Dispensable genes are often grouped in genomic islands which contain mobile elements such as 
phages, plasmids and transposons; and hypothetical proteins (Medini et al., 2005; Tettelin et al., 
2005). Thus, the fact that some virulence, T4S and PAI genes were found in isolates other than 
C. fetus subsp. venerealis seems in agreement with the hypothesis that these gene targets are part of 
the C. fetus dispensable genome which may potentially enhance the virulence of positive strains 
representing other species than C. fetus subsp. venerealis. A recent pan-genomic study analysed 96 
C. coli and C. jejuni genomes and estimated that they shared 754 dispensable genes while 
respectively 310 and 366 were dispensable genes unique to each species (Lefébure et al., 2010). 
Further analysis of complete C. fetus genomes is needed to confirm if the new putative virulence 
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and PAI gene targets are in fact part of the C. fetus subsp. venerealis dispensable genome but absent 
from the dispensable genomes of C. fetus subsp. fetus and other Campylobacter spp.. However, to 
date, only four C. fetus genomes (Barrero et al., 2013; Fouts et al., 2005; Stynen et al., 2011) have 
been fully sequenced and this study shows that it seems to be insufficient to identify unique C. fetus 
subsp. venerealis virulence and PAI genes. 
Nevertheless, all virulence and PAI PCR assays used in this study generated putative virulence and 
PAI gene molecular profiles for the 105 diverse Campylobacter-like culture collection and 
Australian and UK C. fetus field cultures studied here. This isolate-specific data was used to 
recommend C. fetus subsp. venerealis candidates for guinea pigs infection trials (parallel PhD 
project). Only two C. fetus subsp. venerealis bv. venerealis isolates (635 and 98-109383) matched 
exactly the virulence and PAI gene profile of the reference strain B6 while six C. fetus subsp. 
venerealis bv. intermedius isolates (217, 229, 540, 923, 76223 and K8) had a profile identical to 
that obtained from the reference strain 642-21. Other factors including antibiotic resistance and 
biochemical profiles were taken in account when selecting candidates for animal experiments and 
five C. fetus subsp. venerealis isolates (EQC0017, 540, 635, 924, 76223 and B6) were tested on a 
pregnant guinea pig model by Ameera Koya (parallel PhD project). Despite variation in 
pathogenicity (number of aborting animals and time required to induce abortion post challenge) 
there was no obvious association with virulence and PAI molecular profiles. A different percentage 
of aborting animals and average time required to induce abortion were observed from isolates 
exhibiting identical profiles while different abortion rates were induced by isolates being positive 
on only a few additional putative virulence and PAI gene PCR assays. In a previous study, virulence 
gene profiles could not be linked to C. jejuni’s virulence in vivo as all strains tested were able to 
colonise challenged chicken regardless of their positivity for the different virulence genes evaluated 
(Biswas et al., 2011).  
Most of the functions and interactions between the virulence and PAI genes targeted by assays used 
here are currently unknown and it is likely that other factors also play an active role in the 
pathogenesis of C. fetus subsp. venerealis. Some of the published and new putative PAI and gene 
targets have been proven to be actively involved and required in the pathogenesis of C. fetus subsp. 
venerealis (Gorkiewicz et al., 2010; Sprenger et al., 2011; Tu et al., 2005). Significantly a higher 
proportion of HeLa cells infected with wild ATCC19438 strain were killed compared to cells 
infected with a VirB9-mutant while more Caco-2 cells were invaded by the wild V81 strain than by 
a VirD4 mutant (Gorkiewicz et al., 2010). The fic (filamentation induced by cAMP) gene fic1 was 
found to have a cytolethal effect on HeLa cells while fic2 had a lethal effect on bacterial cells 
(Sprenger et al., 2011). Inactivation of an invasin gene found in C. fetus subsp. venerealis 84-112 
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resulted in decreased Caco-2 cell invasion by the mutant strain (Sprenger et al., 2011). One could 
note that C. fetus subsp. venerealis isolates tested in pregnant guinea pigs were positive on new 
virulence and PAI gene PCR assays putatively annotated to fic genes (ab51_contig130_1, 
ab51_contig130_2, ab51_contig76), adhesin/invasin (ab51_contig207_1) and VirD4 
(ab51_contig207_3) among other gene targets. Interactions between these genes and other virulence 
and PAI genes have not yet been explored in C. fetus subsp. venerealis, thus despite the fact that 
some of these genes have been proven to affect colonisation in vitro, it is not known if other 
virulence genes are co-required to achieve similar pathogenic symptoms in animals.  
Lack of amplification in published or new virulence and PAI gene conventional PCR assays may be 
due to nucleotide variation of the targeted sequence while detection of some of these genes does not 
ensure their functionality. Sequencing of putative adhesin/invasin PCR products obtained from four 
random field isolates demonstrated multiple nucleotide differences resulting in amino acid changes 
differing from the original translated gene target. Similarly, in silico analysis of seven T4S gene 
sequences (VirB3/B4, VirB7-VirB11 and VirD4) from the C. fetus subsp. venerealis reference 
strains B6 and 642-21 (Barrero et al., 2013), ATCC19438 (Gorkiewicz et al., 2010), AZUL-94 
(Moolhuijzen et al., 2009) and field isolates 635, 830, 924 and 957 (personal communication, May 
2012, Gabriel Keeble-Gagnère, CCG) compared to C. fetus subsp fetus IMD523 (Abril et al., 2010) 
indicated multiple nucleotide and amino acid differences. Even though, T4S amino acid motifs and 
consensus sequences required to ensure gene functionality and strain virulence in Agrobacterium 
tumefaciens (Bailey et al., 2006; Banta et al., 2011; Bayliss et al., 2007; Christie et al., 2005; 
Jakubowski et al., 2005; Kumar and Das, 2001, 2002; Rabel et al., 2003; Stephens et al., 1995) were 
conserved in six out of the seven available T4S genes of all the C. fetus strains analysed (C. fetus 
VirB7 sequences being different than A. tumefaciens VirB7 reported sequences). Nucleotide and 
amino acid sequence differences here observed may affect the identity of encoded proteins and it is 
yet to be investigated whether or not resulting products still function in a similar fashion and how 
they may affect C. fetus virulence in vivo.  
The cag PAI identified from H. pylori has been reported to have varied gene content depending on 
the geographic origin of the strains while the CagA, CagC and CagY genes exhibited extensive 
sequence variation (Suerbaum and Josenhans, 2007). CagC and CagY are respectively orthologous 
to VirB2 and VirB10, sustaining that sequence variation within T4S genes is common and has been 
associated with host adaptation and altered virulence in H. pylori (Sozzi et al., 2005; Suerbaum and 
Josenhans, 2007). Nucleotide sequence variations and gene losses or gains during H. pylori chronic 
infection have been reported, inducing different clinical symptoms (Sozzi et al., 2005; Suerbaum 
and Josenhans, 2007). H. pylori’s genetic plasticity has been proposed to help adaptation within 
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hosts by modifying surface proteins such as adhesins and outer membrane proteins encoded by the 
phase-variable babA and sabA genes (Suerbaum and Josenhans, 2007). Similar properties have been 
identified from the SLPs of some human C. fetus isolates which exhibit recombination between sap 
loci resulting in antigenic variability, enhancing relapsing infections and actively contributing to 
C. fetus pathogenesis (Tu et al., 2005). In this study, only one surface layer gene was screened for 
(cfvv_19.2623-3742.537-1071) but potential nucleotide sequence variation was not explored; sap 
and flagellar genes were previously found to affect invasive ability of enteric Campylobacter spp. 
(Ketley, 1997) and may also influence virulence of C. fetus subsp. venerealis strains in vivo. 
Hybridisation-based investigations such as DNA-DNA hybridisation and subtractive hybridisation 
studies could have assisted identifying genomic similarities and differences between the strains here 
studied. Such techniques could have assisted selection of isolates to be tested on animals by 
possibly detecting the presence of some virulence and PAI genes not amplified by the PCR assays 
here tested due to sequence variation in priming sites. DNA-DNA hybridisation was previously 
used to confirm the identity of atypical C. fetus subsp. fetus strains and the similarities between 
C. fetus subsp. fetus and C. fetus subsp. venerealis strains from different origins while subtractive 
hybridisation assisted in identifying the PAI of C. fetus subsp. venerealis ATCC19438 (Edmonds et 
al, 1985; Gorkiewicz et al, 2010; Tu et al., 2005). Genes specific to the invasive strains C. jejuni 
ATCC43431 and 81-176 were also explored by whole genome comparison using shotgun DNA 
microarrays which allowed the discovery of several unique regions including PAI and T4S genes 
that were absent from the less invasive C. jejuni NCTC11168 and may directly explained the 
increased virulence of such strains (Poly et al, 2004; 2005).  
 
5. Conclusion and future directions 
The 15 new putative virulence and pathogenicity island (PAI) gene conventional PCR assays 
designed from draft contigs absent from the C. fetus subsp. fetus genome but common to both or 
either C. fetus subsp. venerealis genomes (Barrero et al., 2013; Fouts et al., 2005) assisted the 
evaluation of the virulence status of the Campylobacter-like culture collection. Despite the fact that 
assay specificity was verified using C. fetus and other Campylobacter reference strains, screening 
against the Campylobacter-like culture collection and Australian and UK C. fetus field cultures 
found isolates other than C. fetus subsp. venerealis phenotypes that were positive. 
Whilst the published and new virulence and PAI gene PCR assays assisted selecting C. fetus subsp. 
venerealis isolates for in vivo experiments (parallel PhD project), virulence and PAI profiles 
obtained did not correlate with abortion rates observed in the pregnant guinea pig model. The roles 
of the different genes targeted need to be further investigated in order to confirm their involvement 
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in the pathogenesis of C. fetus subsp. venerealis. Recommendations for in vitro cell assays have 
been detailed and applied to investigate C. fetus subsp. venerealis invasive abilities; similar 
approaches should be undertaken to evaluate other virulence and PAI genes (Friis et al., 2005; 
Gorkiewicz et al., 2010; Sprenger et al., 2011). 
Nucleotide, amino acid and protein sequence variations have been reported to influence bacterial 
pathogenesis in H. pylori and C. fetus in vivo while evidence that frameshift mutations of virulence 
factors can occur in Chlamydia trachomatis affecting bacterial virulence in vivo (Suerbaum and 
Josenhans, 2007; Sturdevant et al., 2010; Tu et al., 2005). We identified that some of the virulence 
and PAI genes targeted in this study exhibited nucleotide and amino acid sequence variation but 
implications in vivo are unknown. Virulence and PAI gene composition pre and post animal testing 
could be investigated for potential sequence variation which may further explain differences of 
strain virulence observed from the pregnant guinea pig model.  
DNA-DNA hybridisation, subtractive hybridisation and whole genome microarray analysis are 
time-consuming and/or expensive methods while they are not as informative, complete or 
qualitative as full genome sequencing which is now affordable and also needed to identify species 
and subspecies-specific regions within the C. fetus core genome. Therefore, in order to further gain 
knowledge about C. fetus subsp. venerealis virulence and PAI genes and other virulence factors 
(part of the C. fetus dispensable genome) and to better understand C. fetus virulence mechanisms, 
this project recommends additional genome sequencing of C. fetus and Campylobacter-like isolates, 
followed by a pan-genomic study. 
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CHAPTER 8: GENERAL DISCUSSION 
 
1. Introduction 
BGC, caused by C. fetus subsp. venerealis, is listed as a notifiable cattle disease by the World 
Organisation for Animal Health (OIE, 2012a). Accurate BGC diagnosis is thus crucial to beef 
exporting countries which are required to provide a “certification of disease free status”(OIE, 
2012b). BGC diagnosis first required isolation of a pure C. fetus subsp. venerealis culture (OIE, 
2012a) which is compounded by the level of contamination and transport time of clinical samples 
and the fastidious nature of the bacterium (Clark, 1971; Clark and Dufty, 1978; Hum et al., 1994a; 
Lander, 1990a). Final identification relies upon biochemical testing which differentiates C. fetus 
subsp. venerealis from the closely related subspecies C. fetus subsp. fetus based on a single test 
considered the gold-standard, growth in 1% glycine (OIE, 2012a; Véron and Châtelain, 1973). 
Existence of atypical strains complicates subspecies discrimination which highlighted the need for 
more specific methods (On and Harrington, 2001; Salama et al., 1992). 
Molecular techniques such as AFLP, MLST, PCR assays and PFGE can identify accurately both 
C. fetus subspecies but necessitate pure culture isolation and adequate equipment (Abril et al., 2007; 
Hum et al., 1997; On and Harrington, 2001; van Bergen et al., 2005b, 2005c; Wang et al., 2002). 
Discrepancies between biochemical and molecular phenotyping emphasised the need for additional 
C. fetus subsp. venerealis-specific gene targets (Vargas et al., 2003; Wagenaar et al., 2001; 
Willoughby et al., 2005). A sensitive real-time PCR assay improved the detection of C. fetus subsp. 
venerealis from crude samples and revealed a much higher prevalence than isolation by culture, 
including from cattle herds with no sign of BGC (McMillen et al., 2006). Absence of evidence of 
disease suggested variation in strain virulence which was supported by the detection of different 
putative virulence genes from the C. fetus subsp. venerealis strains tested (Guo, 2007; Moolhuijzen 
et al., 2009).  
These findings underlined the need to develop new assays for C. fetus subspecies differentiation and 
to study the biology of virulence in C. fetus subsp. venerealis strains in animals (McMillen et al., 
2006; Moolhuijzen et al., 2009). Thus, the present research aims to develop and assess a new 
panel of molecular assays, using comparative genomics and virulence studies, suitable for the 
sensitive diagnosis of bovine genital campylobacteriosis. 
A wider number of isolates to assess efficacy of newly proposed assays was needed, as well as an 
evaluation of virulence and PAI genes and potential implications on isolate pathogenicity, which 
were assessed in animal models. New assays targeting putative C. fetus subsp. venerealis-specific 
 197 
 
genes and other assays specific for C. fetus subsp. venerealis putative virulence and/or PAI genes 
were used to screen field and reference isolates. Infection models using isolates shown to be 
epidemiologically associated with reduced reproductive performance and/or positive for virulence 
and/or PAI genes assisted in determining specificity and ability of the assays to predict disease risk 
and C. fetus subsp. venerealis virulence in vivo.  
 
2. Objective 1: Establishment of a culture collection 
In Australia, samples submitted for BGC culture diagnosis are often transported for up to 72h, 
resulting in low C. fetus subsp. venerealis isolation rate due to overgrowth by contaminants such as 
fungi and Pseudomonas spp. (personal observation from samples accessed through the Biosecurity 
Queensland bacteriological laboratory, DAFF). To establish a culture collection, this study had 
access to such samples while bull genital tracts were also sourced from our local abattoir. In order 
to select optimum microbiological techniques for the isolation of C. fetus subsp. venerealis, an 
evaluation of different selective growth media (modified Skirrow, Karmali and Campylobacter 
selective agar plates) and TEMs (PBS as a TEM, Clark’s and modified Lander’s TEMs) was 
performed under different transport and incubation conditions, using a pure C. fetus subsp. 
venerealis culture, with and without simulated field contamination by Pseudomonas aeruginosa.  
Previously, the modified Skirrow agar was found inferior to Campylobacter selective agar plates 
while another study preferred Skirrow’s agar over other tested media (Hum et al., 1994a; Monke et 
al., 2002). The different types of culture media here tested (Skirrow, Karmali and Campylobacter 
selective agar plates) could all grow C. fetus subsp. venerealis colonies but Campylobacter selective 
agar plates (Oxoid) maximised recovery under all tested conditions, including simulated 
contamination with P. aeruginosa.  
Despite that early studies found Clark’s TEM enhanced C. fetus subsp. venerealis isolation, latest 
studies favoured Lander’s TEM (Clark and Dufty, 1978; Clark et al., 1974; de Lisle et al., 1982; 
Hum et al., 1994a; Jones et al., 1985; Lander, 1990a, 1990b; Monke et al., 2002). In this project, all 
tested TEMs (Clark’s and modified Lander’s TEMs, PBS as a TEM) permitted isolation of C. fetus 
subsp. venerealis but when prolonged transport time (more than 24h up to 72h) and contamination 
with P. aeruginosa were simulated, recovery was better achieved using Clark’s TEM. When 
simulated transport time was reduced (less than 24h) and only pure C. fetus subsp. venerealis 
culture was tested, C. fetus subsp. venerealis recovery was maximised from the modified Lander’s 
TEM. These results suggest that for diagnostic samples, often contaminated with P. aeruginosa, 
that usually require several days to reach a laboratory in Australia, Clark’s TEM can improve 
C. fetus subsp. venerealis isolation over the modified Lander’s TEM, while the presence of other 
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contaminants may affect differently the efficiency of these TEMs. However, if TEMs can be 
cultured within 24h of inoculation, both Clark’s and modified Lander’s TEMs would allow 
successful C. fetus subsp. venerealis isolation, even in presence of P. aeruginosa. 
Therefore, for optimal C. fetus subsp. venerealis isolation and growth, this study recommends that 
TEMs (either Clark’s or modified Lander’s TEMs) should be brought back to the laboratory within 
48h and plated out within 4h if possible, or at least within 24h, onto Campylobacter selective agar 
plates (Oxoid) incubated for 48-72h at 37°C under microaerophilic conditions. TEM incubation was 
found unnecessary for diagnostic samples due to prolonged transport time experienced in Northern 
Australia but could still be applied to samples brought to the laboratory within 4h in order to 
maximise C. fetus subsp. venerealis cell numbers prior to plating. PBS as a TEM is not 
recommended for such diagnostic samples but could be used to isolate C. fetus subsp. venerealis, 
when transport time is minimal (less than 4h). These findings assisted to maximise C. fetus subsp. 
venerealis isolation from bull preputial secretions from abattoir samples.  
As the parA real-time PCR assay was previously found to be more sensitive than culture (McMillen 
et al., 2006), in order to detect putative C. fetus subsp. venerealis infection from abattoir samples, 
this test was used to screen bull preputial secretions. To increase chances of isolation, four 
inoculation procedures (direct plate inoculation from tricamper sampling device, plate inoculation 
from PBS, from Clark’s and modified Lander’s TEMs) were applied to samples screened as real-
time positives. The parA real-time PCR found 174 positives out of 717 tested samples from which 
44 Campylobacter-like organisms were isolated (24.3%); a higher proportion of positives were 
detected than culture, raising concern about its specificity (86.3%) and sensitivity (40.1%). We 
showed that parA positive samples yielding late Ct scores could be the result of primer dimer 
interaction while a random selection of 94 parA negative and 40 questionable status samples 
yielded nine additional isolates, indicating false-negative reactions. C. fetus subsp. venerealis 
strains lacking the parA target have previously been described while an alternative parA sequence, 
recently reported from six clinical samples, may have also been missed by this assay (Chaban et al., 
2012; Willoughby et al., 2005). These findings confirmed the need for additional diagnostic targets. 
Due to the consistent detection of the ISCfe1 insertion element in all C. fetus subsp. venerealis 
strains previously tested by Abril et al. (2007), this study designed a new real-time PCR assay based 
on this element. This assay targets a partial transposase region which appeared specific for C. fetus 
subsp. venerealis during the initial analysis. Sensitivity studies with spiked C. fetus subsp. 
venerealis reference cultures indicated that it was more sensitive than the parA real-time assay. 
Both tests were used concurrently to evaluate 266 additional bull preputial samples, detecting 
 199 
 
similar rates of positives, and a further 31 isolates were obtained. Even though no isolation was 
achieved from samples negative on both tests, ISCfe1 positive/parA negative (6/51; 11.8%) and 
ISCfe1 negative/parA positive (8/44; 18.2%) samples did yield some C. fetus. subsp. venerealis 
isolates by culture. In contrast to the assay sensitivity screening using spiked cultures, the ISCfe1 
real-time assay was found to be less specific (74.2%) and sensitive (52%) than the parA real-time 
assay (80.6% and 56.4%) compared to isolation by culture from bull preputial samples. 
Whilst real-time testing of preputial samples assisted isolation of C. fetus. subsp. venerealis, these 
findings show that the parA and ISCfe1 real-time assays should not be used alone to assess bulls 
positive for C. fetus subsp. venerealis, culture must always be performed simultaneously as 
recommended (OIE, 2012a). Multiple inoculation procedures used in this study allowed isolation of 
84 Campylobacter-like cultures from abattoir samples but such approach is not applicable to routine 
diagnostic as it costly and time-consuming. Sample filtration has been suggested but although use 
of filters decreased contaminants, it also reduced the number of C. fetus subsp. venerealis 
organisms so that only samples containing high numbers could lead to the isolation of a pure culture 
(Lander, 1990b). It was previously determined that about 10
3
 organisms/ml are required to ensure 
C. fetus subsp. venerealis recovery from TEM (Lander, 1990b) while real-time testing with spiked 
C. fetus subsp. venerealis cultures here estimated that a Ct score of approximately 29 and 27 on 
respectively parA and ISCfe1 real-time assays corresponded to 1.66 x 10
3
 cells/ml (Chapter 3). 
Further evaluation of potential BGC samples yielding such Ct scores could be filtered prior to plate 
inoculation to further maximise chances of isolation of pure C. fetus subsp. venerealis cultures. 
Fungi and Pseudomonas spp. were also regularly overgrowing plates inoculated from abattoir 
samples in this study, as previously reported by Monke et al. (2002). A TEM called TTE, 
containing the fungicide amphotericin B in addition to the same antibiotics found in media used 
here, allowed C. fetus subsp. venerealis isolation even after prolonged transport and should be 
further investigated (Harwood et al., 2009). An obvious advantage of TTE is its ability to be 
directly used for PCR testing, however spiked studies with common contaminants indicated that 
P. aeruginosa and P. mirabilis overgrew C. fetus subsp. venerealis 24h after TTE inoculation 
(Harwood et al., 2009). Antimicrobial susceptibility testing of 50 German C. fetus subsp. venerealis 
isolates revealed more common resistance to lincomycin and spectinomycin than other evaluated 
antibiotics but to this date, no other extensive antimicrobial resistance profiling of C. fetus subsp. 
venerealis field isolates has been performed (Hänel et al., 2011). Antimicrobial susceptibility 
testing of the Australian Campylobacter-like culture collection may allow the identification of 
antibiotics to which C. fetus subsp. venerealis is resistant which could be included in currently 
available culture media and TEMs, even if it is likely that common contaminants found in bull 
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preputial samples may also be resistant to such antibiotics. Therefore, antimicrobial susceptibility 
testing of P. aeruginosa field isolates as well as other fast-growing contaminants commonly found 
in bovine secretions should also be tested in order to further improve culture media for BGC testing. 
C. fetus subsp. venerealis isolates and fast-growing contaminants from diverse geographical regions 
should be evaluated in order to have a better representation of the field diversity. 
Although the presence of contaminants may have affected isolation rates, this study established a 
collection of 84 Australian Campylobacter-like isolates from bull preputial samples. Full 
biochemical testing of 51 cultures confirmed 29 C. fetus subsp. venerealis phenotypes (17 bv. 
venerealis; 12 bv. intermedius) but also found some isolates able to grow in the presence of 1% 
glycine, under aerobic conditions or at 42°C; indicating four C. fetus subsp. fetus, seven 
thermophilic Campylobacter spp. and 11 aerotolerant Arcobacter-like organisms (OIE, 2012a). The 
remaining cultures were identified as putative C. fetus subsp. venerealis (n=30) or C. fetus subsp. 
fetus (n=2) phenotypes based solely on glycine tolerance and H2S detection tests. Due to the lack of 
differential properties between C. fetus subspecies and the existence of atypical and mutant strains, 
the need to characterise C. fetus subspecies with more than one biochemical test to limit 
misidentification has previously been emphasised (Chang and Ogg, 1971; Hum et al., 1997; Jones 
et al., 1985; On, 1996; On and Harrington, On and Holmes, 1991b; 2001; Salama et al., 1992; 
Schulze et al., 2006; Vargas et al., 2003; Véron and Châtelain, 1973). This large and diverse 
collection of Australian field cultures will allow further investigation of C. fetus subsp. venerealis 
biochemical properties, including phenotypic microarrays, which could assist identifying additional 
subspecies-specific tests (parallel PhD project; Bochner et al., 2001).  
As phenotyping of suspected C. fetus subsp. venerealis cultures still relies on a few biochemical 
tests, international guidelines also advise the use of molecular techniques to assist confirming 
isolate identity (OIE, 2012a). Two conventional PCR assays (Abril et al., 2007; Hum et al., 1997), 
in conjunction with sequencing of late cycle real-time positive products, were thus applied to screen 
the Campylobacter-like culture collection. Evaluation of gDNA extracts from obtained cultures 
(n=84) found parA (52/84 positives) and ISCfe1 (76/84 positives) gene targets (Abril et al., 2007; 
Hum et al., 1997) in isolates biochemically phenotyped as C. fetus subsp. fetus, thermophilic 
Campylobacter spp. and Arcobacter-like, while they were not present in all confirmed C. fetus 
subsp. venerealis isolates. In fact, the ISCfe1 real-time target was highly similar to newly available 
transposase sequences, with the complete ISCfe1 insertion element (GenBank Accession 
AM260752) sharing 71 to 78% identity with sequences reported from C. coli 6067, C. jejuni subsp. 
jejuni IA3902, C. jejuni plasmid CJG9 and H. pylori F16 (GenBank Accessions JQ613155, 
CP001876, AJ490186 and AP011940) and up to 75% identity with 114 H. pylori putative 
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transposase sequences located onto IS607 insertion elements. IS607 could previously transpose to 
E. coli and as insertion elements are mobile DNA regions acquirable by horizontal transfer, these 
findings sustain the idea that ISCfe1 may be able to spread between C. fetus subspecies, closely 
related Campylobacter spp. and Campylobacter-like organisms by transposition (Abril et al., 2007; 
Kersulyte et al., 2000; Mahillon and Chandler, 1998). Whilst it was suggested that ISCfe1 could be 
useful for C. fetus subspecies differentiation (Abril et al., 2007), this study demonstrates that this 
insertion element will not provide specific C. fetus subsp. venerealis markers.  
Likewise, this project identified that the parA gene, required for plasmid partitioning, was reported 
on a C. fetus subsp. venerealis PAI while a partial parA gene (GenBank Accession FN594949) 
found on a C. fetus subsp. fetus genomic island shares 81% identity with the parA real-time target, 
confirming the presence of parA in both C. fetus subspecies (Abril et al. 2010; Baar et al., 2003; 
Gorkiewicz et al., 2010). The present analysis also found that the parA gene also shared up to 38% 
identity with some available C. fetus subsp. venerealis putative parA sequences (GenBank 
Accessions EGU24836 and ZP06009625). Additionally, it has been recently detected in two 
C. hyointestinalis isolates while the parA homologue cpp12 (GenBank Accession YP063457) was 
identified on C. coli and C. jejuni pCC31 and pTet plasmids respectively (Batchelor et al., 2004; 
Spence et al. 2011). Even if previous attempts to isolate plasmids did not identify the potential 
source of parA in C. fetus subsp. venerealis; exchange of plasmid DNA between C. fetus subspecies 
can occur and as PAIs are known to result from horizontal transfer, these new findings support the 
possible transferability of the parA gene, further highlighting that new species-specific gene targets 
are required (Abril et al., 2010; Baar et al., 2003; Batchelor et al., 2004; Gorkiewicz et al., 2010; 
Kienesberger et al., 2011; Spence et al., 2011). 
  
3. Objective 2: Identification of new putative subspecies-specific gene targets 
Non-C. fetus subsp. venerealis organisms were positive on conventional and real-time PCR assays 
(Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006) used to establish the Campylobacter-
like culture collection, confirming that new gene targets are needed in order to accurately identify 
this bacterium. The draft genomes of two C. fetus subsp. venerealis reference strains (bv. venerealis 
B6 and bv. intermedius 642-21) aligned to the previously available C. fetus subsp. fetus 82-40 
genome revealed 26 unique C. fetus subsp. venerealis regions (Barrero et al., 2013). Thirteen new 
conventional PCR assays from draft contigs common to both C. fetus subsp. venerealis biovars and 
not annotated to putative known virulence factors or PAI genes were designed (October 2010) in 
order to evaluate the culture collection and identify new markers for C. fetus subsp. venerealis.  
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The new putative conventional PCR assays target either membrane proteins (n=3), metabolic 
enzymes (n=5) and hypothetical/predicted proteins (n=5). BLAST searches, screening of C. fetus 
subsp. fetus and other Campylobacter reference strains gDNA extracts as well as in silico analysis 
of additional control strains confirmed assay specificity for C. fetus subsp. venerealis. Different 
field isolates were positive on the 13 new putative conventional PCR assays but a large proportion 
of the culture collection (55/78; 70.5%) was positive on the putative D-mycarose 3-C 
methyltransferase PCR (cfvv_43.1-43748.38016-39466). This metabolic enzyme, required for the 
“biosynthesis of type II polyketide products” is encoded by the mtmC gene, essential to the 
biosynthesis of 2,6-deoxyhexose sugars (Gonzalez et al., 2001; Kanehisa and Goto, 2000). The D-
mycarose 3-C-methyltransferase gene was previously reported from C. fetus subsp. fetus 82-40 
(GenBank Accession ABK82051) and by aligning the complete sequences of both C. fetus D-
mycarose 3-C-methyltransferase genes, an additional real-time assay was designed from a C. fetus 
subsp. venerealis unique region. Quantitative analysis with spiked C. fetus subsp. venerealis 
reference cultures found this new real-time assay as specific but less sensitive than parA or ISCfe1 
real-time tests, probably because the D-mycarose 3-C-methyltransferase gene is single copy in 
C. fetus subsp. venerealis B6 and 6421-21 genomes compared to parA and ISCfe1, present as more 
than one copy.  
Only 40.5% of the culture collection (32/79; 40.5%) was positive on the D-mycarose 3-C-
methyltransferase real-time assay, including a thermophilic Campylobacter spp. and three 
aerotolerant Arcobacter-like organisms while it detected only 41.4% of biochemically confirmed 
C. fetus subsp. venerealis isolates (12/29; 41.4%). These findings pointed out that the new D-
mycarose 3-C-methyltransferase real-time assay produced false-positive/negative results and is thus 
not suitable as a C. fetus subsp. venerealis-specific diagnostic tool. Similarly, C. fetus subsp. 
venerealis isolates was well as some C. fetus subsp. fetus, Campylobacter spp. and Arcobacter-like 
isolates from the culture collection were positive on six new putative conventional PCR assays. The 
seven other new putative gene targets were found only in biochemically confirmed C. fetus subsp. 
venerealis isolates with the exception of two Arcobacter-like organisms which were positive on 
Abril’s and Hum’s PCRs. These findings further deterred the ability to correlate biochemical and 
molecular results (Abril et al., 2007; Hum et al., 1997; McMillen et al., 2006; OIE, 2012a) and 
underlined that specificity of these new primers against additional genomes should be further 
investigated to verify if any of these putative gene targets were in fact unique to C. fetus subsp. 
venerealis.  
The genomes of five of the field strains obtained in this study (isolates 635, 830, 924, 957 and 
76223) have recently been sequenced and are currently being annotated (CCG, May 2012). The 13 
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new putative gene targets have been previously detected in four of these strains (isolates 635, 924, 
957 and 76223), except for a putative hypothetical protein (cfv_28.1-4317.505-1097) which was 
absent from isolate 924. In silico BLAST analysis of all assays also confirmed the conservation of 
the 13 new putative gene targets in the newly sequenced genome of C. fetus subsp. venerealis 
reference strain ATCC19438 (Stynen et al., 2011). Surprisingly, isolate 830 was negative for all 
these assays despite its C. fetus subsp. venerealis biochemical phenotype, preliminary genome data 
also validated the absence of the 13 putative gene targets from this strain (personal communication, 
May 2012, Gabriel Keeble-Gagnère, CCG). Likewise, three other C. fetus subsp. venerealis field 
isolates from the collection were negative in all 13 assays, suggesting that none of the new putative 
conventional PCR assays can detect consistently all C. fetus subsp. venerealis strains. In silico 
BLAST analysis of additional C. fetus strains (personal communication, June 2012, Dr Wagenaar, 
Utrecht University) also confirmed that the 13 new putative gene targets were not found in all 18 
C. fetus subsp. venerealis strains while they were all present in some of the four C. fetus subsp. 
fetus strains examined. Even though comparative analysis included the only three sequenced 
C. fetus genomes available at the commencement of this study, these findings show these regions 
identified as absent from C. fetus subsp. fetus were insufficient to identify C. fetus subsp. 
venerealis-specific gene targets suitable for assay development (Barrero et al., 2013). Given the 
recent publication of the C. fetus subsp. venerealis ATCC19438 genome (Stynen et al., 2011), 
researchers will attempt to design new molecular tests. Real-time assays have recently been 
published (Chaban et al., 2012; Iraola et al., 2012), however this thesis confirms that parA and T4S 
genes will not be specific for C. fetus subsp. venerealis while current genomic data will not yield 
tests specific for C. fetus subspecies. 
Pan-genomic studies compare a large number of genomes to differentiate “core” from “dispensable” 
genes (Medini et al., 2005; Tettelin et al., 2005). Core genes are necessary for bacterial essential 
functions, found in all strains of the same species, while dispensable genes encode facultative 
bacterial properties and can be absent from one or several strains (Medini et al., 2005; Tettelin et 
al., 2005). Evaluation of 17 Campylobacter spp. genomes estimated the genus Campylobacter core 
genome to be composed of 647 genes while another study, comparing 15 Campylobacter spp. 
genomes, reported that it contains 552 gene families (Ali et al., 2012; Lefébure and Stanhope, 
2009). This latest study included only one C. fetus subsp. venerealis and one C. fetus subsp. fetus 
genomes (ATCC19438 and 82-40 respectively) and estimated from these that the C. fetus sp. core 
genome contains 1 628 gene families (Ali et al., 2012; Fouts et al., 2005; Stynen et al., 2011).  
Two C. fetus genomes would be insufficient to determine core genes as for example 13 C. jejuni 
genome sequences were compared to seven other Campylobacter spp. genomes to identify the 
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1 295 core gene families of C. jejuni (Ali et al., 2012; Friis et al., 2010). Comparative analysis of 96 
C. coli and C. jejuni genomes indicated that 76% and 82% of their core genes overlapped while the 
important number of genomes considered revealed that only 82 and 35 core genes were unique to 
C. coli and C. jejuni respectively (Lefébure et al., 2010). Recent investigation of nucleotide and 
amino acid variability of 73 Salmonella enterica core genomes found conserved and highly variable 
core genes (Leekitcharoenphon et al., 2012). Therefore, a pan-genomic study with numerous 
complete C. fetus genomes is needed to further define the species core genome and identify 
conserved core subspecies-specific gene targets. Such analysis should include the new genome data 
from the five Campylobacter-like isolates obtained in this study (isolates 635, 830, 924, 957 and 
76223), the genomes of the recently sequenced C. fetus subsp. venerealis reference strains B6, 642-
21 (Barrero et al., 2013) and ATCC19438 (Stynen et al., 2011) as well as all other previously 
reported genomes from other Campylobacter spp. and closely related organisms.  
This data emphasises that although this research did not identify a new gene target allowing 
irrevocable discrimination between both C. fetus subspecies, known conserved core genes include 
housekeeping genes, targeted in a MLST scheme which is recommended as a co-technique to 
diagnose C. fetus subsp. venerealis (Friis et al., 2010; Laing et al., 2011; Leekitcharoenphon et al., 
2012; Lefébure et al., 2010; OIE, 2012a; van Bergen et al., 2005c). This scheme was used to 
confirm the identity of five of Campylobacter-like field isolates, phenotyped as C. fetus subsp. 
venerealis by biochemical profiling and molecular-based assays (Abril et al., 2007; Hum et al., 
1997; McMillen et al., 2006; OIE, 2012a; van Bergen et al., 2005c). MLST identified these strains 
as ST-4, the most common ST reported in C. fetus subsp. venerealis (van Bergen et al., 2005c). 
These results suggest that the identity of the whole Campylobacter-like culture collection should be 
verified by this method but costs limited the number of strains examined in this study. MLST was 
recently adapted into a high-resolution melting-curve system which was found five times less 
expensive than other typing methods and identified accurately C. jejuni strains tested (Lévesque et 
al., 2011). By comparing the sequences of the seven housekeeping genes of a large number of 
C. fetus and other closely related organisms, conversion of the published MLST scheme (van 
Bergen et al., 2005c) into a high-resolution melting-curve system currently may be the most reliable 
and affordable way to identify of C. fetus subsp. venerealis in diagnostic samples.  
This project also questions the accuracy of biochemical phenotyping (gold standard) which defines 
the identity of C. fetus and Campylobacter-like isolates, considering that original classification was 
based on the evaluation of a limited number of strains (OIE, 2012a; Véron and Châtelain, 1973). 
The field isolates studied in this thesis exhibits atypical biochemical and molecular results but they 
may be more representative of the field diversity of the C. fetus and Campylobacter-like organisms 
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present in the bull prepuce. MLST and cpn60 gene sequencing (Hill et al., 2006; van Bergen et al., 
2005c) could be used to further investigate and confirm the identity of such atypical strains. 
 
4. Objective 3: Characterisation of putative virulence and PAI gene markers 
Bacterial pathogenesis is determined by virulence factors including insertion elements, phages, 
plasmids, transposons and virulence genes, which are often grouped on PAIs (Gal-Mor and Finlay, 
2006; Schmidt and Hensel, 2004). Exposure on the bacterial cell surface or the secretion of these 
virulence factors involves complex mechanisms such as T4Ss (Christie et al., 2005; Schmidt and 
Hensel, 2004). Putative virulence factors including T4S genes, identified from the partial C. fetus 
subsp. venerealis AZUL-94 genome, were detected in some but not all C. fetus subsp. venerealis 
strains tested (Guo, 2007; Moolhuijzen et al., 2009). These findings suggested that the high 
positivity of the parA real-time assay in healthy cattle herds may be explained by the existence of 
avirulent C. fetus subsp. venerealis strains (McMillen et al., 2006; Moolhuijzen et al., 2009). A PAI 
discovered in C. fetus subsp. venerealis ATCC19438, which contains a T4S, was detected in 76% 
of isolates analysed (Gorkiewicz et al., 2010). As PAIs are usually present in pathogenic bacterial 
strains, this study used published conventional T4S and PAI gene PCR assays to evaluate the 
Campylobacter-like culture collection in order to assist to select candidates for animal testing (Gal-
Mor and Finlay, 2006; Gorkiewicz et al., 2010; Moolhuijzen et al., 2009; Schmidt and Hensel, 
2004). Australian and UK C. fetus field cultures (n=21) obtained from bovine abortion cases, from 
preputial samples from bulls from herds with subfertility and from preputial or vaginal mucus 
samples collected from cattle of unknown fertility status were also included. 
Only a small proportion of the field isolates (12/103; 11.7%) was positive on the six new putative 
conventional PCR assays while absence of the PAI was previously reported from just 9% of the 
C. fetus subsp. venerealis strains tested (Gorkiewicz et al., 2010). These results suggested that most 
of the field isolates evaluated here do not possess this PAI (92/103; 88.3%). However, three 
published conventional T4S gene PCR assays (Moolhuijzen et al. 2009), targeting homologous 
genes, found a larger number of field isolates positive (33/105; 33.3%). Unexpectedly, in this study, 
VirB11 and VirD4 gene targets were detected from different field isolates depending on whether 
PAI (Gorkiewicz et al., 2010) or T4S (Moolhuijzen et al., 2009) primers were used. In silico 
sequence analysis indicated that the VirD4 genes reported from C. fetus subsp. venerealis 
ATCC19438 and AZUL-94 (GenBank Accession EU443150.2 and NZ_ACL01001165) shared 
only 67% identity, although PAI and T4S primers target an identical region of the gene. VirB11 
gene sequences (GenBank Accession EU443150.2 and NZ_ACL01001023) were even less similar 
(61% identity), with multiple nucleotide differences between VirB11 PCR targets. These findings 
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highlighted that T4S genes vary among C. fetus subsp. venerealis reference strains and that 
additional virulence and PAI gene targets were needed to further characterise the field isolates. 
Comparative analysis of three available C. fetus genomes divulged 26 regions unique for C. fetus 
subsp. venerealis (Barrero et al., 2013) which led to the design of 15 new conventional PCR assays 
from draft contigs annotated to putative known virulence factors or PAI genes (October 2010). New 
PCR assays targeted either putative PAI genes (n=4), genes of phage origin (n=3) and a virulence 
gene (n=1) common to both C. fetus subsp. venerealis B6 and 642-21 draft genomes. Four PCR 
assays were designed from draft contigs unique to B6 genome, amplifying either putative virulence 
gene (n=1), genes from plasmid origin (n=2) and a T4S gene (n=1). Three assays were designed 
from draft contigs unique to 642-21 genome, amplifying putative virulence genes (n=2) and a T4S 
gene (n=1). New putative conventional virulence and PAI PCR assays were used to further 
characterise the field isolates and again, non-C. fetus subsp. venerealis were positive on these new 
tests; even if assay specificity was verified against other C. fetus subsp. fetus and Campylobacter 
reference strains. Whilst in silico BLAST analysis of further four C. fetus subsp. fetus genomes did 
not find 11 out of the 15 new putative virulence and PAI gene targets (personal communication, 
June 2012, Dr Wagenaar, Utrecht University), all four UK C. fetus subsp. fetus field isolates tested 
here were positive on three to nine new assays. These findings underlined that these 15 new 
putative virulence and PAI genes are shared between C. fetus subspecies and other closely related 
field strains. 
Virulence and PAI genes belong to the dispensable genome category, known to encode accessory 
features (Medini et al., 2005; Tettelin et al., 2005). It is not surprising that bacteria exchange these 
features to increase their fitness and/or their survival. The dispensable genomes of C. fetus subsp. 
venerealis and C. fetus subsp. fetus were recently estimated to 428 and 88 gene families 
respectively while 12 and ten putative PAI sequences were predicted from the genome of each 
subspecies (Ali et al., 2012). Although the PAI reported in C. fetus subsp. venerealis ATCC19438 
(Gorkiewicz et al., 2010) was absent in C. fetus subsp. fetus 82-40 genome (Ali et al., 2012), 
alignment with C. fetus subsp. fetus IMD523’s PAI (Abril et al., 2010) here indicated that they were 
83% identical (GenBank Accessions EU443150.2 and FN594949.1). This sequence analysis, 
together with PCR results presented in this study, confirm high homology of some virulence, T4S 
and PAI genes found in both C. fetus subspecies (Barrero et al., 2013; Moolhuijzen et al., 2009). 
The PAI named PICFV5 identified from C. fetus subsp. venerealis NCTC10354, and the PAI 
named PICFF6, predicted from C. fetus subsp. fetus 82-40, were partially found in the genome of 
the other C. fetus strain examined, further supporting horizontal transfer between C. fetus 
subspecies (Ali et al., 2012). The previous comparative analysis of 96 C. coli and C. jejuni genomes 
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found that they shared 754 dispensable genes while respectively 310 and 366 were dispensable 
genes unique to each species (Lefébure et al., 2010). A pan-genomic study including additional 
C. fetus genomes, as well as other closely related organisms, could confirm if the newly identified 
subspecies-specific dispensable gene families belong to the C. fetus subsp. venerealis dispensable 
genome and whether they are definitely absent from the dispensable genomes of C. fetus subsp. 
fetus and other Campylobacter spp. (Ali et al., 2012).  
Nevertheless, in the present evaluation, detection of putative virulence, T4S and PAI genes in some 
field isolates other than C. fetus subsp. venerealis seems to fit the hypothesis that these genes are 
part of the C. fetus dispensable genome which may enhance the virulence of positive strains. 
Virulence and PAI molecular profiles obtained from reference and field isolates thus assisted 
selecting candidates for animal experiments. Biochemical and antimicrobial resistance profiles were 
also taken in consideration for final selection and five isolates (EQC0017, 540, 635, 924, 76223 and 
B6) were tested on a pregnant guinea pig model by Ameera Koya in a parallel PhD project. 
Variation in strain pathogenicity seemed to occur as evaluated strains induced variable success both 
in causing abortion and the length of time to cause abortion after challenge (personal 
communication, Ameera Koya). However, results obtained from these animals could not be solely 
explained by the presence of virulence and PAI gene screened here as strains with almost identical 
molecular profiles induced completely different results in animals. Similarly, detection of 20 
putative virulence genes from 11 C. jejuni isolates did not correlate with their colonisation and 
invasion potential in vitro or in vivo while all C. jejuni strains tested in a chicken infection model 
colonised infected animals regardless of their positivity for the different virulence genes screened 
for, indicating that virulence gene profiles could not be used to predict disease or colonisation in 
poultry either (Biswas et al., 2011; Müller et al., 2006).  
Most of the functions and interactions between the virulence and PAI genes targeted by new and 
published PCR assays used in this study are currently unknown and it is likely that other factors 
play an active role in the pathogenesis of C. fetus subsp. venerealis. Some of the published and new 
putative PAI and gene targets have been proven to be actively involved in the pathogenesis of 
C. fetus subsp. venerealis (Gorkiewicz et al., 2010; Sprenger et al., 2011; Tu et al., 2005). Yet, only 
few studies have assessed the importance and/or role of virulence genes in vitro even though VirB9, 
VirD4, fic (filamentation induced by cAMP) and adhesin genes seem to be essential to C. fetus 
subsp. venerealis colonisation (Gorkiewicz et al. 2010; Sprenger et al. 2011). One could note that 
C. fetus subsp. venerealis isolates tested in the pregnant guinea pig model were positive on new 
conventional virulence and PAI gene PCR assays putatively annotated to fic genes 
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(ab51_contig130_1, ab51_contig130_2 and ab51_contig76), adhesin/invasin (ab51_contig207_1) 
and VirD4 (ab51_contig207_3) among other gene targets.  
Similarly, even if genes of plasmid origin have been detected from tested isolates and mutations in 
T4S genes carried on plasmids pVir and pTet in other Campylobacter spp. influenced virulence 
both in vivo and in vitro, plasmid content of C. jejuni and C. coli strains did not affect strain 
pathogenicity in the pregnant guinea pig model (Bacon et al., 2000; Bacon et al., 2002; Batchelor et 
al., 2004; Taylor and Bryner, 1984). Interactions between these genes and other virulence and PAI 
genes have not been explored, thus despite the fact that some genes have been shown to affect 
colonisation in vitro, it is not known if other virulence genes are co-required to increase 
pathogenicity in vivo (Bacon et al., 2000; Bacon et al., 2002; Gorkiewicz et al., 2010; Sprenger et 
al., 2011). Additional research is needed to confirm if new and published virulence and PAI genes 
are essential for C. fetus subsp. venerealis pathogenesis. Mutational experiments and cell assays 
could be applied to further investigate the biological significance of described virulence and PAI 
genes (Friis et al., 2005; Kienesberger et al., 2011).  
Nonetheless, multiple nucleotide variation in VirB11 (in silico analysis of reference strains) and fic 
(sequenced PCR products from for four random field isolates) gene targets was observed, 
underlining that negative virulence or PAI gene PCR results may be due to sequence variation while 
positive PCR results do not guarantee functionality of the gene or expression of protein. Primers for 
T4S, PAI and virulence genes were designed from the sequences common to two C. fetus subsp. 
venerealis genomes, which may not be representative of field diversity. Some field strains may 
possess these same genes with a slightly different nucleotide sequence and yield negative PCR 
results. A positive PCR result does not exclude the possibility of sequence variation within the gene 
target. RNA and/or proteomic analysis would be essential to assess the functionality of the T4S, 
PAI and virulence genes identified in C. fetus subsp. venerealis strains in order to further 
understand their involvement into C. fetus virulence mechanisms. In A. tumefaciens, T4S amino 
acid motifs and consensus sequences are essential to ensure gene functionality and/or strain 
virulence (Bailey et al., 2006; Banta et al., 2011; Bayliss et al., 2007; Christie et al., 2005; 
Jakubowski et al., 2005; Kumar and Das, 2001, 2002; Rabel et al., 2003; Stephens et al., 1995). In 
silico analysis of seven T4S genes (VirB3/B4, VirB7-VirB11 and VirD4) from C. fetus subsp. 
venerealis reference strains B6 and 642-21 (Barrero et al., 2013), ATCC19438 (Gorkiewicz et al., 
2010), AZUL-94 (Moolhuijzen et al., 2009) and field isolates 635, 830, 924 and 957 (personal 
communication, May 2012, Gabriel Keeble-Gagnère, CCG) compared to C. fetus subsp fetus 
IMD523 (Abril et al., 2010) indicated that published amino acid motifs and consensus sequences 
were conserved in six out of the seven available T4S genes of all the C. fetus strains examined. 
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C. fetus VirB7 sequences were completely different from the VirB7 sequences reported from A. 
tumefaciens but shared up to 94% identity with VirB7 homologues found in other Campylobacter 
spp. (GenBank Accessions YP_001405777.1, YP_002576146.1, YP_063438.1, YP_005660358.1 
and ZP_00371910.1). T4S gene sequences obtained from C. fetus subsp. venerealis B6, 
ATCC19438 (Gorkiewicz et al., 2010) and 635 were identical and shared up to 99% identity with 
C. fetus subsp. fetus IMD523 available sequences (Abril et al. 2010). Likewise, T4S gene sequences 
identified from C. fetus subsp. venerealis 642-21, 924 and 957 matched 100% while sequences 
from AZUL-94 (Moolhuijzen et al., 2009) and isolate 830 often shared little identity with other 
strains. Multiple nucleotide and amino acid differences were observed between the different sets of 
sequences analysed, some of which were previously found in some other bacterial species 
(supplemental material to Christie et al. 2005, accessible online at 
http://mmg.uth.tmc.edu/faculty/faculty-peter-christie.html). However, such differences may affect 
the identity of encoded proteins and it is yet to be investigated whether or not resulting products still 
function in a similar fashion and how they may affect C. fetus virulence in vivo. 
Even though sequence variation of some virulence and PAI genes was observed while implications 
in vivo are unknown for C. fetus subsp. venerealis, plasticity is thought to enhance bacterial 
pathogenesis in H. pylori and C. fetus in vivo (Suerbaum and Josenhans, 2007; Tu et al., 2005). 
Sequence variation in T4S genes is common and has been associated with host adaptation but also 
altered virulence in H. pylori (Sozzi et al., 2005; Suerbaum and Josenhans, 2007). Nucleotide 
sequence variations, gene losses or gains during H. pylori chronic infections have been reported to 
induce different clinical signs (Sozzi et al., 2005; Suerbaum and Josenhans, 2007). Recent evidence 
that frameshift mutation and single amino acid change in virulence factors of Chlamydia 
trachomatis and Brucellla suis could affect bacterial virulence in vivo was recently reported 
(Andrieux et al., 2011; Sturdevant et al., 2010). Virulence and PAI gene composition pre and post 
animal inoculations could further be investigated for potential sequence variation which may help to 
explain variation of pathogenicity observed with the different C. fetus subsp. venerealis strains 
tested in the pregnant guinea pig model. RNA and/or proteomic analysis of isolates during infection 
may also provide information as to potential differences in virulence determinants to correlate better 
with pathogenicity.  
 
5. Conclusions and future directions 
This study established a large and diverse collection of 84 Australian Campylobacter-like cultures 
which, together with the comparative analysis of three C. fetus genomes (Barrero et al., 2013), 
contributed to further strain molecular differentiation and evaluation of 13 new assays targeting 
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putative C. fetus subsp. venerealis-specific genes, 15 other assays specific for C. fetus subsp. 
venerealis known virulence and PAI genes, in addition to two new real-time PCR assays.  
The identification of new molecular diagnostic targets for C. fetus subsp. venerealis was found to be 
complex due to the high molecular homology between C. fetus subspecies, other Campylobacter 
spp. and Arcobacter-like organisms, complicated by the lack of distinctive reliable biochemical test 
between C. fetus subspecies and these closely related organisms. Pre-screening of new assays using 
sequence databases was thus mis-leading, perhaps this collection of bull preputial flora isolates is 
unique and future genome sequencing of non-C. fetus strains will be found valuable. This large and 
diversified collection will allow further evaluation of biochemical properties and antimicrobial 
susceptibility which may assist identifying traits unique to C. fetus subsp. venerealis.  
This project showed that real-time testing of suspected BGC samples could assist with C. fetus 
subsp. venerealis isolation while biochemical phenotyping and molecular characterisation of 
obtained cultures is still needed to confirm identity. As parA, ISCfe1 and new subspecies-specific 
gene targets were detected from organisms other than C. fetus subsp. venerealis while MLST 
confirmed irrevocably identity of suspected C. fetus subsp. venerealis pure cultures, this study 
advises that the MLST scheme should be used to confirm identity of pure Campylobacter-like 
cultures and that it may be converted into high-resolution melting curve assays to detect C. fetus 
subsp. venerealis from crude samples (van Bergen et al., 2005c). Alternatively, cnp60 gene 
sequencing is another method that could be used to confirm identity of pure cultures as it previously 
allowed discrimination between Arcobacter, Campylobacter and Helicobacter spp. including both 
C. fetus subspecies (Hill et al. 2006). 
This project reports that new and published virulence, T4S and PAI gene targets detected from 
C. fetus subsp. venerealis isolates tested in pregnant guinea pigs could not be solely used to predict 
strain pathogenicity in this model (Gorkiewicz et al., 2010; Moolhuijzen et al., 2009). Multiple 
sequence and amino acid variation in some of these genes were observed but it is currently 
unknown if such variations affect functionality of the genes or strain virulence. Implication of 
virulence, T4S and PAI genes should be further investigated in mutational experiments and cell 
assays in order to verify their implication in C. fetus subsp. venerealis pathogenesis. RNA and/or 
proteomics could also assist to compare genes expressed during animal infection. 
A future pan-genomic study, including multiple C. fetus subsp. venerealis, C. fetus subsp. fetus, 
Campylobacter spp. and Arcobacter spp. genomes, is needed to determine species and subspecies 
core and dispensable genes and to confirm if any of the newly designed assays are in fact reliable 
markers for C. fetus subsp. venerealis strains. Additional C. fetus genomes are required; five field 
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strains isolated by this project have been newly sequenced (635, 830, 924, 957 and 76223) and 
should be included, as well as the only four available C. fetus genomes (Barrero et al., 2013; Fouts 
et al., 2005; Stynen et al., 2011). 
The seven genome sequences (CCG) accessed in this project are currently not fully annotated and 
thus in draft form. Future comparative studies including full biochemical phenotypes and complete 
genome data will be beneficial to guide further research. Future research should also examine the 
genomes of the non-C. fetus subsp. venerealis isolates found present in the bull prepuce and 
seemingly absent in sequence databases. In addition, the significance of these other organisms 
causing bovine infections is also currently under researched. Further investigations should evaluate 
different C. fetus and other closely related organisms in small animal models in order to assess their 
ability to cause disease. A novel detailed examination of the flora contained in this niche is needed 
and perhaps would assist to confirm why culture isolation and molecular assay identification have 
been so complex for C. fetus subsp. venerealis. 
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APPENDICES 
  
1. Appendix 1 
Biochemical phenotyping of the Campylobacter-like culture collection was performed by Ameera Koya (PhD student) following recommended 
procedures (see Chapter 5, section 2.3, Table 8) as part of her PhD project. Results obtained from 51 isolates are presented in Table A. 
Table A. Biochemical phenotyping of 51 Campylobacter-like isolates cultured from bull preputial secretions. 
  Isolate 25°C 42°C Oxidase Catalase 1% 
glycine 
H2S
a
 H2S
b
 Aerobic 
growth 
Nalidixic 
acid 
 Cephalothin Biochemical phenotype 
10 1 0 1 1 0 0 1 0 0 1 C. fetus subsp. venerealis bv. intermedius 
130 1 0 1 0 0 0 0 0 1 1 C. fetus subsp. venerealis bv. venerealis 
154 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
158 1 0 1 0 0 0 0 1 1 0 aerotolerant Arcobacter-like  
166 1 0 1 0 0 0 0 1 1 0 aerotolerant Arcobacter-like  
214 1 0 1 1 0 0 1 0 0 1 C. fetus subsp. venerealis bv. intermedius 
217 1 0 1 1 0 0 1 0 0 1 C. fetus subsp. venerealis bv. intermedius 
218 1 0 1 0 1 0 0 0 0 0 C. fetus subsp. fetus 
227 1 0 1 0 0 0 0 1 1 0 aerotolerant Arcobacter-like  
229 1 0 1 1 0 0 1 0 0 1 C. fetus subsp. venerealis bv. intermedius 
258 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
273 1 0 1 1 0 0 0 0 1 0 C. fetus subsp. venerealis bv. venerealis 
289 1 0 1 1 0 0 0 1 0 1 aerotolerant Arcobacter-like  
305 1 0 1 1 0 0 0 1 1 0 aerotolerant Arcobacter-like  
306 1 0 1 1 0 0 0 1 1 0 aerotolerant Arcobacter-like  
312 1 0 1 0 0 0 0 1 1 0 aerotolerant Arcobacter-like  
317 1 0 1 0 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
337 1 1 1 1 1 0 0 1 0 1 C. fetus subsp. fetus 
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Isolate 25°C 42°C Oxidase Catalase 1% 
glycine 
H2S
a
 H2S
b
 Aerobic 
growth 
Nalidixic 
acid 
Cephalothin Biochemical phenotype 
344 1 0 1 1 0 0 0 0 1 0 C. fetus subsp. venerealis bv. venerealis 
347 1 0 1 1 0 0 0 1 0 1 aerotolerant Arcobacter-like  
385 1 1 1 1 0 0 1 1 0 1 thermophilic Campylobacter sp. 
400 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
412 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
430 1 0 1 1 0 0 0 0 0 0 C. fetus subsp. venerealis bv. venerealis 
475 1 0 1 0 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
520 0 1 0 1 1 1 1 0 0 1 thermophilic Campylobacter sp. 
521 0 0 0 0 0 0 0 1 0 1 C. fetus subsp. venerealis bv. venerealis 
530 0 1 1 1 1 1 1 0 1 1 thermophilic Campylobacter sp. 
531 0 1 0 1 1 1 1 0 0 1 thermophilic Campylobacter sp. 
537 0 0 1 1 0 0 1 0 1 1 C. fetus subsp. venerealis bv. intermedius 
540  0 0 1 1 0 0 1 0 1 1 C. fetus subsp. venerealis bv. intermedius 
628 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
635 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
672 1 0 1 1 0 0 0 1 1 0 aerotolerant Arcobacter-like  
673 1 0 1 1 0 0 0 1 1 1 aerotolerant Arcobacter-like  
676 1 1 1 1 0 0 1 0 0 1 thermophilic Campylobacter sp. 
729 1 0 1 1 0 0 0 1 0 1 aerotolerant Arcobacter-like  
742 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
744 1 0 1 1 0 0 1 0 0 0 C. fetus subsp. venerealis bv. intermedius 
830 1 0 1 1 0 0 1 0 0 1 C. fetus subsp. venerealis bv. intermedius 
849 0 1 1 0 1 0 1 0 0 1 thermophilic Campylobacter sp. 
863 0 1 1 0 1 0 1 0 0 1 thermophilic Campylobacter sp. 
882 1 1 1 1 1 0 0 0 0 1 C. fetus subsp. fetus 
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Isolate 25°C 42°C Oxidase Catalase 1% 
glycine 
H2S
a 
H2S
b 
Aerobic 
growth 
Nalidixic 
acid 
Cephalothin Biochemical phenotype 
890  1 0 1 1 0 0 1 0 0 0 C. fetus subsp. venerealis bv. intermedius 
923 1 0 1 1 0 0 1 0 1 1 C. fetus subsp. venerealis bv. intermedius 
924 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
926 1 0 0 1 0 0 1 0 1 1 C. fetus subsp. venerealis bv. intermedius 
951 1 0 1 1 0 0 1 0 1 1 C. fetus subsp. venerealis bv. intermedius 
957 1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
979 1 1 1 1 1 0 1 0 0 1 C. fetus subsp. fetus 
1036 0 0 1 1 0 0 0 0 0 0 C. fetus subsp. venerealis bv. venerealis 
*ATCC19438
 
1 0 1 1 0 0 0 0 0 1 C. fetus subsp. venerealis bv. venerealis 
ATCC25936 1 0 0 1 1 0 1 0 0 1 C. fetus subsp. fetus 
a
Using triple iron sugar (TSI) slope; 
b
 in cysteine-HCl medium using lead acetate paper (OIE, 2012a) 
1= positive result, 0= negative result; antibiotic susceptibility: 1= susceptible, 0= resistant 
*American Type Culture Collection (ATCC) 
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2. Appendix 2 
Figure A. Gel picture obtained with the reference cultures tested using new putative hypothetical 
protein (ab51_contig98_4075-4315) conventional PCR assay.  
PCR products of 150 bp (arrow) were amplified from the C. fetus subsp. venerealis reference strains 
tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced from the other 
Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-ATCC35221; 7-ATCC43954; 
8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
 
Figure B. Gel picture obtained with the reference cultures tested on the new putative periplasmic 
binding protein (cfvv_28.1-4317.505-1097) and Gp27 (cfvv_28.1-4317.1697-2142) conventional 
PCR assays (bottom row) and (top row).  
 
PCR products of 158 bp (bottom row) and 197 bp (top row) were amplified from the C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced 
from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC33559; 6-ATCC35221; 7-
ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
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Figure C. Gel picture obtained with the reference cultures tested on the new putative serpentine 
domain containing protein (cfvv_36.1-147294.32158-32473) and oxidoreductase (cfvv_43.1-
43748.31801-32913) conventional PCR assays (bottom row) and (top row).  
PCR products of 150 bp (bottom row) and 176 bp (top row) were amplified from C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced 
from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC33559; 6-ATCC35221; 7-
ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
  
Figure D. Gel picture obtained with the reference cultures tested on the new putative Molybdenum 
cofactor biosynthesis protein 1 B (cfvv_43.1-43748.37070-37996) and D-mycarose 3-C 
methyltransferase (cfvv_43.1-43748.38016-39466) conventional PCR assays.  
PCR products of 195 bp (bottom row) and 172 bp (top row) were amplified from C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced 
from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-ATCC35221; 
7-ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
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Figure E. Gel picture obtained with the reference cultures tested on the new putative glycosyl 
transferase (cfvv_44.1-6162.1810-2822) and hypothetical protein (cfvv_45.1-4689.3424-4598) 
conventional PCR assays.  
PCR products of 232 bp (bottom row) and 203 bp (top row) were amplified from C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced 
from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-ATCC35221; 
7-ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
 
Figure F. Gel picture obtained with the reference cultures tested on the new putative hypothetical 
(cfvv_46.1-11977.84-1196) and predicted (cfvv_46.1-11977.1215-2434) proteins conventional 
PCR assays.  
 PCR products of 164 bp (bottom row) and 214 bp (top row) were amplified from C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced 
from the other Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-ATCC35221; 
7-ATCC43954; 8-ATCC35217; 9-ATCC15926) or with no template control (10-water). 
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Figure G. Gel picture obtained with the reference cultures tested on the new putative serpentine 
containing domain protein conventional PCR assay (cfvv_52.1-1223.50-1223).  
PCR products of 175 bp (arrow) were amplified from C. fetus subsp. venerealis reference strains 
tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced from the other 
Campylobacter reference strains (4-ATCC33560; 5-ATCC 33559; 6-ATCC35221; 7-ATCC43954; 
8-ATCC35217; 9-ATCC15926) or with no template control (10-water).  
 
Figure H. Gel picture obtained with the reference cultures tested on the new putative hypothetical 
protein conventional PCR assay (cfvv_79.1-1308.319-829).  
PCR products of 198 bp (arrow) were amplified from C. fetus subsp. venerealis reference strains 
tested (1-B6; 2-642-21; 3-98-109383) while no amplicon was produced from the other 
Campylobacter reference strains (4-ATCC33560; 5-ATCC33559; 6-ATCC35221; 7-ATCC43954; 
8-ATCC35217; 9-ATCC15926) or with no template control (10-water).
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Table B. Screening of the Campylobacter-like culture collection (n=84) using the 13 new conventional PCR assays designed from C. fetus subsp. 
venerealis unique draft contigs that were not annotated to putative known virulence factors or pathogenicity island genes. 
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Phenotype (Chapter 5, Table 13) 
4 + ‡ND ND ND ND ND ND ND ND ND ND ND ND ND 
8 - + - - - + + - - + + - - ND 
10 + + + + + + + - + + + + + C. fetus subsp. venerealis 
*31 + + + + + + + + + + + + + ND 
130 - - - - - + + - - + + - - C. fetus subsp. venerealis 
153 - + - - - + + - - + + - - ND 
154 - - - - - + + + - + + - - C. fetus subsp. venerealis 
158 - - - - - + + + - + + - - Arcobacter-like organism 
166 - - - - - + + - - - + - - Arcobacter-like organism 
*214 + + + + + + + + + + + + + C. fetus subsp. venerealis 
217 + - - + - - + + + + + + + C. fetus subsp. venerealis 
218 - - - - - + + + - + - - + C. fetus subsp. fetus 
*227 + + + + + + + + + + + + + Arcobacter-like organism 
229 + + + - + + + + + + + + + C. fetus subsp. venerealis 
258 - + - - + + + + + + + + - C. fetus subsp. venerealis 
†272 - - - - - - - - - - - - - ND 
273 - - - - - - + - - + + - - C. fetus subsp. venerealis 
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Phenotype (Chapter 5, Table 13) 
289 - - - - - + + - - + + - - Arcobacter-like organism 
305 - - - - - - + + - + + - - Arcobacter-like organism 
306 - - - - - - + + - + + - - Arcobacter-like organism 
312 - - - - - + + - - + + + - Arcobacter-like organism 
317 - - - - - - + - - + + - - C. fetus subsp. venerealis 
331 - - - - - - + - - + + - - ND 
334 - - - - - + + - - + + - - ND 
337 - - - - - + + - - + + - - C. fetus subsp. fetus 
340 - - - - - - + - - + + - - ND 
343 - - - - - - + - - + + - - ND 
344 - - - - - - - - - + + - - C. fetus subsp. venerealis 
†347 - - - - - - - - - - - - - Arcobacter-like organism 
385 - - - - - + - - - - - - - thermophilic Campylobacter sp. 
399 - - - - - ND ND ND ND ND ND ND ND ND 
400 - - - - - - + - - + + - - C. fetus subsp. venerealis 
412 - - - - - - - - - ND ND ND ND C. fetus subsp. venerealis 
†430 - - - - - - - - - - - - - C. fetus subsp. venerealis 
*475 + + + + + + + + + + + + + C. fetus subsp. venerealis 
520 - ND ND ND ND ND ND ND ND ND ND ND ND thermophilic Campylobacter sp. 
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Phenotype (Chapter 5, Table 13) 
521 - - - - - - - + - - - - - C. fetus subsp. venerealis 
530 - ND ND ND ND ND ND + - - - ND ND thermophilic Campylobacter sp. 
†531 - - - - - - - - - - - - - thermophilic Campylobacter sp. 
537 + + + + + + + - + + + + - C. fetus subsp. venerealis 
*540 + + + + + + + + + + + + + C. fetus subsp. venerealis 
543 - ND ND ND ND ND ND + - + + - - ND 
562 - ND ND ND ND ND ND ND ND ND ND ND ND ND 
†573 - - - - - - - - - - - - - ND 
†628 - - - - - - - - - - - - - C. fetus subsp. venerealis 
*635 + + + + + + + + + + + + + C. fetus subsp. venerealis 
672 - - - - - + + + - + + - - Arcobacter-like organism 
673 - - - - - - + + - + + - - Arcobacter-like organism 
676 - - - - - + + - - - - - - thermophilic Campylobacter sp. 
708 - - - - - - + - - - - - - ND 
729 - - - - - - + - - + + - - Arcobacter-like organism 
742 - - - - - - - + - - - - - C. fetus subsp. venerealis 
†744 - - - - - - - - - - - - - C. fetus subsp. venerealis 
787 - - - - - + + - - - - - + ND 
†830 - - - - - - - - - - - - - C. fetus subsp. venerealis 
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Phenotype (Chapter 5, Table 13) 
849 - - - - - - + - - - - - - thermophilic Campylobacter sp. 
856 - - - - - - + - - - + - + ND 
857 - - - - - - - - - - - - + ND 
*859 + + + + + + + + + + + + + ND 
863 - - - - - - - - - + - - + thermophilic Campylobacter sp. 
882 - - - - - - - - - - - - + C. fetus subsp. fetus 
883 - - - - - - - - - - - - + ND 
884 - - - - - - - - - - - - + ND 
889 - - - - - - - - - - - - + ND 
890 - - - - - - + - - - + - - C. fetus subsp. venerealis 
*923 + + + + + + + + + + + + + C. fetus subsp. venerealis 
924 + - + + + + + + + + + + + C. fetus subsp. venerealis 
*926 + + + + + + + + + + + + + C. fetus subsp. venerealis 
948 - - - - - + + - - + + + + ND 
951 + - + + + + + - + + + + + C. fetus subsp. venerealis 
†953 - - - - - - - - - - - - - ND 
954 - - - - - - - - - - - - + ND 
955 - - + - + + + - + + + + + ND 
957 + - + + + + + - + + + + + C. fetus subsp. venerealis 
964 - - - - - - + - - - - - - ND 
970 + - - - - - + - - - - - - ND 
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Phenotype (Chapter 5, Table 13) 
†979 - - - - - - - - - - - - - C. fetus subsp. fetus 
†991 - - - - - - - - - - - - - ND 
1001 - - + + - - + + + + + + + ND 
1011 - - + + - + + + + - + + + ND 
1012 - - + + - + + + + + + + + ND 
1014 - - + + + + + + + + + + + ND 
1025 - - + + - + + - + + + + + ND 
1036 - - + + - - + - + + + - + C. fetus subsp. venerealis 
*Isolates positive on all 13 new conventional PCR assays (31, 214, 227, 475, 540, 635, 859, 923 and 926)  
†Isolates negative on all 13 new conventional PCR assays (272, 347, 430, 531, 573, 628, 744, 830, 953, 979 and 991) 
‡ND not determined, isolates 4, 399, 412, 520, 530 and 543 could not be resuscitated following storage, extracts from these cultures yielded low 
gDNA content, these isolates were thus not all evaluated on the 13 new putative gene PCR assays.  
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Table C. Screening of the Campylobacter-like culture collection extratcs against the new D-
mycarose-3-C-methyltransferase real-time assay compared to previous biochemical phenotypic and 
molecular results. 
Chapter 6 Previous results (Chapter 5, Table 13) 
Isolate 
Ct score 
from gDNA 
Hum's PCR1 
960bp 
Hum's PCR1 
142bp 
Abril's PCR2 
233bp Biochemical phenotype 
4 ND† + + + ND 
8 no Ct score + + + ND 
10 19.68 + + + C. fetus subsp. venerealis 
31 21.49 + + + ND 
130 no Ct score + + + C. fetus subsp. venerealis 
153 31.79 - + + ND 
154 no Ct score - + + C. fetus subsp. venerealis 
158 no Ct score - + + Arcobacter-like organism 
166 no Ct score - + + Arcobacter-like organism 
214 25.65 + + + C. fetus subsp. venerealis 
217 25.52 + + + C. fetus subsp. venerealis 
218 no Ct score + + + C. fetus subsp. fetus 
227 20.79 + + + Arcobacter-like organism 
229 24.11 + + + C. fetus subsp. venerealis 
258 no Ct score + + + C. fetus subsp. venerealis 
272 no Ct score - - - ND 
273 33.6 - + + C. fetus subsp. venerealis 
289 33.29 - - + Arcobacter-like organism 
305 no Ct score - - + Arcobacter-like organism 
306 no Ct score + + + Arcobacter-like organism 
312 no Ct score + + + Arcobacter-like organism 
317 no Ct score - + + C. fetus subsp. venerealis 
331 no Ct score - + + ND 
334 no Ct score - - + ND 
337 no Ct score - + + C. fetus subsp. fetus 
340 no Ct score - - + ND 
343 no Ct score - + - ND 
344 no Ct score - + + C. fetus subsp. venerealis 
347 no Ct score - + - Arcobacter-like organism 
385 no Ct score - - - thermophilic Campylobacter sp. 
399 ND - - + ND 
400 34.73 + + + C. fetus subsp. venerealis 
412 no Ct score - + + C. fetus subsp. venerealis 
430 no Ct score - + + C. fetus subsp. venerealis 
475 24.11 + + + C. fetus subsp. venerealis 
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Chapter 6 Previous results (Chapter 5, Table 13) 
Isolate 
Ct score 
from gDNA 
Hum's PCR1 
960bp 
Hum's PCR1 
142bp 
Abril's PCR2 
233bp Biochemical phenotype 
520 ND + + + thermophilic Campylobacter sp. 
521 34.55 - - + C. fetus subsp. venerealis 
530 ND - + + thermophilic Campylobacter sp. 
531 20.11 - - + thermophilic Campylobacter sp. 
537 13.8 + + + C. fetus subsp. venerealis 
540 18.87 + + + C. fetus subsp. venerealis 
543 33.15 - + + ND 
562 ND - - + ND 
573 no Ct score - - - ND 
628 no Ct score - - + C. fetus subsp. venerealis 
635 20.78 + + + C. fetus subsp. venerealis 
672 36.71 - - + Arcobacter-like organism 
673 no Ct score - - + Arcobacter-like organism 
676 no Ct score - - - thermophilic Campylobacter sp. 
708 no Ct score - - - ND 
729 no Ct score - - + Arcobacter-like organism 
742 no Ct score - - + C. fetus subsp. venerealis 
744 no Ct score - - + C. fetus subsp. venerealis 
787 36.37 - - + ND 
830 no Ct score - + + C. fetus subsp. venerealis 
849 no Ct score - - + thermophilic Campylobacter sp. 
856 36.97 - - - ND 
857 no Ct score - - + ND 
859 no Ct score + + + ND 
863 no Ct score - - + thermophilic Campylobacter sp. 
882 no Ct score - + + C. fetus subsp. fetus 
883 no Ct score + + + ND 
884 no Ct score + + + ND 
889 no Ct score - - + ND 
890 32.1 - - + C. fetus subsp. venerealis 
923 19.75 + + + C. fetus subsp. venerealis 
924 16.96 + + + C. fetus subsp. venerealis 
926 17.74 + + + C. fetus subsp. venerealis 
948 36.92 + + + ND 
951 16.89 + + + C. fetus subsp. venerealis 
953 no Ct score + + + ND 
954 34.44 - - + ND 
955 30.68 + + + ND 
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Chapter 6 Previous results (Chapter 5, Table 13) 
Isolate 
Ct score 
from gDNA 
Hum's PCR1 
960bp 
Hum's PCR1 
142bp 
Abril's PCR2 
233bp Biochemical phenotype 
957 17.22 + + + C. fetus subsp. venerealis 
964 no Ct score + + + ND 
970 34.27 + + + ND 
979 no Ct score + + + C. fetus subsp. fetus 
991 no Ct score - - + ND 
1001 no Ct score - - + ND 
1011 no Ct score - - + ND 
1012 no Ct score - - + ND 
1014 35.28 - + + ND 
1025 33.85 + + + ND 
1036 no Ct score - - + C. fetus subsp. venerealis 
†ND Not determined 
1
Hum et al. (1997) 
 
2
Abril et al. (2007) 
Thermophilic isolate positive on the new real-time assay (n=1). 
Arcobacter-like isolates positive on the new real-time assay (n=3). 
C. fetus subsp. venerealis isolates which were negative the new real-time assay but previously 
found positive on Abril and/or Hum’s conventional PCR assays (n=12). 
Isolates of unknown phenotype which were negative the new real-time assay but previously 
found positive on Abril and/or Hum’s conventional PCR assays (n=15). 
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3. Appendix 3  
Table D. Screening of the Campylobacter-like culture collection and Australian and UK C. fetus 
field cultures against published pathogenicity island gene and type IV secretion system gene PCR 
assays. Positive results are highlighted (blue). 
 
PAI genes PCR assays
1
 T4S genes PCR assays
2
 
Isolate orf21 orf26/27 VirB10 VirD4 VirB8/9 VirB11 VirB11 VirD4 VirB9 
4 - - - ND* ND ND - - - 
8 - - - - - - - - - 
10 - - - - - - + - - 
31 - - - - - - - - - 
130 - - - - - - - + - 
153 - - - - - - - - - 
154 - - - - - - - - - 
158 - - - - - - - - - 
166 - - - - - - - - - 
214 - - - - - - + - - 
217 - - - - - - + - - 
218 - - - - - - - - - 
227 - - - - - - + - - 
229 - - - - - - + - - 
258 - - - - - - - - - 
272 - - - - - - - - - 
273 - - - - - - - - - 
289 - - - - - - - - - 
305 - - - - - - - - - 
306 - - - - - - - - - 
312 - - - - - - - - - 
317 - - + + - + - + + 
331 - - - - - - - - - 
334 - - - + - - - - + 
337 - - - - - - - - - 
340 - - - - - - - - - 
343 - - - - - - - - - 
344 - - - - - - - - - 
347 - - - - - - - - - 
385 - - - - - - - - - 
399 - - - + - - - - - 
400 - - - - - - - - - 
412 - - + + - + - + + 
430 - - - - - - - - - 
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PAI genes PCR assays
1
 T4S genes PCR assays
2
 
Isolate orf21 orf26/27 VirB10 VirD4 VirB8/9 VirB11 VirB11 VirD4 VirB9 
475 - - - - - - + - - 
520 - - - - - - - - - 
521 - - - - - - - - - 
530 - - - - - - - - - 
531 - - - - - - - - - 
537 - - - - - - + - - 
540 - - - - - - + - - 
543 - - - - - - - - - 
562 - ND ND ND ND ND - - - 
573 - - - - - - - - - 
628 - - - - - - - - - 
635 + + + + + + - + + 
672 - - - - - - - - - 
673 - - - - - - - - - 
676 - - - - - - - - - 
708 - - - - - - - - - 
729 - - - - - - - - - 
742 - - - - - - - - - 
744 - - - - - - - - - 
787 - - - - - - - - - 
830 - - - - - - - - - 
849 - - - - - - - - - 
856 - - - - - - - - - 
857 - - - - - - - - - 
859 - - - - - - + - - 
863 - - - - - - - - - 
882 - - - - - - - - - 
883 - - - - - - - - - 
884 - - - - - - - - - 
889 - - - - - - - - - 
890 - - - - - - - - - 
923 - - - - - - + - - 
924 - - - - - - + - - 
926 - - - - - - + - - 
948 - - - - - - - - - 
951 - - - - - - + - - 
953 - - - - - - - - - 
954 - - - - - - - - - 
955 - - - - - - + - - 
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PAI genes PCR assays
1
 T4S genes PCR assays
2
 
Isolate orf21 orf26/27 VirB10 VirD4 VirB8/9 VirB11 VirB11 VirD4 VirB9 
957 - - - - - - + - - 
964 - - - - - - - - - 
970 - - - - - - + - - 
979 - - - - - - - - - 
991 - - - - - - + - - 
1001 - - - - - - - - - 
1011 - - - - - - - - - 
1012 - - - - - - - - - 
1014 - - - - - - - - - 
1025 - - + - - - - + + 
1036 - - - - - - + - - 
D8147/2 - + + + + + - + + 
‡EQC0017 - - - - - - + - - 
F591/1 - - - + - - - - + 
J4494/6B - - - - - - + - - 
Q492 - - - - - - - - - 
A8 - - - - - - + - - 
†75838 - + - + - - + - - 
†76223 - + + + - - + - - 
87-29394 - - - - - - - - - 
‡09-
125181/3 - - - - - - + - - 
‡Becks - - - - - - - - - 
‡K8 - + - + - - + - - 
BT08/04 - - - - - - - - - 
BT23/02 - - - - - - - - - 
BT47/00 - - - - - - - - - 
BT54/00 - - - - - - - - - 
†BT102/00 - + + - - + + + - 
BT194/02 - - - - - - - - - 
BT268/06 - - - - - - - - + 
BT277/06 - - - - - - - - - 
BT376/03 - - - - - - - - - 
1
Pathogenicity island (PAI) gene PCR assays (Gorkiewicz et al. 2010). 
2
Type IV secretion system (T4S) gene PCR assays (Moolhuijzen et al. 2009). 
*ND not determined: isolates 4 and 562 could not be resuscitated following storage; these isolates 
were not evaluated on all six published PAI gene PCR assays.  
†Strains isolated from bovine aborted foetuses. 
‡Strains isolated from cattle from herds with a history of subfertility. 
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Table E. Screening of the Campylobacter-like culture collection (n=84) using the 15 new PCR assays designed from C. fetus subsp. venerealis unique 
draft contigs annotated to putative known virulence factors or PAI genes, compared to previously obtained biochemical phenotypic results. 
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Biochemical phenotypes  
(Chapter 5, Table 13) 
4 + + + + + + ND* ND - - - - + - - ND 
8 - + - + + - - - + + - - - - - ND 
10 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. intermedius 
31 ND ND ND ND ND ND + - ND ND ND ND ND ND ND ND 
130 + + - + - - - - + - - - - - - C. fetus subsp. venerealis bv. venerealis 
153 + + - + + + - - - - - - + + - ND 
154 + + + + + - - - - - - - + - - C. fetus subsp. venerealis bv. venerealis 
158 + + + + + + - - - - - - + - - Arcobacter-like organism 
166 + + - + - + - - - - - - - - - Arcobacter-like organism 
214 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. intermedius 
217 + + + + + + + - - - - - + + + C. fetus subsp. venerealis bv. intermedius 
†218 - - - - - - - - - - - - - - - C. fetus subsp. fetus 
227 + + + + + + + + - - - - + + + Arcobacter-like organism 
229 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. intermedius 
258 - - - - + - + + - - - - - - - C. fetus subsp. venerealis bv. venerealis 
272 + + - - - - - - - - - - - - - ND 
273 - + - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
289 - + - - - - - - - - - - - - - Arcobacter-like organism 
†305 - - - - - - - - - - - - - - - Arcobacter-like organism 
306 - + - - - - - - - - - - - - - Arcobacter-like organism 
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Biochemical phenotypes  
(Chapter 5, Table 13) 
312 - + - - - - - - - - - - - - - Arcobacter-like organism 
317 + + - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
†331 - - - - - - - - - - - - - - - ND 
334 + + - + - - - - - - - - - - - ND 
337 - - - - - - - + - - - - - - - C. fetus subsp. fetus 
†340 - - - - - - - - - - - - - - - ND 
343 + + - - + - - - - - - - - - - ND 
344 - + - - + - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
†347 - - - - - - - - - - - - - - - Arcobacter-like organism 
†385 - - - - - - - - - - - - - - - thermophilic Campylobacter sp. 
399 + + - - - - - - - - - - - - - ND 
†400 - - - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
412 + + - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
†430 - - - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
475 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. venerealis 
†520 - - - - - - ND ND - - - - - - - thermophilic Campylobacter sp. 
†521 - - - - - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
530 + + + - + - - - - - - - - - - thermophilic Campylobacter sp. 
†531 - - - - - - - - - - - - - - - thermophilic Campylobacter sp. 
537 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. intermedius 
540 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. intermedius 
†543 - - - - - - - - - - - - - - - ND 
562 - - - - - - ND ND - - - - - - - ND 
†573 - - - - - - - - - - - - - - - ND 
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Biochemical phenotypes  
(Chapter 5, Table 13) 
628 - + - - + - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
635 + + + + + + + + + + + + - - - C. fetus subsp. venerealis bv. venerealis 
672 - - - - + - - - - - - - - - - Arcobacter-like organism 
†673 - - - - - - - - - - - - - - - Arcobacter-like organism 
676 - + - - - - - - + + + + - - - thermophilic Campylobacter sp. 
708 - + - - - - - - + + + - - - - ND 
729 + + - - - - - - - - - - - - - Arcobacter-like organism 
742 - - - - + - - - + + - + - - - C. fetus subsp. venerealis bv. venerealis 
744 - - - - + + - - - - - - - - - C. fetus subsp. venerealis bv. intermedius 
787 - - - - + - - - - - - - - - - ND 
830 - - - - + - - - + + + - - - - C. fetus subsp. venerealis bv. intermedius 
849 - - - - - - - - + - - - - - + thermophilic Campylobacter sp. 
856 - - - - - - - - + + + - - - - ND 
857 - + - + - - - - + + + + - - - ND 
859 + + + + + + + + - - - - + - - ND 
863 - - - - + - - - - - - - - - - thermophilic Campylobacter sp. 
882 - + - - - - - - - - - - + + - C. fetus subsp. fetus 
883 + + - - - - - - - - - - + - - ND 
884 + + - - - - - - - - - - + - - ND 
889 - + + - - - - - - - - - - - - ND 
890 - + - - + + - - - - - - - + + C. fetus subsp. venerealis bv. intermedius 
923 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. intermedius 
924 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. venerealis 
926 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. intermedius 
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Biochemical phenotypes  
(Chapter 5, Table 13) 
948 - + - - - - - - - - - - + - - ND 
951 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. intermedius 
953 - + - - - - - - - - - - + + - ND 
954 + + - + + - - - - - - - - - - ND 
955 + + + + + + + - - - - - + + - ND 
957 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. venerealis 
964 - + - - - - - - - - - - - - - ND 
970 + + + + + + - + - - - - + + - ND 
979 + + - - - - - - + + + + - - - C. fetus subsp. fetus 
991 - + - - - - - - + + + - - - - ND 
1001 - + - - + + - - + + - - - - - ND 
1011 - - - + + - - - + + - - - - - ND 
1012 - + - + + + - - + + - - - - - ND 
1014 - + - + + + - - + + - - - - - ND 
1025 + + + + + + - - + + - - - - - ND 
1036 + + - + + + - - + + - + - - - C. fetus subsp. venerealis bv. venerealis 
*ND not determined: isolates 4, 31, 520 and 562 could not be resuscitated following storage, extracts from these cultures yielded low gDNA content, 
these isolates were thus not all evaluated on the 15 new putative virulence and PAI gene PCR assays.  
†Isolates negative on all 15 new PCR assays (218, 305, 331, 340, 347, 385, 400, 430, 520, 521, 531, 543, 573 and 673). 
Arcobacter-like isolates positive on some of the new PCR assays. 
C. fetus subsp. fetus isolates positive on some of the new PCR assays. 
Thermophilic Campylobacter spp. isolates positive on some of the new PCR assays. 
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Table F. Screening of the Australian and UK C. fetus cultures (n=21) using the 15 new PCR assays designed from C. fetus subsp. venerealis unique 
draft contigs annotated to putative known virulence factors or PAI genes compared to previously obtained biochemical phenotypic results. 
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Biochemical phenotypes  
(Chapter 5, Table 13) 
D8147/2 + + + + + + + + + + + + - - + C. fetus subsp. venerealis 
‡EQC0017 - + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. venerealis 
F591/1 + + + + + - + - + + - - - - - C. fetus subsp. fetus 
J4494/6B + + + + + + + + + - - - + + - C. fetus subsp. venerealis 
Q492 + + + + + + + + + + + + - - - C. fetus subsp. venerealis 
‡A8 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. venerealis 
†75838 + + + + + + + + - - - + + + + C. fetus subsp. venerealis bv. venerealis 
†76223 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. intermedius 
87-29394 + + - + - - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
‡09-125181/3 + + + + + + + + - - - - + + - C. fetus subsp. venerealis bv. venerealis 
*‡Becks - - - - - - - - - - - - - - - C. fetus subsp. venerealis bv. intermedius 
‡K8 + + + + + + + + - - - - + + + C. fetus subsp. venerealis bv. intermedius 
BT08/04 + + - + + + - - + + + + - - - C. fetus subsp. fetus 
BT23/02 + + - + + - - - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
BT47/00 - + + + + - - - - - - - - - - C. fetus subsp. venerealis bv. intermedius 
BT54/00 - + - + + + - - - - - - - - - C. fetus subsp. fetus 
 254 
 
Isolate T
ra
n
sp
o
sa
se
 o
rf
B
 
ab
5
1
_
co
n
ti
g
8
2
_
1
 
T
ra
n
sp
o
sa
se
 o
rf
B
 
ab
5
1
_
co
n
ti
g
8
2
_
2
 
F
ic
 p
ro
te
in
  
ab
5
1
_
co
n
ti
g
1
3
0
_
4
6
-8
6
4
5
_
1
 
F
ic
 p
ro
te
in
  
ab
5
1
_
co
n
ti
g
1
3
0
_
4
6
-8
6
4
5
_
2
 
B
ac
te
ri
o
p
h
ag
e 
co
n
ju
g
at
iv
e 
D
N
A
 t
ra
n
sf
er
 p
ro
te
in
 B
 
ab
5
1
_
co
n
ti
g
1
6
1
_
2
5
8
0
-2
9
0
4
 
P
ro
p
h
ag
e 
M
u
 p
ro
te
in
 
ab
5
1
_
co
n
ti
g
1
9
8
_
7
7
2
-9
3
9
 
S
u
rf
ac
e 
ar
ra
y
 p
ro
te
in
  
cf
v
v
_
1
9
.2
6
2
3
-3
7
4
2
.5
3
7
-1
0
7
1
 
P
h
ag
e 
p
o
rt
al
/p
ro
p
h
ag
e 
M
u
 p
ro
te
in
s 
cf
v
v
_
2
6
.1
3
9
6
8
.2
5
9
5
-3
3
2
1
 
A
d
h
es
in
/i
n
v
as
in
 
ab
5
1
_
co
n
ti
g
2
0
7
_
1
 
P
la
sm
id
 p
V
ir
 
ab
5
1
_
co
n
ti
g
2
0
7
_
2
 
T
y
p
e 
IV
 s
ec
re
ti
o
n
 s
y
st
em
 
p
ro
te
in
 V
ir
D
4
 
ab
5
1
_
co
n
ti
g
2
0
7
_
3
 
H
y
p
o
th
et
ic
al
/p
la
sm
id
 p
V
ir
 
 p
ro
te
in
 a
b
5
1
_
co
n
ti
g
2
0
7
_
4
 
F
ic
 f
am
il
y
 p
ro
te
in
 
ab
5
1
_
co
n
ti
g
7
6
 
H
y
p
o
th
et
ic
al
/ 
o
u
te
r 
m
em
b
ra
n
e 
p
ro
te
in
 H
o
rA
 
ab
5
1
_
co
n
ti
g
3
4
1
 
P
-t
y
p
e 
co
n
ju
g
at
iv
e 
tr
an
sf
er
 
p
ro
te
in
 T
rb
L
 a
b
5
1
_
co
n
ti
g
4
2
9
 
Biochemical phenotypes  
(Chapter 5, Table 13) 
†BT102/00 - + + + + + - - - - + - - - - C. fetus subsp. venerealis bv. venerealis 
BT194/02 - + - + + - - - - + + + - - - C. fetus subsp. venerealis bv. intermedius 
BT268/06 - + - - + + - - - - - - - - - C. fetus subsp. fetus 
BT277/06 - + - - + + - - - - - - - - - C. fetus subsp. fetus 
BT376/03 - + - - + + + - - - - - - - - C. fetus subsp. venerealis bv. venerealis 
†Isolates from bovine aborted foetuses. 
‡Isolates from cattle from herds with a history of subfertility.  
*Only one C. fetus subsp. venerealis biovar intermedius isolate was negative on all 15 new PCR assays (Becks). 
C. fetus subsp. fetus isolates positive on some of the new PCR assays.
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Figure I. Gel picture obtained following amplification of reference cultures using new putative 
tranposase orfB (ab51_contig82_1 and ab51_contig_2) pathogenicity island conventional PCR 
assays.  
 
PCR products of 194 bp (top row) and 244 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from the other Campylobacter reference strains (5-ATCC15926; 6-
ATCC25936; 7-ATCC33559; 8-ATCC35217; 9-ATCC33560; 10-ATCC35221; 11-ATCC43954) 
or with no template control (12-water). 
 
Figure J. Gel picture obtained following amplification of reference cultures using new putative fic 
protein (ab51_contig130_46-8645_1 and ab51_contig130_46-8645_2) pathogenicity island 
conventional PCR assays.  
 
PCR products of 244 bp (top row) and 179 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from the other Campylobacter reference strains (5-ATCC15926; 6-
ATCC25936; 7-ATCC33559; 8-ATCC35217; 9-ATCC33560; 10-ATCC35221; 11-ATCC43954) 
or with no template control (12-water). 
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Figure K. Gel picture obtained following amplification of reference cultures using new putative 
bacteriophage DNA transposition protein B (ab51_contig161_2580-2904) and prophage Mu protein 
(ab51_contig198_772-939) conventional PCR assays.  
 
 
PCR products of 153 bp (top row) and 150 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from the other Campylobacter reference strains (5-ATCC15926; 6-
ATCC25936; 7-ATCC33559; 8-ATCC35217; 9-ATCC33560; 10-ATCC35221; 11-ATCC43954) 
or with no template control (12-water). 
Figure L. Gel picture obtained following amplification of reference cultures using new surface array 
protein (cfvv_19.2623-3742.537-1071) and phage portal/prophage Mu proteins (cfvv_26.1-
3968.2595-3321) conventional PCR assays.  
PCR products of 226 bp (top row) and 246 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis reference strains tested (1-B6; 2-642-21; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from the other Campylobacter reference strains (5-ATCC15926; 6-
ATCC25936; 7-ATCC33559; 8-ATCC35217; 9-ATCC33560; 10-ATCC35221; 11-ATCC43954) 
or with no template control (12-water).  
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Figure M. Gel picture obtained following amplification of reference cultures using new putative 
adhesin/invasin (ab51_contig207_1) and plasmid pVir (ab51_contig207_2) conventional PCR 
assays.  
 
PCR products of 227 bp (top row) and 245 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis bv. venerealis reference strains tested (1-B6; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from C. fetus subsp. venerealis bv. intermedius (2-642-21), other 
Campylobacter reference strains (5-ATCC15926; 6-ATCC25936; 7-ATCC33559; 8-ATCC35217; 
9-ATCC33560; 10-ATCC35221; 11-ATCC43954) or with no template control (12-water). 
Figure N. Gel picture obtained following amplification of reference cultures using new putative 
type IV secretion protein VirD4 (ab51_contig207_3) and hypothetical/plasmid pVir protein 
(ab51_contig207_4) conventional PCR assays.  
PCR products of 198 bp (top row) and 151 bp (bottom row) were amplified from all C. fetus subsp. 
venerealis bv. venerealis reference strains tested (1-B6; 3-ATCC19438; 4-98-109383) while no 
amplicon was produced from C. fetus subsp. venerealis bv. intermedius (2-642-21), other 
Campylobacter reference strains (5-ATCC15926; 6-ATCC25936; 7-ATCC33559; 8-ATCC35217; 
9-ATCC33560; 10-ATCC35221; 11-ATCC43954) or with no template control (12-water). 
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Figure O. Gel picture obtained following amplification of reference cultures using new putative fic 
family protein (ab51_contig76) and P-type IV conjugative transfer protein TrbL (ab51_contig429) 
conventional PCR assays.  
 
PCR products of 175 bp (top row) and 153 bp (bottom row) were amplified from the C. fetus subsp. 
venerealis bv. intermedius reference strain tested (2-642-21) while no amplicon was produced from 
C. fetus subsp. venerealis bv. venerealis (1-B6; 3-ATCC19438; 4-98-109383), other 
Campylobacter reference strains (5-ATCC15926; 6-ATCC25936; 7-ATCC33559; 8-ATCC35217; 
9-ATCC33560; 10-ATCC35221; 11-ATCC43954) or with no template control (12-water). 
  
Figure P. Gel picture obtained following amplification of reference cultures using new putative 
hypothetical/outer membrane protein HorA (ab51_contig341) conventional PCR assays.  
 
A PCR product of 160 bp was amplified from the C. fetus subsp. venerealis bv. intermedius 
reference strain tested (2-642-21) while no amplicon was produced from C. fetus subsp. venerealis 
bv. venerealis (1-B6; 3-ATCC19438; 4-98-109383), other Campylobacter reference strains (5-
ATCC15926; 6-ATCC25936; 7-ATCC33559; 8-ATCC35217; 9-ATCC33560; 10-ATCC35221; 
11-ATCC43954) or with no template control (12-water). 
